1	Annu	NNP	PERSON	Annu	_	0	SENT_1	[p1l271t1587r294b1667],
2	.	.	O	.	_	0	SENT_1	[p1l271t1587r294b1667],

1	Rev.	NNP	O	Rev.	nn	2	SENT_2	[p1l271t1516r294b1576],
2	Med	NNP	O	Med	_	0	SENT_2	[p1l271t1437r294b1505],
3	.	.	O	.	_	0	SENT_2	[p1l271t1437r294b1505],

1	2002.53	CD	NUMBER	2002.53	num	2	SENT_3	[p1l271t1321r294b1426],
2	:6	CD	NUMBER	:6	_	0	SENT_3	[p1l271t1294r294b1316],
3	1	CD	NUMBER	1	num	4	SENT_3	[p1l271t1280r294b1289],
4	5-627	NN	O	5-627	dep	2	SENT_3	[p1l271t1192r294b1275],
5	.	.	O	.	_	0	SENT_3	[p1l271t1192r294b1275],

1	Downloaded	VBN	O	download	_	0	SENT_4	[p1l271t1013r294b1181],
2	from	IN	O	from	_	0	SENT_4	[p1l271t940r294b1004],
3	www.annualreviews.org	NN	O	www.annualreviews.org	prep_from	1	SENT_4	[p1l271t606r301b931],
4	by	IN	O	by	_	0	SENT_4	[p1l304t1600r335b1633],
5	University	NNP	ORGANIZATION	University	dep	9	SENT_4	[p1l304t1450r335b1591],
6	of	IN	ORGANIZATION	of	_	0	SENT_4	[p1l304t1411r328b1440],
7	Wisconsin	NNP	ORGANIZATION	Wisconsin	prep_of	5	SENT_4	[p1l304t1265r328b1405],
8	-	:	O	-	_	0	SENT_4	[p1l318t1246r321b1255],
9	Madison	NNP	O	Madison	prep_by	1	SENT_4	[p1l304t1120r328b1236],
10	on	IN	O	on	_	0	SENT_4	[p1l312t1079r328b1111],
11	01/05/14	CD	DATE	01/05/14	prep_on	1	SENT_4	[p1l304t947r328b1071],
12	.	.	O	.	_	0	SENT_4	[p1l304t947r328b1071],

1	For	IN	O	for	_	0	SENT_5	[p1l305t890r328b936],
2	personal	JJ	O	personal	amod	3	SENT_5	[p1l304t769r335b881],
3	use	NN	O	use	pobj	1	SENT_5	[p1l312t716r328b760],
4	only	RB	O	only	advmod	3	SENT_5	[p1l304t641r335b706],
5	.	.	O	.	_	0	SENT_5	[p1l304t641r335b706],

1	615-627	CD	NUMBER	615-627	_	0	SENT_6	[p1l279t3605r302b3722],
2	.	.	O	.	_	0	SENT_6	[p1l279t3605r302b3722],

1	Downloaded	VBN	O	download	_	0	SENT_7	[p1l279t3424r302b3594],
2	from	IN	O	from	_	0	SENT_7	[p1l279t3351r302b3415],
3	www.annualreviews.org	JJ	O	www.annualreviews.org	amod	4	SENT_7	[p1l279t3018r309b3342],
4	1sin	NN	O	1sin	prep_from	1	SENT_7	[p1l312t3678r336b3725],
5	-	:	O	-	_	0	SENT_7	[p1l326t3659r329b3668],
6	Madison	NNP	O	Madison	dep	4	SENT_7	[p1l312t3533r336b3649],
7	on	IN	O	on	_	0	SENT_7	[p1l320t3491r336b3523],
8	01/05/14	CD	DATE	01/05/14	prep_on	6	SENT_7	[p1l312t3358r336b3482],
9	.	.	O	.	_	0	SENT_7	[p1l312t3358r336b3482],

1	For	IN	O	for	_	0	SENT_8	[p1l313t3301r336b3347],
2	personal	JJ	O	personal	amod	3	SENT_8	[p1l312t3180r343b3292],
3	use	NN	O	use	pobj	1	SENT_8	[p1l320t3127r336b3171],
4	only	RB	O	only	advmod	3	SENT_8	[p1l312t3053r343b3118],
5	.	.	O	.	_	0	SENT_8	[p1l312t3053r343b3118],

1	Annu	NNP	PERSON	Annu	_	0	SENT_9	[p1l1486t81r1556b102],
2	.	.	O	.	_	0	SENT_9	[p1l1486t81r1556b102],

1	Rev.	NNP	O	Rev.	nn	2	SENT_10	[p1l1565t81r1614b102],
2	Med	NNP	O	Med	_	0	SENT_10	[p1l1624t81r1682b102],
3	.	.	O	.	_	0	SENT_10	[p1l1624t81r1682b102],

1	2002	CD	DATE	2002	_	0	SENT_11	[p1l1692t81r1755b102],
2	.	.	O	.	_	0	SENT_11	[p1l1692t81r1755b102],

1	53:6	CD	NUMBER	53:6	num	2	SENT_12	[p1l1765t81r1887b102],
2	l5	NN	O	l5	_	0	SENT_12	[p1l1765t81r1887b102],
3	—	CD	NUMBER	—	number	4	SENT_12	[p1l1765t81r1887b102],
4	27	CD	NUMBER	27	dep	2	SENT_12	[p1l1765t81r1887b102],
5	Copyright	NN	O	copyright	dep	4	SENT_12	[p1l1200t114r1317b141],
6	©	CD	NUMBER	©	num	7	SENT_12	[p1l1327t113r1355b141],
7	2002	CD	DATE	2002	dep	2	SENT_12	[p1l1366t114r1422b135],
8	by	IN	O	by	_	0	SENT_12	[p1l1430t114r1459b141],
9	Annual	JJ	SET	annual	amod	10	SENT_12	[p1l1467t114r1551b135],
10	Reviews	NNS	O	review	prep_by	7	SENT_12	[p1l1560t114r1663b135],
11	.	.	O	.	_	0	SENT_12	[p1l1560t114r1663b135],

1	All	DT	O	all	det	2	SENT_13	[p1l1673t114r1709b135],
2	rights	NNS	O	rights	nsubj	3	SENT_13	[p1l1717t114r1782b141],
3	reserved	VBD	O	reserve	_	0	SENT_13	[p1l1791t114r1888b135],

1	MECHANISMS	NNS	O	mechanism	_	0	SENT_14	[p1l445t217r841b273],
2	OF	IN	O	of	_	0	SENT_14	[p1l857t233r928b273],
3	CANCER	NNP	O	CANCER	nn	5	SENT_14	[p1l951t216r1192b273],
4	DRUG	NN	O	drug	nn	5	SENT_14	[p1l1212t217r1388b273],
5	RESISTANCE	NN	O	resistance	prep_of	1	SENT_14	[p1l1410t217r1752b273],

1	Michael	NNP	PERSON	Michael	nn	4	SENT_15	[p1l544t378r729b421],
2	M.	NNP	PERSON	M.	nn	4	SENT_15	[p1l744t382r806b421],
3	Gottesman	NNP	PERSON	Gottesman	nn	4	SENT_15	[p1l824t381r1078b421],
4	Laboratory	NNP	PERSON	Laboratory	_	0	SENT_15	[p1l543t440r713b474],
5	of	IN	O	of	_	0	SENT_15	[p1l723t440r757b474],
6	Cell	NN	O	cell	nn	7	SENT_15	[p1l763t440r823b467],
7	Biology	NNP	O	Biology	prep_of	4	SENT_15	[p1l832t440r951b474],
8	,	,	O	,	_	0	SENT_15	[p1l832t440r951b474],
9	National	NNP	ORGANIZATION	National	nn	11	SENT_15	[p1l964t440r1096b467],
10	Cancer	NNP	ORGANIZATION	Cancer	nn	11	SENT_15	[p1l1107t441r1216b467],
11	Institute	NNP	ORGANIZATION	Institute	appos	4	SENT_15	[p1l1224t441r1352b471],
12	,	,	O	,	_	0	SENT_15	[p1l1224t441r1352b471],
13	National	NNP	ORGANIZATION	National	nn	14	SENT_15	[p1l1364t440r1496b467],
14	Institutes	NNPS	ORGANIZATION	Institutes	appos	4	SENT_15	[p1l1505t441r1642b467],
15	of	IN	ORGANIZATION	of	_	0	SENT_15	[p1l1653t440r1686b474],
16	Health	NNP	ORGANIZATION	Health	prep_of	14	SENT_15	[p1l1690t440r1797b471],
17	,	,	O	,	_	0	SENT_15	[p1l1690t440r1797b471],
18	37	CD	NUMBER	37	num	20	SENT_15	[p1l544t485r582b512],
19	Convent	NNP	O	Convent	nn	20	SENT_15	[p1l592t486r714b512],
20	Drive	NNP	O	Drive	appos	4	SENT_15	[p1l722t486r812b516],
21	,	,	O	,	_	0	SENT_15	[p1l722t486r812b516],
22	Bethesda	NNP	LOCATION	Bethesda	appos	4	SENT_15	[p1l826t485r968b516],
23	,	,	O	,	_	0	SENT_15	[p1l826t485r968b516],
24	Maryland	NNP	LOCATION	Maryland	appos	4	SENT_15	[p1l981t485r1130b519],
25	20892-4255	CD	NUMBER	20892-4255	num	24	SENT_15	[p1l1139t485r1329b516],
26	;	:	O	;	_	0	SENT_15	[p1l1139t485r1329b516],
27	e-mail	VB	O	e-mail	dep	29	SENT_15	[p1l1342t485r1446b512],
28	:	:	O	:	_	0	SENT_15	[p1l1342t485r1446b512],
29	mgottesman	NN	O	mgottesman	dep	4	SENT_15	[p1l1458t490r1637b519],
30	@nih	NN	O	@nih	dep	29	SENT_15	[p1l1643t485r1726b512],
31	.	.	O	.	_	0	SENT_15	[p1l1643t485r1726b512],

1	gov	NN	O	gov	_	0	SENT_16	[p1l1730t494r1783b519],

1	Key	NN	O	key	nn	2	SENT_17	[p1l544t594r613b631],
2	Words	NNS	O	word	_	0	SENT_17	[p1l625t594r740b623],
3	cancer	NN	O	cancer	dep	2	SENT_17	[p1l779t604r889b628],
4	,	,	O	,	_	0	SENT_17	[p1l779t604r889b628],
5	multidrug	JJ	O	multidrug	amod	6	SENT_17	[p1l902t595r1056b631],
6	resistance	NN	O	resistance	appos	3	SENT_17	[p1l1067t595r1230b628],
7	,	,	O	,	_	0	SENT_17	[p1l1067t595r1230b628],
8	ABC	NNP	ORGANIZATION	ABC	nn	9	SENT_17	[p1l1242t595r1321b623],
9	transporters	NNS	O	transporter	appos	3	SENT_17	[p1l1333t599r1527b631],
10	,	,	O	,	_	0	SENT_17	[p1l1333t599r1527b631],
11	drug	NN	O	drug	nn	12	SENT_17	[p1l1539t595r1610b631],
12	transport	NN	O	transport	appos	3	SENT_17	[p1l1621t599r1769b631],
13	,	,	O	,	_	0	SENT_17	[p1l1621t599r1769b631],
14	chemotherapy	NN	O	chemotherapy	appos	3	SENT_17	[p1l563t641r784b677],

1	I	PRP	O	I	nsubj	15	SENT_18	[p1l545t710r574b739],
2	Abstract	JJ	O	abstract	amod	4	SENT_18	[p1l596t710r750b739],
3	The	DT	O	the	det	4	SENT_18	[p1l788t711r848b739],
4	design	NN	O	design	nsubj	9	SENT_18	[p1l862t711r963b747],
5	of	IN	O	of	_	0	SENT_18	[p1l977t711r1011b739],
6	cancer	NN	O	cancer	nn	7	SENT_18	[p1l1021t720r1124b739],
7	chemotherapy	NN	O	chemotherapy	prep_of	4	SENT_18	[p1l1136t711r1358b747],
8	has	VBZ	O	have	aux	9	SENT_18	[p1l1371t711r1422b739],
9	become	VBN	O	become	parataxis	15	SENT_18	[p1l1435t712r1557b739],
10	increasingly	RB	O	increasingly	advmod	11	SENT_18	[p1l1570t711r1762b747],
11	sophisticated	JJ	O	sophisticated	acomp	9	SENT_18	[p1l1776t711r1887b747, p1l544t757r656b790],
12	,	,	O	,	_	0	SENT_18	[p1l1776t711r1887b747, p1l544t757r656b790],
13	yet	RB	O	yet	advmod	15	SENT_18	[p1l672t762r719b793],
14	there	EX	O	there	expl	15	SENT_18	[p1l733t757r811b785],
15	is	VBZ	O	be	_	0	SENT_18	[p1l825t757r849b785],
16	no	DT	O	no	det	18	SENT_18	[p1l864t766r902b785],
17	cancer	NN	O	cancer	nn	18	SENT_18	[p1l917t766r1019b785],
18	treatment	NN	O	treatment	nsubj	15	SENT_18	[p1l1032t761r1181b785],
19	that	WDT	O	that	nsubj	23	SENT_18	[p1l1194t757r1253b785],
20	is	VBZ	O	be	cop	23	SENT_18	[p1l1266t757r1290b785],
21	100	CD	PERCENT	100	num	22	SENT_18	[p1l1309t757r1395b785],
22	%	NN	PERCENT	%	npadvmod	23	SENT_18	[p1l1309t757r1395b785],
23	effective	JJ	O	effective	rcmod	18	SENT_18	[p1l1411t757r1545b785],
24	against	IN	O	against	_	0	SENT_18	[p1l1560t757r1670b793],
25	disseminated	VBN	O	disseminate	amod	26	SENT_18	[p1l1684t757r1889b785],
26	cancer	NN	O	cancer	prep_against	23	SENT_18	[p1l544t812r651b831],
27	.	.	O	.	_	0	SENT_18	[p1l544t812r651b831],

1	Resistance	NN	O	resistance	nsubj	7	SENT_19	[p1l665t803r832b831],
2	to	TO	O	to	_	0	SENT_19	[p1l843t807r873b831],
3	treatment	NN	O	treatment	prep_to	1	SENT_19	[p1l884t807r1033b831],
4	with	IN	O	with	_	0	SENT_19	[p1l1043t803r1112b831],
5	anticancer	JJ	O	anticancer	amod	6	SENT_19	[p1l1124t803r1285b831],
6	drugs	NNS	O	drug	prep_with	3	SENT_19	[p1l1296t803r1381b839],
7	results	VBZ	O	result	_	0	SENT_19	[p1l1393t803r1494b831],
8	from	IN	O	from	_	0	SENT_19	[p1l1506t803r1582b831],
9	a	DT	O	a	det	10	SENT_19	[p1l1594t812r1610b831],
10	variety	NN	O	variety	prep_from	7	SENT_19	[p1l1621t803r1728b839],
11	of	IN	O	of	_	0	SENT_19	[p1l1739t803r1773b831],
12	factors	NNS	O	factor	prep_of	10	SENT_19	[p1l1782t803r1887b831],
13	including	VBG	O	include	_	0	SENT_19	[p1l544t849r691b885],
14	individual	JJ	O	individual	amod	15	SENT_19	[p1l705t849r863b877],
15	variations	NNS	O	variation	prep_including	12	SENT_19	[p1l876t849r1028b876],
16	in	IN	O	in	_	0	SENT_19	[p1l1042t849r1072b876],
17	patients	NNS	O	patient	prep_in	15	SENT_19	[p1l1084t849r1205b885],
18	and	CC	O	and	_	0	SENT_19	[p1l1220t849r1275b876],
19	somatic	JJ	O	somatic	amod	20	SENT_19	[p1l1289t849r1409b877],
20	cell	NN	O	cell	prep_in	15	SENT_19	[p1l1423t849r1478b876],
21	genetic	JJ	O	genetic	amod	22	SENT_19	[p1l1492t849r1603b885],
22	differences	NNS	O	difference	dep	15	SENT_19	[p1l1617t849r1789b876],
23	in	IN	O	in	_	0	SENT_19	[p1l1803t849r1833b876],
24	tumors	NNS	O	tumor	prep_in	22	SENT_19	[p1l1845t853r1887b876, p1l544t903r630b927],
25	,	,	O	,	_	0	SENT_19	[p1l1845t853r1887b876, p1l544t903r630b927],
26	even	RB	O	even	advmod	15	SENT_19	[p1l640t903r712b922],
27	those	DT	O	those	dep	15	SENT_19	[p1l721t895r803b922],
28	from	IN	O	from	_	0	SENT_19	[p1l812t894r888b922],
29	the	DT	O	the	det	31	SENT_19	[p1l896t895r943b922],
30	same	JJ	O	same	amod	31	SENT_19	[p1l953t903r1032b922],
31	tissue	NN	O	tissue	prep_from	27	SENT_19	[p1l1040t894r1129b922],
32	of	IN	O	of	_	0	SENT_19	[p1l1138t894r1172b922],
33	origin	NN	O	origin	prep_of	31	SENT_19	[p1l1179t894r1279b930],
34	.	.	O	.	_	0	SENT_19	[p1l1179t894r1279b930],

1	Frequently	RB	O	frequently	advmod	4	SENT_20	[p1l1290t894r1460b930],
2	resistance	NN	O	resistance	nsubj	4	SENT_20	[p1l1468t894r1623b922],
3	is	VBZ	O	be	cop	4	SENT_20	[p1l1632t894r1656b922],
4	intrinsic	JJ	O	intrinsic	_	0	SENT_20	[p1l1665t894r1793b922],
5	to	TO	O	to	_	0	SENT_20	[p1l1802t899r1832b922],
6	the	DT	O	the	det	7	SENT_20	[p1l1841t895r1888b922],
7	cancer	NN	O	cancer	prep_to	4	SENT_20	[p1l544t949r653b973],
8	,	,	O	,	_	0	SENT_20	[p1l544t949r653b973],
9	but	CC	O	but	_	0	SENT_20	[p1l665t940r715b968],
10	as	IN	O	as	mark	13	SENT_20	[p1l726t949r756b968],
11	therapy	NN	O	therapy	nsubj	13	SENT_20	[p1l769t940r885b976],
12	becomes	VBZ	O	become	cop	13	SENT_20	[p1l896t940r1033b968],
13	more	JJR	O	more	advcl	22	SENT_20	[p1l1045t949r1125b968],
14	and	CC	O	and	_	0	SENT_20	[p1l1137t940r1193b968],
15	more	RBR	O	more	advmod	16	SENT_20	[p1l1204t949r1284b968],
16	effective	JJ	O	effective	conj_and	13	SENT_20	[p1l1295t940r1438b973],
17	,	,	O	,	_	0	SENT_20	[p1l1295t940r1438b973],
18	acquired	VBN	O	acquire	amod	19	SENT_20	[p1l1452t940r1586b976],
19	resistance	NN	O	resistance	nsubj	22	SENT_20	[p1l1597t940r1751b968],
20	has	VBZ	O	have	aux	22	SENT_20	[p1l1763t940r1814b968],
21	also	RB	O	also	advmod	22	SENT_20	[p1l1827t940r1888b968],
22	become	VBN	O	become	conj_but	4	SENT_20	[p1l543t986r665b1014],
23	common	JJ	O	common	acomp	22	SENT_20	[p1l679t995r824b1014],
24	.	.	O	.	_	0	SENT_20	[p1l679t995r824b1014],

1	The	DT	O	the	det	4	SENT_21	[p1l839t986r899b1014],
2	most	RBS	O	most	advmod	3	SENT_21	[p1l913t990r990b1014],
3	common	JJ	O	common	amod	4	SENT_21	[p1l1003t995r1140b1014],
4	reason	NN	O	reason	nsubj	17	SENT_21	[p1l1153t995r1255b1014],
5	for	IN	O	for	_	0	SENT_21	[p1l1269t986r1314b1014],
6	acquisition	NN	O	acquisition	prep_for	4	SENT_21	[p1l1328t986r1499b1022],
7	of	IN	O	of	_	0	SENT_21	[p1l1513t986r1547b1014],
8	resistance	NN	O	resistance	prep_of	6	SENT_21	[p1l1557t986r1712b1014],
9	to	TO	O	to	_	0	SENT_21	[p1l1726t990r1755b1014],
10	a	DT	O	a	det	12	SENT_21	[p1l1770t995r1786b1014],
11	broad	JJ	O	broad	amod	12	SENT_21	[p1l1799t986r1888b1014],
12	range	NN	O	range	prep_to	8	SENT_21	[p1l543t1040r630b1067],
13	of	IN	O	of	_	0	SENT_21	[p1l642t1032r676b1059],
14	anticancer	JJ	O	anticancer	amod	15	SENT_21	[p1l685t1032r846b1059],
15	drugs	NNS	O	drug	prep_of	12	SENT_21	[p1l856t1032r942b1067],
16	is	VBZ	O	be	cop	17	SENT_21	[p1l954t1032r978b1059],
17	expression	NN	O	expression	_	0	SENT_21	[p1l990t1032r1157b1067],
18	of	IN	O	of	_	0	SENT_21	[p1l1168t1032r1202b1059],
19	one	CD	NUMBER	one	num	23	SENT_21	[p1l1211t1040r1266b1059],
20	or	CC	O	or	_	0	SENT_21	[p1l1278t1040r1310b1059],
21	more	JJR	O	more	num	23	SENT_21	[p1l1320t1040r1400b1059],
22	energy-dependent	JJ	O	energy-dependent	amod	23	SENT_21	[p1l1411t1032r1692b1068],
23	transporters	NNS	O	transporter	prep_of	17	SENT_21	[p1l1703t1036r1887b1067],
24	that	WDT	O	that	nsubj	27	SENT_21	[p1l544t1076r603b1104],
25	detect	VBP	O	detect	rcmod	23	SENT_21	[p1l615t1076r708b1104],
26	and	CC	O	and	_	0	SENT_21	[p1l721t1076r776b1104],
27	eject	VBP	O	eject	rcmod	23	SENT_21	[p1l789t1076r863b1112],
28	anticancer	JJ	O	anticancer	amod	29	SENT_21	[p1l875t1076r1036b1104],
29	drugs	NNS	O	drug	dobj	25	SENT_21	[p1l1048t1076r1134b1112],
30	from	IN	O	from	_	0	SENT_21	[p1l1147t1076r1223b1104],
31	cells	NNS	O	cell	prep_from	25	SENT_21	[p1l1236t1076r1315b1109],
32	,	,	O	,	_	0	SENT_21	[p1l1236t1076r1315b1109],
33	but	CC	O	but	_	0	SENT_21	[p1l1328t1076r1378b1104],
34	other	JJ	O	other	amod	35	SENT_21	[p1l1391t1076r1471b1104],
35	mechanisms	NNS	O	mechanism	nsubj	49	SENT_21	[p1l1483t1076r1676b1104],
36	of	IN	O	of	_	0	SENT_21	[p1l1689t1076r1723b1104],
37	resistance	NN	O	resistance	prep_of	35	SENT_21	[p1l1733t1076r1888b1104],
38	including	VBG	O	include	_	0	SENT_21	[p1l544t1121r692b1157],
39	insensitivity	NN	O	insensitivity	prep_including	37	SENT_21	[p1l706t1121r897b1157],
40	to	TO	O	to	_	0	SENT_21	[p1l912t1126r941b1149],
41	drug-induced	JJ	O	drug-induced	amod	42	SENT_21	[p1l956t1122r1166b1157],
42	apoptosis	NN	O	apoptosis	prep_to	39	SENT_21	[p1l1181t1122r1327b1157],
43	and	CC	O	and	_	0	SENT_21	[p1l1343t1122r1399b1149],
44	induction	NN	O	induction	prep_to	39	SENT_21	[p1l1413t1121r1561b1149],
45	of	IN	O	of	_	0	SENT_21	[p1l1576t1121r1610b1149],
46	drug-detoxifying	JJ	O	drug-detoxifying	amod	47	SENT_21	[p1l1622t1121r1888b1157],
47	mechanisms	NNS	O	mechanism	prep_of	39	SENT_21	[p1l544t1167r737b1195],
48	probably	RB	O	probably	advmod	49	SENT_21	[p1l751t1167r890b1203],
49	play	VBP	O	play	conj_but	17	SENT_21	[p1l903t1167r970b1203],
50	an	DT	O	a	det	52	SENT_21	[p1l985t1176r1020b1195],
51	important	JJ	O	important	amod	52	SENT_21	[p1l1034t1167r1187b1203],
52	role	NN	O	role	dobj	49	SENT_21	[p1l1199t1167r1260b1195],
53	in	IN	O	in	_	0	SENT_21	[p1l1273t1167r1303b1194],
54	acquired	VBN	O	acquire	amod	57	SENT_21	[p1l1317t1167r1451b1203],
55	anticancer	JJ	O	anticancer	amod	57	SENT_21	[p1l1465t1167r1626b1195],
56	drug	NN	O	drug	nn	57	SENT_21	[p1l1639t1167r1710b1203],
57	resistance	NN	O	resistance	prep_in	52	SENT_21	[p1l1723t1167r1886b1195],
58	.	.	O	.	_	0	SENT_21	[p1l1723t1167r1886b1195],

1	Studies	NNS	O	study	nsubj	9	SENT_22	[p1l545t1213r658b1241],
2	on	IN	O	on	_	0	SENT_22	[p1l671t1222r709b1240],
3	mechanisms	NNS	O	mechanism	prep_on	1	SENT_22	[p1l720t1213r913b1240],
4	of	IN	O	of	_	0	SENT_22	[p1l926t1213r960b1240],
5	cancer	NN	O	cancer	nn	7	SENT_22	[p1l968t1222r1071b1240],
6	drug	NN	O	drug	nn	7	SENT_22	[p1l1082t1213r1152b1249],
7	resistance	NN	O	resistance	prep_of	3	SENT_22	[p1l1163t1213r1318b1240],
8	have	VBP	O	have	aux	9	SENT_22	[p1l1329t1213r1401b1241],
9	yielded	VBN	O	yield	_	0	SENT_22	[p1l1413t1213r1528b1249],
10	important	JJ	O	important	amod	11	SENT_22	[p1l1539t1213r1692b1249],
11	information	NN	O	information	dobj	9	SENT_22	[p1l1703t1213r1888b1240],
12	about	IN	O	about	_	0	SENT_22	[p1l545t1258r631b1286],
13	how	WRB	O	how	advmod	15	SENT_22	[p1l645t1259r711b1286],
14	to	TO	O	to	aux	15	SENT_22	[p1l726t1263r756b1286],
15	circumvent	VB	O	circumvent	prepc_about	9	SENT_22	[p1l771t1258r947b1286],
16	this	DT	O	this	det	17	SENT_22	[p1l962t1258r1017b1286],
17	resistance	NN	O	resistance	dobj	15	SENT_22	[p1l1032t1258r1187b1286],
18	to	TO	O	to	aux	19	SENT_22	[p1l1202t1263r1232b1286],
19	improve	VB	O	improve	infmod	17	SENT_22	[p1l1247t1258r1376b1294],
20	cancer	NN	O	cancer	nn	21	SENT_22	[p1l1391t1267r1494b1286],
21	chemotherapy	NN	O	chemotherapy	dobj	19	SENT_22	[p1l1508t1258r1730b1294],
22	and	CC	O	and	_	0	SENT_22	[p1l1746t1259r1801b1286],
23	have	VBP	O	have	conj_and	9	SENT_22	[p1l1816t1259r1888b1286],
24	implications	NNS	O	implication	dobj	23	SENT_22	[p1l544t1304r737b1340],
25	for	IN	O	for	_	0	SENT_22	[p1l749t1304r794b1332],
26	pharmacokinetics	NNS	O	pharmacokinetic	prep_for	24	SENT_22	[p1l804t1304r1081b1340],
27	of	IN	O	of	_	0	SENT_22	[p1l1093t1304r1127b1332],
28	many	JJ	O	many	amod	31	SENT_22	[p1l1135t1313r1221b1340],
29	commonly	RB	O	commonly	advmod	30	SENT_22	[p1l1233t1304r1400b1340],
30	used	VBN	O	use	amod	31	SENT_22	[p1l1411t1304r1482b1332],
31	drugs	NNS	O	drug	prep_of	26	SENT_22	[p1l1493t1304r1588b1340],
32	.	.	O	.	_	0	SENT_22	[p1l1493t1304r1588b1340],

1	INTRODUCTION	NN	O	introduction	_	0	SENT_23	[p1l445t1424r824b1459],

1	The	DT	O	the	det	2	SENT_24	[p1l544t1531r607b1560],
2	treatment	NN	O	treatment	nsubjpass	9	SENT_24	[p1l616t1535r773b1560],
3	of	IN	O	of	_	0	SENT_24	[p1l782t1531r817b1560],
4	disseminated	VBN	O	disseminate	amod	5	SENT_24	[p1l824t1531r1040b1560],
5	cancer	NN	O	cancer	prep_of	2	SENT_24	[p1l1049t1540r1156b1560],
6	has	VBZ	O	have	aux	9	SENT_24	[p1l1164t1531r1218b1560],
7	become	VBN	O	become	auxpass	9	SENT_24	[p1l1227t1531r1356b1560],
8	increasingly	RB	O	increasingly	advmod	9	SENT_24	[p1l1365t1531r1566b1568],
9	aimed	VBN	O	aim	_	0	SENT_24	[p1l1577t1531r1676b1560],
10	at	IN	O	at	_	0	SENT_24	[p1l1686t1535r1715b1560],
11	molecular	JJ	O	molecular	amod	12	SENT_24	[p1l1723t1531r1889b1560],
12	targets	NNS	O	target	prep_at	9	SENT_24	[p1l544t1585r652b1618],
13	derived	VBN	O	derive	partmod	12	SENT_24	[p1l664t1580r786b1610],
14	from	IN	O	from	_	0	SENT_24	[p1l797t1580r877b1610],
15	studies	NNS	O	study	prep_from	13	SENT_24	[p1l889t1580r1001b1610],
16	of	IN	O	of	_	0	SENT_24	[p1l1013t1580r1049b1610],
17	the	DT	O	the	det	18	SENT_24	[p1l1057t1581r1107b1610],
18	oncogenes	NNS	O	oncogene	prep_of	15	SENT_24	[p1l1118t1590r1291b1618],
19	and	CC	O	and	_	0	SENT_24	[p1l1304t1581r1362b1610],
20	tumor	NN	O	tumor	nn	21	SENT_24	[p1l1373t1585r1472b1610],
21	suppressors	NNS	O	suppressor	nsubj	32	SENT_24	[p1l1483t1590r1674b1618],
22	known	VBN	O	know	partmod	21	SENT_24	[p1l1685t1581r1797b1610],
23	to	TO	O	to	aux	25	SENT_24	[p1l1808t1585r1838b1610],
24	be	VB	O	be	auxpass	25	SENT_24	[p1l1849t1580r1888b1610],
25	involved	VBN	O	involve	xcomp	22	SENT_24	[p1l544t1630r686b1659],
26	in	IN	O	in	_	0	SENT_24	[p1l701t1630r732b1659],
27	the	DT	O	the	det	28	SENT_24	[p1l748t1630r798b1659],
28	development	NN	O	development	prep_in	25	SENT_24	[p1l814t1630r1026b1668],
29	of	IN	O	of	_	0	SENT_24	[p1l1042t1630r1078b1659],
30	human	JJ	O	human	amod	31	SENT_24	[p1l1091t1630r1203b1659],
31	cancers	NNS	O	cancer	prep_of	28	SENT_24	[p1l1219t1640r1341b1659],
32	(	VBP	O	(	conj_and	9	SENT_24	[p1l1359t1631r1414b1666],
33	1	CD	NUMBER	1	number	34	SENT_24	[p1l1359t1631r1414b1666],
34	)	CD	NUMBER	)	dobj	32	SENT_24	[p1l1359t1631r1414b1666],
35	.	.	O	.	_	0	SENT_24	[p1l1359t1631r1414b1666],

1	This	DT	O	this	dep	117	SENT_25	[p1l1432t1630r1504b1659],
2	increase	NN	O	increase	dep	117	SENT_25	[p1l1520t1630r1655b1659],
3	in	IN	O	in	dep	117	SENT_25	[p1l1671t1630r1703b1659],
4	speciﬁcity	NN	O	speciﬁcity	dep	117	SENT_25	[p1l1720t1630r1888b1668],
5	of	IN	O	of	dep	117	SENT_25	[p1l544t1679r580b1708],
6	cancer	NN	O	cancer	dep	117	SENT_25	[p1l594t1688r702b1708],
7	treatment	NN	O	treatment	dep	117	SENT_25	[p1l717t1684r882b1713],
8	,	,	O	,	_	0	SENT_25	[p1l717t1684r882b1713],
9	from	IN	O	from	dep	117	SENT_25	[p1l900t1679r980b1708],
10	the	DT	O	the	dep	117	SENT_25	[p1l996t1679r1045b1708],
11	use	NN	O	use	dep	117	SENT_25	[p1l1061t1688r1115b1708],
12	of	IN	O	of	dep	117	SENT_25	[p1l1132t1679r1168b1708],
13	general	JJ	O	general	dep	117	SENT_25	[p1l1182t1679r1303b1717],
14	cytotoxic	JJ	O	cytotoxic	dep	117	SENT_25	[p1l1319t1679r1471b1717],
15	agents	NNS	O	agent	dep	117	SENT_25	[p1l1489t1684r1592b1717],
16	such	JJ	O	such	dep	117	SENT_25	[p1l1611t1679r1685b1708],
17	as	IN	O	as	dep	117	SENT_25	[p1l1702t1688r1733b1708],
18	nitrogen	NN	O	nitrogen	dep	117	SENT_25	[p1l1750t1679r1888b1717],
19	mustard	NN	O	mustard	dep	117	SENT_25	[p1l544t1728r677b1758],
20	in	IN	O	in	dep	117	SENT_25	[p1l690t1728r722b1757],
21	the	DT	DATE	the	dep	117	SENT_25	[p1l735t1728r784b1758],
22	1940s	CD	DATE	1940s	dep	117	SENT_25	[p1l802t1728r905b1763],
23	,	,	O	,	_	0	SENT_25	[p1l802t1728r905b1763],
24	to	TO	O	to	dep	117	SENT_25	[p1l920t1732r951b1758],
25	the	DT	O	the	dep	117	SENT_25	[p1l965t1728r1014b1758],
26	development	NN	O	development	dep	117	SENT_25	[p1l1029t1728r1241b1766],
27	of	IN	O	of	dep	117	SENT_25	[p1l1254t1728r1290b1758],
28	natural	JJ	O	natural	dep	117	SENT_25	[p1l1300t1728r1556b1766],
29	—	NN	O	—	dep	117	SENT_25	[p1l1300t1728r1556b1766],
30	product	NN	O	product	dep	117	SENT_25	[p1l1300t1728r1556b1766],
31	anticancer	JJ	O	anticancer	dep	117	SENT_25	[p1l1570t1728r1739b1758],
32	drugs	NNS	O	drug	dep	117	SENT_25	[p1l1752t1728r1842b1766],
33	in	IN	O	in	dep	117	SENT_25	[p1l1857t1728r1888b1757],
34	the	DT	DATE	the	dep	117	SENT_25	[p1l544t1778r593b1807],
35	1960s	NNS	DATE	1960	dep	117	SENT_25	[p1l611t1778r705b1808],
36	such	JJ	O	such	dep	117	SENT_25	[p1l721t1778r794b1807],
37	as	IN	O	as	dep	117	SENT_25	[p1l809t1787r841b1807],
38	Vinca	NN	O	vinca	dep	117	SENT_25	[p1l858t1779r948b1808],
39	alkaloids	NNS	O	alkaloid	dep	117	SENT_25	[p1l963t1778r1110b1807],
40	and	CC	O	and	dep	117	SENT_25	[p1l1125t1778r1184b1807],
41	anthracyclines	NNS	O	anthracycline	dep	117	SENT_25	[p1l1198t1778r1444b1816],
42	,	,	O	,	_	0	SENT_25	[p1l1198t1778r1444b1816],
43	which	WDT	O	which	dep	117	SENT_25	[p1l1460t1778r1560b1807],
44	are	VBP	O	be	dep	117	SENT_25	[p1l1574t1787r1623b1807],
45	more	RBR	O	more	dep	117	SENT_25	[p1l1637t1787r1721b1807],
46	cytotoxic	JJ	O	cytotoxic	dep	117	SENT_25	[p1l1735t1778r1887b1816],
47	to	TO	O	to	dep	117	SENT_25	[p1l544t1832r575b1857],
48	cancer	NN	O	cancer	dep	117	SENT_25	[p1l587t1836r695b1857],
49	cells	NNS	O	cell	dep	117	SENT_25	[p1l706t1827r780b1857],
50	than	IN	O	than	dep	117	SENT_25	[p1l793t1827r863b1857],
51	normal	JJ	O	normal	dep	117	SENT_25	[p1l875t1827r991b1857],
52	cells	NNS	O	cell	dep	117	SENT_25	[p1l1003t1827r1087b1862],
53	,	,	O	,	_	0	SENT_25	[p1l1003t1827r1087b1862],
54	to	TO	O	to	dep	117	SENT_25	[p1l1100t1832r1130b1857],
55	the	DT	O	the	dep	117	SENT_25	[p1l1143t1827r1192b1857],
56	use	NN	O	use	dep	117	SENT_25	[p1l1204t1836r1258b1857],
57	of	IN	O	of	dep	117	SENT_25	[p1l1270t1827r1306b1857],
58	speciﬁc	JJ	O	speciﬁc	dep	117	SENT_25	[p1l1317t1827r1440b1865],
59	monoclonal	JJ	O	monoclonal	dep	117	SENT_25	[p1l1452t1827r1647b1857],
60	antibodies	NNS	O	antibody	dep	117	SENT_25	[p1l1660t1827r1828b1857],
61	(	VBP	O	(	dep	117	SENT_25	[p1l1842t1827r1887b1863],
62	2	CD	NUMBER	2	dep	117	SENT_25	[p1l1842t1827r1887b1863],
63	)	CD	NUMBER	)	dep	117	SENT_25	[p1l1842t1827r1887b1863],
64	and	CC	O	and	dep	117	SENT_25	[p1l545t1877r603b1906],
65	immunotoxins	NNS	O	immunotoxin	dep	117	SENT_25	[p1l617t1877r855b1906],
66	(	CD	NUMBER	(	dep	117	SENT_25	[p1l871t1877r916b1913],
67	3	CD	NUMBER	3	dep	117	SENT_25	[p1l871t1877r916b1913],
68	)	NN	O	)	dep	117	SENT_25	[p1l871t1877r916b1913],
69	targeted	VBN	O	target	dep	117	SENT_25	[p1l932t1877r1064b1915],
70	to	TO	O	to	dep	117	SENT_25	[p1l1078t1881r1108b1906],
71	cell	NN	O	cell	dep	117	SENT_25	[p1l1124t1877r1182b1906],
72	surface	NN	O	surface	dep	117	SENT_25	[p1l1198t1877r1315b1906],
73	receptors	NNS	O	receptor	dep	117	SENT_25	[p1l1329t1881r1479b1915],
74	and	CC	O	and	dep	117	SENT_25	[p1l1495t1877r1554b1906],
75	speciﬁc	JJ	O	speciﬁc	dep	117	SENT_25	[p1l1569t1877r1692b1915],
76	agents	NNS	O	agent	dep	117	SENT_25	[p1l1708t1881r1811b1915],
77	that	WDT	O	that	dep	117	SENT_25	[p1l1827t1877r1888b1906],
78	inactivate	VBP	O	inactivate	dep	117	SENT_25	[p1l544t1926r702b1955],
79	kinases	NNS	O	kinase	dep	117	SENT_25	[p1l714t1926r835b1955],
80	in	IN	O	in	dep	117	SENT_25	[p1l848t1926r880b1955],
81	growth	NN	O	growth	dep	117	SENT_25	[p1l893t1926r1194b1964],
82	—	CD	NUMBER	—	dep	117	SENT_25	[p1l893t1926r1194b1964],
83	promoting	VBG	O	promote	dep	117	SENT_25	[p1l893t1926r1194b1964],
84	pathways	NNS	O	pathway	dep	117	SENT_25	[p1l1207t1926r1362b1964],
85	(	CD	NUMBER	(	dep	117	SENT_25	[p1l1376t1926r1431b1962],
86	4	CD	NUMBER	4	dep	117	SENT_25	[p1l1376t1926r1431b1962],
87	)	NN	O	)	dep	117	SENT_25	[p1l1376t1926r1431b1962],
88	,	,	O	,	_	0	SENT_25	[p1l1376t1926r1431b1962],
89	has	VBZ	O	have	dep	117	SENT_25	[p1l1445t1926r1499b1955],
90	improved	VBN	O	improve	dep	117	SENT_25	[p1l1512t1926r1670b1964],
91	the	DT	O	the	dep	117	SENT_25	[p1l1682t1926r1731b1955],
92	response	NN	O	response	dep	117	SENT_25	[p1l1743t1935r1888b1964],
93	rate	NN	O	rate	dep	117	SENT_25	[p1l543t1980r605b2005],
94	in	IN	O	in	dep	117	SENT_25	[p1l622t1975r653b2004],
95	cancer	NN	O	cancer	dep	117	SENT_25	[p1l670t1984r777b2005],
96	and	CC	O	and	dep	117	SENT_25	[p1l794t1975r852b2005],
97	reduced	VBD	O	reduce	dep	117	SENT_25	[p1l868t1975r999b2005],
98	side	JJ	O	side	dep	117	SENT_25	[p1l1017t1975r1081b2005],
99	effects	NNS	O	effect	dep	117	SENT_25	[p1l1098t1975r1205b2005],
100	of	IN	O	of	dep	117	SENT_25	[p1l1224t1975r1259b2004],
101	anticancer	JJ	O	anticancer	dep	117	SENT_25	[p1l1274t1975r1443b2005],
102	treatment	NN	O	treatment	dep	117	SENT_25	[p1l1459t1979r1615b2005],
103	but	CC	O	but	dep	117	SENT_25	[p1l1631t1975r1683b2005],
104	has	VBZ	O	have	dep	117	SENT_25	[p1l1699t1975r1752b2005],
105	not	RB	O	not	dep	117	SENT_25	[p1l1770t1980r1823b2005],
106	yet	RB	O	yet	dep	117	SENT_25	[p1l1838t1980r1889b2013],
107	resulted	VBD	O	result	dep	117	SENT_25	[p1l543t2025r675b2054],
108	in	IN	O	in	dep	117	SENT_25	[p1l685t2025r717b2054],
109	cure	NN	O	cure	dep	117	SENT_25	[p1l728t2034r798b2054],
110	of	IN	O	of	dep	117	SENT_25	[p1l810t2025r846b2054],
111	the	DT	O	the	dep	117	SENT_25	[p1l854t2025r904b2054],
112	majority	NN	O	majority	dep	117	SENT_25	[p1l915t2025r1054b2063],
113	of	IN	O	of	dep	117	SENT_25	[p1l1067t2025r1102b2054],
114	patients	NNS	O	patient	dep	117	SENT_25	[p1l1110t2025r1238b2063],
115	with	IN	O	with	dep	117	SENT_25	[p1l1251t2025r1323b2054],
116	metastatic	JJ	O	metastatic	dep	117	SENT_25	[p1l1334t2025r1501b2054],
117	disease	NN	O	disease	_	0	SENT_25	[p1l1513t2025r1640b2054],
118	.	.	O	.	_	0	SENT_25	[p1l1513t2025r1640b2054],

1	A	DT	O	a	det	2	SENT_26	[p1l1653t2025r1682b2054],
2	study	NN	O	study	nsubj	12	SENT_26	[p1l1695t2025r1782b2063],
3	of	IN	O	of	_	0	SENT_26	[p1l1794t2025r1830b2054],
4	the	DT	O	the	det	5	SENT_26	[p1l1838t2025r1888b2054],
5	mechanisms	NNS	O	mechanism	prep_of	2	SENT_26	[p1l544t2074r747b2103],
6	by	IN	O	by	_	0	SENT_26	[p1l757t2074r797b2112],
7	which	WDT	O	which	rel	9	SENT_26	[p1l807t2074r907b2103],
8	cancers	NNS	O	cancer	nsubj	9	SENT_26	[p1l917t2083r1039b2103],
9	elude	VBP	O	elude	rcmod	5	SENT_26	[p1l1049t2074r1137b2103],
10	treatment	NN	O	treatment	dobj	9	SENT_26	[p1l1147t2079r1303b2103],
11	has	VBZ	O	have	aux	12	SENT_26	[p1l1311t2074r1365b2103],
12	yielded	VBN	O	yield	_	0	SENT_26	[p1l1375t2074r1496b2112],
13	a	DT	O	a	det	14	SENT_26	[p1l1506t2083r1523b2103],
14	wealth	NN	O	wealth	dobj	12	SENT_26	[p1l1532t2074r1641b2103],
15	of	IN	O	of	_	0	SENT_26	[p1l1651t2074r1687b2103],
16	information	NN	O	information	prep_of	14	SENT_26	[p1l1693t2074r1888b2103],
17	about	IN	O	about	_	0	SENT_26	[p1l545t2123r636b2153],
18	why	WRB	O	why	advmod	21	SENT_26	[p1l644t2123r714b2161],
19	these	DT	O	these	det	20	SENT_26	[p1l724t2123r808b2153],
20	therapies	NNS	O	therapy	nsubj	24	SENT_26	[p1l817t2123r965b2161],
21	fail	VBP	O	fail	prepc_about	12	SENT_26	[p1l975t2123r1028b2153],
22	and	CC	O	and	_	0	SENT_26	[p1l1038t2123r1097b2153],
23	is	VBZ	O	be	aux	24	SENT_26	[p1l1105t2123r1131b2153],
24	beginning	VBG	O	begin	conj_and	21	SENT_26	[p1l1140t2123r1305b2161],
25	to	TO	O	to	aux	26	SENT_26	[p1l1314t2128r1345b2153],
26	yield	VB	O	yield	xcomp	24	SENT_26	[p1l1354t2123r1437b2161],
27	valuable	JJ	O	valuable	amod	28	SENT_26	[p1l1446t2123r1584b2153],
28	information	NN	O	information	dobj	26	SENT_26	[p1l1593t2123r1788b2153],
29	about	IN	O	about	_	0	SENT_26	[p1l1798t2123r1889b2153],
30	how	WRB	O	how	advmod	32	SENT_26	[p1l544t2173r613b2202],
31	to	TO	O	to	aux	32	SENT_26	[p1l623t2177r654b2202],
32	circumvent	VB	O	circumvent	prepc_about	26	SENT_26	[p1l664t2173r850b2202],
33	drug	NN	O	drug	nn	34	SENT_26	[p1l859t2173r934b2211],
34	resistance	NN	O	resistance	dobj	32	SENT_26	[p1l943t2173r1106b2202],
35	in	IN	O	in	_	0	SENT_26	[p1l1116t2173r1148b2202],
36	cancer	NN	O	cancer	nn	37	SENT_26	[p1l1158t2182r1265b2202],
37	cells	NNS	O	cell	prep_in	32	SENT_26	[p1l1275t2173r1348b2202],
38	and/or	JJ	O	and/or	amod	40	SENT_26	[p1l1360t2173r1465b2203],
39	design	NN	O	design	nn	40	SENT_26	[p1l1474t2173r1581b2211],
40	agents	NNS	O	agent	dobj	21	SENT_26	[p1l1592t2178r1695b2211],
41	that	WDT	O	that	nsubj	44	SENT_26	[p1l1706t2173r1767b2202],
42	are	VBP	O	be	cop	44	SENT_26	[p1l1778t2182r1826b2202],
43	not	RB	O	not	neg	44	SENT_26	[p1l1836t2177r1889b2202],
44	subject	JJ	O	subject	rcmod	40	SENT_26	[p1l545t2222r661b2260],
45	to	TO	O	to	_	0	SENT_26	[p1l672t2227r703b2252],
46	the	DT	O	the	det	48	SENT_26	[p1l715t2222r764b2252],
47	usual	JJ	O	usual	amod	48	SENT_26	[p1l775t2222r862b2252],
48	means	NNS	O	means	prep_to	44	SENT_26	[p1l874t2231r978b2252],
49	of	IN	O	of	_	0	SENT_26	[p1l991t2222r1026b2252],
50	resistance	NN	O	resistance	prep_of	48	SENT_26	[p1l1035t2222r1206b2252],
51	.	.	O	.	_	0	SENT_26	[p1l1035t2222r1206b2252],

1	0066-4219/02	CD	DURATION	0066-4219/02	_	0	SENT_27	[p1l444t2298r928b2329],
2	/	:	O	/	punct	3	SENT_27	[p1l444t2298r928b2329],
3	0218-06l5	CD	NUMBER	0218-06l5	dep	1	SENT_27	[p1l444t2298r928b2329],
4	$	$	MONEY	$	dep	3	SENT_27	[p1l444t2298r928b2329],
5	l4	CD	MONEY	l4	num	4	SENT_27	[p1l444t2298r928b2329],
6	.00	CD	MONEY	.00	num	4	SENT_27	[p1l444t2298r928b2329],
7	615	CD	MONEY	615	number	8	SENT_27	[p1l1827t2297r1887b2327],
8	616	CD	MONEY	616	dep	4	SENT_27	[p1l433t2356r494b2386],
9	GOTTESMAN	NNP	O	GOTTESMAN	dep	1	SENT_27	[p1l583t2359r810b2386],

1	HOW	NNP	O	HOW	nn	4	SENT_28	[p1l433t2482r554b2516],
2	DO	NNP	O	DO	nn	4	SENT_28	[p1l566t2482r638b2516],
3	CANCER	NNP	O	CANCER	nn	4	SENT_28	[p1l652t2482r846b2516],
4	CELLS	NNS	O	cell	nsubj	5	SENT_28	[p1l858t2482r993b2516],
5	ELUDE	VBP	O	elude	_	0	SENT_28	[p1l1007t2482r1159b2516],
6	CHEMOTHERAPY	NN	O	chemotherapy	dobj	5	SENT_28	[p1l1172t2481r1585b2516],
7	?	.	O	?	_	0	SENT_28	[p1l1172t2481r1585b2516],

1	Failure	NN	O	failure	nsubj	14	SENT_29	[p1l532t2586r648b2616],
2	of	IN	O	of	_	0	SENT_29	[p1l662t2586r698b2616],
3	a	DT	O	a	det	4	SENT_29	[p1l709t2595r726b2616],
4	patient	NN	O	patient	poss	6	SENT_29	[p1l738t2586r878b2624],
5	’s	POS	O	’s	_	0	SENT_29	[p1l738t2586r878b2624],
6	cancer	NN	O	cancer	prep_of	1	SENT_29	[p1l892t2595r1000b2616],
7	to	TO	O	to	aux	8	SENT_29	[p1l1013t2591r1043b2616],
8	respond	VB	O	respond	infmod	6	SENT_29	[p1l1056t2586r1188b2624],
9	to	TO	O	to	_	0	SENT_29	[p1l1201t2591r1231b2616],
10	a	DT	O	a	det	12	SENT_29	[p1l1246t2595r1263b2616],
11	speciﬁc	NN	O	speciﬁc	nn	12	SENT_29	[p1l1277t2586r1401b2624],
12	therapy	NN	O	therapy	prep_to	8	SENT_29	[p1l1415t2586r1538b2624],
13	can	MD	O	can	aux	14	SENT_29	[p1l1551t2595r1608b2616],
14	result	VB	O	result	_	0	SENT_29	[p1l1620t2586r1713b2616],
15	from	IN	O	from	_	0	SENT_29	[p1l1725t2586r1806b2616],
16	one	CD	TIME	one	prep_from	14	SENT_29	[p1l1819t2595r1877b2616],
17	of	IN	TIME	of	_	0	SENT_29	[p1l533t2636r569b2665],
18	two	CD	TIME	two	num	20	SENT_29	[p1l580t2640r640b2665],
19	general	JJ	O	general	amod	20	SENT_29	[p1l655t2636r775b2674],
20	causes	NNS	O	cause	prep_of	16	SENT_29	[p1l790t2645r905b2665],
21	:	:	O	:	_	0	SENT_29	[p1l790t2645r905b2665],
22	host	NN	O	host	nn	23	SENT_29	[p1l922t2636r991b2665],
23	factors	NNS	O	factor	dep	16	SENT_29	[p1l1004t2636r1114b2665],
24	and	CC	O	and	_	0	SENT_29	[p1l1130t2636r1188b2665],
25	speciﬁc	JJ	O	speciﬁc	amod	26	SENT_29	[p1l1203t2636r1327b2674],
26	genetic	JJ	O	genetic	dep	16	SENT_29	[p1l1342t2636r1460b2674],
27	or	CC	O	or	_	0	SENT_29	[p1l1475t2645r1509b2665],
28	epigenetic	JJ	O	epigenetic	amod	29	SENT_29	[p1l1522t2636r1690b2674],
29	alterations	NNS	O	alteration	conj_or	26	SENT_29	[p1l1706t2636r1876b2665],
30	in	IN	O	in	_	0	SENT_29	[p1l532t2685r564b2714],
31	the	DT	O	the	det	33	SENT_29	[p1l578t2685r627b2714],
32	cancer	NN	O	cancer	nn	33	SENT_29	[p1l642t2694r749b2714],
33	cells	NNS	O	cell	prep_in	14	SENT_29	[p1l763t2685r846b2714],
34	.	.	O	.	_	0	SENT_29	[p1l763t2685r846b2714],

1	Host	NN	O	host	dep	179	SENT_30	[p1l862t2686r940b2714],
2	factors	NNS	O	factor	dep	179	SENT_30	[p1l953t2685r1064b2714],
3	include	VBP	O	include	dep	179	SENT_30	[p1l1078t2685r1200b2714],
4	poor	JJ	O	poor	dep	179	SENT_30	[p1l1213t2694r1290b2723],
5	absorption	NN	O	absorption	dep	179	SENT_30	[p1l1304t2685r1477b2723],
6	or	CC	O	or	dep	179	SENT_30	[p1l1491t2694r1525b2714],
7	rapid	JJ	O	rapid	dep	179	SENT_30	[p1l1538t2685r1623b2723],
8	metabolism	NN	O	metabolism	dep	179	SENT_30	[p1l1636t2685r1830b2714],
9	or	CC	O	or	dep	179	SENT_30	[p1l1844t2694r1878b2714],
10	excretion	NN	O	excretion	dep	179	SENT_30	[p1l533t2734r685b2763],
11	of	IN	O	of	dep	179	SENT_30	[p1l702t2734r738b2763],
12	a	DT	O	a	dep	179	SENT_30	[p1l753t2743r770b2763],
13	drug	NN	O	drug	dep	179	SENT_30	[p1l786t2734r869b2772],
14	,	,	O	,	_	0	SENT_30	[p1l786t2734r869b2772],
15	resulting	VBG	O	result	dep	179	SENT_30	[p1l887t2734r1031b2772],
16	in	IN	O	in	dep	179	SENT_30	[p1l1048t2734r1080b2763],
17	low	JJ	O	low	dep	179	SENT_30	[p1l1096t2734r1156b2763],
18	serum	NN	O	serum	dep	179	SENT_30	[p1l1174t2743r1274b2763],
19	levels	NNS	O	level	dep	179	SENT_30	[p1l1289t2734r1394b2768],
20	;	:	O	;	_	0	SENT_30	[p1l1289t2734r1394b2768],
21	poor	JJ	O	poor	dep	179	SENT_30	[p1l1411t2743r1488b2772],
22	tolerance	NN	O	tolerance	dep	179	SENT_30	[p1l1503t2734r1654b2763],
23	to	TO	O	to	dep	179	SENT_30	[p1l1671t2739r1701b2763],
24	effects	NNS	O	effect	dep	179	SENT_30	[p1l1719t2734r1826b2763],
25	of	IN	O	of	dep	179	SENT_30	[p1l1844t2734r1880b2763],
26	a	DT	O	a	dep	179	SENT_30	[p1l533t2792r550b2812],
27	drug	NN	O	drug	dep	179	SENT_30	[p1l565t2783r648b2821],
28	,	,	O	,	_	0	SENT_30	[p1l565t2783r648b2821],
29	especially	RB	O	especially	dep	179	SENT_30	[p1l665t2783r829b2821],
30	in	IN	O	in	dep	179	SENT_30	[p1l844t2783r876b2812],
31	elderly	JJ	O	elderly	dep	179	SENT_30	[p1l891t2783r1004b2821],
32	patients	NNS	O	patient	dep	179	SENT_30	[p1l1019t2783r1156b2821],
33	,	,	O	,	_	0	SENT_30	[p1l1019t2783r1156b2821],
34	resulting	VBG	O	result	dep	179	SENT_30	[p1l1172t2783r1316b2821],
35	in	IN	O	in	dep	179	SENT_30	[p1l1331t2783r1363b2812],
36	a	DT	O	a	dep	179	SENT_30	[p1l1378t2792r1395b2812],
37	need	NN	O	need	dep	179	SENT_30	[p1l1409t2783r1487b2812],
38	to	TO	O	to	dep	179	SENT_30	[p1l1501t2788r1532b2812],
39	reduce	VB	O	reduce	dep	179	SENT_30	[p1l1547t2783r1657b2812],
40	doses	NNS	O	dose	dep	179	SENT_30	[p1l1672t2783r1762b2812],
41	below	IN	O	below	dep	179	SENT_30	[p1l1777t2783r1876b2813],
42	optimal	JJ	O	optimal	dep	179	SENT_30	[p1l533t2832r658b2870],
43	levels	NNS	O	level	dep	179	SENT_30	[p1l668t2832r772b2867],
44	;	:	O	;	_	0	SENT_30	[p1l668t2832r772b2867],
45	inability	NN	O	inability	dep	179	SENT_30	[p1l783t2832r921b2870],
46	to	TO	O	to	dep	179	SENT_30	[p1l931t2837r961b2861],
47	deliver	VB	O	deliver	dep	179	SENT_30	[p1l972t2832r1085b2861],
48	a	DT	O	a	dep	179	SENT_30	[p1l1095t2841r1112b2861],
49	drug	NN	O	drug	dep	179	SENT_30	[p1l1121t2832r1196b2870],
50	to	TO	O	to	dep	179	SENT_30	[p1l1206t2837r1236b2861],
51	the	DT	O	the	dep	179	SENT_30	[p1l1247t2832r1296b2861],
52	site	NN	O	site	dep	179	SENT_30	[p1l1307t2832r1362b2861],
53	of	IN	O	of	dep	179	SENT_30	[p1l1373t2832r1409b2861],
54	a	DT	O	a	dep	179	SENT_30	[p1l1416t2841r1434b2861],
55	tumor	NN	O	tumor	dep	179	SENT_30	[p1l1443t2837r1548b2867],
56	,	,	O	,	_	0	SENT_30	[p1l1443t2837r1548b2867],
57	as	RB	O	as	dep	179	SENT_30	[p1l1560t2841r1592b2861],
58	could	MD	O	could	dep	179	SENT_30	[p1l1603t2832r1694b2861],
59	occur	VB	O	occur	dep	179	SENT_30	[p1l1704t2841r1795b2861],
60	with	IN	O	with	dep	179	SENT_30	[p1l1804t2832r1877b2861],
61	bulky	JJ	O	bulky	dep	179	SENT_30	[p1l532t2881r624b2919],
62	tumors	NNS	O	tumor	dep	179	SENT_30	[p1l638t2886r752b2911],
63	or	CC	O	or	dep	179	SENT_30	[p1l767t2890r801b2910],
64	with	IN	O	with	dep	179	SENT_30	[p1l814t2881r887b2911],
65	biological	JJ	O	biological	dep	179	SENT_30	[p1l900t2881r1065b2919],
66	agents	NNS	O	agent	dep	179	SENT_30	[p1l1080t2886r1183b2919],
67	of	IN	O	of	dep	179	SENT_30	[p1l1199t2881r1234b2911],
68	high	JJ	O	high	dep	179	SENT_30	[p1l1245t2881r1318b2919],
69	molecular	JJ	O	molecular	dep	179	SENT_30	[p1l1332t2881r1498b2911],
70	weight	NN	O	weight	dep	179	SENT_30	[p1l1511t2881r1623b2919],
71	and	CC	O	and	dep	179	SENT_30	[p1l1637t2881r1696b2911],
72	low	JJ	O	low	dep	179	SENT_30	[p1l1709t2881r1769b2911],
73	tissue	NN	O	tissue	dep	179	SENT_30	[p1l1783t2881r1877b2911],
74	penetration	NN	O	penetration	dep	179	SENT_30	[p1l532t2930r718b2968],
75	such	JJ	O	such	dep	179	SENT_30	[p1l730t2930r804b2959],
76	as	IN	O	as	dep	179	SENT_30	[p1l815t2940r847b2959],
77	monoclonal	JJ	O	monoclonal	dep	179	SENT_30	[p1l859t2930r1054b2959],
78	antibodies	NNS	O	antibody	dep	179	SENT_30	[p1l1065t2930r1233b2959],
79	and	CC	O	and	dep	179	SENT_30	[p1l1246t2930r1304b2959],
80	immunotoxins	NNS	O	immunotoxin	dep	179	SENT_30	[p1l1314t2930r1552b2959],
81	(	CD	NUMBER	(	dep	179	SENT_30	[p1l1565t2930r1621b2966],
82	5	CD	NUMBER	5	dep	179	SENT_30	[p1l1565t2930r1621b2966],
83	)	NN	O	)	dep	179	SENT_30	[p1l1565t2930r1621b2966],
84	;	:	O	;	_	0	SENT_30	[p1l1565t2930r1621b2966],
85	and	CC	O	and	dep	179	SENT_30	[p1l1635t2930r1693b2959],
86	various	JJ	O	various	dep	179	SENT_30	[p1l1703t2930r1823b2959],
87	alterations	NNS	O	alteration	dep	179	SENT_30	[p1l1835t2930r1876b2959, p1l532t2980r673b3009],
88	in	IN	O	in	dep	179	SENT_30	[p1l683t2980r715b3009],
89	the	DT	O	the	dep	179	SENT_30	[p1l723t2980r773b3009],
90	host	NN	O	host	dep	179	SENT_30	[p1l782t2980r964b3009],
91	—	NN	O	—	dep	179	SENT_30	[p1l782t2980r964b3009],
92	tumor	NN	O	tumor	dep	179	SENT_30	[p1l782t2980r964b3009],
93	environment	NN	O	environment	dep	179	SENT_30	[p1l972t2980r1180b3009],
94	that	WDT	O	that	dep	179	SENT_30	[p1l1188t2980r1250b3009],
95	affect	VBP	O	affect	dep	179	SENT_30	[p1l1259t2980r1351b3009],
96	response	NN	O	response	dep	179	SENT_30	[p1l1359t2989r1504b3018],
97	of	IN	O	of	dep	179	SENT_30	[p1l1513t2980r1549b3009],
98	the	DT	O	the	dep	179	SENT_30	[p1l1555t2980r1605b3009],
99	tumor	NN	O	tumor	dep	179	SENT_30	[p1l1614t2985r1713b3009],
100	including	VBG	O	include	dep	179	SENT_30	[p1l1721t2980r1876b3018],
101	local	JJ	O	local	dep	179	SENT_30	[p1l532t3030r612b3059],
102	metabolism	NN	O	metabolism	dep	179	SENT_30	[p1l622t3030r815b3059],
103	of	IN	O	of	dep	179	SENT_30	[p1l825t3030r861b3059],
104	a	DT	O	a	dep	179	SENT_30	[p1l868t3039r886b3059],
105	drug	NN	O	drug	dep	179	SENT_30	[p1l895t3030r969b3068],
106	by	IN	O	by	dep	179	SENT_30	[p1l979t3030r1019b3068],
107	nontumor	JJ	O	nontumor	dep	179	SENT_30	[p1l1029t3034r1191b3059],
108	cells	NNS	O	cell	dep	179	SENT_30	[p1l1200t3030r1284b3064],
109	,	,	O	,	_	0	SENT_30	[p1l1200t3030r1284b3064],
110	unusual	JJ	O	unusual	dep	179	SENT_30	[p1l1295t3030r1423b3059],
111	features	NNS	O	feature	dep	179	SENT_30	[p1l1433t3030r1562b3059],
112	of	IN	O	of	dep	179	SENT_30	[p1l1573t3030r1609b3059],
113	the	DT	O	the	dep	179	SENT_30	[p1l1616t3030r1665b3059],
114	tumor	NN	O	tumor	dep	179	SENT_30	[p1l1675t3035r1774b3059],
115	blood	NN	O	blood	dep	179	SENT_30	[p1l1783t3030r1877b3059],
116	supply	NN	O	supply	dep	179	SENT_30	[p1l534t3080r642b3118],
117	that	WDT	O	that	dep	179	SENT_30	[p1l655t3080r717b3109],
118	may	MD	O	may	dep	179	SENT_30	[p1l729t3089r799b3118],
119	affect	VB	O	affect	dep	179	SENT_30	[p1l814t3080r906b3109],
120	transit	NN	O	transit	dep	179	SENT_30	[p1l918t3080r1022b3109],
121	time	NN	O	time	dep	179	SENT_30	[p1l1034t3080r1107b3109],
122	of	IN	O	of	dep	179	SENT_30	[p1l1121t3080r1156b3109],
123	drugs	NNS	O	drug	dep	179	SENT_30	[p1l1167t3080r1257b3118],
124	within	IN	O	within	dep	179	SENT_30	[p1l1271t3080r1376b3109],
125	tumors	NNS	O	tumor	dep	179	SENT_30	[p1l1389t3084r1502b3109],
126	and	CC	O	and	dep	179	SENT_30	[p1l1517t3080r1576b3109],
127	the	DT	O	the	dep	179	SENT_30	[p1l1588t3080r1638b3109],
128	way	NN	O	way	dep	179	SENT_30	[p1l1652t3089r1718b3118],
129	in	IN	O	in	dep	179	SENT_30	[p1l1732t3080r1763b3109],
130	which	WDT	O	which	dep	179	SENT_30	[p1l1777t3080r1877b3109],
131	cells	NNS	O	cell	dep	179	SENT_30	[p1l533t3129r607b3158],
132	in	IN	O	in	dep	179	SENT_30	[p1l621t3129r652b3158],
133	a	DT	O	a	dep	179	SENT_30	[p1l666t3138r683b3158],
134	cancer	NN	O	cancer	dep	179	SENT_30	[p1l696t3138r804b3158],
135	interact	VBP	O	interact	dep	179	SENT_30	[p1l817t3129r941b3158],
136	with	IN	O	with	dep	179	SENT_30	[p1l954t3129r1026b3158],
137	each	DT	O	each	dep	179	SENT_30	[p1l1040t3129r1115b3158],
138	other	JJ	O	other	dep	179	SENT_30	[p1l1128t3129r1213b3158],
139	and	CC	O	and	dep	179	SENT_30	[p1l1226t3129r1285b3158],
140	with	IN	O	with	dep	179	SENT_30	[p1l1298t3129r1371b3158],
141	interstitial	JJ	O	interstitial	dep	179	SENT_30	[p1l1384t3129r1551b3158],
142	cells	NNS	O	cell	dep	179	SENT_30	[p1l1565t3129r1638b3158],
143	from	IN	O	from	dep	179	SENT_30	[p1l1653t3129r1733b3158],
144	the	DT	O	the	dep	179	SENT_30	[p1l1746t3129r1795b3158],
145	host	NN	O	host	dep	179	SENT_30	[p1l1808t3129r1877b3158],
146	(	NN	O	(	dep	179	SENT_30	[p1l534t3179r588b3215, p1l582t3229r623b3258],
147	6	CD	NUMBER	6	dep	179	SENT_30	[p1l534t3179r588b3215, p1l582t3229r623b3258],
148	)	NN	O	)	dep	179	SENT_30	[p1l534t3179r588b3215, p1l582t3229r623b3258],
149	To	TO	O	to	dep	179	SENT_30	[p1l534t3179r588b3215, p1l582t3229r623b3258],
150	paraphrase	VB	O	paraphrase	dep	179	SENT_30	[p1l635t3229r814b3266],
151	Tolstoy	NNP	PERSON	Tolstoy	dep	179	SENT_30	[p1l825t3229r947b3266],
152	in	IN	O	in	dep	179	SENT_30	[p1l959t3229r990b3257],
153	the	DT	O	the	dep	179	SENT_30	[p1l1001t3229r1051b3258],
154	opening	NN	O	opening	dep	179	SENT_30	[p1l1063t3229r1194b3266],
155	lines	NNS	O	line	dep	179	SENT_30	[p1l1206t3229r1283b3258],
156	of	IN	O	of	dep	179	SENT_30	[p1l1295t3229r1331b3258],
157	Anna	NNP	PERSON	Anna	dep	179	SENT_30	[p1l1337t3229r1425b3258],
158	Karenina	NNP	PERSON	Karenina	dep	179	SENT_30	[p1l1437t3230r1600b3263],
159	,	,	O	,	_	0	SENT_30	[p1l1437t3230r1600b3263],
160	normal	JJ	O	normal	dep	179	SENT_30	[p1l1613t3229r1729b3258],
161	cells	NNS	O	cell	dep	179	SENT_30	[p1l1741t3229r1815b3258],
162	are	VBP	O	be	dep	179	SENT_30	[p1l1828t3238r1876b3258],
163	all	DT	O	all	dep	179	SENT_30	[p1l533t3279r573b3308],
164	alike	RB	O	alike	dep	179	SENT_30	[p1l584t3278r662b3308],
165	in	IN	O	in	dep	179	SENT_30	[p1l672t3278r704b3307],
166	their	PRP$	O	they	dep	179	SENT_30	[p1l714t3278r790b3308],
167	response	NN	O	response	dep	179	SENT_30	[p1l798t3288r943b3316],
168	to	TO	O	to	dep	179	SENT_30	[p1l953t3283r984b3308],
169	drugs	NNS	O	drug	dep	179	SENT_30	[p1l995t3279r1094b3316],
170	,	,	O	,	_	0	SENT_30	[p1l995t3279r1094b3316],
171	but	CC	O	but	dep	179	SENT_30	[p1l1105t3279r1158b3308],
172	cancer	NN	O	cancer	dep	179	SENT_30	[p1l1168t3288r1275b3308],
173	cells	NNS	O	cell	dep	179	SENT_30	[p1l1285t3279r1359b3308],
174	each	DT	O	each	dep	179	SENT_30	[p1l1370t3279r1445b3308],
175	respond	NN	O	respond	dep	179	SENT_30	[p1l1454t3279r1585b3316],
176	in	IN	O	in	dep	179	SENT_30	[p1l1595t3278r1627b3307],
177	their	PRP$	O	they	dep	179	SENT_30	[p1l1637t3278r1713b3308],
178	own	JJ	O	own	dep	179	SENT_30	[p1l1722t3288r1791b3308],
179	way	NN	O	way	_	0	SENT_30	[p1l1802t3288r1875b3316],
180	.	.	O	.	_	0	SENT_30	[p1l1802t3288r1875b3316],

1	Each	DT	O	each	det	3	SENT_31	[p1l532t3328r615b3357],
2	cancer	NN	O	cancer	nn	3	SENT_31	[p1l627t3338r735b3357],
3	cell	NN	O	cell	nsubj	8	SENT_31	[p1l747t3328r805b3357],
4	from	IN	O	from	_	0	SENT_31	[p1l818t3328r898b3357],
5	a	DT	O	a	det	7	SENT_31	[p1l911t3338r928b3357],
6	given	VBN	O	give	amod	7	SENT_31	[p1l941t3328r1030b3366],
7	patient	NN	O	patient	prep_from	3	SENT_31	[p1l1042t3328r1155b3366],
8	has	VBZ	O	have	_	0	SENT_31	[p1l1167t3328r1220b3357],
9	a	DT	O	a	det	12	SENT_31	[p1l1235t3337r1252b3357],
10	different	JJ	O	different	amod	12	SENT_31	[p1l1264t3328r1405b3357],
11	genetic	JJ	O	genetic	amod	12	SENT_31	[p1l1418t3328r1535b3366],
12	make-up	NN	O	make-up	dobj	8	SENT_31	[p1l1548t3328r1692b3366],
13	depending	VBG	O	depend	partmod	12	SENT_31	[p1l1705t3328r1876b3366],
14	not	RB	O	not	neg	15	SENT_31	[p1l532t3383r585b3407],
15	only	RB	O	only	preconj	13	SENT_31	[p1l592t3378r665b3416],
16	on	IN	O	on	_	0	SENT_31	[p1l673t3387r713b3407],
17	the	DT	O	the	det	18	SENT_31	[p1l721t3378r770b3407],
18	tissue	NN	O	tissue	prep_on	13	SENT_31	[p1l778t3378r871b3407],
19	of	IN	O	of	_	0	SENT_31	[p1l879t3378r915b3407],
20	origin	NN	O	origin	prep_of	18	SENT_31	[p1l921t3378r1018b3416],
21	but	CC	O	but	_	0	SENT_31	[p1l1025t3378r1078b3407],
22	also	RB	O	also	advmod	13	SENT_31	[p1l1086t3378r1150b3407],
23	on	IN	O	on	_	0	SENT_31	[p1l1159t3387r1199b3407],
24	the	DT	O	the	det	25	SENT_31	[p1l1206t3378r1256b3407],
25	pattern	NN	O	pattern	prep_on	13	SENT_31	[p1l1263t3383r1378b3416],
26	of	IN	O	of	_	0	SENT_31	[p1l1386t3378r1422b3407],
27	activation	NN	O	activation	prep_of	25	SENT_31	[p1l1427t3378r1587b3407],
28	of	IN	O	of	_	0	SENT_31	[p1l1595t3378r1631b3407],
29	oncogenes	NNS	O	oncogene	prep_of	27	SENT_31	[p1l1637t3387r1809b3416],
30	and	CC	O	and	_	0	SENT_31	[p1l1819t3378r1877b3407],
31	inactivation	NN	O	inactivation	prep_of	27	SENT_31	[p1l532t3428r726b3457],
32	of	IN	O	of	_	0	SENT_31	[p1l737t3428r772b3457],
33	tumor	NN	O	tumor	nn	34	SENT_31	[p1l780t3433r879b3457],
34	suppressors	NNS	O	suppressor	prep_of	27	SENT_31	[p1l891t3437r1081b3466],
35	as	RB	O	as	_	0	SENT_31	[p1l1093t3437r1125b3457],
36	well	RB	O	well	_	0	SENT_31	[p1l1137t3428r1207b3457],
37	as	IN	O	as	_	0	SENT_31	[p1l1219t3437r1251b3457],
38	random	JJ	O	random	amod	39	SENT_31	[p1l1262t3428r1389b3457],
39	variations	NNS	O	variation	dobj	8	SENT_31	[p1l1399t3428r1559b3457],
40	in	IN	O	in	_	0	SENT_31	[p1l1571t3428r1602b3457],
41	gene	NN	O	gene	nn	42	SENT_31	[p1l1614t3437r1690b3466],
42	expression	NN	O	expression	prep_in	39	SENT_31	[p1l1701t3428r1877b3466],
43	resulting	VBG	O	result	partmod	39	SENT_31	[p1l532t3478r676b3516],
44	from	IN	O	from	_	0	SENT_31	[p1l687t3478r767b3507],
45	the	DT	O	the	det	49	SENT_31	[p1l777t3478r827b3507],
46	“	NN	O	“	nn	49	SENT_31	[p1l839t3478r1001b3507],
47	mutator	NN	O	mutator	nn	49	SENT_31	[p1l839t3478r1001b3507],
48	”	CD	NUMBER	”	num	49	SENT_31	[p1l839t3478r1001b3507],
49	phenotype	NN	O	phenotype	prep_from	43	SENT_31	[p1l1013t3478r1185b3516],
50	of	IN	O	of	_	0	SENT_31	[p1l1196t3478r1232b3507],
51	most	JJS	O	most	amod	52	SENT_31	[p1l1239t3483r1320b3507],
52	cancers	NNS	O	cancer	prep_of	39	SENT_31	[p1l1330t3487r1461b3507],
53	.	.	O	.	_	0	SENT_31	[p1l1330t3487r1461b3507],

1	As	IN	O	as	_	0	SENT_32	[p1l1474t3478r1518b3507],
2	a	DT	O	a	det	3	SENT_32	[p1l1530t3487r1548b3507],
3	result	NN	O	result	prep_as	7	SENT_32	[p1l1557t3478r1657b3512],
4	,	,	O	,	_	0	SENT_32	[p1l1557t3478r1657b3512],
5	every	DT	O	every	det	6	SENT_32	[p1l1670t3487r1758b3516],
6	cancer	NN	O	cancer	nsubj	7	SENT_32	[p1l1770t3487r1878b3507],
7	expresses	VBZ	O	express	_	0	SENT_32	[p1l533t3537r689b3566],
8	a	DT	O	a	det	10	SENT_32	[p1l707t3537r725b3557],
9	different	JJ	O	different	amod	10	SENT_32	[p1l741t3528r882b3557],
10	array	NN	O	array	dobj	7	SENT_32	[p1l899t3537r982b3566],
11	of	IN	O	of	_	0	SENT_32	[p1l999t3528r1035b3557],
12	drug-resistance	JJ	O	drug-resistance	amod	13	SENT_32	[p1l1049t3528r1301b3566],
13	genes	NNS	O	gene	prep_of	10	SENT_32	[p1l1318t3537r1420b3566],
14	,	,	O	,	_	0	SENT_32	[p1l1318t3537r1420b3566],
15	and	CC	O	and	_	0	SENT_32	[p1l1439t3528r1498b3557],
16	cells	NNS	O	cell	conj_and	10	SENT_32	[p1l1514t3528r1588b3557],
17	within	IN	O	within	_	0	SENT_32	[p1l1606t3528r1710b3557],
18	a	DT	O	a	det	19	SENT_32	[p1l1728t3537r1745b3557],
19	cancer	NN	O	cancer	prep_within	16	SENT_32	[p1l1761t3537r1875b3562],
20	,	,	O	,	_	0	SENT_32	[p1l1761t3537r1875b3562],
21	even	RB	O	even	advmod	26	SENT_32	[p1l533t3587r608b3607],
22	though	IN	O	though	dep	26	SENT_32	[p1l620t3578r734b3616],
23	clonally	RB	O	clonally	advmod	24	SENT_32	[p1l747t3578r879b3616],
24	derived	VBN	O	derive	dep	26	SENT_32	[p1l892t3578r1022b3612],
25	,	,	O	,	_	0	SENT_32	[p1l892t3578r1022b3612],
26	exhibit	VBP	O	exhibit	dep	7	SENT_32	[p1l1036t3578r1150b3607],
27	an	DT	O	a	det	29	SENT_32	[p1l1162t3587r1199b3607],
28	enormous	JJ	O	enormous	amod	29	SENT_32	[p1l1212t3587r1373b3607],
29	amount	NN	O	amount	dobj	26	SENT_32	[p1l1387t3582r1510b3607],
30	of	IN	O	of	_	0	SENT_32	[p1l1522t3578r1558b3607],
31	heterogeneity	NN	O	heterogeneity	prep_of	29	SENT_32	[p1l1567t3578r1792b3616],
32	with	IN	O	with	_	0	SENT_32	[p1l1805t3578r1877b3607],
33	respect	NN	O	respect	prep_with	31	SENT_32	[p1l532t3632r649b3666],
34	to	TO	O	to	_	0	SENT_32	[p1l659t3632r690b3657],
35	drug	NN	O	drug	nn	36	SENT_32	[p1l700t3628r775b3666],
36	resistance	NN	O	resistance	prep_to	26	SENT_32	[p1l785t3628r956b3657],
37	.	.	O	.	_	0	SENT_32	[p1l785t3628r956b3657],

1	In	IN	O	in	_	0	SENT_33	[p1l968t3628r1001b3657],
2	addition	NN	O	addition	pobj	1	SENT_33	[p1l1012t3628r1155b3662],
3	,	,	O	,	_	0	SENT_33	[p1l1012t3628r1155b3662],
4	even	RB	O	even	advmod	10	SENT_33	[p1l1167t3637r1242b3657],
5	if	IN	O	if	dep	10	SENT_33	[p1l1253t3628r1280b3657],
6	tumors	NNS	O	tumor	nsubj	10	SENT_33	[p1l1287t3632r1400b3657],
7	are	VBP	O	be	cop	10	SENT_33	[p1l1412t3637r1460b3657],
8	not	RB	O	not	neg	10	SENT_33	[p1l1470t3632r1523b3657],
9	intrinsically	RB	O	intrinsically	advmod	10	SENT_33	[p1l1532t3628r1729b3666],
10	resistant	JJ	O	resistant	dep	2	SENT_33	[p1l1739t3628r1877b3657],
11	to	TO	O	to	_	0	SENT_33	[p1l532t3682r563b3707],
12	a	DT	O	a	det	15	SENT_33	[p1l582t3687r599b3707],
13	speciﬁc	NN	O	speciﬁc	nn	15	SENT_33	[p1l617t3678r740b3716],
14	anticancer	JJ	O	anticancer	amod	15	SENT_33	[p1l759t3678r929b3707],
15	treatment	NN	O	treatment	prep_to	10	SENT_33	[p1l945t3682r1110b3712],
16	,	,	O	,	_	0	SENT_33	[p1l945t3682r1110b3712],
17	this	DT	O	this	det	21	SENT_33	[p1l1128t3678r1186b3707],
18	genetic	JJ	O	genetic	amod	21	SENT_33	[p1l1205t3678r1323b3716],
19	and	CC	O	and	_	0	SENT_33	[p1l1341t3678r1400b3707],
20	epigenetic	JJ	O	epigenetic	conj_and	18	SENT_33	[p1l1417t3678r1586b3716],
21	heterogeneity	NN	O	heterogeneity	appos	15	SENT_33	[p1l1603t3678r1828b3716],
22	in	IN	O	in	prep	10	SENT_33	[p1l1846t3678r1877b3707],

1	Annu	NNP	PERSON	Annu	_	0	SENT_34	[p2l271t2636r294b2717],
2	.	.	O	.	_	0	SENT_34	[p2l271t2636r294b2717],

1	Rev.	NNP	O	Rev.	nn	2	SENT_35	[p2l271t2566r294b2625],
2	Med	NNP	O	Med	_	0	SENT_35	[p2l271t2488r294b2555],
3	.	.	O	.	_	0	SENT_35	[p2l271t2488r294b2555],

1	2002.53:615	CD	NUMBER	2002.53:615	num	2	SENT_36	[p2l271t2243r294b2477],
2	-627	CD	NUMBER	-627	_	0	SENT_36	[p2l271t2243r294b2477],
3	.	.	O	.	_	0	SENT_36	[p2l271t2243r294b2477],

1	Downloaded	VBN	O	download	_	0	SENT_37	[p2l271t2062r294b2232],
2	from	IN	O	from	_	0	SENT_37	[p2l271t1989r294b2053],
3	www.annualreviews.org	NN	O	www.annualreviews.org	nn	4	SENT_37	[p2l271t1655r301b1980],
4	Annu	NN	PERSON	annu	prep_from	1	SENT_37	[p2l279t311r302b392],
5	.	.	O	.	_	0	SENT_37	[p2l279t311r302b392],

1	Rev.	NNP	O	Rev.	nn	2	SENT_38	[p2l279t241r302b301],
2	Med	NNP	O	Med	_	0	SENT_38	[p2l279t163r302b230],
3	.	.	O	.	_	0	SENT_38	[p2l279t163r302b230],

1	2002.53	CD	NUMBER	2002.53	_	0	SENT_39	[p2l279t38r302b152],
2	:	:	O	:	_	0	SENT_39	[p2l279t38r302b152],
3	by	IN	O	by	_	0	SENT_39	[p2l312t325r343b357],
4	University	NNP	ORGANIZATION	University	prep_by	1	SENT_39	[p2l312t176r343b316],
5	of	IN	ORGANIZATION	of	_	0	SENT_39	[p2l312t137r336b166],
6	Wiscor	NNP	ORGANIZATION	Wiscor	prep_of	1	SENT_39	[p2l312t37r336b131],
7	by	IN	O	by	_	0	SENT_39	[p2l304t2650r335b2683],
8	University	NNP	ORGANIZATION	University	prep_by	6	SENT_39	[p2l304t2501r335b2641],
9	of	IN	ORGANIZATION	of	_	0	SENT_39	[p2l304t2462r328b2491],
10	Wisconsin	NNP	ORGANIZATION	Wisconsin	prep_of	8	SENT_39	[p2l304t2315r328b2456],
11	-	:	O	-	_	0	SENT_39	[p2l318t2297r321b2305],
12	Madison	NNP	O	Madison	dep	1	SENT_39	[p2l304t2171r328b2287],
13	on	IN	O	on	_	0	SENT_39	[p2l312t2129r328b2161],
14	01/05/14	CD	DATE	01/05/14	prep_on	12	SENT_39	[p2l304t1996r328b2120],
15	.	.	O	.	_	0	SENT_39	[p2l304t1996r328b2120],

1	For	IN	O	for	_	0	SENT_40	[p2l305t1939r328b1985],
2	personal	JJ	O	personal	amod	3	SENT_40	[p2l304t1818r335b1930],
3	use	NN	O	use	pobj	1	SENT_40	[p2l312t1765r328b1809],
4	only	RB	O	only	advmod	3	SENT_40	[p2l304t1691r335b1756],
5	.	.	O	.	_	0	SENT_40	[p2l304t1691r335b1756],

1	the	DT	O	the	det	2	SENT_41	[p2l532t40r582b69],
2	face	NN	O	face	nsubj	12	SENT_41	[p2l596t40r663b69],
3	of	IN	O	of	_	0	SENT_41	[p2l678t40r714b69],
4	the	DT	O	the	det	6	SENT_41	[p2l725t40r775b69],
5	powerful	JJ	O	powerful	amod	6	SENT_41	[p2l788t40r936b78],
6	selection	NN	O	selection	prep_of	2	SENT_41	[p2l952t40r1097b69],
7	imposed	VBN	O	impose	partmod	6	SENT_41	[p2l1111t40r1251b78],
8	by	IN	O	by	_	0	SENT_41	[p2l1264t40r1305b78],
9	potent	JJ	O	potent	amod	11	SENT_41	[p2l1319t45r1422b78],
10	anticancer	JJ	O	anticancer	amod	11	SENT_41	[p2l1437t40r1606b69],
11	drugs	NNS	O	drug	agent	7	SENT_41	[p2l1620t40r1709b78],
12	results	VBZ	O	result	_	0	SENT_41	[p2l1724t40r1831b69],
13	in	IN	O	in	_	0	SENT_41	[p2l1846t40r1877b69],
14	overgrowth	NN	O	overgrowth	prep_in	12	SENT_41	[p2l533t90r720b128],
15	of	IN	O	of	_	0	SENT_41	[p2l733t90r768b119],
16	drug	NN	O	drug	npadvmod	18	SENT_41	[p2l778t90r1005b128],
17	—	CD	NUMBER	—	num	16	SENT_41	[p2l778t90r1005b128],
18	resistant	JJ	O	resistant	amod	19	SENT_41	[p2l778t90r1005b128],
19	variants	NNS	O	variant	prep_of	14	SENT_41	[p2l1017t90r1146b119],
20	and	CC	O	and	_	0	SENT_41	[p2l1160t90r1218b119],
21	the	DT	O	the	det	23	SENT_41	[p2l1230t90r1279b119],
22	rapid	JJ	O	rapid	amod	23	SENT_41	[p2l1291t90r1376b128],
23	acquisition	NN	O	acquisition	conj_and	14	SENT_41	[p2l1389t90r1569b128],
24	of	IN	O	of	_	0	SENT_41	[p2l1582t90r1618b119],
25	drug	NN	O	drug	nn	26	SENT_41	[p2l1627t90r1702b128],
26	resistance	NN	O	resistance	prep_of	23	SENT_41	[p2l1714t90r1877b119],
27	by	IN	O	by	_	0	SENT_41	[p2l532t140r573b177],
28	many	JJ	O	many	amod	29	SENT_41	[p2l584t149r675b177],
29	cancers	NNS	O	cancer	prep_by	12	SENT_41	[p2l687t149r818b169],
30	.	.	O	.	_	0	SENT_41	[p2l687t149r818b169],

1	For	IN	O	for	_	0	SENT_42	[p2l582t190r639b218],
2	the	DT	DURATION	the	det	5	SENT_42	[p2l648t189r698b218],
3	past	JJ	DURATION	past	amod	5	SENT_42	[p2l707t194r774b227],
4	40	CD	DURATION	40	num	5	SENT_42	[p2l783t189r824b219],
5	years	NNS	NUMBER	year	prep_for	10	SENT_42	[p2l834t198r929b227],
6	,	,	O	,	_	0	SENT_42	[p2l834t198r929b227],
7	researchers	NNS	O	researcher	nsubj	10	SENT_42	[p2l940t189r1125b218],
8	have	VBP	O	have	aux	10	SENT_42	[p2l1136t189r1212b218],
9	been	VBN	O	be	aux	10	SENT_42	[p2l1221t189r1299b218],
10	tabulating	VBG	O	tabulate	dep	23	SENT_42	[p2l1309t189r1473b227],
11	the	DT	O	the	det	13	SENT_42	[p2l1483t189r1533b218],
12	various	JJ	O	various	amod	13	SENT_42	[p2l1543t189r1662b218],
13	mechanisms	NNS	O	mechanism	dobj	10	SENT_42	[p2l1673t189r1876b218],
14	by	IN	O	by	_	0	SENT_42	[p2l532t239r573b277],
15	which	WDT	O	which	dobj	18	SENT_42	[p2l583t239r684b268],
16	cancer	NN	O	cancer	nn	17	SENT_42	[p2l694t248r802b268],
17	cells	NNS	O	cell	nsubj	18	SENT_42	[p2l811t239r885b268],
18	grown	VBN	O	grow	prepc_by	10	SENT_42	[p2l896t248r1000b277],
19	in	IN	O	in	_	0	SENT_42	[p2l1010t239r1041b268],
20	tissue	NN	O	tissue	nn	21	SENT_42	[p2l1051t239r1145b268],
21	culture	NN	O	culture	prep_in	18	SENT_42	[p2l1155t239r1269b268],
22	become	VBP	O	become	cop	23	SENT_42	[p2l1279t239r1407b268],
23	resistant	JJ	O	resistant	_	0	SENT_42	[p2l1417t239r1555b268],
24	to	TO	O	to	_	0	SENT_42	[p2l1565t244r1596b268],
25	anticancer	JJ	O	anticancer	amod	26	SENT_42	[p2l1607t239r1777b268],
26	drugs	NNS	O	drug	prep_to	23	SENT_42	[p2l1786t239r1876b277],
27	(	CD	NUMBER	(	num	30	SENT_42	[p2l534t289r653b327],
28	Figure	NN	O	figure	nn	30	SENT_42	[p2l534t289r653b327],
29	1	CD	NUMBER	1	num	30	SENT_42	[p2l671t289r708b325],
30	)	NN	O	)	nsubj	23	SENT_42	[p2l671t289r708b325],
31	.	.	O	.	_	0	SENT_42	[p2l671t289r708b325],

1	Some	DT	O	some	nsubj	51	SENT_43	[p2l725t289r817b318],
2	of	IN	O	of	_	0	SENT_43	[p2l831t289r867b318],
3	these	DT	O	these	det	4	SENT_43	[p2l877t289r961b318],
4	mechanisms	NNS	O	mechanism	prep_of	1	SENT_43	[p2l975t289r1188b323],
5	,	,	O	,	_	0	SENT_43	[p2l975t289r1188b323],
6	such	JJ	O	such	_	0	SENT_43	[p2l1204t289r1278b318],
7	as	IN	O	as	_	0	SENT_43	[p2l1292t298r1323b318],
8	loss	NN	O	loss	prep_such_as	1	SENT_43	[p2l1338t289r1400b318],
9	of	IN	O	of	_	0	SENT_43	[p2l1415t289r1451b318],
10	a	DT	O	a	det	13	SENT_43	[p2l1462t298r1479b318],
11	cell	NN	O	cell	nn	13	SENT_43	[p2l1492t289r1550b318],
12	surface	NN	O	surface	nn	13	SENT_43	[p2l1565t289r1682b318],
13	receptor	NN	O	receptor	prep_of	8	SENT_43	[p2l1695t293r1831b327],
14	or	CC	O	or	_	0	SENT_43	[p2l1844t298r1878b318],
15	transporter	NN	O	transporter	conj_or	8	SENT_43	[p2l532t344r712b377],
16	for	IN	O	for	_	0	SENT_43	[p2l723t339r771b368],
17	a	DT	O	a	det	18	SENT_43	[p2l783t348r800b368],
18	drug	NN	O	drug	prep_for	15	SENT_43	[p2l811t339r895b377],
19	,	,	O	,	_	0	SENT_43	[p2l811t339r895b377],
20	speciﬁc	NN	O	speciﬁc	nn	21	SENT_43	[p2l909t339r1033b377],
21	metabolism	NN	O	metabolism	conj_or	8	SENT_43	[p2l1045t339r1238b368],
22	of	IN	O	of	_	0	SENT_43	[p2l1250t339r1286b368],
23	a	DT	O	a	det	24	SENT_43	[p2l1295t348r1313b368],
24	drug	NN	O	drug	prep_of	21	SENT_43	[p2l1324t339r1407b377],
25	,	,	O	,	_	0	SENT_43	[p2l1324t339r1407b377],
26	or	CC	O	or	_	0	SENT_43	[p2l1421t348r1455b368],
27	alteration	NN	O	alteration	prep_such_as	1	SENT_43	[p2l1466t339r1621b368],
28	by	IN	O	by	_	0	SENT_43	[p2l1632t339r1673b377],
29	mutation	NN	O	mutation	prep_by	27	SENT_43	[p2l1685t339r1832b368],
30	of	IN	O	of	_	0	SENT_43	[p2l1843t339r1879b368],
31	the	DT	O	the	det	33	SENT_43	[p2l532t389r582b418],
32	speciﬁc	NN	O	speciﬁc	nn	33	SENT_43	[p2l593t389r717b427],
33	target	NN	O	target	prep_of	29	SENT_43	[p2l727t393r820b427],
34	of	IN	O	of	_	0	SENT_43	[p2l829t389r865b418],
35	a	DT	O	a	det	36	SENT_43	[p2l873t398r890b418],
36	drug	NN	O	drug	prep_of	33	SENT_43	[p2l899t389r982b427],
37	,	,	O	,	_	0	SENT_43	[p2l899t389r982b427],
38	all	DT	O	all	dep	39	SENT_43	[p2l994t389r1034b418],
39	of	IN	O	of	nsubj	41	SENT_43	[p2l1044t389r1079b418],
40	which	WDT	O	which	pobj	39	SENT_43	[p2l1086t389r1187b418],
41	occur	VBP	O	occur	rcmod	36	SENT_43	[p2l1196t398r1288b418],
42	for	IN	O	for	_	0	SENT_43	[p2l1296t389r1344b418],
43	antifolates	NNS	O	antifolate	prep_for	41	SENT_43	[p2l1354t389r1524b418],
44	such	JJ	O	such	_	0	SENT_43	[p2l1536t389r1609b418],
45	as	IN	O	as	_	0	SENT_43	[p2l1620t398r1651b418],
46	methotrexate	NN	O	methotrexate	nn	47	SENT_43	[p2l1662t389r1877b418],
47	(	NN	O	(	prep_such_as	43	SENT_43	[p2l534t439r589b475],
48	7	CD	NUMBER	7	num	49	SENT_43	[p2l534t439r589b475],
49	)	NN	O	)	dep	47	SENT_43	[p2l534t439r589b475],
50	,	,	O	,	_	0	SENT_43	[p2l534t439r589b475],
51	result	VBP	O	result	_	0	SENT_43	[p2l598t439r690b468],
52	in	IN	O	in	_	0	SENT_43	[p2l697t439r728b468],
53	resistance	NN	O	resistance	prep_in	51	SENT_43	[p2l736t439r899b468],
54	to	TO	O	to	_	0	SENT_43	[p2l907t444r937b468],
55	only	RB	O	only	advmod	58	SENT_43	[p2l946t439r1018b477],
56	a	DT	O	a	det	58	SENT_43	[p2l1027t448r1044b468],
57	small	JJ	O	small	amod	58	SENT_43	[p2l1053t439r1140b468],
58	number	NN	O	number	prep_to	51	SENT_43	[p2l1148t439r1275b468],
59	of	IN	O	of	_	0	SENT_43	[p2l1282t439r1318b468],
60	related	JJ	O	related	amod	61	SENT_43	[p2l1323t439r1435b468],
61	drugs	NNS	O	drug	prep_of	58	SENT_43	[p2l1443t439r1542b477],
62	.	.	O	.	_	0	SENT_43	[p2l1443t439r1542b477],

1	In	IN	O	in	_	0	SENT_44	[p2l1552t440r1586b468],
2	such	JJ	O	such	amod	3	SENT_44	[p2l1595t439r1669b468],
3	cases	NNS	O	case	prep_in	20	SENT_44	[p2l1677t448r1772b474],
4	,	,	O	,	_	0	SENT_44	[p2l1677t448r1772b474],
5	use	NN	O	use	nsubj	20	SENT_44	[p2l1781t448r1835b468],
6	of	IN	O	of	_	0	SENT_44	[p2l1844t439r1880b468],
7	multiple	JJ	O	multiple	amod	8	SENT_44	[p2l532t488r670b526],
8	drugs	NNS	O	drug	prep_of	5	SENT_44	[p2l681t488r771b526],
9	with	IN	O	with	_	0	SENT_44	[p2l783t488r856b517],
10	different	JJ	O	different	amod	11	SENT_44	[p2l866t488r1007b517],
11	mechanisms	NNS	O	mechanism	prep_with	8	SENT_44	[p2l1018t488r1221b517],
12	of	IN	O	of	_	0	SENT_44	[p2l1233t488r1269b517],
13	entry	NN	O	entry	prep_of	11	SENT_44	[p2l1277t493r1361b526],
14	into	IN	O	into	_	0	SENT_44	[p2l1372t488r1435b517],
15	cells	NNS	O	cell	prep_into	13	SENT_44	[p2l1447t488r1520b517],
16	and	CC	O	and	_	0	SENT_44	[p2l1533t488r1591b517],
17	different	JJ	O	different	amod	19	SENT_44	[p2l1602t488r1743b517],
18	cellular	JJ	O	cellular	amod	19	SENT_44	[p2l1754t488r1878b517],
19	targets	NNS	O	target	prep_into	13	SENT_44	[p2l532t542r640b575],
20	allows	VBZ	O	allow	_	0	SENT_44	[p2l653t537r758b567],
21	for	IN	O	for	_	0	SENT_44	[p2l770t537r818b567],
22	effective	JJ	O	effective	amod	23	SENT_44	[p2l829t537r970b567],
23	chemotherapy	NN	O	chemotherapy	prep_for	20	SENT_44	[p2l982t537r1215b575],
24	and	CC	O	and	_	0	SENT_44	[p2l1228t537r1286b566],
25	high	JJ	O	high	amod	27	SENT_44	[p2l1296t537r1370b575],
26	cure	NN	O	cure	nn	27	SENT_44	[p2l1381t546r1451b567],
27	rates	NNS	O	rate	prep_for	20	SENT_44	[p2l1462t542r1548b567],
28	.	.	O	.	_	0	SENT_44	[p2l1462t542r1548b567],

1	All	DT	O	all	dep	3	SENT_45	[p2l1561t537r1613b566],
2	too	RB	O	too	advmod	3	SENT_45	[p2l1625t542r1676b567],
3	often	RB	O	often	advmod	8	SENT_45	[p2l1688t537r1781b572],
4	,	,	O	,	_	0	SENT_45	[p2l1688t537r1781b572],
5	however	RB	O	however	advmod	8	SENT_45	[p2l1793t537r1876b567, p2l533t596r608b622],
6	,	,	O	,	_	0	SENT_45	[p2l1793t537r1876b567, p2l533t596r608b622],
7	cells	NNS	O	cell	nsubj	8	SENT_45	[p2l624t587r698b616],
8	express	VBP	O	express	_	0	SENT_45	[p2l712t596r834b625],
9	mechanisms	NNS	O	mechanism	dobj	8	SENT_45	[p2l848t587r1052b616],
10	of	IN	O	of	_	0	SENT_45	[p2l1067t587r1103b616],
11	resistance	NN	O	resistance	prep_of	9	SENT_45	[p2l1113t587r1276b616],
12	that	WDT	O	that	nsubj	13	SENT_45	[p2l1289t587r1351b616],
13	confer	VBP	O	confer	rcmod	9	SENT_45	[p2l1365t587r1470b616],
14	simultaneous	JJ	O	simultaneous	amod	15	SENT_45	[p2l1484t587r1700b616],
15	resistance	NN	O	resistance	dobj	13	SENT_45	[p2l1714t587r1877b616],
16	to	TO	O	to	_	0	SENT_45	[p2l532t641r563b665],
17	many	JJ	O	many	amod	23	SENT_45	[p2l573t645r663b674],
18	different	JJ	O	different	amod	23	SENT_45	[p2l673t636r814b665],
19	structurally	RB	O	structurally	advmod	18	SENT_45	[p2l824t636r1011b674],
20	and	CC	O	and	_	0	SENT_45	[p2l1021t636r1080b665],
21	functionally	RB	O	functionally	advmod	22	SENT_45	[p2l1089t636r1288b674],
22	unrelated	JJ	O	unrelated	conj_and	18	SENT_45	[p2l1297t636r1451b665],
23	drugs	NNS	O	drug	prep_to	13	SENT_45	[p2l1461t636r1560b674],
24	.	.	O	.	_	0	SENT_45	[p2l1461t636r1560b674],

1	This	DT	O	this	det	2	SENT_46	[p2l1571t636r1643b665],
2	phenomenon	NN	O	phenomenon	nsubj	13	SENT_46	[p2l1653t636r1875b674],
3	,	,	O	,	_	0	SENT_46	[p2l1653t636r1875b674],
4	known	VBN	O	know	partmod	2	SENT_46	[p2l532t685r644b715],
5	as	IN	O	as	_	0	SENT_46	[p2l653t694r685b715],
6	multidrug	JJ	O	multidrug	amod	10	SENT_46	[p2l694t685r857b723],
7	resistance	NN	O	resistance	nn	10	SENT_46	[p2l865t685r1028b715],
8	(	NN	O	(	nn	10	SENT_46	[p2l1038t685r1093b721],
9	8	CD	NUMBER	8	num	10	SENT_46	[p2l1038t685r1093b721],
10	)	NN	O	)	prep_as	4	SENT_46	[p2l1038t685r1093b721],
11	,	,	O	,	_	0	SENT_46	[p2l1038t685r1093b721],
12	can	MD	O	can	aux	13	SENT_46	[p2l1104t694r1160b715],
13	result	VB	O	result	_	0	SENT_46	[p2l1168t685r1260b715],
14	from	IN	O	from	_	0	SENT_46	[p2l1269t685r1349b715],
15	changes	NNS	O	change	prep_from	13	SENT_46	[p2l1357t685r1489b723],
16	that	WDT	O	that	nsubj	17	SENT_46	[p2l1498t685r1560b715],
17	limit	VBP	O	limit	rcmod	15	SENT_46	[p2l1568t685r1646b715],
18	accumulation	NN	O	accumulation	dobj	17	SENT_46	[p2l1655t685r1877b715],
19	of	IN	O	of	_	0	SENT_46	[p2l533t735r569b764],
20	drugs	NNS	O	drug	prep_of	18	SENT_46	[p2l577t735r667b773],
21	within	IN	O	within	_	0	SENT_46	[p2l680t735r784b764],
22	cells	NNS	O	cell	prep_within	20	SENT_46	[p2l795t735r869b764],
23	by	IN	O	by	_	0	SENT_46	[p2l881t735r921b773],
24	limiting	VBG	O	limit	prepc_by	17	SENT_46	[p2l933t735r1063b773],
25	uptake	NN	O	uptake	dobj	24	SENT_46	[p2l1074t735r1192b773],
26	,	,	O	,	_	0	SENT_46	[p2l1074t735r1192b773],
27	enhancing	VBG	O	enhance	prepc_by	17	SENT_46	[p2l1205t735r1374b773],
28	efﬂux	NN	O	efﬂux	dobj	27	SENT_46	[p2l1386t735r1489b770],
29	,	,	O	,	_	0	SENT_46	[p2l1386t735r1489b770],
30	or	CC	O	or	_	0	SENT_46	[p2l1502t744r1536b764],
31	affecting	VBG	O	affect	prepc_by	17	SENT_46	[p2l1547t735r1691b773],
32	membrane	NN	O	membrane	nn	33	SENT_46	[p2l1703t735r1877b764],
33	lipids	NNS	O	lipid	dobj	31	SENT_46	[p2l532t784r623b822],
34	such	JJ	O	such	_	0	SENT_46	[p2l638t784r712b813],
35	as	IN	O	as	_	0	SENT_46	[p2l726t793r758b813],
36	ceramide	NN	O	ceramide	prep_such_as	33	SENT_46	[p2l772t784r923b813],
37	(	CD	NUMBER	(	num	36	SENT_46	[p2l937t784r991b820],
38	9	CD	NUMBER	9	num	39	SENT_46	[p2l937t784r991b820],
39	)	NN	O	)	dep	36	SENT_46	[p2l937t784r991b820],
40	.	.	O	.	_	0	SENT_46	[p2l937t784r991b820],

1	These	DT	O	these	det	2	SENT_47	[p2l1007t784r1105b813],
2	changes	NNS	O	change	nsubj	3	SENT_47	[p2l1118t784r1250b822],
3	block	VBP	O	block	_	0	SENT_47	[p2l1263t784r1356b813],
4	(	CD	NUMBER	(	nsubj	10	SENT_47	[p2l1370t785r1414b820],
5	a	DT	O	a	det	6	SENT_47	[p2l1370t785r1414b820],
6	)	NN	O	)	dep	4	SENT_47	[p2l1370t785r1414b820],
7	the	DT	O	the	det	10	SENT_47	[p2l1429t784r1478b813],
8	programmed	VBN	O	program	amod	10	SENT_47	[p2l1491t784r1703b822],
9	cell	NN	O	cell	nn	10	SENT_47	[p2l1716t784r1775b813],
10	death	NN	O	death	xcomp	3	SENT_47	[p2l1788t784r1877b813],
11	(	JJ	O	(	amod	13	SENT_47	[p2l534t833r715b871],
12	apoptosis	NN	O	apoptosis	nn	13	SENT_47	[p2l534t833r715b871],
13	)	NN	O	)	nsubj	21	SENT_47	[p2l534t833r715b871],
14	that	WDT	O	that	nsubjpass	16	SENT_47	[p2l729t833r790b862],
15	is	VBZ	O	be	auxpass	16	SENT_47	[p2l803t833r828b862],
16	activated	VBN	O	activate	rcmod	13	SENT_47	[p2l843t833r989b862],
17	by	IN	O	by	_	0	SENT_47	[p2l1001t833r1042b871],
18	most	JJS	O	most	amod	20	SENT_47	[p2l1055t837r1135b862],
19	anticancer	JJ	O	anticancer	amod	20	SENT_47	[p2l1148t833r1318b862],
20	drugs	NNS	O	drug	agent	16	SENT_47	[p2l1330t833r1420b871],
21	(	VBP	O	(	rcmod	10	SENT_47	[p2l1435t833r1510b869],
22	10	CD	NUMBER	10	number	23	SENT_47	[p2l1435t833r1510b869],
23	)	CD	NUMBER	)	dobj	21	SENT_47	[p2l1435t833r1510b869],
24	,	,	O	,	_	0	SENT_47	[p2l1435t833r1510b869],
25	(	CD	NUMBER	(	num	28	SENT_47	[p2l1526t833r1571b869],
26	I2	NN	O	i2	nn	28	SENT_47	[p2l1526t833r1571b869],
27	)	NN	O	)	nn	28	SENT_47	[p2l1526t833r1571b869],
28	activation	NN	O	activation	appos	23	SENT_47	[p2l1585t833r1745b862],
29	of	IN	O	of	_	0	SENT_47	[p2l1758t833r1794b862],
30	general	JJ	O	general	amod	32	SENT_47	[p2l1805t842r1876b871, p2l533t882r593b911],
31	response	NN	O	response	nn	32	SENT_47	[p2l602t891r746b920],
32	mechanisms	NNS	O	mechanism	prep_of	28	SENT_47	[p2l755t882r959b911],
33	that	WDT	O	that	nsubj	34	SENT_47	[p2l969t882r1030b911],
34	detoxify	VBP	O	detoxify	rcmod	28	SENT_47	[p2l1039t882r1176b920],
35	drugs	NNS	O	drug	dobj	34	SENT_47	[p2l1185t882r1275b920],
36	and	CC	O	and	_	0	SENT_47	[p2l1286t882r1344b911],
37	repair	NN	O	repair	nn	38	SENT_47	[p2l1352t882r1449b920],
38	damage	NN	O	damage	dobj	34	SENT_47	[p2l1458t882r1585b920],
39	to	TO	O	to	_	0	SENT_47	[p2l1594t887r1625b911],
40	DNA	NN	O	dna	nn	41	SENT_47	[p2l1634t883r1722b911],
41	(	NN	O	(	prep_to	34	SENT_47	[p2l1732t883r1760b918],
42	1	CD	NUMBER	1	number	43	SENT_47	[p2l1732t883r1760b918],
43	1	CD	NUMBER	1	num	44	SENT_47	[p2l1769t882r1807b918],
44	)	NN	O	)	dep	41	SENT_47	[p2l1769t882r1807b918],
45	,	,	O	,	_	0	SENT_47	[p2l1769t882r1807b918],
46	and	CC	O	and	_	0	SENT_47	[p2l1819t882r1877b911],
47	(	NN	O	(	nn	48	SENT_47	[p2l534t932r576b967],
48	c	NN	O	c	prep_to	34	SENT_47	[p2l534t932r576b967],
49	)	CD	NUMBER	)	num	50	SENT_47	[p2l534t932r576b967],
50	alterations	NNS	O	alteration	dep	48	SENT_47	[p2l601t931r771b961],
51	in	IN	O	in	_	0	SENT_47	[p2l795t931r826b960],
52	the	DT	O	the	det	54	SENT_47	[p2l849t931r898b961],
53	cell	NN	O	cell	nn	54	SENT_47	[p2l922t931r980b961],
54	cycle	NN	O	cycle	prep_in	34	SENT_47	[p2l1003t931r1089b969],
55	and	CC	O	and	_	0	SENT_47	[p2l1112t931r1171b961],
56	checkpoints	NNS	O	checkpoint	prep_in	34	SENT_47	[p2l1194t931r1390b969],
57	that	WDT	O	that	nsubj	58	SENT_47	[p2l1413t931r1475b961],
58	render	VBP	O	render	rcmod	56	SENT_47	[p2l1497t931r1603b961],
59	cells	NNS	O	cell	nsubj	62	SENT_47	[p2l1625t931r1699b961],
60	relatively	RB	O	relatively	advmod	62	SENT_47	[p2l1722t931r1877b969],
61	DRUG	NN	O	drug	nn	62	SENT_47	[p2l1193t992r1297b1019],
62	RESISTANCE	NN	O	resistance	xcomp	58	SENT_47	[p2l1307t992r1529b1019],
63	IN	IN	O	in	_	0	SENT_47	[p2l1540t993r1578b1019],
64	CANCER	NNP	O	CANCER	prep_in	62	SENT_47	[p2l1589t992r1739b1019],
65	617	CD	NUMBER	617	num	64	SENT_47	[p2l1828t989r1888b1019],

1	Efflux	NNP	O	Efflux	nn	2	SENT_48	[p2l975t1129r1096b1163],
2	pumps	NNS	O	pump	_	0	SENT_48	[p2l1110t1137r1252b1172],

1	Decreased	VBN	O	decrease	_	0	SENT_49	[p2l1655t1408r1874b1442],

1	Altered	JJ	O	altered	amod	4	SENT_50	[p2l840t1464r990b1497],
2	cell	NN	O	cell	nn	4	SENT_50	[p2l1005t1463r1077b1497],
3	cycle	NN	O	cycle	nn	4	SENT_50	[p2l1091t1463r1202b1506],
4	checkpoints	NNS	O	checkpoint	_	0	SENT_50	[p2l1216t1463r1473b1505],

1	Alterations	NNS	O	alteration	_	0	SENT_51	[p2l559t1549r787b1582],
2	in	IN	O	in	_	0	SENT_51	[p2l538t1593r573b1626],
3	membrane	NN	O	membrane	nn	4	SENT_51	[p2l589t1593r809b1626],
4	lipids	NNS	O	lipid	prep_in	1	SENT_51	[p2l618t1637r729b1679],

1	Induction	NN	O	induction	_	0	SENT_52	[p2l875t1561r1071b1595],
2	of	IN	O	of	_	0	SENT_52	[p2l1085t1561r1127b1595],
3	emergency	NN	O	emergency	nn	5	SENT_52	[p2l1140t1569r1373b1604],
4	response	NN	O	response	nn	5	SENT_52	[p2l956t1613r1151b1647],
5	genes	NNS	O	gene	prep_of	1	SENT_52	[p2l1165t1613r1291b1647],

1	Compartmentalizatio	NNP	O	Compartmentalizatio	_	0	SENT_53	[p2l482t1744r916b1786],
2	:	:	O	:	_	0	SENT_53	[p2l926t1758r934b1777],

1	Increased	VBN	O	increase	_	0	SENT_54	[p2l1426t1861r1629b1894],
2	or	CC	O	or	_	0	SENT_54	[p2l1645t1868r1687b1894],
3	altered	VBN	O	alter	conj_or	1	SENT_54	[p2l1485t1904r1627b1938],
4	drug	NN	O	drug	nn	5	SENT_54	[p2l1429t1949r1524b1992],
5	targets	NNS	O	target	dobj	3	SENT_54	[p2l1538t1950r1684b1992],

1	Repair	NN	O	repair	_	0	SENT_55	[p2l877t1917r1011b1961],
2	of	IN	O	of	_	0	SENT_55	[p2l1025t1917r1065b1952],
3	damage	NN	O	damage	prep_of	1	SENT_55	[p2l1079t1918r1245b1961],

1	Increased	VBN	O	increase	_	0	SENT_56	[p2l958t1962r1162b1996],

1	Apoptosls	NNS	O	apoptosl	nsubj	2	SENT_57	[p2l866t2167r1080b2210],
2	lnhlblted	VBD	O	lnhlblted	_	0	SENT_57	[p2l1096t2167r1277b2201],

1	Metabolism	NN	O	metabolism	nn	2	SENT_58	[p2l1172t2331r1412b2366],
2	o	NN	O	o	_	0	SENT_58	[p2l1182t2382r1430b2443],
3	—	CD	NUMBER	—	num	5	SENT_58	[p2l1182t2382r1430b2443],
4	>	JJR	O	>	amod	5	SENT_58	[p2l1182t2382r1430b2443],
5	o	NN	O	o	dep	2	SENT_58	[p2l1182t2382r1430b2443],
6	*	CD	NUMBER	*	dep	2	SENT_58	[p2l1182t2382r1430b2443],

1	Figure	NNP	O	Figure	nsubjpass	17	SENT_59	[p2l446t2576r556b2612],
2	1	CD	NUMBER	1	num	1	SENT_59	[p2l570t2576r585b2604],
3	This	DT	O	this	det	4	SENT_59	[p2l627t2576r695b2604],
4	cartoon	NN	O	cartoon	nsubj	5	SENT_59	[p2l708t2581r825b2604],
5	summarizes	VBZ	O	summarize	rcmod	1	SENT_59	[p2l838t2577r1024b2604],
6	many	JJ	O	many	dobj	5	SENT_59	[p2l1036t2585r1122b2612],
7	of	IN	O	of	_	0	SENT_59	[p2l1135t2576r1169b2604],
8	the	DT	O	the	det	9	SENT_59	[p2l1178t2577r1225b2604],
9	ways	NNS	O	way	prep_of	6	SENT_59	[p2l1238t2585r1316b2612],
10	in	IN	O	in	_	0	SENT_59	[p2l1329t2576r1359b2604],
11	which	WDT	O	which	nsubj	12	SENT_59	[p2l1371t2576r1466b2604],
12	cultured	VBN	O	culture	prepc_in	9	SENT_59	[p2l1478t2577r1607b2604],
13	cancer	NN	O	cancer	nn	14	SENT_59	[p2l1618t2585r1721b2604],
14	cells	NNS	O	cell	dobj	12	SENT_59	[p2l1732t2577r1802b2604],
15	have	VBP	O	have	aux	17	SENT_59	[p2l1815t2577r1887b2604],
16	been	VBN	O	be	auxpass	17	SENT_59	[p2l445t2627r519b2654],
17	shown	VBN	O	show	_	0	SENT_59	[p2l537t2626r637b2654],
18	to	TO	O	to	aux	20	SENT_59	[p2l653t2631r682b2654],
19	become	VB	O	become	cop	20	SENT_59	[p2l699t2626r821b2654],
20	resistant	JJ	O	resistant	xcomp	17	SENT_59	[p2l837t2626r968b2654],
21	to	TO	O	to	_	0	SENT_59	[p2l984t2631r1013b2654],
22	cytotoxic	JJ	O	cytotoxic	amod	24	SENT_59	[p2l1031t2626r1175b2663],
23	anticancer	JJ	O	anticancer	amod	24	SENT_59	[p2l1193t2626r1354b2654],
24	drugs	NNS	O	drug	prep_to	20	SENT_59	[p2l1370t2627r1464b2663],
25	.	.	O	.	_	0	SENT_59	[p2l1370t2627r1464b2663],

1	The	DT	O	the	det	3	SENT_60	[p2l1482t2626r1542b2654],
2	efﬂux	NN	O	efﬂux	nn	3	SENT_60	[p2l1559t2626r1649b2654],
3	pumps	NNS	O	pump	nsubj	4	SENT_60	[p2l1665t2635r1769b2663],
4	shown	VBN	O	show	dep	10	SENT_60	[p2l1787t2626r1887b2655],
5	schematically	RB	O	schematically	advmod	4	SENT_60	[p2l447t2677r661b2713],
6	at	IN	O	at	_	0	SENT_60	[p2l677t2681r704b2705],
7	the	DT	O	the	det	9	SENT_60	[p2l718t2677r765b2705],
8	plasma	NN	O	plasma	nn	9	SENT_60	[p2l779t2677r891b2713],
9	membrane	NN	O	membrane	prep_at	4	SENT_60	[p2l905t2677r1070b2705],
10	include	VBP	O	include	_	0	SENT_60	[p2l1085t2677r1200b2705],
11	MDRl	NN	O	mdrl	dobj	10	SENT_60	[p2l1214t2677r1331b2710],
12	,	,	O	,	_	0	SENT_60	[p2l1214t2677r1331b2710],
13	MRP	NN	ORGANIZATION	mrp	nn	15	SENT_60	[p2l1347t2678r1430b2704],
14	family	NN	O	family	nn	15	SENT_60	[p2l1444t2677r1545b2713],
15	members	NNS	O	member	conj_and	11	SENT_60	[p2l1560t2677r1712b2710],
16	,	,	O	,	_	0	SENT_60	[p2l1560t2677r1712b2710],
17	and	CC	O	and	_	0	SENT_60	[p2l1729t2677r1784b2705],
18	MXR	NN	O	mxr	dobj	10	SENT_60	[p2l1798t2677r1887b2704],
19	(	CD	NUMBER	(	num	22	SENT_60	[p2l447t2727r538b2761],
20	ABC	NNP	ORGANIZATION	ABC	nn	22	SENT_60	[p2l447t2727r538b2761],
21	G2	NN	O	g2	nn	22	SENT_60	[p2l550t2727r619b2761],
22	)	NN	O	)	nsubj	10	SENT_60	[p2l550t2727r619b2761],
23	,	,	O	,	_	0	SENT_60	[p2l550t2727r619b2761],
24	which	WDT	O	which	nsubjpass	26	SENT_60	[p2l631t2727r727b2755],
25	is	VBZ	O	be	auxpass	26	SENT_60	[p2l737t2727r762b2755],
26	presumed	VBN	O	presume	rcmod	22	SENT_60	[p2l773t2727r926b2763],
27	to	TO	O	to	aux	28	SENT_60	[p2l937t2732r966b2755],
28	function	VB	O	function	xcomp	26	SENT_60	[p2l977t2727r1108b2755],
29	as	IN	O	as	_	0	SENT_60	[p2l1119t2736r1149b2755],
30	a	DT	O	a	det	31	SENT_60	[p2l1162t2736r1178b2755],
31	dimer	NN	O	dimer	prep_as	28	SENT_60	[p2l1189t2727r1285b2755],
32	.	.	O	.	_	0	SENT_60	[p2l1189t2727r1285b2755],

1	resistant	JJ	O	resistant	_	0	SENT_61	[p2l543t2838r682b2867],
2	to	TO	O	to	_	0	SENT_61	[p2l695t2842r726b2867],
3	the	DT	O	the	det	5	SENT_61	[p2l740t2838r789b2867],
4	cytotoxic	JJ	O	cytotoxic	amod	5	SENT_61	[p2l803t2838r955b2876],
5	effects	NNS	O	effect	prep_to	1	SENT_61	[p2l970t2838r1077b2867],
6	of	IN	O	of	_	0	SENT_61	[p2l1092t2838r1128b2867],
7	drugs	NNS	O	drug	prep_of	5	SENT_61	[p2l1139t2838r1229b2876],
8	on	IN	O	on	_	0	SENT_61	[p2l1244t2847r1284b2867],
9	cancer	NN	O	cancer	nn	10	SENT_61	[p2l1298t2847r1406b2867],
10	cells	NNS	O	cell	prep_on	7	SENT_61	[p2l1419t2838r1502b2867],
11	.	.	O	.	_	0	SENT_61	[p2l1419t2838r1502b2867],

1	Expression	NN	O	expression	nsubjpass	29	SENT_62	[p2l1517t2838r1701b2876],
2	of	IN	O	of	_	0	SENT_62	[p2l1715t2838r1751b2867],
3	a	DT	O	a	det	6	SENT_62	[p2l1762t2847r1780b2867],
4	major	JJ	O	major	amod	6	SENT_62	[p2l1792t2838r1889b2876],
5	vault	NN	O	vault	nn	6	SENT_62	[p2l544t2887r625b2916],
6	protein	NN	O	protein	prep_of	1	SENT_62	[p2l639t2887r765b2925],
7	,	,	O	,	_	0	SENT_62	[p2l639t2887r765b2925],
8	termed	VBN	O	term	partmod	1	SENT_62	[p2l780t2887r895b2916],
9	lung	NN	O	lung	nn	11	SENT_62	[p2l909t2887r981b2925],
10	resistance	NN	O	resistance	nn	11	SENT_62	[p2l995t2887r1285b2916],
11	—	NN	O	—	dobj	8	SENT_62	[p2l995t2887r1285b2916],
12	related	JJ	O	related	dep	11	SENT_62	[p2l995t2887r1285b2916],
13	protein	NN	O	protein	nn	16	SENT_62	[p2l1299t2887r1416b2925],
14	(	CD	NUMBER	(	num	16	SENT_62	[p2l1431t2888r1542b2923],
15	LRP	NN	ORGANIZATION	lrp	nn	16	SENT_62	[p2l1431t2888r1542b2923],
16	)	NN	O	)	dobj	12	SENT_62	[p2l1431t2888r1542b2923],
17	,	,	O	,	_	0	SENT_62	[p2l1431t2888r1542b2923],
18	which	WDT	O	which	nsubj	20	SENT_62	[p2l1557t2887r1658b2916],
19	may	MD	O	may	aux	20	SENT_62	[p2l1672t2896r1742b2925],
20	regulate	VB	O	regulate	rcmod	16	SENT_62	[p2l1756t2887r1888b2925],
21	nuclear	JJ	O	nuclear	amod	22	SENT_62	[p2l544t2937r666b2967],
22	entry	NN	O	entry	dobj	20	SENT_62	[p2l677t2942r761b2975],
23	of	IN	O	of	_	0	SENT_62	[p2l773t2937r809b2967],
24	drugs	NNS	O	drug	prep_of	22	SENT_62	[p2l818t2937r917b2975],
25	,	,	O	,	_	0	SENT_62	[p2l818t2937r917b2975],
26	has	VBZ	O	have	aux	29	SENT_62	[p2l930t2937r984b2967],
27	also	RB	O	also	advmod	29	SENT_62	[p2l997t2937r1061b2967],
28	been	VBN	O	be	auxpass	29	SENT_62	[p2l1073t2937r1151b2967],
29	described	VBN	O	describe	_	0	SENT_62	[p2l1162t2937r1320b2967],
30	in	IN	O	in	_	0	SENT_62	[p2l1332t2937r1363b2966],
31	multidrug	JJ	O	multidrug	amod	33	SENT_62	[p2l1374t2937r1537b2975],
32	resistance	NN	O	resistance	nn	33	SENT_62	[p2l1548t2937r1711b2967],
33	(	NN	O	(	prep_in	29	SENT_62	[p2l1724t2937r1753b2973],
34	1	CD	NUMBER	1	num	36	SENT_62	[p2l1724t2937r1753b2973],
35	1a	NN	O	1a	nn	36	SENT_62	[p2l1761t2937r1817b2973],
36	)	NN	O	)	dep	33	SENT_62	[p2l1761t2937r1817b2973],
37	.	.	O	.	_	0	SENT_62	[p2l1761t2937r1817b2973],

1	Among	IN	O	among	_	0	SENT_63	[p2l594t2987r717b3025],
2	these	DT	O	these	det	3	SENT_63	[p2l731t2987r815b3016],
3	mechanisms	NNS	O	mechanism	prep_among	6	SENT_63	[p2l829t2987r1042b3022],
4	,	,	O	,	_	0	SENT_63	[p2l829t2987r1042b3022],
5	we	PRP	O	we	nsubj	6	SENT_63	[p2l1058t2996r1105b3016],
6	know	VBP	O	know	ccomp	22	SENT_63	[p2l1118t2987r1208b3016],
7	the	DT	O	the	dobj	6	SENT_63	[p2l1223t2987r1272b3016],
8	most	RBS	O	most	advmod	7	SENT_63	[p2l1286t2992r1366b3016],
9	about	IN	O	about	_	0	SENT_63	[p2l1380t2987r1471b3016],
10	those	DT	O	those	prep_about	6	SENT_63	[p2l1485t2987r1571b3016],
11	that	WDT	O	that	nsubj	12	SENT_63	[p2l1585t2987r1647b3016],
12	alter	VBP	O	alter	rcmod	10	SENT_63	[p2l1661t2987r1733b3016],
13	accumulation	NN	O	accumulation	nsubj	18	SENT_63	[p2l1747t2996r1887b3016, p2l544t3037r638b3067],
14	of	IN	O	of	_	0	SENT_63	[p2l653t3037r689b3067],
15	drugs	NNS	O	drug	prep_of	13	SENT_63	[p2l702t3037r792b3075],
16	within	IN	O	within	_	0	SENT_63	[p2l809t3037r914b3067],
17	cells	NNS	O	cell	prep_within	15	SENT_63	[p2l930t3037r1003b3067],
18	(	VBP	O	(	ccomp	12	SENT_63	[p2l1021t3037r1082b3073],
19	for	IN	O	for	_	0	SENT_63	[p2l1021t3037r1082b3073],
20	reviews	NNS	O	review	prep_for	18	SENT_63	[p2l1096t3037r1231b3072],
21	,	,	O	,	_	0	SENT_63	[p2l1096t3037r1231b3072],
22	see	VBP	O	see	_	0	SENT_63	[p2l1250t3046r1300b3067],
23	12	CD	NUMBER	12	nsubj	22	SENT_63	[p2l1320t3037r1365b3072],
24	,	,	O	,	_	0	SENT_63	[p2l1320t3037r1365b3072],
25	13	CD	NUMBER	13	num	26	SENT_63	[p2l1379t3037r1437b3073],
26	)	NN	O	)	appos	23	SENT_63	[p2l1379t3037r1437b3073],
27	.	.	O	.	_	0	SENT_63	[p2l1379t3037r1437b3073],

1	This	DT	O	this	det	2	SENT_64	[p2l1455t3037r1527b3067],
2	accumulation	NN	O	accumulation	nsubj	3	SENT_64	[p2l1544t3037r1766b3067],
3	results	VBZ	O	result	_	0	SENT_64	[p2l1781t3037r1888b3067],
4	from	IN	O	from	_	0	SENT_64	[p2l544t3087r624b3116],
5	a	DT	O	a	det	6	SENT_64	[p2l635t3096r652b3116],
6	balance	NN	O	balance	prep_from	3	SENT_64	[p2l662t3087r788b3116],
7	between	IN	O	between	_	0	SENT_64	[p2l798t3087r936b3116],
8	drug	NN	O	drug	nn	9	SENT_64	[p2l947t3087r1021b3125],
9	entry	NN	O	entry	prep_between	6	SENT_64	[p2l1033t3092r1116b3125],
10	and	CC	O	and	_	0	SENT_64	[p2l1128t3087r1186b3116],
11	exit	NN	O	exit	nn	12	SENT_64	[p2l1197t3087r1258b3116],
12	mechanisms	NNS	O	mechanism	prep_between	6	SENT_64	[p2l1268t3087r1480b3116],
13	.	.	O	.	_	0	SENT_64	[p2l1268t3087r1480b3116],

1	Drugs	NNS	O	drug	nsubj	2	SENT_65	[p2l1493t3088r1593b3125],
2	enter	VBP	O	enter	_	0	SENT_65	[p2l1605t3092r1687b3116],
3	cells	NNS	O	cell	dobj	2	SENT_65	[p2l1697t3087r1771b3116],
4	in	IN	O	in	_	0	SENT_65	[p2l1782t3087r1814b3116],
5	various	JJ	O	various	amod	6	SENT_65	[p2l1824t3096r1887b3116, p2l544t3136r611b3165],
6	ways	NNS	O	way	prep_in	3	SENT_65	[p2l624t3145r707b3174],
7	(	CD	NUMBER	(	num	8	SENT_65	[p2l721t3136r841b3174],
8	Figure	NN	O	figure	tmod	2	SENT_65	[p2l721t3136r841b3174],
9	2	CD	NUMBER	2	num	10	SENT_65	[p2l854t3136r895b3172],
10	)	NN	O	)	dep	8	SENT_65	[p2l854t3136r895b3172],
11	.	.	O	.	_	0	SENT_65	[p2l854t3136r895b3172],

1	Each	DT	O	each	nsubjpass	9	SENT_66	[p2l909t3136r992b3165],
2	of	IN	O	of	_	0	SENT_66	[p2l1004t3136r1040b3165],
3	these	DT	O	these	det	4	SENT_66	[p2l1049t3136r1133b3165],
4	mechanisms	NNS	O	mechanism	prep_of	1	SENT_66	[p2l1145t3136r1349b3165],
5	of	IN	O	of	_	0	SENT_66	[p2l1362t3136r1398b3165],
6	entry	NN	O	entry	prep_of	4	SENT_66	[p2l1408t3141r1491b3174],
7	has	VBZ	O	have	aux	9	SENT_66	[p2l1503t3136r1557b3165],
8	been	VBN	O	be	auxpass	9	SENT_66	[p2l1569t3136r1648b3165],
9	determined	VBN	O	determine	_	0	SENT_66	[p2l1660t3136r1846b3165],
10	to	TO	O	to	aux	11	SENT_66	[p2l1857t3141r1888b3165],
11	have	VB	O	have	xcomp	9	SENT_66	[p2l544t3186r620b3216],
12	physiological	JJ	O	physiological	amod	13	SENT_66	[p2l631t3186r855b3224],
13	signiﬁcance	NN	O	signiﬁcance	dobj	11	SENT_66	[p2l868t3186r1064b3224],
14	based	VBN	O	base	partmod	13	SENT_66	[p2l1076t3186r1170b3216],
15	on	IN	O	on	_	0	SENT_66	[p2l1182t3195r1222b3216],
16	detailed	JJ	O	detailed	amod	18	SENT_66	[p2l1235t3186r1365b3216],
17	uptake	NN	O	uptake	nn	18	SENT_66	[p2l1377t3186r1486b3224],
18	studies	NNS	O	study	prep_on	14	SENT_66	[p2l1499t3186r1611b3216],
19	and	CC	O	and	_	0	SENT_66	[p2l1625t3186r1684b3216],
20	on	IN	O	on	_	0	SENT_66	[p2l1696t3195r1736b3216],
21	the	DT	O	the	det	22	SENT_66	[p2l1748t3186r1797b3216],
22	existence	NN	O	existence	conj_and	18	SENT_66	[p2l1810t3186r1888b3216, p2l544t3240r630b3265],
23	of	IN	O	of	_	0	SENT_66	[p2l642t3236r677b3265],
24	resistant	JJ	O	resistant	amod	25	SENT_66	[p2l684t3236r823b3265],
25	mutants	NNS	O	mutant	prep_of	22	SENT_66	[p2l833t3240r962b3265],
26	in	IN	O	in	_	0	SENT_66	[p2l974t3236r1005b3265],
27	which	WDT	O	which	nsubj	28	SENT_66	[p2l1016t3236r1116b3265],
28	defects	VBZ	O	defect	prepc_in	25	SENT_66	[p2l1127t3236r1242b3265],
29	in	IN	O	in	mark	34	SENT_66	[p2l1253t3236r1285b3265],
30	these	DT	O	these	det	31	SENT_66	[p2l1295t3236r1379b3265],
31	pathways	NNS	O	pathway	nsubjpass	34	SENT_66	[p2l1389t3236r1544b3274],
32	have	VBP	O	have	aux	34	SENT_66	[p2l1555t3236r1631b3265],
33	been	VBN	O	be	auxpass	34	SENT_66	[p2l1641t3236r1719b3265],
34	observed	VBN	O	observe	advcl	28	SENT_66	[p2l1730t3236r1886b3265],
35	.	.	O	.	_	0	SENT_66	[p2l1730t3236r1886b3265],

1	GOTTESMAN	NNP	PERSON	GOTTESMAN	_	0	SENT_67	[p2l508t3297r735b3324],

1	Diffusion	NNP	O	Diffusion	nn	2	SENT_68	[p3l913t171r1924b354],
2	jl	NN	O	jl	nsubj	3	SENT_68	[p3l693t1058r2153b1351],
3	go	VB	O	go	_	0	SENT_68	[p3l7t2147r110b2342],
4	_	RB	O	_	advmod	5	SENT_68	[p3l213t2309r231b2328],
5	e.g.	FW	O	e.g.	dobj	3	SENT_68	[p3l679t2154r1028b2296],
6	,	,	O	,	_	0	SENT_68	[p3l679t2154r1028b2296],
7	vinb	NN	O	vinb	nn	9	SENT_68	[p3l1091t2122r2071b2328],
8	|	NN	O	|	nn	9	SENT_68	[p3l1091t2122r2071b2328],
9	asti_n9	NN	O	asti_n9	appos	5	SENT_68	[p3l1091t2122r2071b2328],
10	,	,	O	,	_	0	SENT_68	[p3l1091t2122r2071b2328],
11	U	NNP	O	U	appos	5	SENT_68	[p3l7t2357r78b2437],
12	;	:	O	;	_	0	SENT_68	[p3l7t2357r78b2437],
13	,3	CD	NUMBER	,3	number	14	SENT_68	[p3l126t2341r263b2454],
14	»	CD	NUMBER	»	num	15	SENT_68	[p3l126t2341r263b2454],
15	doxorublcln	NN	O	doxorublcln	dep	11	SENT_68	[p3l1096t2305r2107b2438],
16	3	CD	NUMBER	3	num	19	SENT_68	[p3l7t2449r80b2552],
17	Q	NNP	O	Q	nn	19	SENT_68	[p3l158t2458r229b2537],
18	cg	NN	O	cg	nn	19	SENT_68	[p3l7t2556r78b2618],
19	o	NN	O	o	dep	15	SENT_68	[p3l158t2538r231b2605],

1	Transport	NN	O	transport	nn	2	SENT_69	[p3l90t2795r654b2909],
2	Endocytosis	NN	O	endocytosis	_	0	SENT_69	[p3l1294t2791r2003b2909],
3	i	FW	O	i	nn	5	SENT_69	[p3l264t3148r487b3623],
4	(	FW	O	(	nn	5	SENT_69	[p3l584t3574r714b3697],
5	D	NN	O	d	dep	2	SENT_69	[p3l584t3574r714b3697],
6	)	CD	NUMBER	)	dep	2	SENT_69	[p3l584t3574r714b3697],

1	e.g.	FW	O	e.g.	_	0	SENT_70	[p4l25t193r202b266],
2	,	,	O	,	_	0	SENT_70	[p4l25t193r202b266],
3	nucleoside	JJ	O	nucleoside	amod	4	SENT_70	[p4l224t177r696b247],
4	ews.org	NN	O	ews.org	appos	1	SENT_70	[p4l7t3242r60b3484],
5	only	RB	O	only	advmod	4	SENT_70	[p4l68t3325r139b3477],
6	.	.	O	.	_	0	SENT_70	[p4l68t3325r139b3477],

1	19.9	CD	NUMBER	19.9	_	0	SENT_71	[p4l1216t193r1392b266],
2	.	.	O	.	_	0	SENT_71	[p4l1216t193r1392b266],

1	,	,	O	,	_	0	SENT_72	[p4l1216t193r1392b266],
2	immunotoxins	NNS	O	immunotoxin	nn	3	SENT_72	[p4l1429t175r2040b247],
3	analogs	NNS	O	analog	_	0	SENT_72	[p4l222t270r561b358],

1	Annu	NNP	PERSON	Annu	_	0	SENT_73	[p4l281t1311r304b1391],
2	.	.	O	.	_	0	SENT_73	[p4l281t1311r304b1391],

1	Rev.	NNP	O	Rev.	nn	2	SENT_74	[p4l281t1240r304b1300],
2	Med	NNP	O	Med	_	0	SENT_74	[p4l281t1163r304b1230],
3	.	.	O	.	_	0	SENT_74	[p4l281t1163r304b1230],

1	2002.53:6	CD	NUMBER	2002.53:6	_	0	SENT_75	[p4l281t917r304b1152],
2	l5-627	NN	O	l5-627	dep	1	SENT_75	[p4l281t917r304b1152],
3	.	.	O	.	_	0	SENT_75	[p4l281t917r304b1152],

1	Downlo	NNP	PERSON	Downlo	nsubj	2	SENT_76	[p4l281t801r304b907],
2	aded	VBD	O	ade	_	0	SENT_76	[p4l281t729r304b791],
3	from	IN	O	from	_	0	SENT_76	[p4l281t656r304b720],
4	www	NN	O	www	prep_from	2	SENT_76	[p4l281t391r304b611],
5	.	.	O	.	_	0	SENT_76	[p4l281t391r304b611],

1	annualrev1	NN	O	annualrev1	_	0	SENT_77	[p4l281t391r304b611],
2	by	IN	O	by	_	0	SENT_77	[p4l314t1324r345b1357],
3	University	NNP	ORGANIZATION	University	prep_by	1	SENT_77	[p4l314t1176r345b1315],
4	of	IN	ORGANIZATION	of	_	0	SENT_77	[p4l314t1137r338b1166],
5	Wisconsin	NNP	ORGANIZATION	Wisconsin	prep_of	3	SENT_77	[p4l314t990r338b1131],
6	-	:	O	-	_	0	SENT_77	[p4l328t972r331b980],
7	Madison	NNP	O	Madison	dep	1	SENT_77	[p4l314t845r338b962],
8	on	IN	O	on	_	0	SENT_77	[p4l322t804r338b836],
9	01/05/14	CD	DATE	01/05/14	prep_on	7	SENT_77	[p4l314t663r338b787],
10	.	.	O	.	_	0	SENT_77	[p4l314t663r338b787],

1	For	IN	O	for	_	0	SENT_78	[p4l315t570r338b616],
2	personal	JJ	O	personal	amod	3	SENT_78	[p4l314t449r345b562],
3	use	NN	O	use	pobj	1	SENT_78	[p4l322t396r338b440],

1	Figure	NN	O	figure	nn	3	SENT_79	[p4l436t396r546b432],
2	2	CD	NUMBER	2	num	3	SENT_79	[p4l559t396r577b424],
3	Ways	NNP	O	Ways	_	0	SENT_79	[p4l617t397r702b432],
4	in	IN	O	in	_	0	SENT_79	[p4l716t396r745b424],
5	which	WDT	O	which	dobj	8	SENT_79	[p4l758t396r853b424],
6	drugs	NNS	O	drug	nsubj	8	SENT_79	[p4l866t396r951b433],
7	can	MD	O	can	aux	8	SENT_79	[p4l964t405r1018b424],
8	get	VB	O	get	prepc_in	3	SENT_79	[p4l1031t401r1078b433],
9	into	IN	O	into	_	0	SENT_79	[p4l1090t396r1150b424],
10	cells	NNS	O	cell	prep_into	8	SENT_79	[p4l1163t396r1241b424],
11	.	.	O	.	_	0	SENT_79	[p4l1163t396r1241b424],

1	Examples	NNS	O	example	nsubjpass	3	SENT_80	[p4l1255t396r1409b433],
2	are	VBP	O	be	auxpass	3	SENT_80	[p4l1423t405r1469b424],
3	given	VBN	O	give	_	0	SENT_80	[p4l1482t396r1567b433],
4	for	IN	O	for	_	0	SENT_80	[p4l1579t396r1625b424],
5	the	DT	O	the	det	8	SENT_80	[p4l1637t396r1684b424],
6	three	CD	NUMBER	three	num	8	SENT_80	[p4l1696t396r1774b424],
7	major	JJ	O	major	amod	8	SENT_80	[p4l1786t396r1878b432],
8	routes	NNS	O	route	prep_for	3	SENT_80	[p4l436t451r540b474],
9	:	:	O	:	_	0	SENT_80	[p4l436t451r540b474],
10	diffusion	NN	O	diffusion	dep	8	SENT_80	[p4l553t447r693b474],
11	across	IN	O	across	_	0	SENT_80	[p4l704t455r800b474],
12	the	DT	O	the	det	14	SENT_80	[p4l811t447r858b474],
13	plasma	NN	O	plasma	nn	14	SENT_80	[p4l868t447r980b483],
14	membrane	NN	O	membrane	prep_across	10	SENT_80	[p4l990t447r1163b479],
15	,	,	O	,	_	0	SENT_80	[p4l990t447r1163b479],
16	piggy-backing	VBG	O	piggy-back	partmod	10	SENT_80	[p4l1175t447r1402b483],
17	onto	IN	O	onto	_	0	SENT_80	[p4l1413t451r1481b474],
18	a	DT	O	a	det	19	SENT_80	[p4l1492t455r1509b474],
19	receptor	NN	O	receptor	prep_onto	16	SENT_80	[p4l1518t451r1647b483],
20	or	CC	O	or	_	0	SENT_80	[p4l1657t455r1689b474],
21	transporter	NN	O	transporter	conj_or	19	SENT_80	[p4l1699t451r1875b483],
22	,	,	O	,	_	0	SENT_80	[p4l1699t451r1875b483],
23	and	CC	O	and	_	0	SENT_80	[p4l437t497r492b524],
24	endocytosis	NN	O	endocytosis	conj_and	19	SENT_80	[p4l503t497r695b533],
25	.	.	O	.	_	0	SENT_80	[p4l503t497r695b533],

1	The	DT	O	the	det	2	SENT_81	[p4l534t685r598b714],
2	remainder	NN	O	remainder	nsubj	6	SENT_81	[p4l609t685r778b714],
3	of	IN	O	of	_	0	SENT_81	[p4l790t685r826b714],
4	this	DT	O	this	det	5	SENT_81	[p4l835t685r893b714],
5	review	NN	O	review	prep_of	2	SENT_81	[p4l906t685r1016b714],
6	focuses	VBZ	O	focus	_	0	SENT_81	[p4l1029t685r1151b714],
7	on	IN	O	on	_	0	SENT_81	[p4l1165t695r1205b714],
8	the	DT	O	the	det	9	SENT_81	[p4l1217t685r1266b714],
9	mechanisms	NNS	O	mechanism	prep_on	6	SENT_81	[p4l1279t685r1482b714],
10	of	IN	O	of	_	0	SENT_81	[p4l1496t685r1531b714],
11	multidrug	JJ	O	multidrug	amod	12	SENT_81	[p4l1541t685r1703b723],
12	resistance	NN	O	resistance	prep_of	9	SENT_81	[p4l1715t685r1878b714],
13	resulting	VBG	O	result	partmod	12	SENT_81	[p4l534t735r678b773],
14	from	IN	O	from	_	0	SENT_81	[p4l690t735r770b764],
15	alterations	NNS	O	alteration	prep_from	13	SENT_81	[p4l782t735r952b764],
16	in	IN	O	in	_	0	SENT_81	[p4l964t735r996b764],
17	the	DT	O	the	det	18	SENT_81	[p4l1007t735r1057b764],
18	pathways	NNS	O	pathway	prep_in	15	SENT_81	[p4l1068t735r1223b773],
19	of	IN	O	of	_	0	SENT_81	[p4l1236t735r1271b764],
20	drug	NN	O	drug	nn	21	SENT_81	[p4l1280t735r1355b773],
21	uptake	NN	O	uptake	prep_of	18	SENT_81	[p4l1366t735r1475b773],
22	or	CC	O	or	_	0	SENT_81	[p4l1488t744r1521b764],
23	efﬂux	NN	O	efﬂux	conj_or	21	SENT_81	[p4l1532t735r1627b764],
24	from	IN	O	from	_	0	SENT_81	[p4l1638t735r1719b764],
25	the	DT	O	the	det	26	SENT_81	[p4l1729t735r1779b764],
26	cell	NN	O	cell	prep_from	13	SENT_81	[p4l1791t735r1858b764],
27	.	.	O	.	_	0	SENT_81	[p4l1791t735r1858b764],

1	MECHANISMS	NNS	O	mechanism	_	0	SENT_82	[p4l435t872r756b907],
2	OF	IN	O	of	_	0	SENT_82	[p4l770t872r831b907],
3	DRUG	NN	O	drug	nn	4	SENT_82	[p4l844t872r980b907],
4	RESISTANCE	NN	O	resistance	prep_of	1	SENT_82	[p4l993t872r1274b907],
5	THAT	WDT	O	that	dep	8	SENT_82	[p4l1286t872r1412b906],
6	INCREASE	NNP	O	INCREASE	nn	8	SENT_82	[p4l1425t872r1655b907],
7	DRUG	NN	O	drug	nn	8	SENT_82	[p4l435t930r571b965],
8	EFFLUX	NNP	O	EFFLUX	rcmod	4	SENT_82	[p4l584t931r759b965],
9	FROM	IN	O	from	dep	8	SENT_82	[p4l771t930r907b965],
10	CANCER	NNP	O	CANCER	nn	11	SENT_82	[p4l921t930r1114b965],
11	CELLS	NNS	O	cell	pobj	9	SENT_82	[p4l1126t930r1262b965],

1	It	PRP	O	it	nsubj	2	SENT_83	[p4l534t1036r559b1065],
2	came	VBD	O	come	_	0	SENT_83	[p4l575t1045r661b1065],
3	as	IN	O	as	_	0	SENT_83	[p4l678t1045r710b1065],
4	something	NN	O	something	prep_as	2	SENT_83	[p4l729t1036r899b1073],
5	of	IN	O	of	_	0	SENT_83	[p4l916t1036r952b1065],
6	a	DT	O	a	det	7	SENT_83	[p4l966t1045r983b1065],
7	surprise	NN	O	surprise	prep_of	4	SENT_83	[p4l1000t1036r1129b1073],
8	that	IN	O	that	complm	21	SENT_83	[p4l1145t1036r1207b1065],
9	the	DT	O	the	det	11	SENT_83	[p4l1223t1036r1272b1065],
10	major	JJ	O	major	amod	11	SENT_83	[p4l1288t1036r1385b1073],
11	mechanism	NN	O	mechanism	nsubj	21	SENT_83	[p4l1400t1036r1589b1065],
12	of	IN	O	of	_	0	SENT_83	[p4l1605t1036r1641b1065],
13	multidrug	JJ	O	multidrug	amod	14	SENT_83	[p4l1654t1036r1817b1073],
14	resistance	NN	O	resistance	prep_of	11	SENT_83	[p4l1833t1045r1877b1065, p4l536t1085r664b1114],
15	in	IN	O	in	_	0	SENT_83	[p4l677t1085r708b1114],
16	cultured	VBN	O	culture	prepc_in	14	SENT_83	[p4l721t1085r856b1114],
17	cancer	NN	O	cancer	nn	18	SENT_83	[p4l868t1094r976b1114],
18	cells	NNS	O	cell	dobj	16	SENT_83	[p4l987t1085r1061b1114],
19	was	VBD	O	be	cop	21	SENT_83	[p4l1074t1094r1136b1114],
20	the	DT	O	the	det	21	SENT_83	[p4l1149t1085r1199b1114],
21	expression	NN	O	expression	ccomp	2	SENT_83	[p4l1212t1085r1387b1123],
22	of	IN	O	of	_	0	SENT_83	[p4l1400t1085r1436b1114],
23	an	DT	O	a	det	25	SENT_83	[p4l1446t1094r1483b1114],
24	energy	NN	O	energy	nn	25	SENT_83	[p4l1496t1085r1792b1123],
25	—	NN	O	—	prep_of	21	SENT_83	[p4l1496t1085r1792b1123],
26	dependent	JJ	O	dependent	amod	29	SENT_83	[p4l1496t1085r1792b1123],
27	drug	NN	O	drug	nn	29	SENT_83	[p4l1804t1085r1878b1123],
28	efﬂux	NN	O	efﬂux	nn	29	SENT_83	[p4l535t1135r629b1164],
29	pump	NN	O	pump	dep	25	SENT_83	[p4l639t1144r742b1173],
30	,	,	O	,	_	0	SENT_83	[p4l639t1144r742b1173],
31	known	VBN	O	know	partmod	25	SENT_83	[p4l754t1135r865b1164],
32	alternatively	RB	O	alternatively	advmod	31	SENT_83	[p4l877t1135r1080b1173],
33	as	IN	O	as	_	0	SENT_83	[p4l1092t1144r1124b1164],
34	P-glycoprotein	NN	O	p-glycoprotein	nn	36	SENT_83	[p4l1135t1135r1381b1173],
35	(	CD	NUMBER	(	num	36	SENT_83	[p4l1393t1135r1495b1173],
36	P-gp	NN	O	p-gp	prep_as	31	SENT_83	[p4l1393t1135r1495b1173],
37	)	CD	NUMBER	)	num	36	SENT_83	[p4l1393t1135r1495b1173],
38	or	CC	O	or	_	0	SENT_83	[p4l1508t1144r1542b1164],
39	the	DT	O	the	det	42	SENT_83	[p4l1551t1135r1601b1164],
40	multidrug	JJ	O	multidrug	amod	42	SENT_83	[p4l1612t1135r1774b1173],
41	transporter	NN	O	transporter	nn	42	SENT_83	[p4l1785t1139r1877b1164, p4l534t1189r633b1222],
42	(	NN	O	(	conj_or	25	SENT_83	[p4l649t1185r711b1220],
43	14	CD	NUMBER	14	dep	42	SENT_83	[p4l649t1185r711b1220],
44	,	,	O	,	_	0	SENT_83	[p4l649t1185r711b1220],
45	15	CD	NUMBER	15	num	46	SENT_83	[p4l725t1185r783b1220],
46	)	NN	O	)	appos	43	SENT_83	[p4l725t1185r783b1220],
47	.	.	O	.	_	0	SENT_83	[p4l725t1185r783b1220],

1	This	DT	O	this	det	3	SENT_84	[p4l800t1185r872b1214],
2	efﬂux	NN	O	efﬂux	nn	3	SENT_84	[p4l889t1185r983b1214],
3	pump	NN	O	pump	nsubj	39	SENT_84	[p4l998t1194r1101b1222],
4	,	,	O	,	_	0	SENT_84	[p4l998t1194r1101b1222],
5	the	DT	O	the	det	6	SENT_84	[p4l1118t1185r1167b1214],
6	product	NN	O	product	appos	3	SENT_84	[p4l1182t1185r1309b1222],
7	of	IN	O	of	_	0	SENT_84	[p4l1324t1185r1360b1214],
8	the	DT	O	the	det	10	SENT_84	[p4l1372t1185r1422b1214],
9	MDR1	NN	O	mdr1	nn	10	SENT_84	[p4l1436t1185r1543b1213],
10	gene	NN	O	gene	prep_of	6	SENT_84	[p4l1563t1194r1639b1222],
11	in	IN	O	in	_	0	SENT_84	[p4l1655t1185r1686b1213],
12	the	DT	O	the	det	16	SENT_84	[p4l1701t1185r1751b1214],
13	human	JJ	O	human	amod	16	SENT_84	[p4l1766t1185r1878b1214],
14	(	NN	O	(	nn	16	SENT_84	[p4l536t1234r601b1270],
15	16	CD	NUMBER	16	num	16	SENT_84	[p4l536t1234r601b1270],
16	)	NN	O	)	prep_in	10	SENT_84	[p4l536t1234r601b1270],
17	and	CC	O	and	_	0	SENT_84	[p4l613t1234r671b1263],
18	the	DT	O	the	det	19	SENT_84	[p4l680t1234r730b1263],
19	product	NN	O	product	conj_and	10	SENT_84	[p4l739t1234r865b1272],
20	of	IN	O	of	_	0	SENT_84	[p4l875t1234r911b1263],
21	two	CD	NUMBER	two	num	24	SENT_84	[p4l917t1238r977b1263],
22	different	JJ	O	different	amod	24	SENT_84	[p4l988t1234r1129b1263],
23	related	JJ	O	related	amod	24	SENT_84	[p4l1137t1234r1250b1263],
24	genes	NNS	O	gene	prep_of	19	SENT_84	[p4l1259t1243r1361b1272],
25	,	,	O	,	_	0	SENT_84	[p4l1259t1243r1361b1272],
26	mdrla	NN	O	mdrlum	appos	3	SENT_84	[p4l1372t1234r1478b1263],
27	and	CC	O	and	_	0	SENT_84	[p4l1487t1234r1546b1263],
28	mdrlb	NN	O	mdrlb	appos	3	SENT_84	[p4l1555t1234r1661b1263],
29	in	IN	O	in	_	0	SENT_84	[p4l1671t1234r1703b1263],
30	the	DT	O	the	det	32	SENT_84	[p4l1712t1234r1761b1263],
31	mouse	NN	O	mouse	nn	32	SENT_84	[p4l1771t1243r1878b1263],
32	(	NN	O	(	prep_in	26	SENT_84	[p4l536t1284r547b1320],
33	17	CD	NUMBER	17	dep	26	SENT_84	[p4l552t1284r597b1318],
34	,	,	O	,	_	0	SENT_84	[p4l552t1284r597b1318],
35	18	CD	NUMBER	18	num	36	SENT_84	[p4l611t1284r670b1320],
36	)	NN	O	)	appos	3	SENT_84	[p4l611t1284r670b1320],
37	,	,	O	,	_	0	SENT_84	[p4l611t1284r670b1320],
38	was	VBD	O	be	cop	39	SENT_84	[p4l680t1293r741b1313],
39	one	CD	NUMBER	one	_	0	SENT_84	[p4l751t1293r809b1313],
40	of	IN	O	of	_	0	SENT_84	[p4l817t1284r853b1313],
41	the	DT	O	the	det	43	SENT_84	[p4l858t1284r907b1313],
42	ﬁrst	NN	O	ﬁrst	nn	43	SENT_84	[p4l915t1284r979b1313],
43	members	NNS	O	member	prep_of	39	SENT_84	[p4l986t1284r1136b1313],
44	described	VBN	O	describe	partmod	43	SENT_84	[p4l1145t1284r1303b1313],
45	of	IN	O	of	_	0	SENT_84	[p4l1311t1284r1347b1313],
46	a	DT	O	a	det	48	SENT_84	[p4l1352t1293r1370b1313],
47	large	JJ	O	large	amod	48	SENT_84	[p4l1377t1284r1458b1322],
48	family	NN	O	family	prep_of	44	SENT_84	[p4l1466t1284r1572b1322],
49	of	IN	O	of	_	0	SENT_84	[p4l1581t1284r1616b1313],
50	ATP	NN	O	atp	nn	53	SENT_84	[p4l1621t1284r1879b1322],
51	—	NN	O	—	nn	53	SENT_84	[p4l1621t1284r1879b1322],
52	dependent	JJ	O	dependent	amod	53	SENT_84	[p4l1621t1284r1879b1322],
53	transporters	NNS	O	transporter	prep_of	48	SENT_84	[p4l534t1338r728b1371],
54	known	VBN	O	know	partmod	48	SENT_84	[p4l741t1334r853b1363],
55	as	IN	O	as	_	0	SENT_84	[p4l866t1343r898b1363],
56	the	DT	O	the	det	59	SENT_84	[p4l911t1334r960b1363],
57	ATP	NN	O	atp	nn	59	SENT_84	[p4l973t1334r1186b1371],
58	—	NN	O	—	nn	59	SENT_84	[p4l973t1334r1186b1371],
59	binding	NN	O	binding	prep_as	54	SENT_84	[p4l973t1334r1186b1371],
60	cassette	NN	O	cassette	nn	62	SENT_84	[p4l1199t1338r1327b1363],
61	(	CD	NUMBER	(	num	62	SENT_84	[p4l1341t1334r1450b1369],
62	ABC	NNP	ORGANIZATION	ABC	dep	59	SENT_84	[p4l1341t1334r1450b1369],
63	)	CD	NUMBER	)	num	64	SENT_84	[p4l1341t1334r1450b1369],
64	family	NN	O	family	dep	62	SENT_84	[p4l1464t1334r1570b1371],
65	(	CD	NUMBER	(	number	66	SENT_84	[p4l1584t1334r1659b1370],
66	19	CD	NUMBER	19	num	67	SENT_84	[p4l1584t1334r1659b1370],
67	)	NN	O	)	dep	64	SENT_84	[p4l1584t1334r1659b1370],
68	.	.	O	.	_	0	SENT_84	[p4l1584t1334r1659b1370],

1	Every	DT	O	every	det	3	SENT_85	[p4l1674t1334r1771b1371],
2	living	NN	O	living	nn	3	SENT_85	[p4l1784t1334r1878b1371],
3	organism	NN	O	organism	nsubj	5	SENT_85	[p4l535t1383r688b1421],
4	has	VBZ	O	have	aux	5	SENT_85	[p4l699t1384r753b1413],
5	encoded	VBN	O	encode	_	0	SENT_85	[p4l767t1383r904b1413],
6	within	IN	O	within	_	0	SENT_85	[p4l916t1383r1021b1413],
7	its	PRP$	O	its	poss	10	SENT_85	[p4l1033t1383r1070b1413],
8	genome	NN	O	genome	nn	10	SENT_85	[p4l1084t1393r1214b1421],
9	many	JJ	O	many	amod	10	SENT_85	[p4l1227t1393r1317b1421],
10	members	NNS	O	member	prep_within	5	SENT_85	[p4l1330t1384r1480b1413],
11	of	IN	O	of	_	0	SENT_85	[p4l1494t1383r1529b1412],
12	this	DT	O	this	det	13	SENT_85	[p4l1539t1383r1597b1412],
13	family	NN	O	family	prep_of	10	SENT_85	[p4l1610t1383r1723b1421],
14	,	,	O	,	_	0	SENT_85	[p4l1610t1383r1723b1421],
15	and	CC	O	and	_	0	SENT_85	[p4l1738t1383r1797b1413],
16	they	PRP	O	they	nsubj	17	SENT_85	[p4l1809t1383r1878b1421],
17	appear	VBP	O	appear	conj_and	5	SENT_85	[p4l535t1442r645b1471],
18	to	TO	O	to	aux	20	SENT_85	[p4l661t1438r692b1462],
19	be	VB	O	be	auxpass	20	SENT_85	[p4l709t1433r747b1462],
20	involved	VBN	O	involve	xcomp	17	SENT_85	[p4l764t1433r906b1462],
21	not	RB	O	not	neg	22	SENT_85	[p4l922t1438r975b1462],
22	only	RB	O	only	preconj	20	SENT_85	[p4l992t1433r1064b1471],
23	in	IN	O	in	_	0	SENT_85	[p4l1081t1433r1113b1462],
24	efﬂux	NN	O	efﬂux	prep_in	20	SENT_85	[p4l1130t1433r1224b1462],
25	of	IN	O	of	_	0	SENT_85	[p4l1242t1433r1278b1462],
26	drugs	NNS	O	drug	prep_of	24	SENT_85	[p4l1292t1433r1382b1471],
27	but	CC	O	but	_	0	SENT_85	[p4l1399t1433r1452b1462],
28	in	IN	O	in	_	0	SENT_85	[p4l1468t1433r1499b1462],
29	moving	VBG	O	move	prep_in	20	SENT_85	[p4l1516t1433r1641b1471],
30	nutrients	NNS	O	nutrient	dobj	29	SENT_85	[p4l1659t1433r1802b1462],
31	and	CC	O	and	_	0	SENT_85	[p4l1821t1433r1879b1462],
32	other	JJ	O	other	amod	35	SENT_85	[p4l535t1482r619b1512],
33	biologically	RB	O	biologically	advmod	34	SENT_85	[p4l628t1482r825b1520],
34	important	JJ	O	important	amod	35	SENT_85	[p4l835t1482r996b1520],
35	molecules	NNS	O	molecule	conj_and	30	SENT_85	[p4l1005t1482r1172b1512],
36	into	IN	O	into	prep	29	SENT_85	[p4l1182t1482r1255b1517],
37	,	,	O	,	_	0	SENT_85	[p4l1182t1482r1255b1517],
38	out	IN	O	out	advmod	29	SENT_85	[p4l1266t1487r1318b1512],
39	of	IN	O	of	prep	38	SENT_85	[p4l1328t1482r1370b1517],
40	,	,	O	,	_	0	SENT_85	[p4l1328t1482r1370b1517],
41	and	CC	O	and	_	0	SENT_85	[p4l1382t1482r1440b1512],
42	across	IN	O	across	prep	38	SENT_85	[p4l1450t1491r1551b1512],
43	plasma	NN	O	plasma	nn	44	SENT_85	[p4l1561t1482r1679b1520],
44	membranes	NNS	O	membrane	pobj	42	SENT_85	[p4l1688t1482r1877b1512],
45	and	CC	O	and	_	0	SENT_85	[p4l535t1532r594b1561],
46	intracellular	JJ	O	intracellular	amod	47	SENT_85	[p4l608t1532r809b1561],
47	membranes	NNS	O	membrane	pobj	42	SENT_85	[p4l823t1532r1013b1561],
48	in	IN	O	in	_	0	SENT_85	[p4l1029t1532r1060b1561],
49	cells	NNS	O	cell	prep_in	47	SENT_85	[p4l1075t1532r1158b1561],
50	.	.	O	.	_	0	SENT_85	[p4l1075t1532r1158b1561],

1	P-gp	NN	O	p-gp	nsubjpass	4	SENT_86	[p4l1176t1533r1252b1570],
2	is	VBZ	O	be	auxpass	4	SENT_86	[p4l1268t1532r1294b1561],
3	widely	RB	O	widely	advmod	4	SENT_86	[p4l1310t1532r1422b1570],
4	expressed	VBN	O	express	_	0	SENT_86	[p4l1437t1532r1599b1570],
5	in	IN	O	in	_	0	SENT_86	[p4l1614t1532r1646b1561],
6	many	JJ	O	many	amod	8	SENT_86	[p4l1661t1541r1751b1570],
7	human	JJ	O	human	amod	8	SENT_86	[p4l1766t1532r1879b1561],
8	cancers	NNS	O	cancer	prep_in	4	SENT_86	[p4l535t1590r667b1615],
9	,	,	O	,	_	0	SENT_86	[p4l535t1590r667b1615],
10	including	VBG	O	include	_	0	SENT_86	[p4l683t1581r838b1619],
11	cancers	NNS	O	cancer	prep_including	4	SENT_86	[p4l854t1590r976b1610],
12	of	IN	O	of	_	0	SENT_86	[p4l993t1581r1029b1610],
13	the	DT	O	the	det	18	SENT_86	[p4l1041t1581r1090b1610],
14	gastrointestinal	JJ	O	gastrointestinal	amod	18	SENT_86	[p4l1106t1581r1358b1619],
15	(	NN	O	(	nn	18	SENT_86	[p4l1374t1581r1442b1617],
16	GI	NN	O	gi	nn	18	SENT_86	[p4l1374t1581r1442b1617],
17	)	CD	NUMBER	)	num	18	SENT_86	[p4l1374t1581r1442b1617],
18	tract	NN	O	tract	prep_of	11	SENT_86	[p4l1458t1586r1531b1610],
19	(	CD	NUMBER	(	number	20	SENT_86	[p4l1547t1581r1648b1617],
20	small	JJ	O	small	nsubj	62	SENT_86	[p4l1547t1581r1648b1617],
21	and	CC	O	and	_	0	SENT_86	[p4l1664t1581r1723b1610],
22	large	JJ	O	large	amod	23	SENT_86	[p4l1737t1581r1818b1619],
23	intestine	NN	O	intestine	conj_and	20	SENT_86	[p4l1834t1581r1877b1610, p4l534t1630r651b1665],
24	,	,	O	,	_	0	SENT_86	[p4l1834t1581r1877b1610, p4l534t1630r651b1665],
25	liver	NN	O	liver	nn	26	SENT_86	[p4l664t1630r739b1660],
26	cancer	NN	O	cancer	appos	20	SENT_86	[p4l750t1639r864b1665],
27	,	,	O	,	_	0	SENT_86	[p4l750t1639r864b1665],
28	and	CC	O	and	_	0	SENT_86	[p4l879t1630r937b1660],
29	pancreatic	JJ	O	pancreatic	amod	31	SENT_86	[p4l949t1630r1118b1668],
30	cancer	NN	O	cancer	nn	31	SENT_86	[p4l1131t1630r1261b1666],
31	)	NN	O	)	conj_and	20	SENT_86	[p4l1131t1630r1261b1666],
32	,	,	O	,	_	0	SENT_86	[p4l1131t1630r1261b1666],
33	cancers	NNS	O	cancer	conj_and	20	SENT_86	[p4l1275t1639r1397b1660],
34	of	IN	O	of	_	0	SENT_86	[p4l1411t1630r1446b1659],
35	the	DT	O	the	det	39	SENT_86	[p4l1456t1630r1505b1660],
36	hematopoietic	JJ	O	hematopoietic	amod	39	SENT_86	[p4l1517t1630r1751b1668],
37	system	NN	O	system	nn	39	SENT_86	[p4l1765t1634r1879b1668],
38	(	CD	NUMBER	(	num	39	SENT_86	[p4l536t1680r710b1718],
39	myeloma	NN	O	myeloma	prep_of	33	SENT_86	[p4l536t1680r710b1718],
40	,	,	O	,	_	0	SENT_86	[p4l536t1680r710b1718],
41	lymphoma	NN	O	lymphoma	conj_and	20	SENT_86	[p4l728t1680r913b1718],
42	,	,	O	,	_	0	SENT_86	[p4l728t1680r913b1718],
43	leukemia	NN	O	leukemia	nn	44	SENT_86	[p4l931t1680r1104b1716],
44	)	NN	O	)	appos	41	SENT_86	[p4l931t1680r1104b1716],
45	,	,	O	,	_	0	SENT_86	[p4l931t1680r1104b1716],
46	cancers	NNS	O	cancer	conj_and	20	SENT_86	[p4l1122t1689r1244b1709],
47	of	IN	O	of	_	0	SENT_86	[p4l1262t1680r1298b1709],
48	the	DT	O	the	det	52	SENT_86	[p4l1311t1680r1360b1709],
49	genitourinary	JJ	O	genitourinary	amod	52	SENT_86	[p4l1377t1680r1599b1718],
50	system	NN	O	system	nn	52	SENT_86	[p4l1617t1684r1730b1718],
51	(	CD	NUMBER	(	num	52	SENT_86	[p4l1747t1680r1877b1718],
52	kidney	NN	O	kidney	prep_of	46	SENT_86	[p4l1747t1680r1877b1718],
53	,	,	O	,	_	0	SENT_86	[p4l1747t1680r1877b1718],
54	ovary	NN	O	ovary	nsubj	62	SENT_86	[p4l535t1738r632b1767],
55	,	,	O	,	_	0	SENT_86	[p4l535t1738r632b1767],
56	testicle	NN	O	testicle	nn	57	SENT_86	[p4l649t1729r788b1765],
57	)	NN	O	)	appos	54	SENT_86	[p4l649t1729r788b1765],
58	,	,	O	,	_	0	SENT_86	[p4l649t1729r788b1765],
59	and	CC	O	and	_	0	SENT_86	[p4l805t1729r863b1759],
60	childhood	NN	O	childhood	nn	61	SENT_86	[p4l878t1729r1043b1759],
61	cancers	NNS	O	cancer	nsubj	62	SENT_86	[p4l1058t1738r1180b1759],
62	(	VBP	O	(	rcmod	18	SENT_86	[p4l1197t1729r1461b1765],
63	neuroblastoma	NN	O	neuroblastoma	dobj	62	SENT_86	[p4l1197t1729r1461b1765],
64	,	,	O	,	_	0	SENT_86	[p4l1197t1729r1461b1765],
65	ﬁbrosarcoma	NN	O	ﬁbrosarcoma	appos	63	SENT_86	[p4l1478t1729r1706b1765],
66	)	CD	NUMBER	)	num	65	SENT_86	[p4l1478t1729r1706b1765],
67	(	CD	NUMBER	(	number	68	SENT_86	[p4l1723t1729r1798b1765],
68	20	CD	NUMBER	20	num	69	SENT_86	[p4l1723t1729r1798b1765],
69	)	NN	O	)	dep	65	SENT_86	[p4l1723t1729r1798b1765],
70	.	.	O	.	_	0	SENT_86	[p4l1723t1729r1798b1765],

1	The	DT	O	the	det	3	SENT_87	[p4l1815t1729r1878b1759],
2	human	JJ	O	human	amod	3	SENT_87	[p4l534t1779r646b1808],
3	gene	NN	O	gene	nsubj	10	SENT_87	[p4l667t1788r744b1817],
4	most	RBS	O	most	advmod	6	SENT_87	[p4l765t1783r845b1808],
5	closely	RB	O	closely	advmod	6	SENT_87	[p4l865t1779r981b1817],
6	related	JJ	O	related	amod	3	SENT_87	[p4l1002t1779r1115b1808],
7	to	TO	O	to	_	0	SENT_87	[p4l1135t1783r1165b1808],
8	MDR1	NN	O	mdr1	prep_to	6	SENT_87	[p4l1185t1779r1293b1808],
9	is	VBZ	O	be	cop	10	SENT_87	[p4l1317t1779r1343b1808],
10	MDR2	NN	O	mdr2	_	0	SENT_87	[p4l1363t1779r1482b1814],
11	,	,	O	,	_	0	SENT_87	[p4l1363t1779r1482b1814],
12	a	DT	O	a	det	14	SENT_87	[p4l1506t1788r1523b1808],
13	phosphatidylcholine	NN	O	phosphatidylcholine	nn	14	SENT_87	[p4l1542t1779r1878b1817],
14	transporter	NN	O	transporter	appos	10	SENT_87	[p4l535t1833r714b1866],
15	expressed	VBN	O	express	partmod	14	SENT_87	[p4l729t1828r891b1866],
16	in	IN	O	in	_	0	SENT_87	[p4l906t1828r938b1857],
17	liver	NN	O	liver	prep_in	15	SENT_87	[p4l953t1828r1027b1857],
18	whose	WP$	O	whose	poss	19	SENT_87	[p4l1042t1828r1147b1857],
19	defect	NN	O	defect	nsubj	20	SENT_87	[p4l1163t1828r1263b1857],
20	results	VBZ	O	result	rcmod	17	SENT_87	[p4l1278t1828r1385b1857],
21	in	IN	O	in	_	0	SENT_87	[p4l1401t1828r1433b1857],
22	inability	NN	O	inability	prep_in	20	SENT_87	[p4l1448t1828r1585b1866],
23	to	TO	O	to	aux	24	SENT_87	[p4l1601t1833r1631b1857],
24	form	VB	O	form	xcomp	20	SENT_87	[p4l1648t1828r1728b1857],
25	bile	NN	O	bile	dobj	24	SENT_87	[p4l1742t1828r1804b1857],
26	and	CC	O	and	_	0	SENT_87	[p4l1820t1828r1879b1857],
27	progressive	JJ	O	progressive	amod	28	SENT_87	[p4l534t1877r723b1915],
28	cirrhosis	NN	O	cirrhosis	conj_and	25	SENT_87	[p4l735t1877r876b1907],
29	(	CD	NUMBER	(	number	30	SENT_87	[p4l889t1877r964b1913],
30	21	CD	NUMBER	21	num	31	SENT_87	[p4l889t1877r964b1913],
31	)	NN	O	)	dep	28	SENT_87	[p4l889t1877r964b1913],
32	.	.	O	.	_	0	SENT_87	[p4l889t1877r964b1913],

1	P-gp	NN	O	p-gp	nsubj	21	SENT_88	[p4l584t1928r670b1965],
2	,	,	O	,	_	0	SENT_88	[p4l584t1928r670b1965],
3	the	DT	O	the	det	7	SENT_88	[p4l684t1927r734b1956],
4	human	JJ	O	human	amod	7	SENT_88	[p4l746t1927r859b1956],
5	MDR1	NN	O	mdr1	nn	7	SENT_88	[p4l870t1927r977b1956],
6	gene	NN	O	gene	nn	7	SENT_88	[p4l994t1936r1070b1965],
7	product	NN	O	product	appos	1	SENT_88	[p4l1082t1927r1209b1965],
8	and	CC	O	and	_	0	SENT_88	[p4l1222t1927r1281b1956],
9	one	CD	NUMBER	one	appos	1	SENT_88	[p4l1293t1936r1351b1956],
10	of	IN	O	of	_	0	SENT_88	[p4l1365t1927r1400b1956],
11	48	CD	NUMBER	48	num	14	SENT_88	[p4l1410t1927r1449b1957],
12	known	JJ	O	known	amod	14	SENT_88	[p4l1463t1927r1574b1956],
13	ABC	NNP	ORGANIZATION	ABC	nn	14	SENT_88	[p4l1586t1927r1670b1957],
14	transporters	NNS	O	transporter	prep_of	9	SENT_88	[p4l1683t1932r1877b1965],
15	in	IN	O	in	_	0	SENT_88	[p4l534t1976r566b2005],
16	the	DT	O	the	det	17	SENT_88	[p4l594t1976r643b2005],
17	human	JJ	O	human	prep_in	14	SENT_88	[p4l671t1976r792b2011],
18	,	,	O	,	_	0	SENT_88	[p4l671t1976r792b2011],
19	is	VBZ	O	be	cop	21	SENT_88	[p4l822t1976r848b2005],
20	a	DT	O	a	det	21	SENT_88	[p4l878t1985r895b2005],
21	l70	NN	O	l70	_	0	SENT_88	[p4l926t1976r1361b2011],
22	,000	CD	NUMBER	,000	number	23	SENT_88	[p4l926t1976r1361b2011],
23	—	CD	NUMBER	—	num	24	SENT_88	[p4l926t1976r1361b2011],
24	dalton	NN	O	dalton	dep	21	SENT_88	[p4l926t1976r1361b2011],
25	—	CD	NUMBER	—	num	28	SENT_88	[p4l926t1976r1361b2011],
26	molecular	JJ	O	molecular	amod	28	SENT_88	[p4l926t1976r1361b2011],
27	weight	NN	O	weight	nn	28	SENT_88	[p4l1389t1976r1501b2014],
28	phosphoglycoprotein	NN	O	phosphoglycoprotein	dep	24	SENT_88	[p4l1528t1976r1879b2014],

1	DRUG	NN	O	drug	nn	2	SENT_89	[p4l1107t2036r1210b2063],
2	RESISTANCE	NN	O	resistance	_	0	SENT_89	[p4l1220t2036r1442b2063],
3	IN	IN	O	in	_	0	SENT_89	[p4l1453t2037r1491b2063],
4	CANCER	NNP	O	CANCER	prep_in	2	SENT_89	[p4l1502t2036r1652b2063],
5	619	CD	NUMBER	619	num	4	SENT_89	[p4l1741t2033r1801b2063],

1	Common	JJ	O	common	amod	3	SENT_90	[p4l385t2165r566b2198],
2	Official	NNP	O	Official	nn	3	SENT_90	[p4l617t2165r758b2198],
3	Names	NNPS	O	Names	nsubj	4	SENT_90	[p4l409t2221r544b2252],
4	Name	VB	O	name	_	0	SENT_90	[p4l633t2221r746b2252],
5	Structure	NN	O	structure	nn	6	SENT_90	[p4l826t2220r1013b2252],
6	Substrates	NNS	O	substrate	nsubj	8	SENT_90	[p4l1123t2221r1338b2253],
7	Normal	JJ	O	normal	amod	8	SENT_90	[p4l1440t2221r1581b2253],
8	location	NN	O	location	xcomp	4	SENT_90	[p4l1597t2220r1754b2252],

1	P-gp	NN	O	p-gp	_	0	SENT_91	[p4l455t2413r641b2489],
2	,	,	O	,	_	0	SENT_91	[p4l455t2413r641b2489],
3	MDR1	NN	O	mdr1	nn	5	SENT_91	[p4l669t2413r872b2473],
4	ABC	NNP	ORGANIZATION	ABC	nn	5	SENT_91	[p4l1020t2413r1185b2473],
5	B1	NN	O	b1	appos	1	SENT_91	[p4l1215t2413r1296b2473],

1	MFIP1	NN	O	mfip1	_	0	SENT_92	[p4l479t2657r677b2714],

1	MRP2	NN	O	mrp2	_	0	SENT_93	[p4l450t2948r679b3016],
2	,	,	O	,	_	0	SENT_93	[p4l450t2948r679b3016],
3	cMOAT	NN	O	cmoat	appos	1	SENT_93	[p4l448t3023r717b3085],

1	MRP3	NN	O	mrp3	_	0	SENT_94	[p4l450t3250r679b3321],
2	,	,	O	,	_	0	SENT_94	[p4l450t3250r679b3321],
3	MOAT-D	NN	O	moat-d	appos	1	SENT_94	[p4l450t3327r754b3387],

1	Neutral	JJ	O	neutral	amod	4	SENT_95	[p5l10t137r339b214],
2	and	CC	O	and	_	0	SENT_95	[p5l373t137r545b214],
3	cationic	JJ	O	cationic	conj_and	1	SENT_95	[p5l576t137r942b214],
4	intestine	NN	O	intestine	_	0	SENT_95	[p5l1102t137r1522b228],
5	,	,	O	,	_	0	SENT_95	[p5l1102t137r1522b228],
6	liver	NN	O	liver	appos	4	SENT_95	[p5l1560t137r1780b228],
7	,	,	O	,	_	0	SENT_95	[p5l1560t137r1780b228],
8	kidney	NN	O	kidney	appos	4	SENT_95	[p5l1818t137r2143b231],
9	,	,	O	,	_	0	SENT_95	[p5l1818t137r2143b231],
10	organic	JJ	O	organic	amod	11	SENT_95	[p5l7t234r360b332],
11	compounds	NNS	O	compound	appos	4	SENT_95	[p5l391t237r942b332],
12	blood-brain	JJ	O	blood-brain	amod	13	SENT_95	[p5l1099t234r1630b311],
13	barrier	NN	O	barrier	dep	11	SENT_95	[p5l1668t234r1975b311],

1	GS-X	NN	O	gs-x	_	0	SENT_96	[p5l7t499r245b572],
2	and	CC	O	and	_	0	SENT_96	[p5l275t499r443b572],
3	other	JJ	O	other	conj_and	1	SENT_96	[p5l478t499r719b572],
4	widespread	JJ	O	widespread	amod	5	SENT_96	[p5l1095t499r1630b593],
5	conjugates	NNS	O	conjugate	dep	1	SENT_96	[p5l7t596r548b690],
6	,	,	O	,	_	0	SENT_96	[p5l7t596r548b690],
7	organic	JJ	O	organic	amod	8	SENT_96	[p5l7t711r360b809],
8	anions	NNS	O	anion	appos	5	SENT_96	[p5l391t711r702b788],

1	GS-X	NN	O	gs-x	nn	4	SENT_97	[p5l7t1021r245b1098],
2	and	CC	O	and	_	0	SENT_97	[p5l275t1021r443b1098],
3	other	JJ	O	other	nn	4	SENT_97	[p5l478t1021r719b1098],
4	liver	NN	O	liver	_	0	SENT_97	[p5l1102t1021r1323b1112],
5	,	,	O	,	_	0	SENT_97	[p5l1102t1021r1323b1112],
6	kidney	NN	O	kidney	appos	4	SENT_97	[p5l1361t1021r1686b1115],
7	,	,	O	,	_	0	SENT_97	[p5l1361t1021r1686b1115],
8	intestine	NN	O	intestine	nn	9	SENT_97	[p5l1724t1021r2118b1094],
9	conjugates	NNS	O	conjugate	appos	4	SENT_97	[p5l7t1118r548b1216],
10	,	,	O	,	_	0	SENT_97	[p5l7t1118r548b1216],
11	organic	JJ	O	organic	amod	12	SENT_97	[p5l7t1219r360b1312],
12	anions	NNS	O	anion	appos	4	SENT_97	[p5l391t1215r702b1291],

1	GS-X	NN	O	gs-x	nn	2	SENT_98	[p5l7t1512r245b1586],
2	conjugates	NNS	O	conjugate	_	0	SENT_98	[p5l275t1512r813b1607],
3	,	,	O	,	_	0	SENT_98	[p5l275t1512r813b1607],
4	pancreas	NN	O	pancreas	dep	2	SENT_98	[p5l1099t1522r1550b1617],
5	,	,	O	,	_	0	SENT_98	[p5l1099t1522r1550b1617],
6	ttidney	NN	O	ttidney	appos	4	SENT_98	[p5l1584t1500r1916b1617],
7	,	,	O	,	_	0	SENT_98	[p5l1584t1500r1916b1617],
8	anti-folates	NNS	O	anti-folate	appos	4	SENT_98	[p5l7t1610r552b1701],
9	,	,	O	,	_	0	SENT_98	[p5l7t1610r552b1701],
10	bile	NN	O	bile	nn	11	SENT_98	[p5l586t1610r751b1687],
11	Intestine	NN	O	intestine	appos	4	SENT_98	[p5l1099t1606r1522b1694],
12	,	,	O	,	_	0	SENT_98	[p5l1099t1606r1522b1694],
13	lwer	NN	O	lwer	appos	4	SENT_98	[p5l1556t1603r1776b1691],
14	,	,	O	,	_	0	SENT_98	[p5l1556t1603r1776b1691],
15	adrenal	JJ	O	adrenal	amod	16	SENT_98	[p5l1811t1603r2153b1677],
16	acids	NNS	O	acid	appos	4	SENT_98	[p5l7t1708r279b1799],
17	,	,	O	,	_	0	SENT_98	[p5l7t1708r279b1799],
18	etoposide	NN	O	etoposide	appos	4	SENT_98	[p5l310t1708r796b1802],
19	,	,	O	,	_	0	SENT_98	[p5l310t1708r796b1802],

1	MRP4	NN	O	mrp4	_	0	SENT_99	[p5l467t1834r563b1864],
2	,	,	O	,	_	0	SENT_99	[p5l467t1834r563b1864],
3	ABC	NNP	ORGANIZATION	ABC	nn	6	SENT_99	[p5l708t1838r778b1864],
4	C4	NN	O	c4	nn	6	SENT_99	[p5l790t1838r830b1864],
5	nucleoslde	NN	O	nucleoslde	nn	6	SENT_99	[p5l1225t1833r1370b1855],
6	analogs	NNS	O	analog	dep	1	SENT_99	[p5l1379t1833r1491b1861],
7	,	,	O	,	_	0	SENT_99	[p5l1379t1833r1491b1861],
8	prostate	NN	O	prostate	appos	6	SENT_99	[p5l1537t1819r1653b1866],
9	,	,	O	,	_	0	SENT_99	[p5l1537t1819r1653b1866],
10	testls	NNS	O	testl	appos	6	SENT_99	[p5l1662t1832r1742b1859],
11	,	,	O	,	_	0	SENT_99	[p5l1662t1832r1742b1859],
12	ovary	NN	O	ovary	appos	6	SENT_99	[p5l1752t1838r1833b1861],
13	,	,	O	,	_	0	SENT_99	[p5l1752t1838r1833b1861],

1	>	JJR	O	>	amod	3	SENT_100	[p5l279t1827r294b1842],
2	a	DT	O	a	det	3	SENT_100	[p5l312t1823r328b1849],
3	£	NN	MONEY	£	_	0	SENT_100	[p5l271t1843r294b1892],
4	1	CD	PERCENT	1	dep	3	SENT_100	[p5l271t1843r294b1892],
5	;	:	PERCENT	;	_	0	SENT_100	[p5l271t1843r294b1892],
6	%	NN	PERCENT	%	nn	7	SENT_100	[p5l304t1851r328b1898],
7	MOA1	NN	O	moa1	dep	3	SENT_100	[p5l467t1866r595b1892],
8	-.3	CD	NUMBER	-.3	num	10	SENT_100	[p5l467t1866r595b1892],
9	methotrexate	NN	O	methotrexate	nn	10	SENT_100	[p5l1225t1861r1399b1884],
10	Intestine	NNP	O	Intestine	rcmod	7	SENT_100	[p5l1537t1861r1658b1888],
11	,	,	O	,	_	0	SENT_100	[p5l1537t1861r1658b1888],
12	pancreas	NN	O	pancreas	appos	10	SENT_100	[p5l1668t1866r1797b1889],
13	,	,	O	,	_	0	SENT_100	[p5l1668t1866r1797b1889],
14	lung	NN	O	lung	nn	15	SENT_100	[p5l1808t1861r1864b1889],
15	§	NN	O	§	appos	10	SENT_100	[p5l278t1893r294b1942],
16	5	CD	NUMBER	5	num	19	SENT_100	[p5l312t1900r328b1932],
17	g	NN	O	g	nn	19	SENT_100	[p5l278t1943r294b1989],
18	E	NN	O	e	nn	19	SENT_100	[p5l312t1934r335b1988],
19	MRP5	NN	O	mrp5	dep	15	SENT_100	[p5l466t1949r563b1980],
20	,	,	O	,	_	0	SENT_100	[p5l466t1949r563b1980],
21	ABC	NNP	ORGANIZATION	ABC	nn	24	SENT_100	[p5l708t1949r778b1975],
22	c5	NN	O	c5	nn	24	SENT_100	[p5l790t1949r830b1975],
23	nucleoslde	NN	O	nucleoslde	nn	24	SENT_100	[p5l1225t1948r1370b1981],
24	analogs	NNS	O	analog	appos	10	SENT_100	[p5l1379t1949r1491b1976],
25	,	,	O	,	_	0	SENT_100	[p5l1379t1949r1491b1976],
26	widespread	JJ	O	widespread	amod	29	SENT_100	[p5l1535t1948r1689b1976],
27	3	CD	NUMBER	3	tmod	26	SENT_100	[p5l279t1991r294b2013],
28	H	NN	O	h	nn	29	SENT_100	[p5l312t1996r327b2008],
29	MQA1	NN	O	mqa1	appos	10	SENT_100	[p5l466t1981r595b2008],
30	-	:	O	-	_	0	SENT_100	[p5l466t1981r595b2008],
31	.	.	O	.	_	0	SENT_100	[p5l466t1981r595b2008],

1	c	NN	O	c	nn	2	SENT_101	[p5l466t1981r595b2008],
2	cychqnucleotldes	NNS	O	cychqnucleotlde	_	0	SENT_101	[p5l1224t1976r1472b2010],
3	,	,	O	,	_	0	SENT_101	[p5l1224t1976r1472b2010],
4	3	CD	NUMBER	3	num	5	SENT_101	[p5l279t2015r294b2037],
5	[	NN	O	[	appos	2	SENT_101	[p5l305t2008r328b2043],
6	2	CD	NUMBER	2	num	8	SENT_101	[p5l305t2008r328b2043],
7	orgame	NN	O	orgame	nn	8	SENT_101	[p5l1224t2010r1324b2033],
8	amons	NNS	O	amon	rcmod	5	SENT_101	[p5l1334t2010r1422b2027],
9	S	NN	O	s	advmod	8	SENT_101	[p5l278t2047r327b2100],
10	:	:	O	:	_	0	SENT_101	[p5l278t2047r327b2100],
11	. . .	CD	NUMBER	. . .	num	12	SENT_101	[p5l1386t2088r1390b2092],[p5l1257t2088r1262b2092],
12	‘	NN	O	‘	dep	8	SENT_101	[p5l271t2098r294b2111],
13	H	NN	O	h	nn	15	SENT_101	[p5l271t2098r294b2111],
14	R	NN	O	r	nn	15	SENT_101	[p5l304t2093r328b2118],
15	MRP6	NN	O	mrp6	dep	12	SENT_101	[p5l467t2092r563b2121],
16	,	,	O	,	_	0	SENT_101	[p5l467t2092r563b2121],
17	ABC	NNP	ORGANIZATION	ABC	nn	18	SENT_101	[p5l708t2091r779b2116],
18	C6	NNP	O	C6	appos	8	SENT_101	[p5l790t2091r830b2116],
19	a	DT	O	a	det	23	SENT_101	[p5l1224t2093r1321b2109],
20	"	``	O	"	punct	23	SENT_101	[p5l1224t2093r1321b2109],
21	|	NN	O	|	nn	23	SENT_101	[p5l1224t2093r1321b2109],
22	°	CD	NUMBER	°	num	23	SENT_101	[p5l1224t2093r1321b2109],
23	|	NN	O	|	dep	18	SENT_101	[p5l1224t2093r1321b2109],
24	'	''	O	'	_	0	SENT_101	[p5l1224t2093r1321b2109],
25	“	CD	NUMBER	“	number	26	SENT_101	[p5l1224t2093r1321b2109],
26	°	CD	NUMBER	°	dep	8	SENT_101	[p5l1224t2093r1321b2109],
27	°	CD	NUMBER	°	num	28	SENT_101	[p5l1330t2088r1407b2120],
28	V	NN	O	v	dep	26	SENT_101	[p5l1330t2088r1407b2120],
29	_	CD	NUMBER	_	num	30	SENT_101	[p5l1330t2088r1407b2120],
30	¢	NN	O	¢	dep	26	SENT_101	[p5l1330t2088r1407b2120],
31	'	''	O	'	_	0	SENT_101	[p5l1330t2088r1407b2120],
32	|	CD	NUMBER	|	num	34	SENT_101	[p5l1330t2088r1407b2120],
33	G	NN	O	g	nn	34	SENT_101	[p5l1330t2088r1407b2120],
34	liver	NN	O	liver	dep	8	SENT_101	[p5l1537t2093r1600b2119],
35	,	,	O	,	_	0	SENT_101	[p5l1537t2093r1600b2119],
36	kidney	NN	O	kidney	appos	34	SENT_101	[p5l1611t2093r1697b2120],
37	'	''	O	'	_	0	SENT_101	[p5l271t2120r294b2151],
38	3	CD	NUMBER	3	num	40	SENT_101	[p5l271t2120r294b2151],
39	g	NN	O	g	nn	40	SENT_101	[p5l304t2120r328b2158],
40	MOA-I	NN	O	moa-i	dep	8	SENT_101	[p5l467t2124r594b2149],
41	-	:	O	-	_	0	SENT_101	[p5l467t2124r594b2149],
42	_	NN	O	_	nn	46	SENT_101	[p5l467t2124r594b2149],
43	E	NN	O	e	nn	46	SENT_101	[p5l467t2124r594b2149],
44	pentapeptnde	NN	O	pentapeptnde	nn	46	SENT_101	[p5l1225t2116r1398b2144],
45	E	NN	O	e	nn	46	SENT_101	[p5l271t2151r294b2199],
46	o	NN	O	o	dep	8	SENT_101	[p5l304t2162r328b2178],
47	_	CD	NUMBER	_	dep	46	SENT_101	[p5l271t2200r294b2208],
48	:	:	O	:	_	0	SENT_101	[p5l312t2187r327b2203],
49	§	CD	NUMBER	§	dep	8	SENT_101	[p5l278t2209r294b2249],
50	:	:	O	:	_	0	SENT_101	[p5l312t2204r328b2245],
51	MXR	NN	O	mxr	dep	8	SENT_101	[p5l467t2224r545b2254],
52	,	,	O	,	_	0	SENT_101	[p5l467t2224r545b2254],
53	Bcnp	NN	O	bcnp	appos	51	SENT_101	[p5l558t2224r657b2254],
54	,	,	O	,	_	0	SENT_101	[p5l558t2224r657b2254],
55	ABC	NNP	ORGANIZATION	ABC	nn	57	SENT_101	[p5l708t2224r779b2249],
56	G2	NN	O	g2	nn	57	SENT_101	[p5l790t2224r831b2249],
57	an_thracyclines	NNS	O	an_thracyclines	appos	51	SENT_101	[p5l1224t2221r1427b2253],
58	,	,	O	,	_	0	SENT_101	[p5l1224t2221r1427b2253],
59	placenta	NN	O	placenta	appos	51	SENT_101	[p5l1537t2222r1656b2253],
60	,	,	O	,	_	0	SENT_101	[p5l1537t2222r1656b2253],
61	intestine	NN	O	intestine	appos	51	SENT_101	[p5l1667t2221r1788b2246],
62	,	,	O	,	_	0	SENT_101	[p5l1667t2221r1788b2246],
63	o	NN	O	o	nn	66	SENT_101	[p5l278t2250r294b2265],
64	8	CD	NUMBER	8	num	66	SENT_101	[p5l312t2246r328b2273],
65	_	NN	O	_	nn	66	SENT_101	[p5l537t2269r547b2274],
66	mntoxantrone	NN	O	mntoxantrone	appos	51	SENT_101	[p5l1225t2250r1401b2271],
67	breast	NN	O	breast	dep	66	SENT_101	[p5l1537t2250r1627b2275],
68	,	,	O	,	_	0	SENT_101	[p5l1537t2250r1627b2275],
69	lwer	NN	O	lwer	nn	72	SENT_101	[p5l1638t2249r1693b2271],
70	Q	NNP	O	Q	nn	72	SENT_101	[p5l271t2267r294b2290],
71	,5	CD	NUMBER	,5	num	72	SENT_101	[p5l304t2275r328b2300],
72	ABC	NNP	ORGANIZATION	ABC	appos	51	SENT_101	[p5l465t2257r535b2282],
73	P	NN	O	p	dep	72	SENT_101	[p5l549t2257r568b2282],
74	2	CD	NUMBER	2	number	75	SENT_101	[p5l271t2300r294b2339],
75	‘	CD	NUMBER	‘	num	76	SENT_101	[p5l271t2300r294b2339],
76	é	NN	O	é	dep	2	SENT_101	[p5l305t2300r328b2344],
77	’	CD	NUMBER	’	num	78	SENT_101	[p5l305t2300r328b2344],
78	Ea	NN	O	ea	dep	76	SENT_101	[p5l271t2341r327b2398],

1	Figure	NNP	O	Figure	nsubj	4	SENT_102	[p5l446t2359r556b2394],
2	3	CD	NUMBER	3	num	4	SENT_102	[p5l566t2359r584b2387],
3	ABC	NNP	ORGANIZATION	ABC	nn	4	SENT_102	[p5l625t2359r704b2387],
4	transporters	NNS	O	transporter	_	0	SENT_102	[p5l714t2363r899b2395],
5	with	IN	O	with	_	0	SENT_102	[p5l910t2359r979b2387],
6	known	VBN	O	know	amod	8	SENT_102	[p5l988t2359r1094b2387],
7	drug	NN	O	drug	nn	8	SENT_102	[p5l1104t2359r1174b2395],
8	substrates	NNS	O	substrate	prep_with	4	SENT_102	[p5l1186t2359r1347b2387],
9	.	.	O	.	_	0	SENT_102	[p5l1186t2359r1347b2387],

1	Curved	JJ	O	curved	amod	2	SENT_103	[p5l1359t2359r1473b2387],
2	lines	NNS	O	line	nsubj	3	SENT_103	[p5l1483t2359r1555b2387],
3	represent	VBP	O	represent	_	0	SENT_103	[p5l1565t2363r1710b2395],
4	transmem	NN	O	transmem	nn	5	SENT_103	[p5l1719t2363r1886b2387, p5l271t2475r294b2516],
5	§	NN	O	§	dobj	3	SENT_103	[p5l1719t2363r1886b2387, p5l271t2475r294b2516],

1	§	NN	O	§	nn	3	SENT_104	[p5l312t2473r328b2517],
2	brane	NN	O	brane	nn	3	SENT_104	[p5l445t2483r532b2510],
3	domains	NNS	O	domain	nsubj	11	SENT_104	[p5l543t2482r684b2515],
4	,	,	O	,	_	0	SENT_104	[p5l543t2482r684b2515],
5	and	CC	O	and	_	0	SENT_104	[p5l697t2483r752b2510],
6	the	DT	O	the	det	7	SENT_104	[p5l762t2482r809b2510],
7	ATP	NN	ORGANIZATION	atp	conj_and	3	SENT_104	[p5l820t2483r889b2510],
8	in	IN	O	in	_	0	SENT_104	[p5l899t2482r929b2510],
9	the	DT	O	the	det	10	SENT_104	[p5l939t2483r987b2510],
10	ovals	NNS	O	oval	prep_in	7	SENT_104	[p5l998t2483r1077b2510],
11	represents	VBZ	O	represent	_	0	SENT_104	[p5l1088t2487r1246b2519],
12	the	DT	O	the	det	14	SENT_104	[p5l1258t2483r1305b2510],
13	ATP-binding	JJ	O	atp-binding	amod	14	SENT_104	[p5l1315t2482r1518b2518],
14	cassettes	NNS	O	cassette	dep	11	SENT_104	[p5l1529t2487r1665b2510],
15	in	IN	O	in	_	0	SENT_104	[p5l1676t2482r1706b2510],
16	these	DT	O	these	det	17	SENT_104	[p5l1716t2482r1796b2510],
17	ABC	NNP	ORGANIZATION	ABC	prep_in	14	SENT_104	[p5l1807t2483r1886b2510],
18	If	IN	O	if	dep	14	SENT_104	[p5l271t2519r294b2533],
19	}	CD	NUMBER	}	num	22	SENT_104	[p5l271t2519r294b2533],
20	U	NNP	O	U	nn	22	SENT_104	[p5l312t2519r328b2532],
21	éi	NNP	O	éi	nn	22	SENT_104	[p5l271t2534r328b2592],
22	transporters	NNS	O	transporter	pobj	18	SENT_104	[p5l446t2537r639b2569],
23	.	.	O	.	_	0	SENT_104	[p5l446t2537r639b2569],

1	GS-X	NN	O	gs-x	nsubj	2	SENT_105	[p5l652t2533r743b2560],
2	represents	VBZ	O	represent	_	0	SENT_105	[p5l753t2537r912b2569],
3	glutathione	NN	O	glutathione	nn	4	SENT_105	[p5l924t2532r1100b2568],
4	conjugates	NNS	O	conjugate	dobj	2	SENT_105	[p5l1111t2532r1278b2569],
5	of	IN	O	of	_	0	SENT_105	[p5l1290t2532r1324b2560],
6	drugs	NNS	O	drug	prep_of	4	SENT_105	[p5l1332t2533r1427b2569],
7	.	.	O	.	_	0	SENT_105	[p5l1332t2533r1427b2569],

1	51	CD	NUMBER	51	num	2	SENT_106	[p5l278t2704r328b2747],
2	>	JJR	O	>	nsubj	24	SENT_106	[p5l278t2704r328b2747],
3	’	CD	NUMBER	’	dep	2	SENT_106	[p5l278t2704r328b2747],
4	consisting	VBG	O	consist	partmod	2	SENT_106	[p5l544t2708r711b2742],
5	of	IN	O	of	_	0	SENT_106	[p5l728t2704r764b2733],
6	two	CD	NUMBER	two	num	9	SENT_106	[p5l777t2708r837b2733],
7	ATP	NN	O	atp	nn	9	SENT_106	[p5l853t2704r926b2733],
8	binding	NN	O	binding	nn	9	SENT_106	[p5l942t2704r1068b2742],
9	cassettes	NNS	O	cassette	prep_of	4	SENT_106	[p5l1084t2709r1227b2733],
10	and	CC	O	and	_	0	SENT_106	[p5l1245t2704r1304b2733],
11	two	CD	NUMBER	two	num	13	SENT_106	[p5l1319t2709r1379b2733],
12	transmembrane	NN	O	transmembrane	nn	13	SENT_106	[p5l1396t2704r1651b2733],
13	regions	NNS	O	region	conj_and	9	SENT_106	[p5l1666t2713r1796b2742],
14	,	,	O	,	_	0	SENT_106	[p5l1666t2713r1796b2742],
15	each	DT	O	each	det	16	SENT_106	[p5l1814t2704r1889b2733],
16	’”	NN	O	’”	appos	9	SENT_106	[p5l271t2745r328b2803],
17	:5	CD	NUMBER	:5	nsubj	20	SENT_106	[p5l271t2745r328b2803],
18	of	IN	O	of	_	0	SENT_106	[p5l544t2754r580b2783],
19	which	WDT	O	which	prep_of	17	SENT_106	[p5l593t2754r693b2783],
20	contains	VBZ	O	contain	rcmod	16	SENT_106	[p5l708t2754r844b2783],
21	six	CD	NUMBER	six	num	23	SENT_106	[p5l862t2754r908b2783],
22	transmembrane	JJ	O	transmembrane	amod	23	SENT_106	[p5l923t2754r1178b2783],
23	domains	NNS	O	domain	dobj	20	SENT_106	[p5l1193t2754r1332b2783],
24	(	VBP	O	(	_	0	SENT_106	[p5l1349t2754r1414b2790],
25	16	CD	NUMBER	16	dobj	24	SENT_106	[p5l1349t2754r1414b2790],
26	)	CD	NUMBER	)	number	27	SENT_106	[p5l1349t2754r1414b2790],
27	(	CD	NUMBER	(	num	30	SENT_106	[p5l1432t2754r1552b2792],
28	Figure	NNP	O	Figure	nn	30	SENT_106	[p5l1432t2754r1552b2792],
29	3	CD	NUMBER	3	num	30	SENT_106	[p5l1568t2754r1609b2790],
30	)	NN	O	)	dep	25	SENT_106	[p5l1568t2754r1609b2790],
31	.	.	O	.	_	0	SENT_106	[p5l1568t2754r1609b2790],

1	P	NN	O	p	nsubj	8	SENT_107	[p5l1626t2755r1703b2792],
2	—	CD	NUMBER	—	num	3	SENT_107	[p5l1626t2755r1703b2792],
3	gp	NN	O	gp	dep	1	SENT_107	[p5l1626t2755r1703b2792],
4	can	MD	O	can	aux	5	SENT_107	[p5l1719t2763r1775b2783],
5	detect	VB	O	detect	_	0	SENT_107	[p5l1790t2754r1889b2783],
6	355	CD	NUMBER	355	dobj	5	SENT_107	[p5l271t2794r335b2861],
7	and	CC	O	and	_	0	SENT_107	[p5l545t2804r603b2833],
8	bind	VBP	O	bind	conj_and	5	SENT_107	[p5l617t2804r691b2833],
9	a	DT	O	a	det	11	SENT_107	[p5l706t2813r723b2833],
10	large	JJ	O	large	amod	11	SENT_107	[p5l738t2804r819b2841],
11	Variety	NNP	O	Variety	dobj	8	SENT_107	[p5l834t2804r946b2841],
12	of	IN	O	of	_	0	SENT_107	[p5l962t2804r998b2833],
13	hydrophobic	JJ	O	hydrophobic	amod	17	SENT_107	[p5l1010t2804r1218b2841],
14	natural	JJ	O	natural	amod	17	SENT_107	[p5l1234t2804r1489b2841],
15	—	NN	O	—	nn	17	SENT_107	[p5l1234t2804r1489b2841],
16	product	NN	O	product	nn	17	SENT_107	[p5l1234t2804r1489b2841],
17	drugs	NNS	O	drug	prep_of	11	SENT_107	[p5l1504t2804r1594b2841],
18	as	IN	O	as	mark	20	SENT_107	[p5l1610t2813r1642b2833],
19	they	PRP	O	they	nsubj	20	SENT_107	[p5l1658t2804r1727b2841],
20	enter	VBP	O	enter	advcl	5	SENT_107	[p5l1743t2808r1825b2833],
21	the	DT	O	the	det	23	SENT_107	[p5l1839t2804r1889b2833],
22	plasma	NN	O	plasma	nn	23	SENT_107	[p5l543t2853r661b2891],
23	membrane	NN	O	membrane	dobj	20	SENT_107	[p5l678t2854r861b2883],
24	.	.	O	.	_	0	SENT_107	[p5l678t2854r861b2883],

1	These	DT	O	these	det	2	SENT_108	[p5l881t2854r979b2883],
2	drugs	NNS	O	drug	nsubj	3	SENT_108	[p5l997t2853r1087b2891],
3	include	VBP	O	include	_	0	SENT_108	[p5l1106t2853r1227b2883],
4	many	JJ	O	many	amod	11	SENT_108	[p5l1245t2863r1336b2891],
5	of	IN	O	of	_	0	SENT_108	[p5l1354t2853r1390b2883],
6	the	DT	O	the	det	9	SENT_108	[p5l1405t2853r1455b2883],
7	commonly	RB	O	commonly	advmod	8	SENT_108	[p5l1473t2853r1649b2891],
8	used	VBN	O	use	amod	9	SENT_108	[p5l1667t2853r1743b2883],
9	naturalproduct	NN	O	naturalproduct	prep_of	4	SENT_108	[p5l1760t2853r1887b2883, p5l543t2903r670b2941],
10	anticancer	JJ	O	anticancer	amod	11	SENT_108	[p5l684t2903r854b2932],
11	drugs	NNS	O	drug	dobj	3	SENT_108	[p5l867t2903r957b2941],
12	such	JJ	O	such	_	0	SENT_108	[p5l973t2903r1047b2932],
13	as	IN	O	as	_	0	SENT_108	[p5l1061t2912r1092b2932],
14	doxorubicin	NN	O	doxorubicin	prep_such_as	11	SENT_108	[p5l1107t2903r1307b2932],
15	and	CC	O	and	_	0	SENT_108	[p5l1321t2903r1379b2932],
16	daunorubicin	NN	O	daunorubicin	prep_such_as	11	SENT_108	[p5l1393t2903r1620b2938],
17	,	,	O	,	_	0	SENT_108	[p5l1393t2903r1620b2938],
18	Vinblastine	NNP	O	Vinblastine	prep_such_as	11	SENT_108	[p5l1635t2903r1816b2932],
19	and	CC	O	and	_	0	SENT_108	[p5l1830t2903r1889b2932],
20	vincristine	NN	O	vincristine	conj_and	18	SENT_108	[p5l544t2952r727b2987],
21	,	,	O	,	_	0	SENT_108	[p5l544t2952r727b2987],
22	and	CC	O	and	_	0	SENT_108	[p5l743t2952r801b2982],
23	taxol	NN	O	taxol	prep_such_as	11	SENT_108	[p5l814t2952r905b2987],
24	,	,	O	,	_	0	SENT_108	[p5l814t2952r905b2987],
25	as	RB	O	as	_	0	SENT_108	[p5l921t2961r953b2982],
26	well	RB	O	well	_	0	SENT_108	[p5l967t2952r1037b2982],
27	as	IN	O	as	_	0	SENT_108	[p5l1052t2961r1083b2982],
28	many	JJ	O	many	amod	31	SENT_108	[p5l1098t2961r1188b2990],
29	commonly	RB	O	commonly	advmod	30	SENT_108	[p5l1202t2952r1378b2990],
30	used	VBN	O	use	amod	31	SENT_108	[p5l1392t2952r1467b2982],
31	pharmaceuticals	NNS	O	pharmaceutical	conj_and	11	SENT_108	[p5l1480t2952r1748b2990],
32	ranging	VBG	O	range	partmod	31	SENT_108	[p5l1762t2952r1888b2990],
33	from	IN	O	from	_	0	SENT_108	[p5l544t3002r624b3031],
34	antiairhythmics	NNS	O	antiairhythmic	prep_from	32	SENT_108	[p5l637t3002r895b3040],
35	and	CC	O	and	_	0	SENT_108	[p5l910t3002r968b3031],
36	antihistamines	NNS	O	antihistamine	conj_and	34	SENT_108	[p5l981t3002r1219b3031],
37	to	TO	O	to	_	0	SENT_108	[p5l1232t3006r1263b3031],
38	cholesterol	NN	O	cholesterol	prep_to	32	SENT_108	[p5l1277t3002r1618b3040],
39	—	CD	NUMBER	—	num	38	SENT_108	[p5l1277t3002r1618b3040],
40	lowering	VBG	O	lower	partmod	38	SENT_108	[p5l1277t3002r1618b3040],
41	statins	NNS	O	statin	dobj	40	SENT_108	[p5l1632t3002r1735b3031],
42	(	CD	NUMBER	(	number	43	SENT_108	[p5l1750t3002r1816b3038],
43	22	CD	NUMBER	22	num	44	SENT_108	[p5l1750t3002r1816b3038],
44	)	NN	O	)	nsubj	49	SENT_108	[p5l1750t3002r1816b3038],
45	and	CC	O	and	_	0	SENT_108	[p5l1830t3002r1889b3031],
46	HIV	NN	MISC	hiv	nn	48	SENT_108	[p5l544t3052r616b3080],
47	protease	NN	O	protease	nn	48	SENT_108	[p5l630t3056r768b3089],
48	inhibitors	NNS	O	inhibitor	conj_and	44	SENT_108	[p5l781t3051r939b3080],
49	(	VBP	O	(	rcmod	41	SENT_108	[p5l954t3051r1030b3087],
50	23	CD	NUMBER	23	num	51	SENT_108	[p5l954t3051r1030b3087],
51	)	CD	NUMBER	)	dobj	49	SENT_108	[p5l954t3051r1030b3087],
52	.	.	O	.	_	0	SENT_108	[p5l954t3051r1030b3087],

1	Binding	NN	O	binding	nsubj	5	SENT_109	[p5l1045t3051r1178b3089],
2	of	IN	O	of	_	0	SENT_109	[p5l1192t3051r1228b3080],
3	these	DT	O	these	det	4	SENT_109	[p5l1239t3051r1323b3080],
4	drugs	NNS	O	drug	prep_of	1	SENT_109	[p5l1337t3051r1427b3089],
5	results	VBZ	O	result	_	0	SENT_109	[p5l1441t3051r1548b3080],
6	in	IN	O	in	_	0	SENT_109	[p5l1563t3051r1594b3080],
7	activation	NN	O	activation	prep_in	5	SENT_109	[p5l1609t3051r1769b3080],
8	of	IN	O	of	_	0	SENT_109	[p5l1783t3051r1819b3080],
9	one	CD	NUMBER	one	prep_of	7	SENT_109	[p5l1830t3060r1888b3080],
10	of	IN	O	of	_	0	SENT_109	[p5l544t3100r580b3130],
11	the	DT	O	the	det	16	SENT_109	[p5l592t3100r641b3130],
12	AT	NNP	O	AT	nn	16	SENT_109	[p5l656t3100r706b3129],
13	P	NN	O	p	nn	16	SENT_109	[p5l707t3100r869b3138],
14	—	NN	O	—	nn	16	SENT_109	[p5l707t3100r869b3138],
15	binding	NN	O	binding	nn	16	SENT_109	[p5l707t3100r869b3138],
16	domains	NNS	O	domain	prep_of	9	SENT_109	[p5l885t3100r1033b3135],
17	,	,	O	,	_	0	SENT_109	[p5l885t3100r1033b3135],
18	and	CC	O	and	_	0	SENT_109	[p5l1050t3100r1108b3130],
19	the	DT	O	the	det	20	SENT_109	[p5l1122t3100r1172b3130],
20	hydrolysis	NN	O	hydrolysis	nsubj	23	SENT_109	[p5l1186t3100r1357b3138],
21	of	IN	O	of	_	0	SENT_109	[p5l1373t3100r1409b3130],
22	ATP	NN	ORGANIZATION	atp	prep_of	20	SENT_109	[p5l1421t3100r1494b3129],
23	causes	VBZ	O	cause	conj_and	5	SENT_109	[p5l1508t3109r1614b3130],
24	a	DT	O	a	det	26	SENT_109	[p5l1631t3109r1648b3129],
25	major	JJ	O	major	amod	26	SENT_109	[p5l1662t3100r1758b3138],
26	change	NN	O	change	dobj	23	SENT_109	[p5l1772t3100r1888b3138],
27	in	IN	O	in	_	0	SENT_109	[p5l544t3150r575b3179],
28	the	DT	O	the	det	29	SENT_109	[p5l593t3150r642b3179],
29	shape	NN	O	shape	prep_in	26	SENT_109	[p5l662t3150r754b3188],
30	of	IN	O	of	_	0	SENT_109	[p5l772t3150r808b3179],
31	P	NN	O	p	nn	33	SENT_109	[p5l823t3151r909b3188],
32	—	CD	NUMBER	—	num	33	SENT_109	[p5l823t3151r909b3188],
33	gp	NN	O	gp	prep_of	29	SENT_109	[p5l823t3151r909b3188],
34	,	,	O	,	_	0	SENT_109	[p5l823t3151r909b3188],
35	which	WDT	O	which	nsubj	36	SENT_109	[p5l929t3150r1029b3179],
36	results	VBZ	O	result	rcmod	33	SENT_109	[p5l1046t3150r1153b3179],
37	in	IN	O	in	_	0	SENT_109	[p5l1171t3150r1203b3179],
38	release	NN	O	release	prep_in	36	SENT_109	[p5l1220t3150r1335b3179],
39	of	IN	O	of	_	0	SENT_109	[p5l1353t3150r1389b3179],
40	the	DT	O	the	det	41	SENT_109	[p5l1404t3150r1453b3179],
41	drug	NN	O	drug	prep_of	38	SENT_109	[p5l1471t3150r1546b3188],
42	into	IN	O	into	_	0	SENT_109	[p5l1564t3150r1627b3179],
43	the	DT	O	the	det	45	SENT_109	[p5l1645t3150r1694b3179],
44	extracellular	JJ	O	extracellular	amod	45	SENT_109	[p5l1713t3150r1887b3179, p5l544t3199r588b3229],
45	space	NN	O	space	prep_into	36	SENT_109	[p5l602t3208r691b3237],
46	(	CD	NUMBER	(	number	47	SENT_109	[p5l707t3199r782b3235],
47	24	CD	NUMBER	24	num	48	SENT_109	[p5l707t3199r782b3235],
48	)	NN	O	)	dep	36	SENT_109	[p5l707t3199r782b3235],
49	.	.	O	.	_	0	SENT_109	[p5l707t3199r782b3235],

1	Hydrolysis	NN	O	hydrolysis	nsubjpass	9	SENT_110	[p5l798t3199r978b3237],
2	of	IN	O	of	_	0	SENT_110	[p5l993t3199r1029b3229],
3	a	DT	DURATION	a	det	5	SENT_110	[p5l1041t3208r1058b3229],
4	second	JJ	DURATION	second	amod	5	SENT_110	[p5l1072t3199r1185b3229],
5	molecule	NN	O	molecule	prep_of	1	SENT_110	[p5l1199t3199r1350b3229],
6	of	IN	O	of	_	0	SENT_110	[p5l1364t3199r1400b3229],
7	ATP	NN	ORGANIZATION	atp	prep_of	5	SENT_110	[p5l1411t3199r1484b3228],
8	is	VBZ	O	be	auxpass	9	SENT_110	[p5l1498t3199r1523b3229],
9	needed	VBN	O	need	_	0	SENT_110	[p5l1538t3199r1655b3229],
10	to	TO	O	to	aux	11	SENT_110	[p5l1668t3204r1699b3229],
11	restore	VB	O	restore	xcomp	9	SENT_110	[p5l1713t3204r1825b3229],
12	the	DT	O	the	det	13	SENT_110	[p5l1839t3199r1888b3229],
13	transporter	NN	O	transporter	dobj	11	SENT_110	[p5l544t3253r724b3287],
14	to	TO	O	to	_	0	SENT_110	[p5l740t3254r771b3278],
15	its	PRP$	O	its	poss	17	SENT_110	[p5l789t3249r826b3278],
16	original	JJ	O	original	amod	17	SENT_110	[p5l846t3249r973b3287],
17	state	NN	O	state	prep_to	11	SENT_110	[p5l992t3253r1066b3278],
18	so	IN	O	so	mark	22	SENT_110	[p5l1085t3258r1119b3278],
19	that	IN	O	that	dep	22	SENT_110	[p5l1137t3249r1199b3278],
20	it	PRP	O	it	nsubj	22	SENT_110	[p5l1216t3249r1239b3278],
21	can	MD	O	can	aux	22	SENT_110	[p5l1256t3258r1312b3278],
22	repeat	VB	O	repeat	advcl	11	SENT_110	[p5l1329t3254r1431b3287],
23	the	DT	O	the	det	24	SENT_110	[p5l1448t3249r1497b3278],
24	cycle	NN	O	cycle	dobj	22	SENT_110	[p5l1515t3249r1601b3287],
25	of	IN	O	of	_	0	SENT_110	[p5l1619t3249r1655b3278],
26	drug	NN	O	drug	nn	27	SENT_110	[p5l1670t3249r1745b3287],
27	binding	NN	O	binding	prep_of	24	SENT_110	[p5l1762t3249r1888b3287],
28	and	CC	O	and	_	0	SENT_110	[p5l545t3298r603b3327],
29	release	NN	O	release	conj_and	27	SENT_110	[p5l618t3298r733b3327],
30	(	CD	NUMBER	(	number	31	SENT_110	[p5l750t3298r812b3334],
31	25	CD	NUMBER	25	dep	27	SENT_110	[p5l750t3298r812b3334],
32	,	,	O	,	_	0	SENT_110	[p5l750t3298r812b3334],
33	26	CD	NUMBER	26	num	34	SENT_110	[p5l822t3298r884b3334],
34	)	NN	O	)	appos	27	SENT_110	[p5l822t3298r884b3334],
35	.	.	O	.	_	0	SENT_110	[p5l822t3298r884b3334],

1	Although	IN	O	although	mark	13	SENT_111	[p5l902t3298r1058b3336],
2	the	DT	O	the	det	4	SENT_111	[p5l1074t3298r1123b3327],
3	detailed	JJ	O	detailed	amod	4	SENT_111	[p5l1139t3298r1270b3327],
4	mechanism	NN	O	mechanism	nsubjpass	13	SENT_111	[p5l1285t3298r1474b3327],
5	of	IN	O	of	_	0	SENT_111	[p5l1490t3298r1525b3327],
6	action	NN	O	action	prep_of	4	SENT_111	[p5l1539t3298r1639b3327],
7	of	IN	O	of	_	0	SENT_111	[p5l1655t3298r1691b3327],
8	other	JJ	O	other	amod	10	SENT_111	[p5l1704t3298r1789b3327],
9	ABC	NNP	ORGANIZATION	ABC	nn	10	SENT_111	[p5l1804t3298r1887b3327],
10	transporters	NNS	O	transporter	prep_of	6	SENT_111	[p5l544t3352r738b3385],
11	is	VBZ	O	be	auxpass	13	SENT_111	[p5l755t3347r780b3377],
12	not	RB	O	not	neg	13	SENT_111	[p5l797t3352r850b3377],
13	known	VBN	O	know	advcl	17	SENT_111	[p5l865t3347r985b3382],
14	,	,	O	,	_	0	SENT_111	[p5l865t3347r985b3382],
15	it	PRP	O	it	nsubjpass	17	SENT_111	[p5l1002t3347r1025b3377],
16	is	VBZ	O	be	auxpass	17	SENT_111	[p5l1040t3347r1066b3377],
17	presumed	VBN	O	presume	_	0	SENT_111	[p5l1082t3347r1243b3385],
18	that	IN	O	that	complm	23	SENT_111	[p5l1259t3347r1321b3377],
19	the	DT	O	the	det	22	SENT_111	[p5l1336t3347r1385b3377],
20	ATP	NN	O	atp	nn	22	SENT_111	[p5l1401t3347r1474b3376],
21	binding	NN	O	binding	nn	22	SENT_111	[p5l1489t3347r1615b3385],
22	cassette	NN	O	cassette	nsubj	23	SENT_111	[p5l1632t3352r1760b3377],
23	acts	VBZ	O	act	ccomp	17	SENT_111	[p5l1776t3352r1838b3377],
24	as	IN	O	as	_	0	SENT_111	[p5l1856t3356r1888b3377],
25	the	DT	O	the	det	26	SENT_111	[p5l544t3397r593b3426],
26	engine	NN	O	engine	prep_as	23	SENT_111	[p5l609t3397r718b3435],
27	for	IN	O	for	_	0	SENT_111	[p5l733t3397r781b3426],
28	the	DT	O	the	det	29	SENT_111	[p5l795t3397r844b3426],
29	transport	NN	O	transport	prep_for	26	SENT_111	[p5l859t3401r1006b3435],
30	mediated	VBN	O	mediate	partmod	29	SENT_111	[p5l1020t3397r1172b3426],
31	by	IN	O	by	_	0	SENT_111	[p5l1186t3397r1226b3435],
32	members	NNS	O	member	agent	30	SENT_111	[p5l1241t3397r1392b3426],
33	of	IN	O	of	_	0	SENT_111	[p5l1408t3397r1444b3426],
34	this	DT	O	this	det	36	SENT_111	[p5l1455t3397r1513b3426],
35	large	JJ	O	large	amod	36	SENT_111	[p5l1529t3397r1610b3435],
36	family	NN	O	family	prep_of	32	SENT_111	[p5l1625t3397r1732b3435],
37	of	IN	O	of	_	0	SENT_111	[p5l1747t3397r1783b3426],
38	transporters	NNS	O	transporter	prep_of	36	SENT_111	[p5l1795t3401r1887b3426, p5l543t3451r666b3485],
39	.	.	O	.	_	0	SENT_111	[p5l1795t3401r1887b3426, p5l543t3451r666b3485],

1	620	CD	NUMBER	620	_	0	SENT_112	[p5l433t3506r494b3536],
2	GOTTESMAN	NNP	O	GOTTESMAN	dep	1	SENT_112	[p5l583t3509r810b3536],

1	53:615	CD	NUMBER	53:615	num	2	SENT_113	[p6l270t3499r293b3658],
2	-627	CD	NUMBER	-627	_	0	SENT_113	[p6l270t3499r293b3658],
3	.	.	O	.	_	0	SENT_113	[p6l270t3499r293b3658],

1	Downloaded	VBN	O	download	_	0	SENT_114	[p6l270t3318r293b3488],
2	from	IN	O	from	_	0	SENT_114	[p6l270t3245r293b3309],
3	www	NN	O	www	prep_from	1	SENT_114	[p6l270t3016r293b3236],
4	.	.	O	.	_	0	SENT_114	[p6l270t3016r293b3236],

1	annualrevi	NN	O	annualrevus	nn	2	SENT_115	[p6l270t3016r293b3236],
2	ews.org	NN	O	ews.org	_	0	SENT_115	[p6l277t2890r300b2993],
3	Annu	NNP	PERSON	Annu	dep	2	SENT_115	[p6l279t1577r302b1657],
4	.	.	O	.	_	0	SENT_115	[p6l279t1577r302b1657],

1	Rev.	NNP	O	Rev.	nn	2	SENT_116	[p6l279t1506r302b1566],
2	Med	NNP	O	Med	_	0	SENT_116	[p6l279t1429r302b1496],
3	.	.	O	.	_	0	SENT_116	[p6l279t1429r302b1496],

1	2002.53:6	CD	NUMBER	2002.53:6	_	0	SENT_117	[p6l279t1183r302b1418],
2	l5-627	NN	O	l5-627	dep	1	SENT_117	[p6l279t1183r302b1418],
3	.	.	O	.	_	0	SENT_117	[p6l279t1183r302b1418],

1	Downloaded	VBN	O	download	_	0	SENT_118	[p6l279t1003r302b1172],
2	from	IN	O	from	_	0	SENT_118	[p6l279t930r302b994],
3	www	NN	O	www	prep_from	1	SENT_118	[p6l279t701r302b921],
4	.	.	O	.	_	0	SENT_118	[p6l279t701r302b921],

1	annualrevi	NN	O	annualrevus	nn	2	SENT_119	[p6l279t701r302b921],
2	ews.org	NN	O	ews.org	_	0	SENT_119	[p6l286t575r309b678],
3	by	IN	O	by	_	0	SENT_119	[p6l312t1590r343b1623],
4	University	NNP	ORGANIZATION	University	prep_by	2	SENT_119	[p6l312t1442r343b1581],
5	of	IN	ORGANIZATION	of	_	0	SENT_119	[p6l312t1403r336b1432],
6	Wisconsin	NNP	ORGANIZATION	Wisconsin	nn	8	SENT_119	[p6l312t1256r336b1397],
7	—	NNP	O	—	nn	8	SENT_119	[p6l326t1237r329b1246],
8	Madison	NNP	O	Madison	prep_of	2	SENT_119	[p6l312t1111r336b1227],
9	on	IN	O	on	_	0	SENT_119	[p6l320t1070r336b1102],
10	01/05/14	CD	DATE	01/05/14	prep_on	8	SENT_119	[p6l312t937r336b1060],
11	.	.	O	.	_	0	SENT_119	[p6l312t937r336b1060],

1	For	IN	O	for	_	0	SENT_120	[p6l313t880r336b926],
2	personal	JJ	O	personal	amod	3	SENT_120	[p6l312t759r343b871],
3	use	NN	O	use	pobj	1	SENT_120	[p6l320t706r336b750],
4	only	RB	O	only	advmod	3	SENT_120	[p6l312t610r343b675],
5	.	.	O	.	_	0	SENT_120	[p6l312t610r343b675],

1	consin	NN	O	consin	_	0	SENT_121	[p6l303t3572r327b3658],
2	-	:	O	-	_	0	SENT_121	[p6l317t3553r320b3562],
3	Madison	NNP	O	Madison	dep	1	SENT_121	[p6l303t3426r327b3543],
4	on	IN	O	on	_	0	SENT_121	[p6l311t3385r327b3417],
5	01/05/14	CD	DATE	01/05/14	prep_on	3	SENT_121	[p6l303t3252r327b3375],
6	.	.	O	.	_	0	SENT_121	[p6l303t3252r327b3375],

1	For	IN	O	for	_	0	SENT_122	[p6l304t3195r327b3241],
2	personal	JJ	O	personal	amod	3	SENT_122	[p6l303t3074r334b3186],
3	use	NN	O	use	pobj	1	SENT_122	[p6l311t3021r327b3065],
4	only	RB	O	only	advmod	3	SENT_122	[p6l303t2925r334b2990],
5	.	.	O	.	_	0	SENT_122	[p6l303t2925r334b2990],

1	Because	IN	O	because	mark	10	SENT_123	[p6l582t42r719b70],
2	of	IN	O	of	_	0	SENT_123	[p6l738t41r774b70],
3	the	DT	O	the	det	4	SENT_123	[p6l789t41r839b70],
4	promiscuity	NN	O	promiscuity	prep_of	10	SENT_123	[p6l856t41r1054b79],
5	with	IN	O	with	_	0	SENT_123	[p6l1073t41r1145b70],
6	which	WDT	O	which	dep	7	SENT_123	[p6l1163t41r1264b70],
7	P	NN	O	p	prep_with	4	SENT_123	[p6l1281t42r1358b79],
8	—	CD	NUMBER	—	num	9	SENT_123	[p6l1281t42r1358b79],
9	gp	NN	O	gp	nsubj	10	SENT_123	[p6l1281t42r1358b79],
10	binds	VBZ	O	bind	advcl	34	SENT_123	[p6l1376t41r1465b70],
11	electrically	RB	O	electrically	advmod	12	SENT_123	[p6l1484t41r1667b79],
12	neutral	JJ	O	neutral	acomp	10	SENT_123	[p6l1685t41r1800b70],
13	and	CC	O	and	_	0	SENT_123	[p6l1819t41r1877b70],
14	positively	RB	O	positively	advmod	15	SENT_123	[p6l532t90r693b128],
15	charged	VBN	O	charge	advcl	34	SENT_123	[p6l701t90r831b128],
16	hydrophobic	JJ	O	hydrophobic	amod	17	SENT_123	[p6l838t90r1046b128],
17	drugs	NNS	O	drug	dobj	15	SENT_123	[p6l1055t90r1144b128],
18	within	IN	O	within	_	0	SENT_123	[p6l1153t90r1258b119],
19	the	DT	O	the	det	21	SENT_123	[p6l1265t90r1315b119],
20	plasma	NN	O	plasma	nn	21	SENT_123	[p6l1322t90r1440b128],
21	membrane	NN	O	membrane	prep_within	15	SENT_123	[p6l1446t90r1629b125],
22	,	,	O	,	_	0	SENT_123	[p6l1446t90r1629b125],
23	many	JJ	O	many	amod	26	SENT_123	[p6l1638t99r1729b128],
24	different	JJ	O	different	amod	26	SENT_123	[p6l1737t90r1878b119],
25	anticancer	JJ	O	anticancer	amod	26	SENT_123	[p6l533t139r703b169],
26	drugs	NNS	O	drug	nsubj	34	SENT_123	[p6l715t139r805b177],
27	and	CC	O	and	_	0	SENT_123	[p6l820t139r878b169],
28	other	JJ	O	other	amod	29	SENT_123	[p6l891t139r976b169],
29	drugs	NNS	O	drug	nsubj	34	SENT_123	[p6l988t139r1078b177],
30	in	IN	O	in	_	0	SENT_123	[p6l1092t139r1123b168],
31	common	JJ	O	common	amod	32	SENT_123	[p6l1136t148r1280b169],
32	use	NN	O	use	prep_in	29	SENT_123	[p6l1293t148r1347b169],
33	are	VBP	O	be	cop	34	SENT_123	[p6l1361t148r1410b169],
34	substrates	NNS	O	substrate	_	0	SENT_123	[p6l1424t139r1584b169],
35	for	IN	O	for	_	0	SENT_123	[p6l1598t139r1646b169],
36	this	DT	O	this	det	38	SENT_123	[p6l1659t139r1716b169],
37	transport	NN	O	transport	nn	38	SENT_123	[p6l1730t144r1877b177],
38	system	NN	O	system	prep_for	34	SENT_123	[p6l534t194r655b227],
39	.	.	O	.	_	0	SENT_123	[p6l534t194r655b227],

1	Any	DT	O	any	det	2	SENT_124	[p6l668t189r737b227],
2	drug	NN	O	drug	nsubj	16	SENT_124	[p6l749t189r823b227],
3	that	WDT	O	that	nsubj	4	SENT_124	[p6l834t189r896b218],
4	interacts	VBZ	O	interact	rcmod	2	SENT_124	[p6l906t189r1045b218],
5	with	IN	O	with	_	0	SENT_124	[p6l1057t189r1130b218],
6	the	DT	O	the	det	10	SENT_124	[p6l1140t189r1190b218],
7	substrate	NN	O	substrate	nn	10	SENT_124	[p6l1202t189r1488b227],
8	—	NN	O	—	nn	10	SENT_124	[p6l1202t189r1488b227],
9	binding	NN	O	binding	nn	10	SENT_124	[p6l1202t189r1488b227],
10	region	NN	O	region	prep_with	4	SENT_124	[p6l1498t189r1603b227],
11	of	IN	O	of	_	0	SENT_124	[p6l1615t189r1650b218],
12	P	NN	O	p	nn	14	SENT_124	[p6l1658t190r1735b227],
13	—	CD	NUMBER	—	num	14	SENT_124	[p6l1658t190r1735b227],
14	gp	NN	O	gp	prep_of	10	SENT_124	[p6l1658t190r1735b227],
15	is	VBZ	O	be	cop	16	SENT_124	[p6l1746t189r1772b218],
16	likely	JJ	O	likely	_	0	SENT_124	[p6l1784t189r1877b227],
17	to	TO	O	to	aux	21	SENT_124	[p6l532t243r563b267],
18	be	VB	O	be	cop	21	SENT_124	[p6l572t238r610b267],
19	a	DT	O	a	det	21	SENT_124	[p6l620t247r637b267],
20	competitive	JJ	O	competitive	amod	21	SENT_124	[p6l645t238r838b276],
21	inhibitor	NN	O	inhibitor	xcomp	16	SENT_124	[p6l847t238r990b267],
22	of	IN	O	of	_	0	SENT_124	[p6l998t238r1034b267],
23	the	DT	O	the	det	24	SENT_124	[p6l1040t238r1089b267],
24	binding	NN	O	binding	prep_of	21	SENT_124	[p6l1097t238r1223b276],
25	of	IN	O	of	_	0	SENT_124	[p6l1233t238r1269b267],
26	other	JJ	O	other	amod	27	SENT_124	[p6l1275t238r1360b267],
27	drugs	NNS	O	drug	prep_of	24	SENT_124	[p6l1368t238r1467b276],
28	.	.	O	.	_	0	SENT_124	[p6l1368t238r1467b276],

1	Because	IN	O	because	mark	18	SENT_125	[p6l1477t239r1615b267],
2	of	IN	O	of	dep	16	SENT_125	[p6l1624t238r1660b267],
3	the	DT	O	the	det	5	SENT_125	[p6l1665t238r1715b267],
4	large	JJ	O	large	amod	5	SENT_125	[p6l1724t238r1805b276],
5	size	NN	O	size	pobj	2	SENT_125	[p6l1815t238r1877b267],
6	and	CC	O	and	_	0	SENT_125	[p6l533t287r592b317],
7	complex	JJ	O	complex	amod	8	SENT_125	[p6l601t287r742b325],
8	structure	NN	O	structure	dep	16	SENT_125	[p6l752t292r895b317],
9	of	IN	O	of	_	0	SENT_125	[p6l905t287r940b317],
10	P	NN	O	p	nn	14	SENT_125	[p6l946t288r1023b325],
11	—	CD	NUMBER	—	num	14	SENT_125	[p6l946t288r1023b325],
12	gp	NN	O	gp	nn	14	SENT_125	[p6l946t288r1023b325],
13	drug	NN	O	drug	nn	14	SENT_125	[p6l1033t287r1248b325],
14	—	NN	O	—	prep_of	8	SENT_125	[p6l1033t287r1248b325],
15	binding	NN	O	binding	nn	16	SENT_125	[p6l1033t287r1248b325],
16	region	NN	O	region	dep	18	SENT_125	[p6l1257t287r1415b325],
17	(	CD	NUMBER	(	num	18	SENT_125	[p6l1257t287r1415b325],
18	s	NNS	O	s	advcl	24	SENT_125	[p6l1257t287r1415b325],
19	)	RB	O	)	advmod	18	SENT_125	[p6l1257t287r1415b325],
20	,	,	O	,	_	0	SENT_125	[p6l1257t287r1415b325],
21	not	RB	O	not	neg	23	SENT_125	[p6l1425t291r1478b317],
22	all	DT	O	all	det	23	SENT_125	[p6l1487t287r1527b317],
23	inhibitors	NNS	O	inhibitor	nsubj	24	SENT_125	[p6l1536t287r1693b317],
24	have	VBP	O	have	_	0	SENT_125	[p6l1703t287r1779b317],
25	equal	JJ	O	equal	amod	26	SENT_125	[p6l1789t287r1877b325],
26	potency	NN	O	potency	dobj	24	SENT_125	[p6l532t341r662b375],
27	against	IN	O	against	_	0	SENT_125	[p6l673t337r789b375],
28	all	DT	O	all	det	29	SENT_125	[p6l800t337r839b366],
29	substrates	NNS	O	substrate	prep_against	26	SENT_125	[p6l851t337r1020b366],
30	.	.	O	.	_	0	SENT_125	[p6l851t337r1020b366],

1	Active	JJ	O	active	amod	2	SENT_126	[p6l1033t337r1141b366],
2	development	NN	O	development	nsubj	13	SENT_126	[p6l1151t337r1363b375],
3	of	IN	O	of	_	0	SENT_126	[p6l1373t337r1409b366],
4	potent	JJ	O	potent	amod	7	SENT_126	[p6l1416t341r1528b375],
5	,	,	O	,	_	0	SENT_126	[p6l1416t341r1528b375],
6	speciﬁc	JJ	O	speciﬁc	amod	7	SENT_126	[p6l1541t337r1665b375],
7	inhibitors	NNS	O	inhibitor	prep_of	2	SENT_126	[p6l1675t337r1833b366],
8	of	IN	O	of	_	0	SENT_126	[p6l1844t337r1880b366],
9	P	NN	O	p	nn	11	SENT_126	[p6l532t387r609b424],
10	—	CD	NUMBER	—	num	11	SENT_126	[p6l532t387r609b424],
11	gp	NN	O	gp	prep_of	7	SENT_126	[p6l532t387r609b424],
12	is	VBZ	O	be	cop	13	SENT_126	[p6l620t386r646b415],
13	underway	NN	O	underway	_	0	SENT_126	[p6l657t386r820b424],
14	as	IN	O	as	_	0	SENT_126	[p6l831t395r863b415],
15	a	DT	O	a	det	16	SENT_126	[p6l875t395r893b415],
16	means	NN	O	means	prep_as	13	SENT_126	[p6l903t395r1007b415],
17	to	TO	O	to	aux	18	SENT_126	[p6l1018t391r1049b415],
18	reverse	VB	O	reverse	infmod	16	SENT_126	[p6l1060t395r1177b415],
19	multidrug	JJ	O	multidrug	amod	20	SENT_126	[p6l1188t386r1350b424],
20	resistance	NN	O	resistance	dobj	18	SENT_126	[p6l1361t386r1524b415],
21	in	IN	O	in	_	0	SENT_126	[p6l1535t386r1566b415],
22	cancers	NNS	O	cancer	prep_in	18	SENT_126	[p6l1577t395r1709b420],
23	,	,	O	,	_	0	SENT_126	[p6l1577t395r1709b420],
24	and	CC	O	and	_	0	SENT_126	[p6l1722t386r1780b415],
25	some	DT	O	some	nsubj	27	SENT_126	[p6l1792t395r1877b415],
26	have	VBP	O	have	aux	27	SENT_126	[p6l532t435r608b464],
27	shown	VBN	O	show	conj_and	13	SENT_126	[p6l621t435r726b464],
28	activity	NN	O	activity	dobj	27	SENT_126	[p6l738t435r860b473],
29	in	IN	O	in	_	0	SENT_126	[p6l872t435r903b464],
30	sensitizing	VBG	O	sensitize	prepc_in	27	SENT_126	[p6l916t435r1090b473],
31	drug	NN	O	drug	nn	32	SENT_126	[p6l1103t435r1330b473],
32	—	NN	O	—	nsubj	33	SENT_126	[p6l1103t435r1330b473],
33	resistant	JJ	O	resistant	xcomp	30	SENT_126	[p6l1103t435r1330b473],
34	cancers	NNS	O	cancer	dep	33	SENT_126	[p6l1341t444r1464b464],
35	in	IN	O	in	dep	33	SENT_126	[p6l1476t435r1507b464],
36	patients	NNS	O	patient	pobj	35	SENT_126	[p6l1518t435r1646b473],
37	(	IN	O	(	mark	38	SENT_126	[p6l1659t435r1724b471],
38	see	VBP	O	see	advcl	30	SENT_126	[p6l1659t435r1724b471],
39	below	IN	O	below	_	0	SENT_126	[p6l1735t435r1857b471],
40	)	NN	O	)	prep_below	38	SENT_126	[p6l1735t435r1857b471],
41	.	.	O	.	_	0	SENT_126	[p6l1735t435r1857b471],

1	After	IN	O	after	_	0	SENT_127	[p6l582t484r670b513],
2	the	DT	O	the	det	3	SENT_127	[p6l684t484r733b513],
3	discovery	NN	O	discovery	prep_after	22	SENT_127	[p6l748t484r907b522],
4	of	IN	O	of	_	0	SENT_127	[p6l923t484r958b513],
5	P	NN	O	p	nn	7	SENT_127	[p6l970t485r1047b522],
6	—	CD	NUMBER	—	num	7	SENT_127	[p6l970t485r1047b522],
7	gp	NN	O	gp	prep_of	3	SENT_127	[p6l970t485r1047b522],
8	and	CC	O	and	_	0	SENT_127	[p6l1063t484r1122b513],
9	the	DT	O	the	det	10	SENT_127	[p6l1136t484r1186b513],
10	demonstration	NN	O	demonstration	prep_after	22	SENT_127	[p6l1201t484r1438b513],
11	of	IN	O	of	_	0	SENT_127	[p6l1453t484r1489b513],
12	its	PRP$	O	its	poss	14	SENT_127	[p6l1500t484r1538b513],
13	widespread	JJ	O	widespread	amod	14	SENT_127	[p6l1554t484r1742b522],
14	expression	NN	O	expression	prep_of	10	SENT_127	[p6l1757t493r1876b522, p6l534t533r601b563],
15	in	IN	O	in	_	0	SENT_127	[p6l612t533r644b562],
16	many	JJ	O	many	amod	18	SENT_127	[p6l655t542r745b571],
17	human	JJ	O	human	amod	18	SENT_127	[p6l757t533r869b563],
18	cancers	NNS	O	cancer	prep_in	14	SENT_127	[p6l881t542r1013b568],
19	,	,	O	,	_	0	SENT_127	[p6l881t542r1013b568],
20	it	PRP	O	it	nsubjpass	22	SENT_127	[p6l1026t533r1049b563],
21	was	VBD	O	be	auxpass	22	SENT_127	[p6l1060t542r1122b563],
22	found	VBN	O	find	_	0	SENT_127	[p6l1134t533r1230b563],
23	that	IN	O	that	complm	34	SENT_127	[p6l1242t533r1304b563],
24	many	JJ	O	many	amod	26	SENT_127	[p6l1314t542r1405b571],
25	multidrug-resistant	JJ	O	multidrug-resistant	amod	26	SENT_127	[p6l1417t533r1732b571],
26	cancers	NNS	O	cancer	nsubj	34	SENT_127	[p6l1744t542r1875b568],
27	,	,	O	,	_	0	SENT_127	[p6l1744t542r1875b568],
28	such	JJ	O	such	_	0	SENT_127	[p6l534t582r608b611],
29	as	IN	O	as	_	0	SENT_127	[p6l618t592r650b611],
30	lung	NN	O	lung	nn	31	SENT_127	[p6l661t582r734b620],
31	cancers	NNS	O	cancer	prep_such_as	26	SENT_127	[p6l745t592r877b617],
32	,	,	O	,	_	0	SENT_127	[p6l745t592r877b617],
33	rarely	RB	O	rarely	advmod	34	SENT_127	[p6l888t582r984b620],
34	express	VBP	O	express	ccomp	22	SENT_127	[p6l995t592r1116b620],
35	P	NN	O	p	nn	37	SENT_127	[p6l1127t583r1213b620],
36	—	CD	NUMBER	—	num	37	SENT_127	[p6l1127t583r1213b620],
37	gp	NN	O	gp	dobj	34	SENT_127	[p6l1127t583r1213b620],
38	.	.	O	.	_	0	SENT_127	[p6l1127t583r1213b620],

1	Using	VBG	O	use	_	0	SENT_128	[p6l1225t582r1323b620],
2	a	DT	O	a	det	7	SENT_128	[p6l1335t592r1352b611],
3	multidrug-resistant	JJ	O	multidrug-resistant	amod	7	SENT_128	[p6l1361t582r1677b620],
4	lung	NN	O	lung	nn	7	SENT_128	[p6l1686t582r1759b620],
5	cancer	NN	O	cancer	nn	7	SENT_128	[p6l1770t591r1878b611],
6	cell	NN	O	cell	nn	7	SENT_128	[p6l533t632r591b661],
7	line	NN	O	line	dobj	1	SENT_128	[p6l602t632r663b661],
8	as	IN	O	as	_	0	SENT_128	[p6l675t641r707b661],
9	a	DT	O	a	det	11	SENT_128	[p6l720t641r737b661],
10	model	NN	O	model	nn	11	SENT_128	[p6l747t632r850b661],
11	system	NN	O	system	prep_as	1	SENT_128	[p6l863t637r984b670],
12	,	,	O	,	_	0	SENT_128	[p6l863t637r984b670],
13	Deeley	NNP	PERSON	Deeley	prep_as	1	SENT_128	[p6l997t632r1113b670],
14	and	CC	O	and	_	0	SENT_128	[p6l1125t632r1183b661],
15	Cole	NNP	PERSON	Cole	conj_and	11	SENT_128	[p6l1194t632r1271b661],
16	and	CC	O	and	_	0	SENT_128	[p6l1283t632r1342b661],
17	colleagues	NNS	O	colleague	prep_as	1	SENT_128	[p6l1353t632r1526b670],
18	cloned	VBN	O	clone	partmod	17	SENT_128	[p6l1538t632r1648b661],
19	another	DT	O	another	det	20	SENT_128	[p6l1659t632r1782b661],
20	ABC	NNP	ORGANIZATION	ABC	dobj	18	SENT_128	[p6l1793t632r1876b661],

1	family	NN	O	family	nn	2	SENT_129	[p6l532t703r639b741],
2	member	NN	O	member	nsubj	16	SENT_129	[p6l653t704r795b738],
3	,	,	O	,	_	0	SENT_129	[p6l653t704r795b738],
4	known	VBN	O	know	partmod	2	SENT_129	[p6l810t704r922b733],
5	as	IN	O	as	_	0	SENT_129	[p6l936t713r968b733],
6	MRP1	NN	O	mrp1	nn	7	SENT_129	[p6l981t704r1084b732],
7	(	NN	O	(	prep_as	4	SENT_129	[p6l1103t703r1164b739],
8	for	IN	O	for	_	0	SENT_129	[p6l1103t703r1164b739],
9	multidrug	JJ	O	multidrug	amod	10	SENT_129	[p6l1176t703r1339b741],
10	resistance	NN	O	resistance	prep_for	7	SENT_129	[p6l1353t703r1515b733],
11	associated	VBN	O	associate	_	0	SENT_129	[p6l1530t703r1699b733],
12	protein	NN	O	protein	nn	14	SENT_129	[p6l1712t704r1830b741],
13	1	CD	NUMBER	1	num	14	SENT_129	[p6l1847t704r1875b739],
14	)	NN	O	)	dobj	11	SENT_129	[p6l1847t704r1875b739],
15	and	CC	O	and	_	0	SENT_129	[p6l533t753r592b782],
16	showed	VBD	O	show	conj_and	11	SENT_129	[p6l604t753r727b782],
17	that	IN	O	that	complm	19	SENT_129	[p6l738t753r800b782],
18	it	PRP	O	it	nsubj	19	SENT_129	[p6l810t753r833b782],
19	had	VBD	O	have	ccomp	16	SENT_129	[p6l842t753r902b782],
20	a	DT	O	a	det	22	SENT_129	[p6l913t762r931b782],
21	broad	JJ	O	broad	amod	22	SENT_129	[p6l940t753r1035b782],
22	spectrum	NN	O	spectrum	dobj	19	SENT_129	[p6l1047t758r1197b791],
23	of	IN	O	of	_	0	SENT_129	[p6l1208t753r1244b782],
24	anticancer	JJ	O	anticancer	amod	27	SENT_129	[p6l1252t753r1422b782],
25	drug	NN	O	drug	nn	27	SENT_129	[p6l1432t753r1507b791],
26	transport	NN	O	transport	nn	27	SENT_129	[p6l1518t758r1665b791],
27	activity	NN	O	activity	prep_of	22	SENT_129	[p6l1676t753r1798b791],
28	(	CD	NUMBER	(	number	29	SENT_129	[p6l1810t754r1876b789],
29	27	CD	NUMBER	27	dep	27	SENT_129	[p6l1810t754r1876b789],
30	)	NN	O	)	nn	32	SENT_129	[p6l1810t754r1876b789],
31	(	CD	NUMBER	(	num	32	SENT_129	[p6l534t803r653b841],
32	Figure	NNP	O	Figure	dep	29	SENT_129	[p6l534t803r653b841],
33	3	CD	NUMBER	3	num	34	SENT_129	[p6l669t803r710b839],
34	)	NN	O	)	dep	29	SENT_129	[p6l669t803r710b839],
35	.	.	O	.	_	0	SENT_129	[p6l669t803r710b839],

1	MRPl	NNP	ORGANIZATION	MRPl	nsubj	6	SENT_130	[p6l727t803r843b837],
2	,	,	O	,	_	0	SENT_130	[p6l727t803r843b837],
3	unlike	IN	O	unlike	_	0	SENT_130	[p6l859t803r962b832],
4	MDR1	NN	O	mdr1	prep_unlike	6	SENT_130	[p6l976t803r1100b837],
5	,	,	O	,	_	0	SENT_130	[p6l976t803r1100b837],
6	transports	VBZ	O	transport	_	0	SENT_130	[p6l1116t808r1278b841],
7	negatively	RB	O	negatively	advmod	8	SENT_130	[p6l1293t803r1463b841],
8	charged	VBN	O	charge	ccomp	6	SENT_130	[p6l1478t803r1608b841],
9	natural	JJ	O	natural	amod	12	SENT_130	[p6l1622t803r1878b841],
10	—	NN	O	—	nn	12	SENT_130	[p6l1622t803r1878b841],
11	product	NN	O	product	nn	12	SENT_130	[p6l1622t803r1878b841],
12	drugs	NNS	O	drug	dobj	8	SENT_130	[p6l533t853r623b891],
13	and	CC	O	and	_	0	SENT_130	[p6l640t853r699b882],
14	drugs	NNS	O	drug	conj_and	12	SENT_130	[p6l715t853r804b891],
15	that	WDT	O	that	nsubjpass	18	SENT_130	[p6l821t853r883b882],
16	have	VBP	O	have	aux	18	SENT_130	[p6l898t853r974b882],
17	been	VBN	O	be	auxpass	18	SENT_130	[p6l989t853r1067b882],
18	modiﬁed	VBN	O	modiﬁed	rcmod	14	SENT_130	[p6l1083t853r1230b882],
19	by	IN	O	by	_	0	SENT_130	[p6l1245t853r1285b891],
20	glutathione	NN	O	glutathione	agent	18	SENT_130	[p6l1302t853r1496b891],
21	,	,	O	,	_	0	SENT_130	[p6l1302t853r1496b891],
22	conjugation	NN	O	conjugation	agent	18	SENT_130	[p6l1514t853r1718b891],
23	,	,	O	,	_	0	SENT_130	[p6l1514t853r1718b891],
24	glucosy	NN	O	glucosy	nn	26	SENT_130	[p6l1735t853r1876b891],
25	—	NN	O	—	nn	26	SENT_130	[p6l1735t853r1876b891],
26	lation	NN	O	lation	agent	18	SENT_130	[p6l533t903r635b937],
27	,	,	O	,	_	0	SENT_130	[p6l533t903r635b937],
28	sulfation	NN	O	sulfation	agent	18	SENT_130	[p6l654t903r805b937],
29	,	,	O	,	_	0	SENT_130	[p6l654t903r805b937],
30	and	CC	O	and	_	0	SENT_130	[p6l823t903r882b932],
31	glucuronylation	NN	O	glucuronylation	agent	18	SENT_130	[p6l898t903r1167b940],
32	.	.	O	.	_	0	SENT_130	[p6l898t903r1167b940],

1	In	IN	O	in	_	0	SENT_131	[p6l1185t903r1219b931],
2	some	DT	O	some	det	4	SENT_131	[p6l1236t912r1321b932],
3	cases	NNS	O	case	nn	4	SENT_131	[p6l1337t912r1423b932],
4	cotransport	NN	O	cotransport	prep_in	15	SENT_131	[p6l1440t907r1626b940],
5	of	IN	O	of	_	0	SENT_131	[p6l1642t903r1678b932],
6	glutathione	NN	O	glutathione	prep_of	4	SENT_131	[p6l1691t903r1876b940],
7	with	IN	O	with	_	0	SENT_131	[p6l533t952r605b982],
8	positively	RB	O	positively	advmod	9	SENT_131	[p6l616t952r777b990],
9	charged	VBN	O	charge	prepc_with	6	SENT_131	[p6l789t953r918b990],
10	drugs	NNS	O	drug	nsubj	15	SENT_131	[p6l930t953r1019b990],
11	such	JJ	O	such	_	0	SENT_131	[p6l1033t953r1107b982],
12	as	IN	O	as	_	0	SENT_131	[p6l1118t962r1150b982],
13	vinblastine	NN	O	vinblastine	prep_such_as	10	SENT_131	[p6l1162t952r1343b982],
14	can	MD	O	can	aux	15	SENT_131	[p6l1355t962r1411b982],
15	occur	VB	O	occur	_	0	SENT_131	[p6l1422t962r1519b982],
16	.	.	O	.	_	0	SENT_131	[p6l1422t962r1519b982],

1	MRP1	NN	O	mrp1	nsubjpass	5	SENT_132	[p6l1532t953r1636b981],
2	is	VBZ	O	be	auxpass	5	SENT_132	[p6l1650t952r1676b982],
3	also	RB	O	also	advmod	5	SENT_132	[p6l1689t953r1754b982],
4	widely	RB	O	widely	advmod	5	SENT_132	[p6l1765t952r1877b990],
5	expressed	VBN	O	express	_	0	SENT_132	[p6l533t1002r695b1040],
6	in	IN	O	in	_	0	SENT_132	[p6l706t1002r737b1031],
7	many	JJ	O	many	amod	9	SENT_132	[p6l749t1011r839b1040],
8	human	JJ	O	human	amod	9	SENT_132	[p6l850t1002r963b1031],
9	tissues	NNS	O	tissue	prep_in	5	SENT_132	[p6l974t1002r1083b1031],
10	and	CC	O	and	_	0	SENT_132	[p6l1096t1002r1155b1031],
11	cancers	NNS	O	cancer	nsubj	12	SENT_132	[p6l1166t1011r1288b1031],
12	(	VBP	O	(	conj_and	5	SENT_132	[p6l1302t1002r1377b1038],
13	12	CD	NUMBER	12	num	14	SENT_132	[p6l1302t1002r1377b1038],
14	)	CD	NUMBER	)	dobj	12	SENT_132	[p6l1302t1002r1377b1038],
15	.	.	O	.	_	0	SENT_132	[p6l1302t1002r1377b1038],

1	The	DT	O	the	det	2	SENT_133	[p6l582t1052r645b1081],
2	discovery	NN	O	discovery	nsubj	5	SENT_133	[p6l664t1052r823b1089],
3	of	IN	O	of	_	0	SENT_133	[p6l842t1052r878b1081],
4	MRP1	NN	O	mrp1	prep_of	2	SENT_133	[p6l893t1052r997b1080],
5	led	VBD	O	lead	_	0	SENT_133	[p6l1019t1052r1069b1081],
6	to	TO	O	to	_	0	SENT_133	[p6l1087t1056r1118b1081],
7	a	DT	O	a	det	8	SENT_133	[p6l1137t1061r1155b1081],
8	search	NN	O	search	prep_to	5	SENT_133	[p6l1174t1052r1277b1081],
9	for	IN	O	for	_	0	SENT_133	[p6l1296t1052r1344b1081],
10	other	JJ	O	other	amod	11	SENT_133	[p6l1362t1052r1446b1081],
11	members	NNS	O	member	prep_for	5	SENT_133	[p6l1464t1052r1614b1081],
12	of	IN	O	of	_	0	SENT_133	[p6l1634t1052r1670b1081],
13	this	DT	O	this	det	14	SENT_133	[p6l1685t1052r1743b1081],
14	family	NN	O	family	prep_of	11	SENT_133	[p6l1762t1052r1875b1089],
15	,	,	O	,	_	0	SENT_133	[p6l1762t1052r1875b1089],
16	resulting	VBG	O	result	xcomp	5	SENT_133	[p6l532t1101r676b1139],
17	in	IN	O	in	_	0	SENT_133	[p6l692t1102r723b1130],
18	the	DT	O	the	det	19	SENT_133	[p6l739t1102r788b1131],
19	discovery	NN	O	discovery	prep_in	16	SENT_133	[p6l804t1102r963b1139],
20	of	IN	O	of	_	0	SENT_133	[p6l979t1101r1015b1131],
21	a	DT	O	a	det	22	SENT_133	[p6l1028t1111r1045b1131],
22	total	NN	O	total	prep_of	19	SENT_133	[p6l1060t1102r1132b1131],
23	of	IN	O	of	_	0	SENT_133	[p6l1148t1101r1184b1131],
24	9	CD	NUMBER	9	num	28	SENT_133	[p6l1197t1102r1216b1131],
25	or	CC	O	or	_	0	SENT_133	[p6l1232t1111r1266b1131],
26	10	CD	NUMBER	10	num	28	SENT_133	[p6l1285t1102r1321b1131],
27	MRP	NN	ORGANIZATION	mrp	nn	28	SENT_133	[p6l1336t1102r1423b1130],
28	genes	NNS	O	gene	prep_of	22	SENT_133	[p6l1439t1111r1541b1139],
29	,	,	O	,	_	0	SENT_133	[p6l1439t1111r1541b1139],
30	at	IN	O	at	quantmod	32	SENT_133	[p6l1559t1106r1587b1131],
31	least	JJS	O	least	mwe	30	SENT_133	[p6l1602t1102r1678b1131],
32	6	CD	NUMBER	6	nsubjpass	37	SENT_133	[p6l1693t1101r1712b1131],
33	of	IN	O	of	_	0	SENT_133	[p6l1728t1101r1764b1131],
34	which	WDT	O	which	prep_of	32	SENT_133	[p6l1777t1101r1877b1131],
35	have	VBP	O	have	aux	37	SENT_133	[p6l532t1151r608b1180],
36	been	VBN	O	be	auxpass	37	SENT_133	[p6l626t1151r704b1180],
37	characterized	VBN	O	characterize	rcmod	28	SENT_133	[p6l722t1151r943b1180],
38	enough	RB	O	enough	advmod	37	SENT_133	[p6l961t1151r1082b1189],
39	to	TO	O	to	aux	40	SENT_133	[p6l1100t1156r1131b1180],
40	indicate	VB	O	indicate	xcomp	37	SENT_133	[p6l1149t1151r1280b1180],
41	that	IN	O	that	complm	43	SENT_133	[p6l1298t1151r1360b1180],
42	they	PRP	O	they	nsubj	43	SENT_133	[p6l1378t1151r1447b1189],
43	transport	VBP	O	transport	ccomp	40	SENT_133	[p6l1466t1156r1613b1189],
44	anticancer	JJ	O	anticancer	amod	47	SENT_133	[p6l1631t1151r1801b1180],
45	and	CC	O	and	_	0	SENT_133	[p6l1819t1151r1877b1180],
46	antiviral	JJ	O	antiviral	amod	47	SENT_133	[p6l533t1201r669b1230],
47	compounds	NNS	O	compound	nsubj	48	SENT_133	[p6l685t1201r874b1239],
48	(	VBP	O	(	ccomp	43	SENT_133	[p6l893t1201r955b1237],
49	12	CD	NUMBER	12	dobj	48	SENT_133	[p6l893t1201r955b1237],
50	,	,	O	,	_	0	SENT_133	[p6l893t1201r955b1237],
51	28-32	CD	NUMBER	28-32	appos	49	SENT_133	[p6l965t1201r1080b1237],
52	)	CD	NUMBER	)	number	53	SENT_133	[p6l965t1201r1080b1237],
53	(	CD	NUMBER	(	num	56	SENT_133	[p6l1099t1201r1218b1239],
54	Figure	NNP	O	Figure	nn	56	SENT_133	[p6l1099t1201r1218b1239],
55	3	CD	NUMBER	3	num	56	SENT_133	[p6l1236t1201r1277b1237],
56	)	NN	O	)	dep	51	SENT_133	[p6l1236t1201r1277b1237],
57	.	.	O	.	_	0	SENT_133	[p6l1236t1201r1277b1237],

1	Many	JJ	O	many	nsubj	4	SENT_134	[p6l1295t1202r1390b1239],
2	of	IN	O	of	_	0	SENT_134	[p6l1407t1201r1443b1230],
3	these	DT	O	these	prep_of	1	SENT_134	[p6l1456t1201r1541b1230],
4	appear	VBP	O	appear	_	0	SENT_134	[p6l1558t1210r1667b1239],
5	to	TO	O	to	aux	6	SENT_134	[p6l1683t1206r1714b1230],
6	transport	VB	O	transport	xcomp	4	SENT_134	[p6l1730t1206r1878b1239],
7	drugs	NNS	O	drug	nsubj	9	SENT_134	[p6l533t1252r623b1289],
8	potentially	RB	O	potentially	advmod	9	SENT_134	[p6l633t1251r809b1289],
9	important	JJ	O	important	xcomp	6	SENT_134	[p6l819t1251r980b1289],
10	for	IN	O	for	_	0	SENT_134	[p6l989t1251r1037b1281],
11	the	DT	O	the	det	12	SENT_134	[p6l1046t1252r1095b1281],
12	treatment	NN	O	treatment	prep_for	9	SENT_134	[p6l1105t1256r1261b1281],
13	of	IN	O	of	_	0	SENT_134	[p6l1271t1251r1306b1281],
14	cancer	NN	O	cancer	prep_of	12	SENT_134	[p6l1313t1261r1428b1286],
15	,	,	O	,	_	0	SENT_134	[p6l1313t1261r1428b1286],
16	and	CC	O	and	_	0	SENT_134	[p6l1439t1251r1498b1281],
17	their	PRP$	O	they	poss	18	SENT_134	[p6l1507t1251r1583b1281],
18	role	NN	O	role	nsubj	26	SENT_134	[p6l1591t1251r1655b1281],
19	in	IN	O	in	_	0	SENT_134	[p6l1664t1251r1696b1280],
20	conferring	VBG	O	confer	prepc_in	18	SENT_134	[p6l1705t1251r1877b1289],
21	drug	NN	O	drug	nn	22	SENT_134	[p6l533t1302r607b1340],
22	resistance	NN	O	resistance	dobj	20	SENT_134	[p6l618t1302r781b1331],
23	on	IN	O	on	_	0	SENT_134	[p6l794t1311r833b1331],
24	cancer	NN	O	cancer	nn	25	SENT_134	[p6l845t1311r953b1331],
25	cells	NNS	O	cell	prep_on	20	SENT_134	[p6l964t1302r1038b1331],
26	is	VBZ	O	be	conj_and	4	SENT_134	[p6l1050t1302r1076b1331],
27	under	IN	O	under	_	0	SENT_134	[p6l1088t1302r1183b1331],
28	active	JJ	O	active	amod	29	SENT_134	[p6l1194t1302r1289b1331],
29	investigation	NN	O	investigation	prep_under	26	SENT_134	[p6l1301t1302r1521b1340],
30	.	.	O	.	_	0	SENT_134	[p6l1301t1302r1521b1340],

1	A	DT	O	a	det	4	SENT_135	[p6l582t1351r611b1380],
2	third	JJ	ORDINAL	third	amod	4	SENT_135	[p6l623t1351r701b1380],
3	ABC	NNP	ORGANIZATION	ABC	nn	4	SENT_135	[p6l712t1351r795b1380],
4	transporter	NN	O	transporter	nsubjpass	10	SENT_135	[p6l808t1356r987b1389],
5	for	IN	O	for	_	0	SENT_135	[p6l998t1351r1046b1380],
6	anticancer	JJ	O	anticancer	amod	7	SENT_135	[p6l1058t1351r1227b1380],
7	drugs	NNS	O	drug	prep_for	4	SENT_135	[p6l1238t1351r1328b1389],
8	has	VBZ	O	have	aux	10	SENT_135	[p6l1340t1351r1394b1380],
9	been	VBN	O	be	auxpass	10	SENT_135	[p6l1406t1351r1484b1380],
10	called	VBN	O	call	_	0	SENT_135	[p6l1496t1351r1594b1380],
11	MXR	NNP	O	MXR	dobj	10	SENT_135	[p6l1605t1352r1708b1385],
12	,	,	O	,	_	0	SENT_135	[p6l1605t1352r1708b1385],
13	BCRP	NN	O	bcrp	conj_or	11	SENT_135	[p6l1721t1351r1830b1385],
14	,	,	O	,	_	0	SENT_135	[p6l1721t1351r1830b1385],
15	or	CC	O	or	_	0	SENT_135	[p6l1844t1360r1878b1380],
16	ABC-P	NN	O	abc-p	conj_or	11	SENT_135	[p6l533t1401r654b1430],
17	(	CD	NUMBER	(	num	16	SENT_135	[p6l667t1401r795b1437],
18	33-35	CD	NUMBER	33-35	num	19	SENT_135	[p6l667t1401r795b1437],
19	)	NN	O	)	dep	16	SENT_135	[p6l667t1401r795b1437],
20	(	CD	NUMBER	(	num	23	SENT_135	[p6l809t1401r929b1439],
21	Figure	NNP	O	Figure	nn	23	SENT_135	[p6l809t1401r929b1439],
22	3	CD	NUMBER	3	num	23	SENT_135	[p6l942t1401r983b1437],
23	)	NN	O	)	xcomp	10	SENT_135	[p6l942t1401r983b1437],
24	.	.	O	.	_	0	SENT_135	[p6l942t1401r983b1437],

1	It	PRP	O	it	nsubjpass	3	SENT_136	[p6l997t1402r1022b1430],
2	was	VBD	O	be	auxpass	3	SENT_136	[p6l1033t1410r1095b1430],
3	found	VBN	O	find	_	0	SENT_136	[p6l1108t1401r1204b1430],
4	to	TO	O	to	aux	6	SENT_136	[p6l1215t1406r1246b1430],
5	be	VB	O	be	auxpass	6	SENT_136	[p6l1258t1401r1296b1430],
6	overexpressed	VBN	O	overexpress	xcomp	3	SENT_136	[p6l1309t1401r1544b1439],
7	in	IN	O	in	_	0	SENT_136	[p6l1555t1401r1586b1430],
8	cells	NNS	O	cell	prep_in	6	SENT_136	[p6l1599t1401r1672b1430],
9	selected	VBN	O	select	partmod	8	SENT_136	[p6l1687t1401r1818b1430],
10	for	IN	O	for	_	0	SENT_136	[p6l1830t1401r1878b1430],
11	resistance	NN	O	resistance	prep_for	9	SENT_136	[p6l532t1451r695b1480],
12	to	TO	O	to	_	0	SENT_136	[p6l707t1455r738b1480],
13	mitoxantrone	NN	O	mitoxantrone	prep_to	9	SENT_136	[p6l750t1451r970b1480],
14	or	CC	O	or	_	0	SENT_136	[p6l983t1460r1017b1480],
15	anthracyclines	NNS	O	anthracycline	prep_to	9	SENT_136	[p6l1029t1451r1275b1488],
16	.	.	O	.	_	0	SENT_136	[p6l1029t1451r1275b1488],

1	Unlike	IN	O	unlike	_	0	SENT_137	[p6l1289t1451r1400b1480],
2	MDR1	NN	O	mdr1	prep_unlike	11	SENT_137	[p6l1412t1451r1523b1479],
3	and	CC	O	and	_	0	SENT_137	[p6l1539t1451r1598b1480],
4	the	DT	O	the	det	7	SENT_137	[p6l1609t1451r1659b1480],
5	MRP	NN	ORGANIZATION	mrp	nn	7	SENT_137	[p6l1671t1451r1758b1479],
6	family	NN	O	family	nn	7	SENT_137	[p6l1770t1451r1876b1488],
7	members	NNS	O	member	conj_and	2	SENT_137	[p6l532t1500r692b1534],
8	,	,	O	,	_	0	SENT_137	[p6l532t1500r692b1534],
9	it	PRP	O	it	nsubjpass	32	SENT_137	[p6l709t1500r732b1529],
10	only	RB	O	only	advmod	11	SENT_137	[p6l747t1500r819b1538],
11	has	VBZ	O	have	_	0	SENT_137	[p6l834t1500r887b1529],
12	one	CD	NUMBER	one	num	13	SENT_137	[p6l904t1509r962b1529],
13	region	NN	O	region	dobj	11	SENT_137	[p6l977t1500r1082b1538],
14	with	IN	O	with	_	0	SENT_137	[p6l1097t1500r1170b1529],
15	six	CD	NUMBER	six	num	17	SENT_137	[p6l1186t1500r1232b1529],
16	transmembrane	NN	O	transmembrane	nn	17	SENT_137	[p6l1247t1500r1502b1529],
17	domains	NNS	O	domain	prep_with	13	SENT_137	[p6l1518t1500r1656b1529],
18	and	CC	O	and	_	0	SENT_137	[p6l1673t1500r1732b1529],
19	a	DT	O	a	det	23	SENT_137	[p6l1747t1509r1764b1529],
20	single	JJ	O	single	amod	23	SENT_137	[p6l1780t1500r1877b1538],
21	ATP	NN	O	atp	nn	23	SENT_137	[p6l532t1550r746b1588],
22	—	NN	O	—	nn	23	SENT_137	[p6l532t1550r746b1588],
23	binding	NN	O	binding	prep_with	13	SENT_137	[p6l532t1550r746b1588],
24	cassette	NN	O	cassette	nsubj	26	SENT_137	[p6l755t1554r883b1579],
25	(	CD	NUMBER	(	num	24	SENT_137	[p6l894t1550r958b1586],
26	see	VBP	O	see	rcmod	13	SENT_137	[p6l894t1550r958b1586],
27	Figure	NN	O	figure	nn	29	SENT_137	[p6l967t1550r1075b1588],
28	1	CD	NUMBER	1	num	29	SENT_137	[p6l1088t1550r1116b1586],
29	)	NN	O	)	dobj	26	SENT_137	[p6l1088t1550r1116b1586],
30	but	CC	O	but	_	0	SENT_137	[p6l1127t1550r1179b1579],
31	is	VBZ	O	be	auxpass	32	SENT_137	[p6l1188t1550r1213b1579],
32	presumed	VBN	O	presume	conj_but	11	SENT_137	[p6l1223t1550r1384b1588],
33	to	TO	O	to	aux	34	SENT_137	[p6l1393t1554r1424b1579],
34	function	VB	O	function	xcomp	32	SENT_137	[p6l1433t1550r1571b1579],
35	as	IN	O	as	_	0	SENT_137	[p6l1581t1559r1613b1579],
36	a	DT	O	a	det	37	SENT_137	[p6l1624t1559r1641b1579],
37	dimer	NN	O	dimer	prep_as	34	SENT_137	[p6l1650t1550r1751b1579],
38	.	.	O	.	_	0	SENT_137	[p6l1650t1550r1751b1579],

1	Recent	JJ	O	recent	amod	2	SENT_138	[p6l1763t1551r1877b1579],
2	evidence	NN	O	evidence	nsubj	3	SENT_138	[p6l533t1600r678b1629],
3	suggests	VBZ	O	suggest	_	0	SENT_138	[p6l695t1604r833b1637],
4	that	IN	O	that	complm	12	SENT_138	[p6l849t1600r912b1629],
5	the	DT	O	the	det	9	SENT_138	[p6l927t1600r976b1629],
6	wild	JJ	O	wild	amod	9	SENT_138	[p6l993t1600r1150b1637],
7	—	NN	O	—	nn	9	SENT_138	[p6l993t1600r1150b1637],
8	type	NN	O	type	nn	9	SENT_138	[p6l993t1600r1150b1637],
9	form	NN	O	form	nsubj	12	SENT_138	[p6l1167t1600r1247b1629],
10	of	IN	O	of	_	0	SENT_138	[p6l1263t1600r1299b1629],
11	MXR	NN	O	mxr	prep_of	9	SENT_138	[p6l1312t1600r1406b1628],
12	shows	VBZ	O	show	ccomp	3	SENT_138	[p6l1423t1600r1522b1629],
13	a	DT	O	a	det	15	SENT_138	[p6l1540t1609r1557b1629],
14	narrower	JJR	O	narrower	amod	15	SENT_138	[p6l1573t1609r1721b1629],
15	range	NN	O	range	dobj	12	SENT_138	[p6l1736t1609r1827b1637],
16	of	IN	O	of	_	0	SENT_138	[p6l1844t1600r1880b1629],
17	substrates	NNS	O	substrate	prep_of	15	SENT_138	[p6l534t1650r694b1679],
18	for	IN	O	for	_	0	SENT_138	[p6l706t1649r754b1679],
19	drug	NN	O	drug	nn	20	SENT_138	[p6l764t1650r838b1687],
20	transport	NN	O	transport	prep_for	17	SENT_138	[p6l849t1654r996b1687],
21	than	IN	O	than	mark	51	SENT_138	[p6l1006t1650r1077b1679],
22	a	DT	O	a	det	24	SENT_138	[p6l1088t1659r1105b1679],
23	mutant	JJ	O	mutant	amod	24	SENT_138	[p6l1115t1654r1230b1679],
24	form	NN	O	form	nsubj	51	SENT_138	[p6l1240t1649r1320b1679],
25	of	IN	O	of	_	0	SENT_138	[p6l1330t1649r1366b1679],
26	the	DT	O	the	det	27	SENT_138	[p6l1374t1650r1423b1679],
27	protein	NN	O	protein	prep_of	24	SENT_138	[p6l1433t1650r1551b1687],
28	in	IN	O	in	_	0	SENT_138	[p6l1561t1650r1592b1678],
29	which	WDT	O	which	rel	37	SENT_138	[p6l1603t1649r1703b1679],
30	the	DT	O	the	det	33	SENT_138	[p6l1714t1650r1763b1679],
31	amino	NN	O	amino	nn	33	SENT_138	[p6l1775t1649r1876b1679],
32	acid	NN	O	acid	nn	33	SENT_138	[p6l533t1699r601b1728],
33	threonine	NN	O	threonine	nsubjpass	37	SENT_138	[p6l616t1699r771b1728],
34	or	CC	O	or	_	0	SENT_138	[p6l787t1708r821b1728],
35	glycine	NN	O	glycine	conj_or	33	SENT_138	[p6l836t1699r956b1737],
36	is	VBZ	O	be	auxpass	37	SENT_138	[p6l972t1699r997b1728],
37	substituted	VBN	O	substitute	rcmod	27	SENT_138	[p6l1015t1699r1193b1728],
38	for	IN	O	for	_	0	SENT_138	[p6l1207t1699r1256b1728],
39	arginine	NN	O	arginine	prep_for	37	SENT_138	[p6l1271t1699r1404b1737],
40	at	IN	O	at	_	0	SENT_138	[p6l1420t1703r1449b1728],
41	position	NN	O	position	prep_at	37	SENT_138	[p6l1463t1699r1596b1737],
42	482	CD	NUMBER	482	num	41	SENT_138	[p6l1611t1699r1681b1734],
43	,	,	O	,	_	0	SENT_138	[p6l1611t1699r1681b1734],
44	which	WDT	O	which	nsubjpass	46	SENT_138	[p6l1698t1699r1799b1728],
45	was	VBD	O	be	auxpass	46	SENT_138	[p6l1814t1708r1876b1728],
46	isolated	VBN	O	isolate	rcmod	41	SENT_138	[p6l532t1748r661b1778],
47	in	IN	O	in	_	0	SENT_138	[p6l677t1748r709b1777],
48	the	DT	O	the	det	50	SENT_138	[p6l725t1748r775b1778],
49	early	JJ	O	early	amod	50	SENT_138	[p6l792t1748r873b1786],
50	studies	NNS	O	study	prep_in	46	SENT_138	[p6l891t1748r1003b1778],
51	(	VBP	O	(	advcl	12	SENT_138	[p6l1022t1748r1097b1784],
52	36	CD	NUMBER	36	number	53	SENT_138	[p6l1022t1748r1097b1784],
53	)	CD	NUMBER	)	dobj	51	SENT_138	[p6l1022t1748r1097b1784],
54	.	.	O	.	_	0	SENT_138	[p6l1022t1748r1097b1784],

1	The	DT	O	the	det	2	SENT_139	[p6l1116t1748r1179b1778],
2	role	NN	O	role	nsubj	9	SENT_139	[p6l1196t1748r1260b1778],
3	of	IN	O	of	_	0	SENT_139	[p6l1277t1748r1313b1778],
4	MXR	NN	O	mxr	prep_of	2	SENT_139	[p6l1326t1749r1420b1777],
5	in	IN	O	in	_	0	SENT_139	[p6l1437t1748r1468b1777],
6	clinical	JJ	O	clinical	amod	8	SENT_139	[p6l1485t1748r1606b1778],
7	drug	NN	O	drug	nn	8	SENT_139	[p6l1623t1748r1697b1786],
8	resistance	NN	O	resistance	prep_in	4	SENT_139	[p6l1714t1748r1876b1778],
9	remains	VBZ	O	remain	_	0	SENT_139	[p6l532t1798r662b1827],
10	to	TO	O	to	aux	12	SENT_139	[p6l674t1802r705b1827],
11	be	VB	O	be	auxpass	12	SENT_139	[p6l716t1798r755b1827],
12	determined	VBN	O	determine	xcomp	9	SENT_139	[p6l767t1798r960b1827],
13	.	.	O	.	_	0	SENT_139	[p6l767t1798r960b1827],

1	Three	CD	NUMBER	three	nsubjpass	7	SENT_140	[p6l582t1847r678b1876],
2	additional	JJ	O	additional	amod	4	SENT_140	[p6l693t1847r857b1876],
3	ABC	NNP	ORGANIZATION	ABC	nn	4	SENT_140	[p6l871t1847r955b1876],
4	transporters	NNS	O	transporter	dep	1	SENT_140	[p6l970t1852r1164b1885],
5	have	VBP	O	have	aux	7	SENT_140	[p6l1178t1847r1254b1876],
6	been	VBN	O	be	auxpass	7	SENT_140	[p6l1268t1847r1346b1876],
7	implicated	VBN	O	implicate	_	0	SENT_140	[p6l1360t1847r1535b1885],
8	in	IN	O	in	_	0	SENT_140	[p6l1548t1847r1580b1876],
9	drug	NN	O	drug	nn	10	SENT_140	[p6l1594t1847r1668b1885],
10	transport	NN	O	transport	prep_in	7	SENT_140	[p6l1683t1852r1830b1885],
11	of	IN	O	of	_	0	SENT_140	[p6l1844t1847r1880b1876],
12	potential	JJ	O	potential	amod	13	SENT_140	[p6l532t1896r677b1934],
13	signiﬁcance	NN	O	signiﬁcance	prep_of	10	SENT_140	[p6l689t1896r885b1934],
14	to	TO	O	to	_	0	SENT_140	[p6l897t1901r927b1926],
15	cancer	NN	O	cancer	prep_to	7	SENT_140	[p6l940t1905r1054b1931],
16	,	,	O	,	_	0	SENT_140	[p6l940t1905r1054b1931],
17	including	VBG	O	include	_	0	SENT_140	[p6l1067t1896r1222b1934],
18	the	DT	O	the	det	21	SENT_140	[p6l1234t1896r1283b1926],
19	MDR2	NN	O	mdr2	nn	21	SENT_140	[p6l1293t1896r1404b1925],
20	gene	NN	O	gene	nn	21	SENT_140	[p6l1416t1905r1493b1934],
21	product	NN	O	product	prep_including	7	SENT_140	[p6l1504t1896r1631b1934],
22	(	CD	NUMBER	(	number	23	SENT_140	[p6l1643t1896r1719b1932],
23	37	CD	NUMBER	37	num	24	SENT_140	[p6l1643t1896r1719b1932],
24	)	NN	O	)	dep	21	SENT_140	[p6l1643t1896r1719b1932],
25	,	,	O	,	_	0	SENT_140	[p6l1643t1896r1719b1932],
26	a	DT	O	a	det	27	SENT_140	[p6l1732t1905r1750b1926],
27	protein	NN	O	protein	appos	21	SENT_140	[p6l1760t1896r1877b1934],
28	named	VBN	O	name	partmod	27	SENT_140	[p6l532t1946r642b1975],
29	SPGP	NNP	O	SPGP	nn	31	SENT_140	[p6l661t1946r759b1975],
30	(	CD	NUMBER	(	num	31	SENT_140	[p6l778t1946r878b1982],
31	sister	NN	O	sister	dobj	28	SENT_140	[p6l778t1946r878b1982],
32	of	IN	O	of	_	0	SENT_140	[p6l896t1946r932b1975],
33	P	NN	O	p	nn	36	SENT_140	[p6l947t1946r1037b1984],
34	—	CD	NUMBER	—	num	36	SENT_140	[p6l947t1946r1037b1984],
35	gp	NN	O	gp	nn	36	SENT_140	[p6l947t1946r1037b1984],
36	)	NN	O	)	prep_of	31	SENT_140	[p6l947t1946r1037b1984],
37	(	CD	NUMBER	(	number	38	SENT_140	[p6l1058t1946r1134b1982],
38	38	CD	NUMBER	38	num	39	SENT_140	[p6l1058t1946r1134b1982],
39	)	NN	O	)	dep	36	SENT_140	[p6l1058t1946r1134b1982],
40	,	,	O	,	_	0	SENT_140	[p6l1058t1946r1134b1982],
41	and	CC	O	and	_	0	SENT_140	[p6l1155t1946r1213b1975],
42	ABC	NNP	ORGANIZATION	ABC	nn	43	SENT_140	[p6l1231t1946r1314b1975],
43	A2	NN	O	a2	prep_of	31	SENT_140	[p6l1333t1946r1383b1975],
44	(	CD	NUMBER	(	number	45	SENT_140	[p6l1403t1946r1478b1982],
45	39	CD	NUMBER	39	num	46	SENT_140	[p6l1403t1946r1478b1982],
46	)	NN	O	)	dep	43	SENT_140	[p6l1403t1946r1478b1982],
47	,	,	O	,	_	0	SENT_140	[p6l1403t1946r1478b1982],
48	but	CC	O	but	_	0	SENT_140	[p6l1498t1946r1550b1975],
49	these	DT	O	these	det	50	SENT_140	[p6l1568t1946r1652b1975],
50	data	NNS	O	datum	nsubj	53	SENT_140	[p6l1671t1946r1739b1975],
51	are	VBP	O	be	cop	53	SENT_140	[p6l1758t1955r1806b1975],
52	too	RB	O	too	advmod	53	SENT_140	[p6l1825t1950r1876b1975],
53	preliminary	JJ	O	preliminary	conj_but	7	SENT_140	[p6l532t1995r725b2033],
54	to	TO	O	to	aux	55	SENT_140	[p6l738t2000r768b2024],
55	include	VB	O	include	xcomp	53	SENT_140	[p6l781t1995r903b2024],
56	in	IN	O	in	_	0	SENT_140	[p6l915t1995r947b2024],
57	our	PRP$	O	we	poss	58	SENT_140	[p6l960t2004r1014b2024],
58	ﬁgure	NN	O	ﬁgure	prep_in	55	SENT_140	[p6l1026t1995r1130b2033],
59	.	.	O	.	_	0	SENT_140	[p6l1026t1995r1130b2033],

1	It	PRP	O	it	nsubj	4	SENT_141	[p6l1145t1996r1169b2024],
2	is	VBZ	O	be	cop	4	SENT_141	[p6l1181t1995r1207b2024],
3	also	RB	O	also	advmod	4	SENT_141	[p6l1222t1995r1286b2024],
4	possible	JJ	O	possible	_	0	SENT_141	[p6l1299t1995r1434b2033],
5	that	IN	O	that	complm	26	SENT_141	[p6l1447t1995r1508b2024],
6	other	JJ	O	other	amod	7	SENT_141	[p6l1521t1995r1606b2024],
7	members	NNS	O	member	nsubjpass	26	SENT_141	[p6l1617t1995r1768b2024],
8	of	IN	O	of	_	0	SENT_141	[p6l1782t1995r1817b2024],
9	the	DT	O	the	det	12	SENT_141	[p6l1827t1995r1877b2024],
10	ABC	NNP	ORGANIZATION	ABC	nn	12	SENT_141	[p6l532t2044r616b2074],
11	transporter	NN	O	transporter	nn	12	SENT_141	[p6l627t2049r806b2082],
12	family	NN	O	family	prep_of	7	SENT_141	[p6l816t2044r922b2082],
13	in	IN	O	in	_	0	SENT_141	[p6l933t2044r964b2073],
14	addition	NN	O	addition	_	0	SENT_141	[p6l975t2044r1109b2074],
15	to	TO	O	to	_	0	SENT_141	[p6l1119t2049r1150b2074],
16	the	DT	O	the	det	17	SENT_141	[p6l1160t2044r1210b2074],
17	MDR	NN	ORGANIZATION	mdr	prep_in_addition_to	12	SENT_141	[p6l1220t2045r1322b2079],
18	,	,	O	,	_	0	SENT_141	[p6l1220t2045r1322b2079],
19	MRP	NN	ORGANIZATION	mrp	prep_in_addition_to	12	SENT_141	[p6l1334t2045r1425b2079],
20	,	,	O	,	_	0	SENT_141	[p6l1334t2045r1425b2079],
21	and	CC	O	and	_	0	SENT_141	[p6l1437t2044r1496b2074],
22	MXR	NN	O	mxr	nn	24	SENT_141	[p6l1505t2045r1599b2073],
23	family	NN	O	family	nn	24	SENT_141	[p6l1609t2044r1716b2082],
24	members	NNS	O	member	prep_in_addition_to	12	SENT_141	[p6l1726t2044r1876b2074],
25	are	VBP	O	be	auxpass	26	SENT_141	[p6l533t2103r582b2123],
26	involved	VBN	O	involve	ccomp	4	SENT_141	[p6l595t2094r736b2123],
27	in	IN	O	in	_	0	SENT_141	[p6l749t2094r780b2123],
28	clinical	JJ	O	clinical	amod	31	SENT_141	[p6l793t2094r914b2123],
29	cancer	NN	O	cancer	nn	31	SENT_141	[p6l927t2103r1035b2123],
30	drug	NN	O	drug	nn	31	SENT_141	[p6l1048t2094r1122b2132],
31	resistance	NN	O	resistance	prep_in	26	SENT_141	[p6l1135t2094r1298b2123],
32	or	CC	O	or	_	0	SENT_141	[p6l1311t2103r1345b2123],
33	in	IN	O	in	_	0	SENT_141	[p6l1357t2094r1388b2123],
34	drug	NN	O	drug	nn	35	SENT_141	[p6l1401t2094r1476b2132],
35	transport	NN	O	transport	prep_in	26	SENT_141	[p6l1489t2098r1636b2132],
36	in	IN	O	in	_	0	SENT_141	[p6l1648t2094r1679b2123],
37	the	DT	O	the	det	38	SENT_141	[p6l1692t2094r1742b2123],
38	human	JJ	O	human	prep_in	35	SENT_141	[p6l1754t2094r1875b2123],
39	.	.	O	.	_	0	SENT_141	[p6l1754t2094r1875b2123],

1	Based	VBN	O	base	_	0	SENT_142	[p6l532t2143r633b2173],
2	on	IN	O	on	prepc_based_on	22	SENT_142	[p6l641t2152r681b2173],
3	the	DT	O	the	det	6	SENT_142	[p6l689t2143r738b2173],
4	known	JJ	O	known	amod	6	SENT_142	[p6l746t2143r857b2173],
5	DNA	NN	O	dna	nn	6	SENT_142	[p6l865t2143r953b2173],
6	sequences	NNS	O	sequence	pobj	22	SENT_142	[p6l961t2152r1126b2181],
7	of	IN	O	of	_	0	SENT_142	[p6l1136t2143r1172b2173],
8	these	DT	O	these	det	9	SENT_142	[p6l1177t2143r1261b2173],
9	genes	NNS	O	gene	prep_of	6	SENT_142	[p6l1269t2152r1371b2181],
10	,	,	O	,	_	0	SENT_142	[p6l1269t2152r1371b2181],
11	efforts	NNS	O	effort	nsubj	22	SENT_142	[p6l1380t2143r1486b2173],
12	to	TO	O	to	aux	13	SENT_142	[p6l1494t2148r1525b2173],
13	explore	VB	O	explore	infmod	11	SENT_142	[p6l1534t2143r1656b2181],
14	their	PRP$	O	they	poss	15	SENT_142	[p6l1664t2143r1740b2173],
15	patterns	NNS	O	pattern	dobj	13	SENT_142	[p6l1746t2148r1876b2181],
16	of	IN	O	of	_	0	SENT_142	[p6l533t2193r569b2222],
17	expression	NN	O	expression	prep_of	15	SENT_142	[p6l583t2193r759b2231],
18	and	CC	O	and	_	0	SENT_142	[p6l777t2193r835b2222],
19	determine	VB	O	determine	conj_and	13	SENT_142	[p6l852t2193r1016b2222],
20	their	PRP$	O	they	poss	21	SENT_142	[p6l1033t2193r1109b2222],
21	function	NN	O	function	dobj	19	SENT_142	[p6l1126t2193r1263b2222],
22	are	VBP	O	be	_	0	SENT_142	[p6l1281t2202r1329b2222],
23	under	IN	O	under	_	0	SENT_142	[p6l1346t2193r1441b2222],
24	way	NN	O	way	prep_under	22	SENT_142	[p6l1457t2202r1530b2231],
25	.	.	O	.	_	0	SENT_142	[p6l1457t2202r1530b2231],

1	One	CD	NUMBER	one	num	2	SENT_143	[p6l1550t2193r1617b2223],
2	approach	NN	O	approach	nsubj	3	SENT_143	[p6l1635t2193r1785b2231],
3	is	VBZ	O	be	_	0	SENT_143	[p6l1802t2193r1828b2222],
4	to	TO	O	to	_	0	SENT_143	[p6l1846t2197r1876b2222],
5	DRUG	NN	O	drug	nn	6	SENT_143	[p6l1192t2253r1296b2280],
6	RESISTANCE	NN	O	resistance	prep_to	3	SENT_143	[p6l1306t2253r1528b2280],
7	IN	IN	O	in	_	0	SENT_143	[p6l1538t2254r1577b2280],
8	CANCER	NNP	O	CANCER	prep_in	6	SENT_143	[p6l1587t2253r1738b2280],
9	621	CD	NUMBER	621	num	8	SENT_143	[p6l1826t2250r1885b2280],

1	examine	VB	O	examine	_	0	SENT_144	[p6l543t2376r682b2405],
2	intrinsically	RB	O	intrinsically	advmod	3	SENT_144	[p6l695t2376r892b2414],
3	resistant	JJ	O	resistant	amod	4	SENT_144	[p6l905t2376r1043b2405],
4	cancers	NNS	O	cancer	dobj	1	SENT_144	[p6l1056t2385r1178b2405],
5	and	CC	O	and	_	0	SENT_144	[p6l1192t2376r1251b2405],
6	those	DT	O	those	conj_and	4	SENT_144	[p6l1263t2376r1350b2405],
7	that	WDT	O	that	nsubj	9	SENT_144	[p6l1363t2376r1424b2405],
8	have	VBP	O	have	aux	9	SENT_144	[p6l1437t2376r1513b2405],
9	acquired	VBN	O	acquire	rcmod	6	SENT_144	[p6l1526t2376r1668b2414],
10	resistance	NN	O	resistance	dobj	9	SENT_144	[p6l1680t2376r1843b2405],
11	to	TO	O	to	_	0	SENT_144	[p6l1856t2380r1887b2405],
12	anticancer	JJ	O	anticancer	amod	13	SENT_144	[p6l544t2425r713b2454],
13	drugs	NNS	O	drug	prep_to	9	SENT_144	[p6l730t2425r820b2463],
14	and	CC	O	and	_	0	SENT_144	[p6l839t2425r897b2454],
15	determine	VB	O	determine	conj_and	1	SENT_144	[p6l914t2425r1079b2454],
16	whether	IN	O	whether	complm	22	SENT_144	[p6l1096t2425r1229b2454],
17	expression	NN	O	expression	nsubj	22	SENT_144	[p6l1246t2425r1422b2463],
18	of	IN	O	of	_	0	SENT_144	[p6l1439t2425r1475b2454],
19	other	JJ	O	other	amod	21	SENT_144	[p6l1490t2425r1574b2454],
20	ABC	NNP	ORGANIZATION	ABC	nn	21	SENT_144	[p6l1590t2425r1674b2454],
21	transporters	NNS	O	transporter	prep_of	17	SENT_144	[p6l1692t2430r1886b2463],
22	occurs	VBZ	O	occur	ccomp	15	SENT_144	[p6l543t2483r649b2504],
23	commonly	RB	O	commonly	advmod	22	SENT_144	[p6l662t2474r844b2512],
24	.	.	O	.	_	0	SENT_144	[p6l662t2474r844b2512],

1	DRUG	NN	O	drug	nn	3	SENT_145	[p6l444t2587r580b2622],
2	RESISTANCE	NN	O	resistance	nn	3	SENT_145	[p6l593t2587r873b2622],
3	DUE	NN	O	due	_	0	SENT_145	[p6l886t2588r985b2622],
4	TO	TO	O	to	infmod	3	SENT_145	[p6l998t2587r1061b2622],
5	REDUCED	NNP	O	REDUCED	nn	6	SENT_145	[p6l1075t2587r1303b2622],
6	UPTAKE	NNP	O	UPTAKE	dep	3	SENT_145	[p6l444t2645r627b2680],
7	OF	IN	O	of	_	0	SENT_145	[p6l641t2645r701b2680],
8	DRUGS	NNS	O	drug	prep_of	6	SENT_145	[p6l715t2645r874b2680],

1	As	IN	O	as	mark	2	SENT_146	[p6l543t2750r587b2779],
2	illustrated	VBN	O	illustrate	advcl	15	SENT_146	[p6l600t2750r766b2779],
3	in	IN	O	in	_	0	SENT_146	[p6l777t2750r809b2779],
4	Figure	NN	O	figure	prep_in	2	SENT_146	[p6l821t2750r928b2788],
5	2	CD	NUMBER	2	num	4	SENT_146	[p6l941t2750r969b2785],
6	,	,	O	,	_	0	SENT_146	[p6l941t2750r969b2785],
7	speciﬁc	NN	O	speciﬁc	nn	10	SENT_146	[p6l984t2750r1108b2788],
8	and	CC	O	and	_	0	SENT_146	[p6l1122t2750r1180b2779],
9	nonspeciﬁc	JJ	O	nonspeciﬁc	nn	10	SENT_146	[p6l1192t2750r1379b2788],
10	uptake	NN	O	uptake	nsubj	15	SENT_146	[p6l1392t2750r1501b2788],
11	of	IN	O	of	_	0	SENT_146	[p6l1514t2750r1550b2779],
12	water-soluble	JJ	O	water-soluble	amod	13	SENT_146	[p6l1560t2750r1783b2780],
13	drugs	NNS	O	drug	prep_of	10	SENT_146	[p6l1796t2750r1886b2788],
14	can	MD	O	can	aux	15	SENT_146	[p6l543t2808r600b2828],
15	occur	VB	O	occur	_	0	SENT_146	[p6l616t2808r707b2828],
16	across	IN	O	across	_	0	SENT_146	[p6l723t2808r824b2828],
17	the	DT	O	the	det	19	SENT_146	[p6l840t2799r890b2828],
18	plasma	NN	O	plasma	nn	19	SENT_146	[p6l905t2799r1023b2837],
19	membrane	NN	O	membrane	prep_across	15	SENT_146	[p6l1037t2799r1211b2828],
20	based	VBN	O	base	partmod	19	SENT_146	[p6l1227t2799r1321b2828],
21	on	IN	O	on	_	0	SENT_146	[p6l1337t2808r1377b2828],
22	piggy	NN	O	piggy	nn	24	SENT_146	[p6l1392t2799r1631b2837],
23	—	CD	NUMBER	—	num	24	SENT_146	[p6l1392t2799r1631b2837],
24	backing	NN	O	backing	prep_on	20	SENT_146	[p6l1392t2799r1631b2837],
25	of	IN	O	of	_	0	SENT_146	[p6l1647t2799r1683b2828],
26	these	DT	O	these	det	27	SENT_146	[p6l1696t2799r1780b2828],
27	drugs	NNS	O	drug	prep_of	24	SENT_146	[p6l1796t2799r1886b2837],
28	on	IN	O	on	_	0	SENT_146	[p6l543t2857r584b2878],
29	known	JJ	O	known	amod	30	SENT_146	[p6l601t2848r712b2878],
30	transporters	NNS	O	transporter	prep_on	20	SENT_146	[p6l729t2853r923b2886],
31	involved	VBN	O	involve	partmod	30	SENT_146	[p6l942t2848r1083b2878],
32	in	IN	O	in	_	0	SENT_146	[p6l1101t2848r1132b2877],
33	uptake	NN	O	uptake	prep_in	31	SENT_146	[p6l1149t2848r1258b2886],
34	of	IN	O	of	_	0	SENT_146	[p6l1277t2848r1313b2877],
35	nutrients	NNS	O	nutrient	prep_of	33	SENT_146	[p6l1327t2848r1471b2878],
36	and	CC	O	and	_	0	SENT_146	[p6l1490t2848r1548b2878],
37	other	JJ	O	other	amod	42	SENT_146	[p6l1566t2848r1651b2878],
38	essential	JJ	O	essential	amod	42	SENT_146	[p6l1668t2848r1809b2878],
39	low	JJ	O	low	amod	42	SENT_146	[p6l1827t2848r1887b2878],
40	molecular	JJ	O	molecular	amod	42	SENT_146	[p6l543t2897r709b2926],
41	weight	NN	O	weight	nn	42	SENT_146	[p6l723t2897r835b2935],
42	molecules	NNS	O	molecule	conj_and	35	SENT_146	[p6l849t2897r1016b2926],
43	and	CC	O	and	_	0	SENT_146	[p6l1032t2897r1091b2926],
44	by	IN	O	by	_	0	SENT_146	[p6l1104t2897r1145b2935],
45	the	DT	O	the	det	46	SENT_146	[p6l1160t2897r1210b2926],
46	process	NN	O	process	agent	31	SENT_146	[p6l1224t2906r1347b2935],
47	of	IN	O	of	_	0	SENT_146	[p6l1363t2897r1399b2926],
48	endocytosis	NN	O	endocytosis	prep_of	46	SENT_146	[p6l1411t2897r1614b2935],
49	,	,	O	,	_	0	SENT_146	[p6l1411t2897r1614b2935],
50	either	CC	O	either	preconj	51	SENT_146	[p6l1631t2897r1725b2926],
51	receptormediated	JJ	O	receptormediated	amod	46	SENT_146	[p6l1738t2902r1886b2935, p6l543t2947r694b2976],
52	or	CC	O	or	_	0	SENT_146	[p6l704t2956r738b2976],
53	nonspeciﬁc	JJ	O	nonspeciﬁc	conj_or	51	SENT_146	[p6l746t2947r943b2985],
54	.	.	O	.	_	0	SENT_146	[p6l746t2947r943b2985],

1	The	DT	O	the	det	3	SENT_147	[p6l954t2947r1018b2976],
2	latter	JJ	O	latter	amod	3	SENT_147	[p6l1027t2947r1112b2976],
3	process	NN	O	process	nsubj	9	SENT_147	[p6l1121t2956r1244b2985],
4	has	VBZ	O	have	aux	6	SENT_147	[p6l1254t2947r1307b2976],
5	been	VBN	O	be	auxpass	6	SENT_147	[p6l1317t2947r1395b2976],
6	termed	VBN	O	term	_	0	SENT_147	[p6l1405t2947r1519b2976],
7	pinocytosis	NN	O	pinocytosis	dobj	6	SENT_147	[p6l1528t2947r1715b2985],
8	and	CC	O	and	_	0	SENT_147	[p6l1726t2947r1784b2976],
9	refers	VBZ	O	refer	conj_and	6	SENT_147	[p6l1793t2947r1886b2976],
10	to	TO	O	to	_	0	SENT_147	[p6l543t3023r574b3048],
11	the	DT	O	the	det	13	SENT_147	[p6l584t3019r633b3048],
12	general	JJ	O	general	amod	13	SENT_147	[p6l644t3019r764b3056],
13	means	NNS	O	means	prep_to	9	SENT_147	[p6l774t3028r878b3048],
14	by	IN	O	by	_	0	SENT_147	[p6l889t3018r929b3056],
15	which	WDT	O	which	dobj	17	SENT_147	[p6l940t3019r1040b3048],
16	cells	NNS	O	cell	nsubj	17	SENT_147	[p6l1050t3019r1124b3048],
17	“	VBP	O	“	prepc_by	9	SENT_147	[p6l1136t3018r1257b3048],
18	drink	NN	O	drink	dobj	17	SENT_147	[p6l1136t3018r1257b3048],
19	”	CD	NUMBER	”	num	21	SENT_147	[p6l1136t3018r1257b3048],
20	extracellular	JJ	O	extracellular	amod	21	SENT_147	[p6l1268t3018r1474b3048],
21	ﬂuids	NNS	O	ﬂuids	dobj	6	SENT_147	[p6l1484t3018r1574b3048],
22	and	CC	O	and	_	0	SENT_147	[p6l1585t3019r1644b3048],
23	internalize	VBP	O	internalize	conj_and	6	SENT_147	[p6l1653t3018r1827b3048],
24	the	DT	O	the	det	25	SENT_147	[p6l1837t3019r1887b3048],
25	Variety	NNP	O	Variety	dobj	23	SENT_147	[p6l543t3068r656b3106],
26	of	IN	O	of	_	0	SENT_147	[p6l668t3068r704b3097],
27	compounds	NNS	O	compound	prep_of	25	SENT_147	[p6l713t3068r902b3106],
28	that	WDT	O	that	nsubjpass	31	SENT_147	[p6l914t3068r976b3097],
29	may	MD	O	may	aux	31	SENT_147	[p6l987t3078r1057b3106],
30	be	VB	O	be	auxpass	31	SENT_147	[p6l1068t3068r1107b3097],
31	dissolved	VBN	O	dissolve	rcmod	27	SENT_147	[p6l1119t3068r1274b3097],
32	in	IN	O	in	_	0	SENT_147	[p6l1285t3068r1316b3097],
33	the	DT	O	the	det	35	SENT_147	[p6l1328t3068r1377b3097],
34	extracellular	JJ	O	extracellular	amod	35	SENT_147	[p6l1389t3068r1595b3097],
35	ﬂuid	NN	O	ﬂuid	prep_in	31	SENT_147	[p6l1607t3068r1689b3097],
36	.	.	O	.	_	0	SENT_147	[p6l1607t3068r1689b3097],

1	Selection	NN	O	selection	nsubj	16	SENT_148	[p6l594t3118r746b3147],
2	of	IN	O	of	_	0	SENT_148	[p6l759t3118r794b3147],
3	cells	NNS	O	cell	prep_of	1	SENT_148	[p6l804t3118r877b3147],
4	for	IN	O	for	_	0	SENT_148	[p6l890t3118r938b3147],
5	resistance	NN	O	resistance	prep_for	3	SENT_148	[p6l949t3118r1112b3147],
6	to	TO	O	to	_	0	SENT_148	[p6l1124t3123r1155b3147],
7	drugs	NNS	O	drug	prep_to	5	SENT_148	[p6l1167t3118r1257b3156],
8	that	WDT	O	that	nsubj	9	SENT_148	[p6l1270t3118r1332b3147],
9	enter	VBP	O	enter	rcmod	7	SENT_148	[p6l1343t3123r1426b3147],
10	cells	NNS	O	cell	dobj	9	SENT_148	[p6l1437t3118r1511b3147],
11	via	IN	O	via	_	0	SENT_148	[p6l1524t3118r1574b3147],
12	receptors	NNS	O	receptor	prep_via	10	SENT_148	[p6l1585t3123r1735b3156],
13	or	CC	O	or	_	0	SENT_148	[p6l1749t3127r1782b3147],
14	transporters	NNS	O	transporter	conj_or	12	SENT_148	[p6l1793t3123r1886b3147, p6l543t3172r656b3206],
15	can	MD	O	can	aux	16	SENT_148	[p6l664t3177r720b3197],
16	result	VB	O	result	_	0	SENT_148	[p6l727t3168r819b3197],
17	in	IN	O	in	_	0	SENT_148	[p6l826t3168r856b3197],
18	mutations	NNS	O	mutation	prep_in	16	SENT_148	[p6l863t3168r1025b3197],
19	that	WDT	O	that	nsubj	22	SENT_148	[p6l1033t3168r1095b3197],
20	eliminate	VBP	O	eliminate	rcmod	18	SENT_148	[p6l1101t3168r1254b3197],
21	or	CC	O	or	_	0	SENT_148	[p6l1262t3177r1296b3197],
22	modify	VBP	O	modify	conj_or	20	SENT_148	[p6l1302t3168r1420b3206],
23	these	DT	O	these	det	26	SENT_148	[p6l1427t3168r1511b3197],
24	cell	NN	O	cell	nn	26	SENT_148	[p6l1519t3168r1577b3197],
25	surface	NN	O	surface	nn	26	SENT_148	[p6l1585t3168r1702b3197],
26	molecules	NNS	O	molecule	dobj	20	SENT_148	[p6l1709t3168r1885b3197],
27	.	.	O	.	_	0	SENT_148	[p6l1709t3168r1885b3197],

1	For	IN	O	for	_	0	SENT_149	[p6l543t3218r600b3247],
2	example	NN	O	example	prep_for	13	SENT_149	[p6l614t3218r761b3255],
3	,	,	O	,	_	0	SENT_149	[p6l614t3218r761b3255],
4	resistance	NN	O	resistance	nsubj	13	SENT_149	[p6l777t3218r939b3247],
5	to	TO	O	to	_	0	SENT_149	[p6l954t3222r985b3247],
6	toxic	JJ	O	toxic	amod	8	SENT_149	[p6l999t3218r1081b3247],
7	folate	NN	O	folate	nn	8	SENT_149	[p6l1096t3218r1189b3247],
8	analogs	NNS	O	analog	prep_to	4	SENT_149	[p6l1205t3218r1328b3255],
9	such	JJ	O	such	_	0	SENT_149	[p6l1345t3218r1419b3247],
10	as	IN	O	as	_	0	SENT_149	[p6l1434t3227r1466b3247],
11	methotrexate	NN	O	methotrexate	prep_such_as	8	SENT_149	[p6l1481t3218r1696b3247],
12	commonly	RB	O	commonly	advmod	13	SENT_149	[p6l1711t3218r1887b3255],
13	occurs	VBZ	O	occur	dep	24	SENT_149	[p6l543t3277r649b3297],
14	by	IN	O	by	_	0	SENT_149	[p6l659t3268r700b3305],
15	mutation	NN	O	mutation	prep_by	13	SENT_149	[p6l709t3267r856b3297],
16	of	IN	O	of	_	0	SENT_149	[p6l865t3267r901b3297],
17	one	CD	NUMBER	one	prep_of	15	SENT_149	[p6l908t3277r966b3297],
18	or	CC	O	or	_	0	SENT_149	[p6l976t3277r1010b3297],
19	both	DT	O	both	prep_by	13	SENT_149	[p6l1018t3268r1091b3297],
20	of	IN	O	of	_	0	SENT_149	[p6l1101t3267r1137b3297],
21	the	DT	O	the	det	23	SENT_149	[p6l1143t3268r1192b3297],
22	folate	NN	O	folate	nn	23	SENT_149	[p6l1202t3267r1295b3297],
23	transporters	NNS	O	transporter	prep_of	19	SENT_149	[p6l1304t3272r1498b3305],
24	(	VBP	O	(	_	0	SENT_149	[p6l1510t3267r1616b3303],
25	folate	NN	O	folate	nn	27	SENT_149	[p6l1510t3267r1616b3303],
26	binding	NN	O	binding	nn	27	SENT_149	[p6l1625t3267r1750b3305],
27	protein	NN	O	protein	dobj	24	SENT_149	[p6l1760t3267r1885b3305],
28	,	,	O	,	_	0	SENT_149	[p6l1760t3267r1885b3305],
29	and/or	IN	O	and/or	_	0	SENT_149	[p6l544t3317r649b3346],
30	the	DT	O	the	det	33	SENT_149	[p6l663t3317r712b3346],
31	reduced	VBN	O	reduce	amod	33	SENT_149	[p6l727t3317r858b3346],
32	folate	NN	O	folate	nn	33	SENT_149	[p6l873t3317r966b3346],
33	transporter	NN	O	transporter	prep_and/or	24	SENT_149	[p6l982t3317r1173b3355],
34	)	CD	NUMBER	)	num	37	SENT_149	[p6l982t3317r1173b3355],
35	(	NN	O	(	nn	37	SENT_149	[p6l1191t3317r1245b3353],
36	7	CD	NUMBER	7	num	37	SENT_149	[p6l1191t3317r1245b3353],
37	)	NN	O	)	nsubj	24	SENT_149	[p6l1191t3317r1245b3353],
38	.	.	O	.	_	0	SENT_149	[p6l1191t3317r1245b3353],

1	Resistance	NN	O	resistance	nsubjpass	7	SENT_150	[p6l1262t3317r1438b3346],
2	to	TO	O	to	_	0	SENT_150	[p6l1454t3321r1485b3346],
3	nucleoside	NN	O	nucleoside	nn	4	SENT_150	[p6l1500t3317r1676b3346],
4	analogs	NNS	O	analog	prep_to	1	SENT_150	[p6l1693t3317r1817b3355],
5	has	VBZ	O	have	aux	7	SENT_150	[p6l1832t3317r1886b3346],
6	been	VBN	O	be	auxpass	7	SENT_150	[p6l543t3367r620b3396],
7	described	VBN	O	describe	_	0	SENT_150	[p6l634t3367r791b3396],
8	as	IN	O	as	_	0	SENT_150	[p6l805t3376r837b3396],
9	a	DT	O	a	det	10	SENT_150	[p6l851t3376r868b3396],
10	result	NN	O	result	prep_as	7	SENT_150	[p6l880t3367r972b3396],
11	of	IN	O	of	_	0	SENT_150	[p6l985t3367r1021b3396],
12	mutation	NN	O	mutation	prep_of	10	SENT_150	[p6l1031t3367r1177b3396],
13	of	IN	O	of	_	0	SENT_150	[p6l1191t3367r1227b3396],
14	speciﬁc	NN	O	speciﬁc	nn	16	SENT_150	[p6l1238t3367r1362b3405],
15	nucleoside	NN	O	nucleoside	nn	16	SENT_150	[p6l1375t3367r1551b3396],
16	transporters	NNS	O	transporter	prep_of	12	SENT_150	[p6l1565t3371r1768b3405],
17	,	,	O	,	_	0	SENT_150	[p6l1565t3371r1768b3405],
18	etc.	FW	O	etc.	appos	16	SENT_150	[p6l1783t3371r1838b3396],
19	.	.	O	.	_	0	SENT_150	[p6l1783t3371r1838b3396],

1	In	IN	O	in	_	0	SENT_151	[p6l1853t3368r1887b3396],
2	general	JJ	O	general	prep_in	9	SENT_151	[p6l543t3417r673b3455],
3	,	,	O	,	_	0	SENT_151	[p6l543t3417r673b3455],
4	these	DT	O	these	det	5	SENT_151	[p6l684t3417r768b3446],
5	mechanisms	NNS	O	mechanism	nsubj	9	SENT_151	[p6l778t3417r982b3446],
6	of	IN	O	of	_	0	SENT_151	[p6l993t3417r1029b3446],
7	resistance	NN	O	resistance	prep_of	5	SENT_151	[p6l1035t3417r1198b3446],
8	are	VBP	O	be	cop	9	SENT_151	[p6l1209t3426r1257b3446],
9	speciﬁc	NN	O	speciﬁc	_	0	SENT_151	[p6l1269t3417r1393b3455],
10	for	IN	O	for	_	0	SENT_151	[p6l1403t3417r1451b3446],
11	these	DT	O	these	det	13	SENT_151	[p6l1460t3417r1544b3446],
12	nutrient	JJ	O	nutrient	amod	13	SENT_151	[p6l1554t3417r1683b3446],
13	analogs	NNS	O	analog	nn	17	SENT_151	[p6l1693t3417r1817b3455],
14	and	CC	O	and	_	0	SENT_151	[p6l1829t3417r1887b3446],
15	structurally	RB	O	structurally	advmod	16	SENT_151	[p6l544t3467r730b3504],
16	related	JJ	O	related	conj_and	13	SENT_151	[p6l742t3467r855b3496],
17	compounds	NNS	O	compound	prep_for	9	SENT_151	[p6l866t3467r1064b3505],
18	.	.	O	.	_	0	SENT_151	[p6l866t3467r1064b3505],

1	Very	RB	O	very	advmod	4	SENT_152	[p6l593t3517r670b3555],
2	few	JJ	O	few	amod	3	SENT_152	[p6l684t3516r743b3546],
3	drugs	NNS	O	drug	nsubj	4	SENT_152	[p6l758t3517r848b3555],
4	enter	VBP	O	enter	_	0	SENT_152	[p6l862t3521r945b3546],
5	cells	NNS	O	cell	dobj	4	SENT_152	[p6l958t3517r1032b3546],
6	by	IN	O	by	_	0	SENT_152	[p6l1045t3517r1086b3555],
7	endocytosis	NN	O	endocytosis	prep_by	4	SENT_152	[p6l1100t3517r1303b3555],
8	.	.	O	.	_	0	SENT_152	[p6l1100t3517r1303b3555],

1	However	RB	O	however	advmod	22	SENT_153	[p6l1318t3517r1474b3551],
2	,	,	O	,	_	0	SENT_153	[p6l1318t3517r1474b3551],
3	some	DT	O	some	nsubj	22	SENT_153	[p6l1490t3526r1575b3546],
4	of	IN	O	of	_	0	SENT_153	[p6l1590t3517r1625b3546],
5	the	DT	O	the	det	8	SENT_153	[p6l1636t3517r1686b3546],
6	newer	JJR	O	newer	amod	8	SENT_153	[p6l1699t3526r1799b3546],
7	anticancer	JJ	O	anticancer	amod	8	SENT_153	[p6l1813t3516r1886b3546, p6l543t3576r651b3596],
8	agents	NNS	O	agent	prep_of	3	SENT_153	[p6l660t3572r773b3605],
9	,	,	O	,	_	0	SENT_153	[p6l660t3572r773b3605],
10	such	JJ	O	such	_	0	SENT_153	[p6l785t3567r858b3596],
11	as	IN	O	as	_	0	SENT_153	[p6l868t3576r900b3596],
12	immunotoxins	NNS	O	immunotoxin	prep_such_as	3	SENT_153	[p6l910t3567r1147b3596],
13	that	WDT	O	that	nsubj	14	SENT_153	[p6l1157t3567r1219b3596],
14	bind	VBP	O	bind	rcmod	12	SENT_153	[p6l1227t3567r1300b3596],
15	to	TO	O	to	_	0	SENT_153	[p6l1309t3571r1339b3596],
16	cell	NN	O	cell	nn	18	SENT_153	[p6l1349t3567r1407b3596],
17	surface	NN	O	surface	nn	18	SENT_153	[p6l1418t3567r1535b3596],
18	receptors	NNS	O	receptor	prep_to	14	SENT_153	[p6l1543t3571r1704b3605],
19	,	,	O	,	_	0	SENT_153	[p6l1543t3571r1704b3605],
20	can	MD	O	can	aux	22	SENT_153	[p6l1714t3571r1824b3596],
21	not	RB	O	not	neg	22	SENT_153	[p6l1714t3571r1824b3596],
22	kill	VB	O	kill	_	0	SENT_153	[p6l1832t3567r1886b3596],
23	cells	NNS	O	cell	dobj	22	SENT_153	[p6l543t3617r617b3646],
24	unless	IN	O	unless	mark	27	SENT_153	[p6l628t3617r730b3646],
25	they	PRP	O	they	nsubjpass	27	SENT_153	[p6l741t3617r811b3654],
26	are	VBP	O	be	auxpass	27	SENT_153	[p6l823t3626r871b3646],
27	internalized	VBN	O	internalize	advcl	22	SENT_153	[p6l882t3617r1077b3646],
28	(	NN	O	(	nn	30	SENT_153	[p6l1089t3617r1143b3653],
29	3	CD	NUMBER	3	num	30	SENT_153	[p6l1089t3617r1143b3653],
30	)	NN	O	)	dobj	27	SENT_153	[p6l1089t3617r1143b3653],
31	.	.	O	.	_	0	SENT_153	[p6l1089t3617r1143b3653],

1	They	PRP	O	they	nsubjpass	4	SENT_154	[p6l1155t3617r1239b3654],
2	are	VBP	O	be	auxpass	4	SENT_154	[p6l1250t3626r1299b3646],
3	generally	RB	O	generally	advmod	4	SENT_154	[p6l1310t3617r1463b3654],
4	internalized	VBN	O	internalize	_	0	SENT_154	[p6l1474t3617r1669b3646],
5	via	IN	O	via	_	0	SENT_154	[p6l1679t3617r1729b3646],
6	receptorAnnu	NN	O	receptorannu	prep_via	4	SENT_154	[p6l1738t3621r1886b3654, p7l270t270r293b350],
7	.	.	O	.	_	0	SENT_154	[p6l1738t3621r1886b3654, p7l270t270r293b350],

1	Rev.	NNP	O	Rev.	nn	2	SENT_155	[p7l270t199r293b259],
2	Med	NNP	O	Med	_	0	SENT_155	[p7l270t122r293b189],
3	.	.	O	.	_	0	SENT_155	[p7l270t122r293b189],

1	2002	CD	DATE	2002	_	0	SENT_156	[p7l270t39r293b111],
2	.	.	O	.	_	0	SENT_156	[p7l270t39r293b111],

1	by	IN	O	by	_	0	SENT_157	[p7l303t283r334b316],
2	University	NNP	ORGANIZATION	University	pobj	1	SENT_157	[p7l304t135r334b274],
3	of	IN	ORGANIZATION	of	_	0	SENT_157	[p7l303t96r327b125],
4	Wis	NNP	ORGANIZATION	Wis	prep_of	2	SENT_157	[p7l303t37r327b90],

1	Annu	NNP	PERSON	Annu	_	0	SENT_158	[p7l280t2588r303b2669],
2	.	.	O	.	_	0	SENT_158	[p7l280t2588r303b2669],

1	Rev.	NNP	O	Rev.	nn	2	SENT_159	[p7l280t2518r303b2578],
2	Med	NNP	O	Med	_	0	SENT_159	[p7l280t2440r303b2507],
3	.	.	O	.	_	0	SENT_159	[p7l280t2440r303b2507],

1	2002532615-627	CD	NUMBER	2002532615-627	_	0	SENT_160	[p7l280t2194r303b2429],
2	.	.	O	.	_	0	SENT_160	[p7l280t2194r303b2429],

1	Downloaded	VBN	O	download	_	0	SENT_161	[p7l280t2014r303b2184],
2	from	IN	O	from	_	0	SENT_161	[p7l280t1940r303b2005],
3	www.annualreviews.org	NN	O	www.annualreviews.org	prep_from	1	SENT_161	[p7l280t1607r310b1931],
4	by	IN	O	by	_	0	SENT_161	[p7l313t2602r344b2634],
5	University	NNP	ORGANIZATION	University	dep	9	SENT_161	[p7l313t2453r344b2593],
6	of	IN	ORGANIZATION	of	_	0	SENT_161	[p7l313t2414r337b2443],
7	Wisconsin	NNP	ORGANIZATION	Wisconsin	prep_of	5	SENT_161	[p7l313t2267r337b2408],
8	-	:	O	-	_	0	SENT_161	[p7l327t2249r330b2257],
9	Madison	NNP	O	Madison	prep_by	1	SENT_161	[p7l313t2122r337b2239],
10	on	IN	O	on	_	0	SENT_161	[p7l321t2081r337b2113],
11	01/05/14	CD	DATE	01/05/14	prep_on	1	SENT_161	[p7l313t1947r337b2072],
12	.	.	O	.	_	0	SENT_161	[p7l313t1947r337b2072],

1	For	IN	O	for	_	0	SENT_162	[p7l314t1890r337b1936],
2	personal	JJ	O	personal	amod	3	SENT_162	[p7l313t1769r344b1882],
3	use	NN	O	use	pobj	1	SENT_162	[p7l321t1716r337b1760],
4	only	RB	O	only	advmod	3	SENT_162	[p7l313t1642r344b1707],
5	.	.	O	.	_	0	SENT_162	[p7l313t1642r344b1707],

1	mediated	VBN	O	mediate	_	0	SENT_163	[p7l543t44r694b73],
2	endocytosis	NN	O	endocytosis	dobj	1	SENT_163	[p7l711t44r914b82],
3	.	.	O	.	_	0	SENT_163	[p7l711t44r914b82],

1	Cancer	NN	O	cancer	nn	3	SENT_164	[p7l933t44r1050b73],
2	cell	NN	O	cell	nn	3	SENT_164	[p7l1066t44r1125b73],
3	mutants	NNS	O	mutant	nsubj	9	SENT_164	[p7l1142t48r1271b73],
4	that	WDT	O	that	nsubj	5	SENT_164	[p7l1289t44r1351b73],
5	have	VBP	O	have	rcmod	3	SENT_164	[p7l1367t44r1443b73],
6	defective	JJ	O	defective	amod	7	SENT_164	[p7l1460t44r1609b73],
7	endocytosis	NN	O	endocytosis	dobj	5	SENT_164	[p7l1627t44r1820b82],
8	are	VBP	O	be	cop	9	SENT_164	[p7l1838t53r1887b73],
9	resistant	JJ	O	resistant	_	0	SENT_164	[p7l543t94r681b123],
10	to	TO	O	to	_	0	SENT_164	[p7l692t98r722b123],
11	both	DT	O	both	det	12	SENT_164	[p7l734t94r807b123],
12	toxins	NNS	O	toxin	prep_to	9	SENT_164	[p7l818t94r918b123],
13	and	CC	O	and	_	0	SENT_164	[p7l931t94r990b123],
14	immunotoxins	NNS	O	immunotoxin	conj_and	12	SENT_164	[p7l1001t94r1239b123],
15	(	CD	NUMBER	(	number	16	SENT_164	[p7l1252t94r1327b130],
16	40	CD	NUMBER	40	num	17	SENT_164	[p7l1252t94r1327b130],
17	)	NN	O	)	dep	14	SENT_164	[p7l1252t94r1327b130],
18	.	.	O	.	_	0	SENT_164	[p7l1252t94r1327b130],

1	Cisplatin	NNP	MISC	Cisplatin	nsubjpass	4	SENT_165	[p7l593t144r742b181],
2	is	VBZ	O	be	auxpass	4	SENT_165	[p7l758t144r784b173],
3	commonly	RB	O	commonly	advmod	4	SENT_165	[p7l802t144r978b181],
4	used	VBN	O	use	_	0	SENT_165	[p7l995t144r1070b173],
5	to	TO	O	to	aux	6	SENT_165	[p7l1087t148r1118b173],
6	treat	VB	O	treat	xcomp	4	SENT_165	[p7l1135t148r1208b173],
7	cancers	NNS	O	cancer	dobj	6	SENT_165	[p7l1225t153r1347b173],
8	such	JJ	O	such	_	0	SENT_165	[p7l1366t144r1440b173],
9	as	IN	O	as	_	0	SENT_165	[p7l1457t153r1489b173],
10	head	NN	O	head	nn	13	SENT_165	[p7l1507t144r1584b173],
11	and	CC	O	and	_	0	SENT_165	[p7l1602t144r1660b173],
12	neck	NN	O	neck	conj_and	10	SENT_165	[p7l1677t144r1755b173],
13	cancer	NN	O	cancer	prep_such_as	7	SENT_165	[p7l1771t153r1885b178],
14	,	,	O	,	_	0	SENT_165	[p7l1771t153r1885b178],
15	testicular	JJ	O	testicular	amod	16	SENT_165	[p7l543t193r695b222],
16	cancer	NN	O	cancer	prep_such_as	7	SENT_165	[p7l705t202r819b227],
17	,	,	O	,	_	0	SENT_165	[p7l705t202r819b227],
18	ovarian	JJ	O	ovarian	amod	19	SENT_165	[p7l832t193r954b222],
19	cancer	NN	O	cancer	prep_such_as	7	SENT_165	[p7l965t202r1079b227],
20	,	,	O	,	_	0	SENT_165	[p7l965t202r1079b227],
21	and	CC	O	and	_	0	SENT_165	[p7l1093t193r1151b222],
22	other	JJ	O	other	amod	24	SENT_165	[p7l1162t193r1247b222],
23	solid	JJ	O	solid	amod	24	SENT_165	[p7l1258t193r1337b222],
24	tumors	NNS	O	tumor	prep_such_as	7	SENT_165	[p7l1347t198r1470b222],
25	.	.	O	.	_	0	SENT_165	[p7l1347t198r1470b222],

1	It	PRP	O	it	nsubjpass	4	SENT_166	[p7l1483t194r1508b222],
2	is	VBZ	O	be	auxpass	4	SENT_166	[p7l1518t193r1544b222],
3	not	RB	O	not	neg	4	SENT_166	[p7l1556t197r1608b222],
4	known	VBN	O	know	_	0	SENT_166	[p7l1618t193r1730b222],
5	with	IN	O	with	_	0	SENT_166	[p7l1741t193r1813b222],
6	certainty	NN	O	certainty	prep_with	4	SENT_166	[p7l1825t202r1886b222, p7l543t243r636b281],
7	how	WRB	O	how	advmod	16	SENT_166	[p7l648t243r717b272],
8	cisplatin	NN	O	cisplatin	nsubj	16	SENT_166	[p7l730t243r878b281],
9	,	,	O	,	_	0	SENT_166	[p7l730t243r878b281],
10	a	DT	O	a	det	12	SENT_166	[p7l892t252r909b272],
11	water	NN	O	water	nn	12	SENT_166	[p7l921t243r1144b272],
12	—	NN	O	—	appos	8	SENT_166	[p7l921t243r1144b272],
13	soluble	JJ	O	soluble	amod	14	SENT_166	[p7l921t243r1144b272],
14	compound	NN	O	compound	dep	12	SENT_166	[p7l1156t243r1339b281],
15	,	,	O	,	_	0	SENT_166	[p7l1156t243r1339b281],
16	enters	VBZ	O	enter	ccomp	4	SENT_166	[p7l1353t247r1449b272],
17	cells	NNS	O	cell	nsubj	20	SENT_166	[p7l1462t243r1536b272],
18	(	CD	NUMBER	(	number	19	SENT_166	[p7l1550t243r1625b279],
19	41	CD	NUMBER	41	num	20	SENT_166	[p7l1550t243r1625b279],
20	)	NN	O	)	xcomp	16	SENT_166	[p7l1550t243r1625b279],
21	.	.	O	.	_	0	SENT_166	[p7l1550t243r1625b279],

1	Many	JJ	O	many	amod	6	SENT_167	[p7l1639t244r1734b281],
2	different	JJ	O	different	amod	6	SENT_167	[p7l1746t243r1888b272],
3	cisplatin-resistant	JJ	O	cisplatin-resistant	amod	6	SENT_167	[p7l543t293r835b330],
4	cancer	NN	O	cancer	nn	6	SENT_167	[p7l846t302r954b322],
5	cell	NN	O	cell	nn	6	SENT_167	[p7l964t293r1023b322],
6	lines	NNS	O	line	nsubjpass	9	SENT_167	[p7l1034t293r1110b322],
7	have	VBP	O	have	aux	9	SENT_167	[p7l1121t293r1198b322],
8	been	VBN	O	be	auxpass	9	SENT_167	[p7l1208t293r1286b322],
9	isolated	VBN	O	isolate	_	0	SENT_167	[p7l1297t293r1425b322],
10	in	IN	O	in	_	0	SENT_167	[p7l1436t293r1467b321],
11	the	DT	O	the	det	12	SENT_167	[p7l1478t293r1527b322],
12	laboratory	NN	O	laboratory	prep_in	9	SENT_167	[p7l1539t293r1714b330],
13	.	.	O	.	_	0	SENT_167	[p7l1539t293r1714b330],

1	These	DT	O	these	nsubj	2	SENT_168	[p7l1727t293r1825b322],
2	exhibit	VBP	O	exhibit	_	0	SENT_168	[p7l1836t302r1886b322, p7l543t342r619b372],
3	a	DT	O	a	det	4	SENT_168	[p7l627t352r644b372],
4	variety	NN	O	variety	dobj	2	SENT_168	[p7l652t342r764b380],
5	of	IN	O	of	_	0	SENT_168	[p7l773t342r809b372],
6	mechanisms	NNS	O	mechanism	prep_of	4	SENT_168	[p7l814t342r1018b372],
7	of	IN	O	of	_	0	SENT_168	[p7l1027t342r1063b372],
8	resistance	NN	O	resistance	prep_of	6	SENT_168	[p7l1068t342r1240b377],
9	,	,	O	,	_	0	SENT_168	[p7l1068t342r1240b377],
10	but	CC	O	but	_	0	SENT_168	[p7l1249t342r1301b372],
11	reduced	VBD	O	reduce	conj_but	2	SENT_168	[p7l1308t342r1439b372],
12	accumulation	NN	O	accumulation	nsubjpass	18	SENT_168	[p7l1448t342r1670b372],
13	of	IN	O	of	_	0	SENT_168	[p7l1678t342r1714b372],
14	the	DT	O	the	det	15	SENT_168	[p7l1719t342r1769b372],
15	drug	NN	O	drug	prep_of	12	SENT_168	[p7l1777t342r1852b380],
16	is	VBZ	O	be	auxpass	18	SENT_168	[p7l1860t342r1886b372],
17	commonly	RB	O	commonly	advmod	18	SENT_168	[p7l543t392r719b430],
18	seen	VBN	O	see	ccomp	11	SENT_168	[p7l729t401r809b427],
19	,	,	O	,	_	0	SENT_168	[p7l729t401r809b427],
20	as	IN	O	as	mark	24	SENT_168	[p7l820t401r852b421],
21	is	VBZ	O	be	cop	24	SENT_168	[p7l861t392r887b421],
22	cross	JJ	O	cross	amod	24	SENT_168	[p7l897t392r1158b421],
23	—	NN	O	—	nn	24	SENT_168	[p7l897t392r1158b421],
24	resistance	NN	O	resistance	advcl	18	SENT_168	[p7l897t392r1158b421],
25	to	TO	O	to	_	0	SENT_168	[p7l1166t397r1197b421],
26	methotrexate	NN	O	methotrexate	prep_to	24	SENT_168	[p7l1206t392r1430b427],
27	,	,	O	,	_	0	SENT_168	[p7l1206t392r1430b427],
28	heavy	JJ	O	heavy	amod	29	SENT_168	[p7l1440t392r1537b430],
29	metals	NNS	O	metal	advcl	18	SENT_168	[p7l1546t392r1652b421],
30	such	JJ	O	such	_	0	SENT_168	[p7l1663t392r1736b421],
31	as	IN	O	as	_	0	SENT_168	[p7l1746t401r1777b421],
32	arsenite	NN	O	arsenite	prep_such_as	29	SENT_168	[p7l1787t401r1886b421, p7l543t441r583b470],
33	and	CC	O	and	_	0	SENT_168	[p7l592t441r651b470],
34	arsenate	NN	O	arsenate	prep_such_as	29	SENT_168	[p7l659t446r802b475],
35	,	,	O	,	_	0	SENT_168	[p7l659t446r802b475],
36	cadmium	NN	O	cadmium	conj_and	32	SENT_168	[p7l813t441r966b470],
37	and	CC	O	and	_	0	SENT_168	[p7l975t441r1033b470],
38	mercury	NN	O	mercury	conj_and	32	SENT_168	[p7l1041t450r1184b479],
39	,	,	O	,	_	0	SENT_168	[p7l1041t450r1184b479],
40	and	CC	O	and	_	0	SENT_168	[p7l1195t441r1253b470],
41	resistance	NN	O	resistance	conj_and	24	SENT_168	[p7l1261t441r1424b470],
42	to	TO	O	to	_	0	SENT_168	[p7l1432t446r1463b470],
43	some	DT	O	some	det	45	SENT_168	[p7l1473t450r1558b470],
44	nucleoside	NN	O	nucleoside	nn	45	SENT_168	[p7l1566t441r1742b470],
45	analogs	NNS	O	analog	prep_to	41	SENT_168	[p7l1752t441r1885b479],
46	.	.	O	.	_	0	SENT_168	[p7l1752t441r1885b479],

1	We	PRP	O	we	nsubj	4	SENT_169	[p7l542t491r596b519],
2	have	VBP	O	have	aux	4	SENT_169	[p7l606t490r682b519],
3	recently	RB	DATE	recently	advmod	4	SENT_169	[p7l693t490r825b528],
4	shown	VBN	O	show	_	0	SENT_169	[p7l838t490r943b520],
5	that	IN	O	that	complm	16	SENT_169	[p7l953t490r1015b519],
6	cisplatin-resistant	JJ	O	cisplatin-resistant	amod	7	SENT_169	[p7l1025t490r1317b528],
7	cells	NNS	O	cell	nsubj	16	SENT_169	[p7l1327t490r1401b519],
8	demonstrating	VBG	O	demonstrate	partmod	7	SENT_169	[p7l1413t490r1649b528],
9	this	DT	O	this	det	10	SENT_169	[p7l1659t490r1718b519],
10	pattern	NN	O	pattern	dobj	8	SENT_169	[p7l1728t494r1843b528],
11	of	IN	O	of	_	0	SENT_169	[p7l1854t490r1890b519],
12	cross	JJ	O	cross	amod	14	SENT_169	[p7l543t539r804b568],
13	—	NN	O	—	nn	14	SENT_169	[p7l543t539r804b568],
14	resistance	NN	O	resistance	prep_of	10	SENT_169	[p7l543t539r804b568],
15	and	CC	O	and	cc	8	SENT_169	[p7l819t539r878b568],
16	reduced	VBD	O	reduce	ccomp	4	SENT_169	[p7l891t539r1022b568],
17	accumulation	NN	O	accumulation	nsubj	21	SENT_169	[p7l1037t539r1259b568],
18	of	IN	O	of	_	0	SENT_169	[p7l1273t539r1309b568],
19	the	DT	O	the	det	20	SENT_169	[p7l1320t539r1369b568],
20	drug	NN	O	drug	prep_of	17	SENT_169	[p7l1384t539r1458b577],
21	have	VBP	O	have	ccomp	16	SENT_169	[p7l1472t539r1548b568],
22	a	DT	O	a	det	24	SENT_169	[p7l1563t548r1581b568],
23	pleiotropic	JJ	O	pleiotropic	amod	24	SENT_169	[p7l1593t539r1772b577],
24	defect	NN	O	defect	dobj	21	SENT_169	[p7l1787t539r1887b568],
25	resulting	VBG	O	result	partmod	24	SENT_169	[p7l542t588r687b626],
26	in	IN	O	in	_	0	SENT_169	[p7l697t588r729b617],
27	reduced	VBN	O	reduce	amod	30	SENT_169	[p7l738t588r869b618],
28	plasma	NN	O	plasma	nn	30	SENT_169	[p7l879t588r996b626],
29	membrane	NN	O	membrane	nn	30	SENT_169	[p7l1006t588r1180b618],
30	receptors	NNS	O	receptor	prep_in	25	SENT_169	[p7l1190t592r1340b626],
31	and	CC	O	and	_	0	SENT_169	[p7l1352t588r1411b618],
32	transporters	NNS	O	transporter	prep_in	25	SENT_169	[p7l1420t593r1614b626],
33	and	CC	O	and	_	0	SENT_169	[p7l1626t588r1685b618],
34	reduced	VBD	O	reduce	conj_and	16	SENT_169	[p7l1694t588r1825b618],
35	endocytosis	NN	O	endocytosis	iobj	34	SENT_169	[p7l1835t597r1886b618, p7l543t638r697b676],
36	(	CD	NUMBER	(	number	37	SENT_169	[p7l712t638r787b674],
37	42	CD	NUMBER	42	num	38	SENT_169	[p7l712t638r787b674],
38	)	NN	O	)	dobj	34	SENT_169	[p7l712t638r787b674],
39	.	.	O	.	_	0	SENT_169	[p7l712t638r787b674],

1	In	IN	O	in	_	0	SENT_170	[p7l801t639r835b667],
2	these	DT	O	these	det	3	SENT_170	[p7l847t638r931b667],
3	cells	NNS	O	cell	prep_in	5	SENT_170	[p7l944t638r1018b667],
4	there	EX	O	there	expl	5	SENT_170	[p7l1031t638r1112b667],
5	is	VBZ	O	be	_	0	SENT_170	[p7l1125t638r1151b667],
6	no	DT	O	no	det	7	SENT_170	[p7l1164t647r1204b667],
7	evidence	NN	O	evidence	nsubj	5	SENT_170	[p7l1217t638r1362b667],
8	for	IN	O	for	_	0	SENT_170	[p7l1374t638r1422b667],
9	an	DT	O	a	det	14	SENT_170	[p7l1435t647r1472b667],
10	energy	NN	O	energy	nn	14	SENT_170	[p7l1485t638r1780b676],
11	—	NN	O	—	nn	14	SENT_170	[p7l1485t638r1780b676],
12	dependent	JJ	O	dependent	amod	14	SENT_170	[p7l1485t638r1780b676],
13	efﬂux	NN	O	efﬂux	nn	14	SENT_170	[p7l1793t638r1887b667],
14	pump	NN	O	pump	prep_for	5	SENT_170	[p7l542t696r636b725],
15	for	IN	O	for	_	0	SENT_170	[p7l646t687r694b717],
16	cisplatin	NN	O	cisplatin	prep_for	5	SENT_170	[p7l703t687r842b725],
17	(	CD	NUMBER	(	num	16	SENT_170	[p7l853t687r928b723],
18	43	CD	NUMBER	43	num	19	SENT_170	[p7l853t687r928b723],
19	)	NN	O	)	tmod	5	SENT_170	[p7l853t687r928b723],
20	,	,	O	,	_	0	SENT_170	[p7l853t687r928b723],
21	which	WDT	O	which	nsubjpass	24	SENT_170	[p7l940t687r1040b717],
22	has	VBZ	O	have	aux	24	SENT_170	[p7l1049t687r1102b717],
23	been	VBN	O	be	auxpass	24	SENT_170	[p7l1112t687r1190b717],
24	described	VBN	O	describe	rcmod	19	SENT_170	[p7l1200t687r1358b717],
25	by	IN	O	by	_	0	SENT_170	[p7l1366t687r1407b725],
26	other	JJ	O	other	amod	27	SENT_170	[p7l1417t687r1502b717],
27	researchers	NNS	O	researcher	agent	24	SENT_170	[p7l1510t687r1695b717],
28	in	IN	O	in	_	0	SENT_170	[p7l1705t687r1737b716],
29	different	JJ	O	different	amod	31	SENT_170	[p7l1746t687r1887b717],
30	cell	NN	O	cell	nn	31	SENT_170	[p7l543t737r602b767],
31	lines	NNS	O	line	prep_in	27	SENT_170	[p7l613t737r699b767],
32	.	.	O	.	_	0	SENT_170	[p7l613t737r699b767],

1	These	DT	O	these	det	2	SENT_171	[p7l712t737r810b767],
2	results	NNS	O	result	nsubj	3	SENT_171	[p7l821t737r928b767],
3	suggest	VBP	O	suggest	_	0	SENT_171	[p7l941t742r1064b775],
4	that	IN	O	that	complm	7	SENT_171	[p7l1074t737r1136b767],
5	cisplatin	NN	O	cisplatin	nsubj	7	SENT_171	[p7l1147t737r1287b775],
6	may	MD	O	may	aux	7	SENT_171	[p7l1298t746r1368b775],
7	enter	VB	O	enter	ccomp	3	SENT_171	[p7l1380t742r1462b767],
8	cells	NNS	O	cell	dobj	7	SENT_171	[p7l1473t737r1546b767],
9	via	IN	O	via	_	0	SENT_171	[p7l1559t737r1609b767],
10	receptors	NNS	O	receptor	prep_via	8	SENT_171	[p7l1619t742r1770b775],
11	and/or	IN	O	and/or	prep	7	SENT_171	[p7l1782t737r1887b767],
12	via	IN	O	via	pcomp	11	SENT_171	[p7l543t787r593b816],
13	endocytosis	NN	O	endocytosis	pobj	12	SENT_171	[p7l607t787r809b825],
14	.	.	O	.	_	0	SENT_171	[p7l607t787r809b825],

1	Whether	IN	O	whether	complm	10	SENT_172	[p7l825t787r968b816],
2	clinical	JJ	O	clinical	amod	3	SENT_172	[p7l981t787r1102b816],
3	resistance	NN	O	resistance	nsubj	10	SENT_172	[p7l1116t787r1279b816],
4	to	TO	O	to	_	0	SENT_172	[p7l1293t791r1324b816],
5	cisplatin	NN	O	cisplatin	prep_to	3	SENT_172	[p7l1338t787r1478b825],
6	by	IN	O	by	_	0	SENT_172	[p7l1491t787r1532b825],
7	this	DT	O	this	det	8	SENT_172	[p7l1546t787r1604b816],
8	mechanism	NN	O	mechanism	prep_by	5	SENT_172	[p7l1619t787r1808b816],
9	also	RB	O	also	advmod	10	SENT_172	[p7l1822t787r1886b816],
10	occurs	VBZ	O	occur	ccomp	23	SENT_172	[p7l543t845r659b870],
11	,	,	O	,	_	0	SENT_172	[p7l543t845r659b870],
12	with	IN	O	with	_	0	SENT_172	[p7l676t836r749b865],
13	attendant	JJ	O	attendant	amod	16	SENT_172	[p7l765t836r916b865],
14	cross	NN	O	cross	nn	16	SENT_172	[p7l931t836r1192b865],
15	—	NN	O	—	nn	16	SENT_172	[p7l931t836r1192b865],
16	resistance	NN	O	resistance	prep_with	23	SENT_172	[p7l931t836r1192b865],
17	to	TO	O	to	_	0	SENT_172	[p7l1208t841r1238b865],
18	methotrexate	NN	O	methotrexate	nn	21	SENT_172	[p7l1254t836r1469b865],
19	and	CC	O	and	_	0	SENT_172	[p7l1485t836r1544b865],
20	nucleoside	NN	O	nucleoside	conj_and	18	SENT_172	[p7l1559t836r1735b865],
21	analogs	NNS	O	analog	prep_to	16	SENT_172	[p7l1751t836r1885b874],
22	,	,	O	,	_	0	SENT_172	[p7l1751t836r1885b874],
23	remains	VBZ	O	remain	_	0	SENT_172	[p7l543t885r672b914],
24	to	TO	O	to	aux	26	SENT_172	[p7l685t889r715b914],
25	be	VB	O	be	auxpass	26	SENT_172	[p7l727t885r765b914],
26	determined	VBN	O	determine	xcomp	23	SENT_172	[p7l777t885r971b914],
27	.	.	O	.	_	0	SENT_172	[p7l777t885r971b914],

1	GOTTESMAN	NNP	PERSON	GOTTESMAN	_	0	SENT_173	[p7l584t946r811b973],

1	CLINICAL	JJ	O	clinical	amod	2	SENT_174	[p7l435t1069r657b1103],
2	RELEVANCE	NN	O	relevance	_	0	SENT_174	[p7l669t1069r939b1103],
3	OF	IN	O	of	_	0	SENT_174	[p7l952t1069r1013b1103],
4	LABORATORY	NN	O	laboratory	nn	5	SENT_174	[p7l1026t1068r1339b1103],
5	STUDIES	NNS	O	study	prep_of	2	SENT_174	[p7l1351t1068r1546b1103],

1	ON	IN	O	on	_	0	SENT_175	[p7l435t1126r507b1161],
2	CANCER	NNP	O	CANCER	nn	4	SENT_175	[p7l520t1126r713b1161],
3	DRUG	NN	O	drug	nn	4	SENT_175	[p7l725t1126r861b1161],
4	RESISTANCE	NN	O	resistance	pobj	1	SENT_175	[p7l874t1126r1154b1161],

1	As	IN	O	as	mark	2	SENT_176	[p7l533t1231r577b1260],
2	noted	VBN	O	note	advcl	6	SENT_176	[p7l588t1231r688b1266],
3	,	,	O	,	_	0	SENT_176	[p7l588t1231r688b1266],
4	it	PRP	O	it	nsubj	6	SENT_176	[p7l700t1231r722b1260],
5	is	VBZ	O	be	cop	6	SENT_176	[p7l731t1231r757b1260],
6	possible	JJ	O	possible	_	0	SENT_176	[p7l767t1231r903b1269],
7	to	TO	O	to	aux	8	SENT_176	[p7l913t1236r943b1260],
8	demonstrate	VB	O	demonstrate	xcomp	6	SENT_176	[p7l954t1231r1155b1260],
9	the	DT	O	the	det	10	SENT_176	[p7l1166t1231r1215b1260],
10	presence	NN	O	presence	dobj	8	SENT_176	[p7l1224t1240r1369b1269],
11	of	IN	O	of	_	0	SENT_176	[p7l1379t1231r1415b1260],
12	several	JJ	O	several	amod	16	SENT_176	[p7l1424t1231r1537b1260],
13	different	JJ	O	different	amod	16	SENT_176	[p7l1547t1231r1688b1260],
14	drug	NN	O	drug	nn	16	SENT_176	[p7l1698t1231r1772b1269],
15	efﬂux	NN	O	efﬂux	nn	16	SENT_176	[p7l1783t1231r1877b1260],
16	pumps	NNS	O	pump	prep_of	10	SENT_176	[p7l533t1289r642b1318],
17	in	IN	O	in	_	0	SENT_176	[p7l653t1280r685b1309],
18	human	JJ	O	human	amod	19	SENT_176	[p7l694t1280r807b1310],
19	cancers	NNS	O	cancer	prep_in	8	SENT_176	[p7l817t1289r948b1310],
20	.	.	O	.	_	0	SENT_176	[p7l817t1289r948b1310],

1	Evidence	NN	O	evidence	dep	230	SENT_177	[p7l961t1280r1114b1310],
2	that	WDT	O	that	dep	230	SENT_177	[p7l1125t1280r1186b1310],
3	ABC	NNP	ORGANIZATION	ABC	dep	230	SENT_177	[p7l1196t1280r1279b1310],
4	transporters	NNS	O	transporter	dep	230	SENT_177	[p7l1291t1285r1494b1318],
5	,	,	O	,	_	0	SENT_177	[p7l1291t1285r1494b1318],
6	especially	RB	O	especially	dep	230	SENT_177	[p7l1506t1280r1671b1318],
7	P	NN	O	p	dep	230	SENT_177	[p7l1681t1281r1767b1318],
8	—	CD	NUMBER	—	dep	230	SENT_177	[p7l1681t1281r1767b1318],
9	gp	NN	O	gp	dep	230	SENT_177	[p7l1681t1281r1767b1318],
10	,	,	O	,	_	0	SENT_177	[p7l1681t1281r1767b1318],
11	play	VBP	O	play	dep	230	SENT_177	[p7l1779t1280r1849b1318],
12	a	DT	O	a	dep	230	SENT_177	[p7l1861t1289r1878b1310],
13	signiﬁcant	JJ	O	signiﬁcant	dep	230	SENT_177	[p7l535t1330r706b1368],
14	role	NN	O	role	dep	230	SENT_177	[p7l713t1330r777b1359],
15	in	IN	O	in	dep	230	SENT_177	[p7l785t1330r817b1359],
16	clinical	JJ	O	clinical	dep	230	SENT_177	[p7l825t1330r946b1359],
17	drug	NN	O	drug	dep	230	SENT_177	[p7l954t1330r1029b1368],
18	resistance	NN	O	resistance	dep	230	SENT_177	[p7l1037t1330r1200b1359],
19	has	VBZ	O	have	dep	230	SENT_177	[p7l1208t1330r1261b1359],
20	been	VBN	O	be	dep	230	SENT_177	[p7l1270t1330r1348b1359],
21	reviewed	VBN	O	review	dep	230	SENT_177	[p7l1356t1330r1505b1359],
22	extensively	RB	O	extensively	dep	230	SENT_177	[p7l1514t1330r1699b1368],
23	and	CC	O	and	dep	230	SENT_177	[p7l1708t1330r1767b1359],
24	can	MD	O	can	dep	230	SENT_177	[p7l1775t1339r1831b1359],
25	be	VB	O	be	dep	230	SENT_177	[p7l1839t1330r1877b1359],
26	summarized	VBN	O	summarize	dep	230	SENT_177	[p7l535t1379r736b1408],
27	as	IN	O	as	dep	230	SENT_177	[p7l746t1388r778b1408],
28	follows	VBZ	O	follow	dep	230	SENT_177	[p7l789t1379r920b1408],
29	:	:	O	:	_	0	SENT_177	[p7l789t1379r920b1408],
30	(	CD	NUMBER	(	dep	230	SENT_177	[p7l935t1380r979b1415],
31	a	DT	O	a	dep	230	SENT_177	[p7l935t1380r979b1415],
32	)	NN	O	)	dep	230	SENT_177	[p7l935t1380r979b1415],
33	Levels	NNS	O	level	dep	230	SENT_177	[p7l991t1379r1098b1408],
34	of	IN	O	of	dep	230	SENT_177	[p7l1109t1379r1145b1408],
35	expression	NN	O	expression	dep	230	SENT_177	[p7l1153t1379r1329b1417],
36	of	IN	O	of	dep	230	SENT_177	[p7l1339t1379r1375b1408],
37	P	NN	O	p	dep	230	SENT_177	[p7l1382t1380r1459b1417],
38	—	CD	NUMBER	—	dep	230	SENT_177	[p7l1382t1380r1459b1417],
39	gp	NN	O	gp	dep	230	SENT_177	[p7l1382t1380r1459b1417],
40	in	IN	O	in	dep	230	SENT_177	[p7l1470t1379r1501b1408],
41	many	JJ	O	many	dep	230	SENT_177	[p7l1511t1388r1602b1417],
42	different	JJ	O	different	dep	230	SENT_177	[p7l1613t1379r1754b1408],
43	tumors	NNS	O	tumor	dep	230	SENT_177	[p7l1763t1384r1877b1408],
44	are	VBP	O	be	dep	230	SENT_177	[p7l534t1437r583b1458],
45	high	JJ	O	high	dep	230	SENT_177	[p7l598t1428r671b1466],
46	enough	RB	O	enough	dep	230	SENT_177	[p7l686t1428r807b1466],
47	to	TO	O	to	dep	230	SENT_177	[p7l822t1432r853b1458],
48	confer	VB	O	confer	dep	230	SENT_177	[p7l869t1428r974b1458],
49	signiﬁcant	JJ	O	signiﬁcant	dep	230	SENT_177	[p7l990t1428r1161b1466],
50	drug	NN	O	drug	dep	230	SENT_177	[p7l1176t1428r1250b1466],
51	resistance	NN	O	resistance	dep	230	SENT_177	[p7l1265t1428r1437b1463],
52	,	,	O	,	_	0	SENT_177	[p7l1265t1428r1437b1463],
53	and	CC	O	and	dep	230	SENT_177	[p7l1454t1428r1513b1458],
54	the	DT	O	the	dep	230	SENT_177	[p7l1527t1428r1577b1458],
55	presence	NN	O	presence	dep	230	SENT_177	[p7l1592t1437r1736b1466],
56	of	IN	O	of	dep	230	SENT_177	[p7l1752t1428r1788b1457],
57	P	NN	O	p	dep	230	SENT_177	[p7l1800t1429r1877b1466],
58	—	CD	NUMBER	—	dep	230	SENT_177	[p7l1800t1429r1877b1466],
59	gp	NN	O	gp	dep	230	SENT_177	[p7l1800t1429r1877b1466],
60	correlates	VBZ	O	correlate	dep	230	SENT_177	[p7l534t1478r693b1507],
61	with	IN	O	with	dep	230	SENT_177	[p7l705t1478r778b1507],
62	drug	NN	O	drug	dep	230	SENT_177	[p7l789t1478r863b1516],
63	resistance	NN	O	resistance	dep	230	SENT_177	[p7l874t1478r1037b1507],
64	in	IN	O	in	dep	230	SENT_177	[p7l1048t1478r1080b1507],
65	several	JJ	O	several	dep	230	SENT_177	[p7l1092t1478r1205b1507],
66	different	JJ	O	different	dep	230	SENT_177	[p7l1217t1478r1358b1507],
67	cancers	NNS	O	cancer	dep	230	SENT_177	[p7l1369t1487r1491b1507],
68	(	VBP	O	(	dep	230	SENT_177	[p7l1504t1478r1581b1514],
69	20	CD	NUMBER	20	dep	230	SENT_177	[p7l1504t1478r1581b1514],
70	)	CD	NUMBER	)	dep	230	SENT_177	[p7l1504t1478r1581b1514],
71	;	:	O	;	_	0	SENT_177	[p7l1504t1478r1581b1514],
72	(	CD	NUMBER	(	dep	230	SENT_177	[p7l1595t1478r1639b1514],
73	b	NN	O	b	dep	230	SENT_177	[p7l1595t1478r1639b1514],
74	)	CD	NUMBER	)	dep	230	SENT_177	[p7l1595t1478r1639b1514],
75	acquisition	NN	O	acquisition	dep	230	SENT_177	[p7l1652t1478r1833b1516],
76	of	IN	O	of	dep	230	SENT_177	[p7l1844t1478r1880b1507],
77	drug	NN	O	drug	dep	230	SENT_177	[p7l534t1527r608b1565],
78	resistance	NN	O	resistance	dep	230	SENT_177	[p7l620t1527r783b1557],
79	after	IN	O	after	dep	230	SENT_177	[p7l796t1527r871b1557],
80	chemotherapy	NN	O	chemotherapy	dep	230	SENT_177	[p7l883t1527r1116b1565],
81	is	VBZ	O	be	dep	230	SENT_177	[p7l1129t1527r1155b1557],
82	associated	VBN	O	associate	dep	230	SENT_177	[p7l1169t1527r1338b1557],
83	with	IN	O	with	dep	230	SENT_177	[p7l1350t1527r1423b1557],
84	increased	VBN	O	increase	dep	230	SENT_177	[p7l1435t1527r1591b1557],
85	P	NN	O	p	dep	230	SENT_177	[p7l1603t1528r1680b1565],
86	—	CD	NUMBER	—	dep	230	SENT_177	[p7l1603t1528r1680b1565],
87	gp	NN	O	gp	dep	230	SENT_177	[p7l1603t1528r1680b1565],
88	levels	NNS	O	level	dep	230	SENT_177	[p7l1693t1527r1786b1557],
89	(	VBP	O	(	dep	230	SENT_177	[p7l1800t1527r1876b1563],
90	20	CD	NUMBER	20	dep	230	SENT_177	[p7l1800t1527r1876b1563],
91	)	CD	NUMBER	)	dep	230	SENT_177	[p7l1800t1527r1876b1563],
92	,	,	O	,	_	0	SENT_177	[p7l1800t1527r1876b1563],
93	and	CC	O	and	dep	230	SENT_177	[p7l534t1577r593b1606],
94	this	DT	O	this	dep	230	SENT_177	[p7l610t1577r668b1606],
95	increased	VBN	O	increase	dep	230	SENT_177	[p7l686t1577r842b1606],
96	expression	NN	O	expression	dep	230	SENT_177	[p7l860t1577r1035b1615],
97	occurs	VBZ	O	occur	dep	230	SENT_177	[p7l1053t1586r1159b1606],
98	via	IN	O	via	dep	230	SENT_177	[p7l1178t1577r1228b1606],
99	speciﬁc	NN	O	speciﬁc	dep	230	SENT_177	[p7l1246t1577r1370b1615],
100	molecular	JJ	O	molecular	dep	230	SENT_177	[p7l1388t1577r1554b1606],
101	mechanisms	NNS	O	mechanism	dep	230	SENT_177	[p7l1570t1577r1783b1612],
102	,	,	O	,	_	0	SENT_177	[p7l1570t1577r1783b1612],
103	such	JJ	O	such	dep	230	SENT_177	[p7l1804t1577r1878b1606],
104	as	IN	O	as	dep	230	SENT_177	[p7l534t1636r566b1656],
105	gene	NN	O	gene	dep	230	SENT_177	[p7l580t1636r656b1665],
106	rearrangement	NN	O	rearrangement	dep	230	SENT_177	[p7l669t1631r908b1665],
107	and	CC	O	and	dep	230	SENT_177	[p7l921t1627r979b1656],
108	selection	NN	O	selection	dep	230	SENT_177	[p7l993t1627r1138b1656],
109	of	IN	O	of	dep	230	SENT_177	[p7l1151t1627r1187b1656],
110	cells	NNS	O	cell	dep	230	SENT_177	[p7l1197t1627r1270b1656],
111	showing	VBG	O	show	dep	230	SENT_177	[p7l1285t1627r1422b1665],
112	these	DT	O	these	dep	230	SENT_177	[p7l1435t1627r1519b1656],
113	rearrangements	NNS	O	rearrangement	dep	230	SENT_177	[p7l1531t1631r1785b1665],
114	(	VBP	O	(	dep	230	SENT_177	[p7l1800t1627r1876b1663],
115	44	CD	NUMBER	44	dep	230	SENT_177	[p7l1800t1627r1876b1663],
116	)	CD	NUMBER	)	dep	230	SENT_177	[p7l1800t1627r1876b1663],
117	,	,	O	,	_	0	SENT_177	[p7l1800t1627r1876b1663],
118	which	WDT	O	which	dep	230	SENT_177	[p7l533t1677r634b1706],
119	argues	VBZ	O	argue	dep	230	SENT_177	[p7l647t1686r752b1714],
120	that	IN	O	that	dep	230	SENT_177	[p7l765t1677r827b1706],
121	the	DT	O	the	dep	230	SENT_177	[p7l839t1677r889b1706],
122	P	NN	O	p	dep	230	SENT_177	[p7l901t1677r1169b1714],
123	—	CD	NUMBER	—	dep	230	SENT_177	[p7l901t1677r1169b1714],
124	gp	NN	O	gp	dep	230	SENT_177	[p7l901t1677r1169b1714],
125	—	CD	NUMBER	—	dep	230	SENT_177	[p7l901t1677r1169b1714],
126	expressing	NN	O	expressing	dep	230	SENT_177	[p7l901t1677r1169b1714],
127	cells	NNS	O	cell	dep	230	SENT_177	[p7l1182t1677r1256b1706],
128	have	VBP	O	have	dep	230	SENT_177	[p7l1269t1677r1345b1706],
129	a	DT	O	a	dep	230	SENT_177	[p7l1359t1686r1376b1706],
130	selective	JJ	O	selective	dep	230	SENT_177	[p7l1389t1677r1530b1706],
131	advantage	NN	O	advantage	dep	230	SENT_177	[p7l1544t1677r1719b1714],
132	;	:	O	;	_	0	SENT_177	[p7l1544t1677r1719b1714],
133	(	CD	NUMBER	(	dep	230	SENT_177	[p7l1735t1677r1777b1712],
134	c	NN	O	c	dep	230	SENT_177	[p7l1735t1677r1777b1712],
135	)	CD	NUMBER	)	dep	230	SENT_177	[p7l1735t1677r1777b1712],
136	acute	JJ	O	acute	dep	230	SENT_177	[p7l1792t1681r1877b1706],
137	induction	NN	O	induction	dep	230	SENT_177	[p7l533t1726r689b1756],
138	of	IN	O	of	dep	230	SENT_177	[p7l701t1726r736b1755],
139	P	NN	O	p	dep	230	SENT_177	[p7l744t1727r821b1764],
140	—	CD	NUMBER	—	dep	230	SENT_177	[p7l744t1727r821b1764],
141	gp	NN	O	gp	dep	230	SENT_177	[p7l744t1727r821b1764],
142	has	VBZ	O	have	dep	230	SENT_177	[p7l832t1726r886b1756],
143	been	VBN	O	be	dep	230	SENT_177	[p7l897t1726r975b1756],
144	observed	VBN	O	observe	dep	230	SENT_177	[p7l986t1727r1134b1756],
145	in	IN	O	in	dep	230	SENT_177	[p7l1145t1726r1176b1755],
146	human	JJ	O	human	dep	230	SENT_177	[p7l1187t1726r1299b1756],
147	tumors	NNS	O	tumor	dep	230	SENT_177	[p7l1310t1731r1423b1756],
148	following	VBG	O	follow	dep	230	SENT_177	[p7l1435t1726r1594b1764],
149	exposure	NN	O	exposure	dep	230	SENT_177	[p7l1606t1736r1753b1764],
150	in	FW	O	in	dep	230	SENT_177	[p7l1764t1726r1796b1755],
151	vivo	FW	O	vivo	dep	230	SENT_177	[p7l1806t1726r1877b1756],
152	to	TO	O	to	dep	230	SENT_177	[p7l534t1781r564b1805],
153	doxorubicin	NN	O	doxorubicin	dep	230	SENT_177	[p7l580t1776r779b1805],
154	(	CD	NUMBER	(	dep	230	SENT_177	[p7l794t1776r871b1812],
155	45	CD	NUMBER	45	dep	230	SENT_177	[p7l794t1776r871b1812],
156	)	NN	O	)	dep	230	SENT_177	[p7l794t1776r871b1812],
157	;	:	O	;	_	0	SENT_177	[p7l794t1776r871b1812],
158	(	CD	NUMBER	(	dep	230	SENT_177	[p7l888t1776r937b1812],
159	d	NN	O	d	dep	230	SENT_177	[p7l888t1776r937b1812],
160	)	NN	O	)	dep	230	SENT_177	[p7l888t1776r937b1812],
161	in	IN	O	in	dep	230	SENT_177	[p7l952t1776r984b1805],
162	early	JJ	O	early	dep	230	SENT_177	[p7l998t1776r1080b1814],
163	clinical	JJ	O	clinical	dep	230	SENT_177	[p7l1095t1776r1216b1805],
164	trials	NNS	O	trial	dep	230	SENT_177	[p7l1230t1776r1311b1805],
165	testing	VBG	O	test	dep	230	SENT_177	[p7l1327t1776r1436b1814],
166	P	NN	O	p	dep	230	SENT_177	[p7l1451t1777r1528b1814],
167	—	CD	NUMBER	—	dep	230	SENT_177	[p7l1451t1777r1528b1814],
168	gp	NN	O	gp	dep	230	SENT_177	[p7l1451t1777r1528b1814],
169	modulation	NN	O	modulation	dep	230	SENT_177	[p7l1542t1776r1731b1805],
170	in	IN	O	in	dep	230	SENT_177	[p7l1745t1776r1776b1805],
171	acute	JJ	O	acute	dep	230	SENT_177	[p7l1792t1781r1877b1805],
172	leukemia	NN	O	leukemia	dep	230	SENT_177	[p7l533t1826r693b1861],
173	,	,	O	,	_	0	SENT_177	[p7l533t1826r693b1861],
174	cells	NNS	O	cell	dep	230	SENT_177	[p7l702t1826r776b1855],
175	that	WDT	O	that	dep	230	SENT_177	[p7l784t1826r846b1855],
176	survived	VBD	O	survive	dep	230	SENT_177	[p7l854t1826r994b1855],
177	chemotherapy	NN	O	chemotherapy	dep	230	SENT_177	[p7l1001t1826r1234b1864],
178	in	IN	O	in	dep	230	SENT_177	[p7l1242t1826r1273b1855],
179	the	DT	O	the	dep	230	SENT_177	[p7l1280t1826r1330b1855],
180	presence	NN	O	presence	dep	230	SENT_177	[p7l1337t1835r1481b1864],
181	of	IN	O	of	dep	230	SENT_177	[p7l1489t1826r1525b1855],
182	modulators	NNS	O	modulator	dep	230	SENT_177	[p7l1530t1826r1724b1861],
183	,	,	O	,	_	0	SENT_177	[p7l1530t1826r1724b1861],
184	resulting	VBG	O	result	dep	230	SENT_177	[p7l1733t1826r1877b1864],
185	in	IN	O	in	dep	230	SENT_177	[p7l533t1876r565b1905],
186	clinical	JJ	O	clinical	dep	230	SENT_177	[p7l576t1876r697b1905],
187	relapse	NN	O	relapse	dep	230	SENT_177	[p7l708t1876r834b1914],
188	,	,	O	,	_	0	SENT_177	[p7l708t1876r834b1914],
189	had	VBD	O	have	dep	230	SENT_177	[p7l847t1876r906b1905],
190	reduced	VBN	O	reduce	dep	230	SENT_177	[p7l917t1876r1048b1905],
191	expression	NN	O	expression	dep	230	SENT_177	[p7l1059t1876r1235b1914],
192	of	IN	O	of	dep	230	SENT_177	[p7l1247t1876r1282b1905],
193	P	NN	O	p	dep	230	SENT_177	[p7l1291t1877r1368b1914],
194	—	CD	NUMBER	—	dep	230	SENT_177	[p7l1291t1877r1368b1914],
195	gp	NN	O	gp	dep	230	SENT_177	[p7l1291t1877r1368b1914],
196	(	NN	O	(	dep	230	SENT_177	[p7l1381t1876r1443b1912],
197	46	CD	NUMBER	46	dep	230	SENT_177	[p7l1381t1876r1443b1912],
198	,	,	O	,	_	0	SENT_177	[p7l1381t1876r1443b1912],
199	47	CD	NUMBER	47	dep	230	SENT_177	[p7l1452t1876r1517b1912],
200	)	NN	O	)	dep	230	SENT_177	[p7l1452t1876r1517b1912],
201	;	:	O	;	_	0	SENT_177	[p7l1452t1876r1517b1912],
202	and	CC	O	and	dep	230	SENT_177	[p7l1531t1876r1589b1905],
203	(	NN	O	(	dep	230	SENT_177	[p7l1601t1876r1644b1912],
204	e	SYM	O	e	dep	230	SENT_177	[p7l1601t1876r1644b1912],
205	)	CD	NUMBER	)	dep	230	SENT_177	[p7l1601t1876r1644b1912],
206	expression	NN	O	expression	dep	230	SENT_177	[p7l1657t1876r1832b1914],
207	of	IN	O	of	dep	230	SENT_177	[p7l1844t1876r1880b1905],
208	P	NN	O	p	dep	230	SENT_177	[p7l533t1927r610b1964],
209	—	CD	NUMBER	—	dep	230	SENT_177	[p7l533t1927r610b1964],
210	gp	NN	O	gp	dep	230	SENT_177	[p7l533t1927r610b1964],
211	in	IN	O	in	dep	230	SENT_177	[p7l623t1926r654b1955],
212	some	DT	O	some	dep	230	SENT_177	[p7l668t1935r753b1955],
213	tumors	NNS	O	tumor	dep	230	SENT_177	[p7l765t1930r878b1955],
214	predicts	VBZ	O	predict	dep	230	SENT_177	[p7l891t1926r1021b1964],
215	poor	JJ	O	poor	dep	230	SENT_177	[p7l1033t1935r1109b1964],
216	response	NN	O	response	dep	230	SENT_177	[p7l1120t1935r1265b1964],
217	to	TO	O	to	dep	230	SENT_177	[p7l1277t1930r1308b1955],
218	chemotherapy	NN	O	chemotherapy	dep	230	SENT_177	[p7l1321t1926r1554b1964],
219	with	IN	O	with	dep	230	SENT_177	[p7l1567t1926r1639b1955],
220	drugs	NNS	O	drug	dep	230	SENT_177	[p7l1652t1926r1741b1964],
221	that	WDT	O	that	dep	230	SENT_177	[p7l1754t1926r1816b1955],
222	are	VBP	O	be	dep	230	SENT_177	[p7l1829t1935r1877b1955],
223	transported	VBN	O	transport	dep	230	SENT_177	[p7l533t1977r719b2014],
224	by	IN	O	by	dep	230	SENT_177	[p7l730t1977r771b2014],
225	P	NN	O	p	dep	230	SENT_177	[p7l782t1977r859b2014],
226	—	CD	NUMBER	—	dep	230	SENT_177	[p7l782t1977r859b2014],
227	gp	NN	O	gp	dep	230	SENT_177	[p7l782t1977r859b2014],
228	(	CD	NUMBER	(	dep	230	SENT_177	[p7l872t1977r948b2012],
229	48	CD	NUMBER	48	dep	230	SENT_177	[p7l872t1977r948b2012],
230	)	NN	O	)	_	0	SENT_177	[p7l872t1977r948b2012],
231	.	.	O	.	_	0	SENT_177	[p7l872t1977r948b2012],

1	This	DT	O	this	det	2	SENT_178	[p7l583t2026r655b2055],
2	evidence	NN	O	evidence	nsubjpass	5	SENT_178	[p7l672t2026r817b2055],
3	has	VBZ	O	have	aux	5	SENT_178	[p7l832t2026r886b2055],
4	been	VBN	O	be	auxpass	5	SENT_178	[p7l902t2026r980b2055],
5	used	VBN	O	use	_	0	SENT_178	[p7l995t2026r1071b2055],
6	to	TO	O	to	aux	7	SENT_178	[p7l1086t2031r1117b2055],
7	support	VB	O	support	xcomp	5	SENT_178	[p7l1134t2031r1257b2064],
8	the	DT	O	the	det	9	SENT_178	[p7l1272t2026r1321b2055],
9	introduction	NN	O	introduction	dobj	7	SENT_178	[p7l1337t2026r1539b2055],
10	of	IN	O	of	_	0	SENT_178	[p7l1555t2026r1591b2055],
11	various	JJ	O	various	amod	15	SENT_178	[p7l1604t2026r1723b2055],
12	P	NN	O	p	nn	15	SENT_178	[p7l1739t2027r1816b2064],
13	—	CD	NUMBER	—	num	15	SENT_178	[p7l1739t2027r1816b2064],
14	gp	NN	O	gp	nn	15	SENT_178	[p7l1739t2027r1816b2064],
15	inhibitors	NNS	O	inhibitor	prep_of	9	SENT_178	[p7l1832t2026r1876b2055, p7l533t2076r658b2105],
16	into	IN	O	into	_	0	SENT_178	[p7l669t2076r732b2105],
17	the	DT	O	the	det	18	SENT_178	[p7l742t2076r792b2105],
18	clinic	NN	O	clinic	prep_into	7	SENT_178	[p7l802t2076r902b2110],
19	,	,	O	,	_	0	SENT_178	[p7l802t2076r902b2110],
20	and	CC	O	and	_	0	SENT_178	[p7l914t2076r972b2105],
21	many	JJ	O	many	amod	22	SENT_178	[p7l981t2085r1072b2114],
22	studies	NNS	O	study	nsubjpass	28	SENT_178	[p7l1083t2076r1195b2105],
23	using	VBG	O	use	partmod	22	SENT_178	[p7l1206t2076r1294b2114],
24	such	JJ	O	such	amod	25	SENT_178	[p7l1306t2076r1380b2105],
25	inhibitors	NNS	O	inhibitor	dobj	23	SENT_178	[p7l1389t2076r1546b2105],
26	have	VBP	O	have	aux	28	SENT_178	[p7l1557t2076r1633b2105],
27	been	VBN	O	be	auxpass	28	SENT_178	[p7l1642t2076r1720b2105],
28	reported	VBN	O	report	conj_and	5	SENT_178	[p7l1729t2076r1876b2114],
29	,	,	O	,	_	0	SENT_178	[p7l1729t2076r1876b2114],
30	with	IN	O	with	_	0	SENT_178	[p7l534t2125r606b2155],
31	more	RBR	O	more	prep_with	28	SENT_178	[p7l615t2135r699b2155],
32	in	IN	O	in	_	0	SENT_178	[p7l709t2125r740b2154],
33	progress	NN	O	progress	prep_in	31	SENT_178	[p7l749t2135r897b2163],
34	.	.	O	.	_	0	SENT_178	[p7l749t2135r897b2163],

1	The	DT	O	the	det	3	SENT_179	[p7l909t2125r972b2155],
2	ﬁrst	JJ	O	ﬁrst	amod	3	SENT_179	[p7l982t2125r1046b2155],
3	studies	NNS	O	study	nsubjpass	5	SENT_179	[p7l1056t2125r1168b2155],
4	were	VBD	O	be	auxpass	5	SENT_179	[p7l1178t2135r1257b2155],
5	performed	VBN	O	perform	_	0	SENT_179	[p7l1267t2125r1439b2163],
6	with	IN	O	with	_	0	SENT_179	[p7l1448t2125r1521b2155],
7	modulators	NNS	O	modulator	prep_with	5	SENT_179	[p7l1530t2125r1715b2155],
8	approved	VBN	O	approve	partmod	7	SENT_179	[p7l1726t2125r1878b2163],
9	for	IN	O	for	_	0	SENT_179	[p7l534t2175r581b2204],
10	clinical	JJ	O	clinical	amod	11	SENT_179	[p7l591t2175r712b2205],
11	uses	NNS	O	use	prep_for	8	SENT_179	[p7l722t2185r792b2205],
12	other	JJ	O	other	dep	11	SENT_179	[p7l803t2175r888b2205],
13	than	IN	O	than	_	0	SENT_179	[p7l898t2175r968b2205],
14	inhibition	NN	O	inhibition	prep_than	11	SENT_179	[p7l978t2175r1139b2205],
15	of	IN	O	of	_	0	SENT_179	[p7l1149t2175r1185b2205],
16	P	NN	O	p	nn	18	SENT_179	[p7l1192t2176r1278b2213],
17	—	CD	NUMBER	—	num	18	SENT_179	[p7l1192t2176r1278b2213],
18	gp	NN	O	gp	prep_of	14	SENT_179	[p7l1192t2176r1278b2213],
19	.	.	O	.	_	0	SENT_179	[p7l1192t2176r1278b2213],

1	Subsequent	JJ	O	subsequent	amod	2	SENT_180	[p7l1292t2175r1481b2213],
2	studies	NNS	O	study	nsubjpass	4	SENT_180	[p7l1493t2175r1604b2205],
3	were	VBD	O	be	auxpass	4	SENT_180	[p7l1616t2185r1695b2205],
4	performed	VBN	O	perform	_	0	SENT_180	[p7l1705t2175r1878b2213],
5	with	IN	O	with	_	0	SENT_180	[p7l534t2225r606b2254],
6	“	NN	O	“	prep_with	4	SENT_180	[p7l621t2225r753b2254],
7	second	JJ	ORDINAL	second	amod	10	SENT_180	[p7l621t2225r753b2254],
8	generation	NN	O	generation	nn	10	SENT_180	[p7l767t2225r958b2263],
9	”	NN	O	”	nn	10	SENT_180	[p7l767t2225r958b2263],
10	modulators	NNS	O	modulator	tmod	4	SENT_180	[p7l973t2225r1167b2260],
11	,	,	O	,	_	0	SENT_180	[p7l973t2225r1167b2260],
12	compounds	NNS	O	compound	appos	10	SENT_180	[p7l1183t2225r1372b2263],
13	with	IN	O	with	prep	12	SENT_180	[p7l1387t2225r1460b2255],
14	somewhat	RB	O	somewhat	pcomp	13	SENT_180	[p7l1475t2225r1640b2255],
15	increased	VBN	O	increase	dep	12	SENT_180	[p7l1653t2225r1809b2254],
16	potency	NN	O	potency	dobj	15	SENT_180	[p7l1823t2234r1876b2263, p7l534t2280r621b2313],
17	but	CC	O	but	_	0	SENT_180	[p7l637t2275r690b2304],
18	still	RB	O	still	advmod	19	SENT_180	[p7l707t2275r766b2304],
19	limited	VBN	O	limit	conj_but	15	SENT_180	[p7l783t2275r900b2304],
20	by	IN	O	by	_	0	SENT_180	[p7l915t2275r955b2313],
21	toxicity	NN	O	toxicity	prep_by	19	SENT_180	[p7l972t2275r1103b2313],
22	.	.	O	.	_	0	SENT_180	[p7l972t2275r1103b2313],

1	Recently	RB	DATE	recently	advmod	9	SENT_181	[p7l1122t2275r1274b2313],
2	,	,	O	,	_	0	SENT_181	[p7l1122t2275r1274b2313],
3	a	DT	O	a	det	5	SENT_181	[p7l1293t2284r1310b2304],
4	new	JJ	O	new	amod	5	SENT_181	[p7l1326t2284r1392b2304],
5	generation	NN	O	generation	nsubj	9	SENT_181	[p7l1409t2275r1583b2313],
6	of	IN	O	of	_	0	SENT_181	[p7l1600t2275r1636b2304],
7	inhibitors	NNS	O	inhibitor	prep_of	5	SENT_181	[p7l1649t2275r1806b2304],
8	has	VBZ	O	have	aux	9	SENT_181	[p7l1823t2275r1877b2304],
9	reached	VBN	O	reach	_	0	SENT_181	[p7l533t2325r662b2354],
10	clinical	JJ	O	clinical	amod	11	SENT_181	[p7l677t2325r798b2354],
11	testing	NN	O	testing	dobj	9	SENT_181	[p7l813t2325r931b2363],
12	.	.	O	.	_	0	SENT_181	[p7l813t2325r931b2363],

1	These	DT	O	these	det	6	SENT_182	[p7l948t2325r1046b2354],
2	“	CD	NUMBER	“	num	6	SENT_182	[p7l1063t2325r1158b2354],
3	third	JJ	ORDINAL	third	amod	6	SENT_182	[p7l1063t2325r1158b2354],
4	generation	NN	O	generation	nn	6	SENT_182	[p7l1173t2325r1364b2363],
5	”	NN	O	”	nn	6	SENT_182	[p7l1173t2325r1364b2363],
6	inhibitors	NNS	O	inhibitor	nsubj	7	SENT_182	[p7l1381t2325r1538b2354],
7	promise	VBP	O	promise	_	0	SENT_182	[p7l1554t2325r1687b2363],
8	to	TO	O	to	aux	10	SENT_182	[p7l1702t2330r1733b2354],
9	be	VB	O	be	cop	10	SENT_182	[p7l1748t2325r1787b2354],
10	nontoxic	JJ	O	nontoxic	xcomp	7	SENT_182	[p7l1802t2334r1876b2354, p7l533t2375r624b2409],
11	,	,	O	,	_	0	SENT_182	[p7l1802t2334r1876b2354, p7l533t2375r624b2409],
12	more	RBR	O	more	advmod	13	SENT_182	[p7l636t2384r720b2404],
13	speciﬁc	JJ	O	speciﬁc	xcomp	7	SENT_182	[p7l732t2375r865b2413],
14	,	,	O	,	_	0	SENT_182	[p7l732t2375r865b2413],
15	and	CC	O	and	_	0	SENT_182	[p7l878t2375r936b2404],
16	more	RBR	O	more	advmod	17	SENT_182	[p7l946t2384r1030b2404],
17	potent	JJ	O	potent	xcomp	7	SENT_182	[p7l1040t2379r1144b2413],
18	than	IN	O	than	_	0	SENT_182	[p7l1154t2375r1224b2404],
19	the	DT	O	the	det	21	SENT_182	[p7l1235t2375r1284b2404],
20	earlier	JJR	O	earlier	amod	21	SENT_182	[p7l1295t2375r1400b2404],
21	inhibitors	NNS	O	inhibitor	prep_than	10	SENT_182	[p7l1410t2375r1567b2404],
22	used	VBN	O	use	partmod	21	SENT_182	[p7l1578t2375r1654b2404],
23	in	IN	O	in	_	0	SENT_182	[p7l1664t2375r1695b2404],
24	trials	NNS	O	trial	prep_in	22	SENT_182	[p7l1705t2375r1786b2404],
25	of	IN	O	of	_	0	SENT_182	[p7l1798t2375r1834b2404],
26	Pgp	NNP	O	Pgp	nn	27	SENT_182	[p7l1841t2376r1876b2404, p7l534t2434r573b2463],
27	modulation	NN	O	modulation	prep_of	24	SENT_182	[p7l582t2425r779b2454],
28	.	.	O	.	_	0	SENT_182	[p7l582t2425r779b2454],

1	These	DT	O	these	det	2	SENT_183	[p7l789t2425r887b2454],
2	compounds	NNS	O	compound	nsubj	3	SENT_183	[p7l897t2425r1086b2463],
3	include	VBP	O	include	_	0	SENT_183	[p7l1095t2425r1216b2454],
4	XR9576	NN	O	xr9576	dobj	3	SENT_183	[p7l1225t2425r1373b2459],
5	,	,	O	,	_	0	SENT_183	[p7l1225t2425r1373b2459],
6	R10l933	NN	O	r10l933	appos	4	SENT_183	[p7l1383t2425r1544b2459],
7	,	,	O	,	_	0	SENT_183	[p7l1383t2425r1544b2459],
8	Biricodar	NNP	PERSON	Biricodar	dobj	3	SENT_183	[p7l1554t2425r1710b2454],
9	(	CD	NUMBER	(	num	11	SENT_183	[p7l1719t2425r1876b2461],
10	VX7lO	NN	O	vx7lo	nn	11	SENT_183	[p7l1719t2425r1876b2461],
11	)	NN	O	)	dep	8	SENT_183	[p7l1719t2425r1876b2461],
12	,	,	O	,	_	0	SENT_183	[p7l1719t2425r1876b2461],
13	and	CC	O	and	_	0	SENT_183	[p7l534t2475r593b2504],
14	LY335979	NN	O	ly335979	dobj	3	SENT_183	[p7l603t2475r787b2504],
15	.	.	O	.	_	0	SENT_183	[p7l603t2475r787b2504],

1	In	IN	O	in	_	0	SENT_184	[p7l583t2525r617b2553],
2	studies	NNS	O	study	prep_in	34	SENT_184	[p7l630t2524r742b2554],
3	reported	VBD	O	report	conj_and	3	SENT_184	[p7l754t2524r892b2562],
4	to	TO	O	to	_	0	SENT_184	[p7l903t2529r934b2554],
5	date	NN	O	date	prep_to	3	SENT_184	[p7l947t2525r1023b2559],
6	,	,	O	,	_	0	SENT_184	[p7l947t2525r1023b2559],
7	with	IN	O	with	_	0	SENT_184	[p7l1037t2524r1109b2554],
8	ﬁrst	NN	O	ﬁrst	nn	10	SENT_184	[p7l1121t2524r1185b2554],
9	generation	NN	O	generation	nn	10	SENT_184	[p7l1197t2524r1370b2562],
10	modulators	NNS	O	modulator	prep_with	3	SENT_184	[p7l1382t2524r1567b2554],
11	and	CC	O	and	_	0	SENT_184	[p7l1580t2524r1638b2554],
12	with	IN	O	with	_	0	SENT_184	[p7l1650t2524r1723b2554],
13	dexvera	NN	O	dexvera	nn	15	SENT_184	[p7l1735t2525r1876b2554],
14	—	NN	O	—	nn	15	SENT_184	[p7l1735t2525r1876b2554],
15	pamil	NN	O	pamil	prep_with	3	SENT_184	[p7l533t2574r636b2612],
16	,	,	O	,	_	0	SENT_184	[p7l533t2574r636b2612],
17	dexniguldipine	NN	O	dexniguldipine	prep_with	3	SENT_184	[p7l647t2574r903b2612],
18	,	,	O	,	_	0	SENT_184	[p7l647t2574r903b2612],
19	and	CC	O	and	_	0	SENT_184	[p7l915t2574r973b2604],
20	the	DT	O	the	det	23	SENT_184	[p7l982t2574r1031b2604],
21	cyclosporin	NN	O	cyclosporin	nn	23	SENT_184	[p7l1041t2574r1233b2612],
22	D	NN	O	d	nn	23	SENT_184	[p7l1242t2575r1270b2603],
23	analogue	NN	O	analogue	prep_with	3	SENT_184	[p7l1281t2574r1429b2612],
24	Valspodar	NNP	O	Valspodar	tmod	3	SENT_184	[p7l1439t2574r1604b2612],
25	(	CD	NUMBER	(	num	27	SENT_184	[p7l1614t2574r1785b2610],
26	PSC833	NN	O	psc833	nn	27	SENT_184	[p7l1614t2574r1785b2610],
27	)	NN	O	)	dep	24	SENT_184	[p7l1614t2574r1785b2610],
28	,	,	O	,	_	0	SENT_184	[p7l1614t2574r1785b2610],
29	there	EX	O	there	expl	34	SENT_184	[p7l1795t2574r1877b2604],
30	have	VBP	O	have	aux	34	SENT_184	[p7l533t2624r609b2654],
31	been	VBN	O	be	cop	34	SENT_184	[p7l624t2625r702b2654],
32	no	DT	O	no	det	34	SENT_184	[p7l717t2634r757b2654],
33	dramatic	JJ	O	dramatic	amod	34	SENT_184	[p7l774t2624r916b2654],
34	changes	NNS	O	change	_	0	SENT_184	[p7l933t2624r1064b2662],
35	in	IN	O	in	_	0	SENT_184	[p7l1081t2624r1112b2653],
36	response	NN	O	response	nn	37	SENT_184	[p7l1127t2634r1271b2662],
37	rates	NNS	O	rate	prep_in	34	SENT_184	[p7l1286t2629r1363b2654],
38	in	IN	O	in	mark	44	SENT_184	[p7l1379t2624r1411b2653],
39	a	DT	O	a	det	40	SENT_184	[p7l1427t2634r1444b2654],
40	variety	NN	O	variety	nsubj	44	SENT_184	[p7l1459t2624r1572b2662],
41	of	IN	O	of	_	0	SENT_184	[p7l1588t2624r1624b2654],
42	human	JJ	O	human	amod	43	SENT_184	[p7l1636t2624r1748b2654],
43	tumors	NNS	O	tumor	prep_of	40	SENT_184	[p7l1763t2629r1877b2654],
44	(	VBP	O	(	advcl	34	SENT_184	[p7l535t2674r610b2710],
45	49	CD	NUMBER	49	num	46	SENT_184	[p7l535t2674r610b2710],
46	)	CD	NUMBER	)	dobj	44	SENT_184	[p7l535t2674r610b2710],
47	.	.	O	.	_	0	SENT_184	[p7l535t2674r610b2710],

1	Cancers	NNS	O	cancer	dep	30	SENT_185	[p7l623t2675r754b2704],
2	such	JJ	O	such	_	0	SENT_185	[p7l767t2674r841b2704],
3	as	IN	O	as	_	0	SENT_185	[p7l852t2684r883b2704],
4	acute	JJ	O	acute	amod	5	SENT_185	[p7l896t2679r981b2704],
5	myelocytic	JJ	O	myelocytic	amod	6	SENT_185	[p7l992t2674r1174b2712],
6	leukemia	NN	O	leukemia	prep_such_as	1	SENT_185	[p7l1185t2674r1337b2703],
7	and	CC	O	and	_	0	SENT_185	[p7l1347t2674r1405b2703],
8	myeloma	NN	O	myeloma	prep_such_as	1	SENT_185	[p7l1416t2674r1578b2712],
9	,	,	O	,	_	0	SENT_185	[p7l1416t2674r1578b2712],
10	which	WDT	O	which	nsubj	12	SENT_185	[p7l1590t2674r1691b2704],
11	commonly	RB	O	commonly	advmod	12	SENT_185	[p7l1701t2674r1877b2712],
12	express	VBP	O	express	rcmod	1	SENT_185	[p7l534t2733r655b2762],
13	P	NN	O	p	nn	15	SENT_185	[p7l665t2725r742b2762],
14	—	CD	NUMBER	—	num	15	SENT_185	[p7l665t2725r742b2762],
15	gp	NN	O	gp	dobj	12	SENT_185	[p7l665t2725r742b2762],
16	at	IN	O	at	_	0	SENT_185	[p7l752t2729r780b2753],
17	a	DT	O	a	det	19	SENT_185	[p7l789t2733r807b2753],
18	low	JJ	O	low	amod	19	SENT_185	[p7l815t2724r874b2753],
19	level	NN	O	level	prep_at	12	SENT_185	[p7l883t2724r961b2753],
20	at	IN	O	at	_	0	SENT_185	[p7l971t2729r999b2753],
21	presentation	NN	O	presentation	prep_at	19	SENT_185	[p7l1007t2724r1210b2762],
22	and	CC	O	and	_	0	SENT_185	[p7l1219t2724r1277b2753],
23	with	IN	O	with	_	0	SENT_185	[p7l1286t2724r1359b2753],
24	increasing	VBG	O	increase	amod	25	SENT_185	[p7l1367t2724r1536b2762],
25	frequency	NN	O	frequency	prep_with	12	SENT_185	[p7l1545t2724r1709b2762],
26	following	VBG	O	follow	_	0	SENT_185	[p7l1718t2724r1877b2762],
27	chemotherapy	NN	O	chemotherapy	prep_following	25	SENT_185	[p7l534t2773r773b2811],
28	,	,	O	,	_	0	SENT_185	[p7l534t2773r773b2811],
29	may	MD	O	may	aux	30	SENT_185	[p7l784t2782r854b2811],
30	give	VB	O	give	_	0	SENT_185	[p7l864t2773r932b2811],
31	higher	JJR	O	higher	amod	33	SENT_185	[p7l942t2773r1048b2811],
32	response	NN	O	response	nn	33	SENT_185	[p7l1056t2782r1200b2811],
33	rates	NNS	O	rate	dobj	30	SENT_185	[p7l1209t2777r1286b2803],
34	when	WRB	O	when	advmod	41	SENT_185	[p7l1297t2773r1385b2803],
35	a	DT	O	a	det	39	SENT_185	[p7l1395t2782r1412b2803],
36	P	NN	O	p	nn	39	SENT_185	[p7l1421t2774r1498b2811],
37	—	CD	NUMBER	—	num	39	SENT_185	[p7l1421t2774r1498b2811],
38	gp	NN	O	gp	nn	39	SENT_185	[p7l1421t2774r1498b2811],
39	inhibitor	NN	O	inhibitor	nsubjpass	41	SENT_185	[p7l1508t2773r1650b2803],
40	is	VBZ	O	be	auxpass	41	SENT_185	[p7l1659t2773r1685b2803],
41	included	VBN	O	include	advcl	30	SENT_185	[p7l1695t2773r1837b2803],
42	in	IN	O	in	_	0	SENT_185	[p7l1846t2773r1877b2802],
43	the	DT	O	the	det	45	SENT_185	[p7l533t2823r583b2852],
44	chemotherapy	NN	O	chemotherapy	nn	45	SENT_185	[p7l593t2823r826b2861],
45	regimen	NN	O	regimen	prep_in	41	SENT_185	[p7l835t2823r970b2861],
46	(	CD	NUMBER	(	num	48	SENT_185	[p7l980t2823r1074b2859],
47	49a	NN	O	49a	nn	48	SENT_185	[p7l980t2823r1074b2859],
48	)	NN	O	)	nsubj	30	SENT_185	[p7l980t2823r1074b2859],
49	.	.	O	.	_	0	SENT_185	[p7l980t2823r1074b2859],

1	Solid	JJ	O	solid	amod	2	SENT_186	[p7l1086t2823r1172b2852],
2	tumors	NNS	O	tumor	nsubj	15	SENT_186	[p7l1181t2827r1304b2858],
3	,	,	O	,	_	0	SENT_186	[p7l1181t2827r1304b2858],
4	such	JJ	O	such	_	0	SENT_186	[p7l1316t2823r1390b2852],
5	as	IN	O	as	_	0	SENT_186	[p7l1400t2832r1432b2852],
6	renal	JJ	O	renal	amod	8	SENT_186	[p7l1442t2823r1524b2852],
7	cell	NN	O	cell	nn	8	SENT_186	[p7l1534t2823r1592b2852],
8	cancer	NN	O	cancer	prep_such_as	2	SENT_186	[p7l1602t2832r1710b2852],
9	and	CC	O	and	_	0	SENT_186	[p7l1719t2823r1777b2852],
10	colon	NN	O	colon	nn	11	SENT_186	[p7l1787t2823r1877b2852],
11	cancer	NN	O	cancer	prep_such_as	2	SENT_186	[p7l534t2881r648b2906],
12	,	,	O	,	_	0	SENT_186	[p7l534t2881r648b2906],
13	do	VBP	O	do	aux	15	SENT_186	[p7l665t2872r705b2901],
14	not	RB	O	not	neg	15	SENT_186	[p7l721t2877r773b2901],
15	respond	VB	O	respond	_	0	SENT_186	[p7l788t2872r919b2910],
16	signiﬁcantly	RB	O	signiﬁcantly	advmod	15	SENT_186	[p7l935t2872r1138b2910],
17	despite	IN	O	despite	_	0	SENT_186	[p7l1154t2872r1270b2910],
18	relatively	RB	O	relatively	advmod	19	SENT_186	[p7l1285t2872r1439b2910],
19	high	JJ	O	high	amod	20	SENT_186	[p7l1455t2872r1528b2910],
20	levels	NNS	O	level	prep_despite	15	SENT_186	[p7l1543t2872r1637b2901],
21	of	IN	O	of	_	0	SENT_186	[p7l1653t2872r1689b2901],
22	expression	NN	O	expression	prep_of	20	SENT_186	[p7l1702t2872r1878b2910],
23	of	IN	O	of	_	0	SENT_186	[p7l534t2921r570b2950],
24	P	NN	O	p	nn	26	SENT_186	[p7l582t2922r668b2959],
25	—	CD	NUMBER	—	num	26	SENT_186	[p7l582t2922r668b2959],
26	gp	NN	O	gp	prep_of	22	SENT_186	[p7l582t2922r668b2959],
27	,	,	O	,	_	0	SENT_186	[p7l582t2922r668b2959],
28	suggesting	VBG	O	suggest	partmod	20	SENT_186	[p7l686t2921r860b2959],
29	that	IN	O	that	complm	36	SENT_186	[p7l875t2921r937b2950],
30	other	JJ	O	other	amod	31	SENT_186	[p7l952t2921r1036b2950],
31	mechanisms	NNS	O	mechanism	nsubj	36	SENT_186	[p7l1050t2921r1253b2950],
32	of	IN	O	of	_	0	SENT_186	[p7l1270t2921r1305b2950],
33	drug	NN	O	drug	nn	34	SENT_186	[p7l1318t2921r1392b2959],
34	resistance	NN	O	resistance	prep_of	31	SENT_186	[p7l1407t2921r1569b2950],
35	also	RB	O	also	advmod	36	SENT_186	[p7l1585t2921r1650b2950],
36	contribute	VBP	O	contribute	ccomp	28	SENT_186	[p7l1665t2921r1831b2950],
37	to	TO	O	to	_	0	SENT_186	[p7l1846t2925r1877b2950],
38	the	DT	O	the	det	39	SENT_186	[p7l533t2971r583b3000],
39	resistance	NN	O	resistance	prep_to	36	SENT_186	[p7l594t2971r757b3000],
40	of	IN	O	of	_	0	SENT_186	[p7l770t2971r806b3000],
41	these	DT	O	these	det	43	SENT_186	[p7l815t2971r899b3000],
42	solid	JJ	O	solid	amod	43	SENT_186	[p7l912t2971r991b3000],
43	tumors	NNS	O	tumor	prep_of	39	SENT_186	[p7l1002t2976r1116b3000],
44	to	TO	O	to	_	0	SENT_186	[p7l1128t2975r1159b3000],
45	many	JJ	O	many	amod	46	SENT_186	[p7l1172t2980r1262b3009],
46	forms	NNS	O	form	prep_to	36	SENT_186	[p7l1274t2971r1369b3000],
47	of	IN	O	of	_	0	SENT_186	[p7l1382t2971r1418b3000],
48	chemotherapy	NN	O	chemotherapy	prep_of	46	SENT_186	[p7l1427t2971r1660b3009],
49	(	CD	NUMBER	(	number	50	SENT_186	[p7l1674t2971r1749b3007],
50	20	CD	NUMBER	20	num	51	SENT_186	[p7l1674t2971r1749b3007],
51	)	NN	O	)	dep	48	SENT_186	[p7l1674t2971r1749b3007],
52	.	.	O	.	_	0	SENT_186	[p7l1674t2971r1749b3007],

1	Recent	JJ	O	recent	amod	2	SENT_187	[p7l1763t2972r1878b3000],
2	knowledge	NN	O	knowledge	nsubj	20	SENT_187	[p7l533t3020r713b3058],
3	about	IN	O	about	_	0	SENT_187	[p7l724t3020r815b3049],
4	other	JJ	O	other	amod	6	SENT_187	[p7l824t3020r909b3049],
5	ABC	NNP	ORGANIZATION	ABC	nn	6	SENT_187	[p7l918t3020r1001b3049],
6	transporters	NNS	O	transporter	prep_about	2	SENT_187	[p7l1012t3025r1206b3058],
7	such	JJ	O	such	_	0	SENT_187	[p7l1218t3020r1291b3049],
8	as	IN	O	as	_	0	SENT_187	[p7l1302t3029r1333b3049],
9	MRP	NN	O	mrp	nn	10	SENT_187	[p7l1344t3021r1431b3049],
10	transporters	NNS	O	transporter	prep_such_as	6	SENT_187	[p7l1440t3025r1634b3058],
11	and	CC	O	and	_	0	SENT_187	[p7l1646t3020r1704b3049],
12	MXR	NN	O	mxr	prep_such_as	6	SENT_187	[p7l1713t3021r1807b3049],
13	that	WDT	O	that	nsubj	15	SENT_187	[p7l1816t3020r1878b3049],
14	might	MD	O	might	aux	15	SENT_187	[p7l533t3069r630b3107],
15	contribute	VB	O	contribute	rcmod	6	SENT_187	[p7l644t3069r810b3098],
16	to	TO	O	to	_	0	SENT_187	[p7l824t3073r855b3098],
17	drug	NN	O	drug	nn	18	SENT_187	[p7l870t3069r944b3107],
18	resistance	NN	O	resistance	prep_to	15	SENT_187	[p7l958t3069r1121b3098],
19	has	VBZ	O	have	aux	20	SENT_187	[p7l1135t3069r1189b3098],
20	caused	VBN	O	cause	_	0	SENT_187	[p7l1204t3069r1316b3098],
21	clinicians	NNS	O	clinician	dobj	20	SENT_187	[p7l1330t3069r1487b3098],
22	to	TO	O	to	aux	23	SENT_187	[p7l1502t3074r1533b3098],
23	reconsider	VB	O	reconsider	xcomp	20	SENT_187	[p7l1547t3069r1720b3098],
24	what	WP	O	what	dobj	29	SENT_187	[p7l1734t3069r1814b3099],
25	the	DT	O	the	det	27	SENT_187	[p7l1828t3069r1877b3098],
26	best	JJS	O	best	amod	27	SENT_187	[p7l533t3118r600b3147],
27	inhibitors	NNS	O	inhibitor	nsubj	29	SENT_187	[p7l613t3118r771b3147],
28	might	MD	O	might	aux	29	SENT_187	[p7l786t3118r882b3156],
29	be	VB	O	be	dep	33	SENT_187	[p7l895t3118r943b3147],
30	:	:	O	:	_	0	SENT_187	[p7l895t3118r943b3147],
31	a	DT	O	a	det	33	SENT_187	[p7l961t3127r978b3147],
32	nonspeciﬁc	JJ	O	nonspeciﬁc	amod	33	SENT_187	[p7l992t3118r1179b3156],
33	inhibitor	NN	O	inhibitor	dobj	23	SENT_187	[p7l1194t3118r1337b3147],
34	of	IN	O	of	_	0	SENT_187	[p7l1351t3118r1387b3147],
35	ABC	NNP	ORGANIZATION	ABC	nn	36	SENT_187	[p7l1398t3118r1481b3147],
36	transporters	NNS	O	transporter	prep_of	33	SENT_187	[p7l1497t3123r1691b3156],
37	that	WDT	O	that	nsubj	39	SENT_187	[p7l1706t3118r1768b3147],
38	might	MD	O	might	aux	39	SENT_187	[p7l1781t3118r1878b3156],
39	have	VB	O	have	rcmod	33	SENT_187	[p7l533t3167r609b3197],
40	the	DT	O	the	det	42	SENT_187	[p7l623t3167r672b3197],
41	broadest	JJS	O	broadest	amod	42	SENT_187	[p7l686t3167r826b3197],
42	spectrum	NN	O	spectrum	dobj	39	SENT_187	[p7l841t3172r999b3205],
43	,	,	O	,	_	0	SENT_187	[p7l841t3172r999b3205],
44	but	CC	O	but	_	0	SENT_187	[p7l1014t3167r1066b3197],
45	a	DT	O	a	det	47	SENT_187	[p7l1080t3176r1098b3197],
46	higher	JJR	O	higher	amod	47	SENT_187	[p7l1110t3167r1216b3205],
47	likelihood	NN	O	likelihood	nsubj	58	SENT_187	[p7l1229t3167r1396b3197],
48	of	IN	O	of	_	0	SENT_187	[p7l1410t3167r1446b3197],
49	side	JJ	O	side	amod	50	SENT_187	[p7l1458t3167r1522b3197],
50	effects	NNS	O	effect	prep_of	47	SENT_187	[p7l1537t3167r1654b3202],
51	,	,	O	,	_	0	SENT_187	[p7l1537t3167r1654b3202],
52	or	CC	O	or	_	0	SENT_187	[p7l1669t3176r1703b3197],
53	a	DT	O	a	det	54	SENT_187	[p7l1717t3176r1734b3197],
54	cocktail	NN	O	cocktail	nsubj	58	SENT_187	[p7l1747t3167r1877b3197],
55	of	IN	O	of	_	0	SENT_187	[p7l534t3217r570b3246],
56	speciﬁc	NN	O	speciﬁc	nn	57	SENT_187	[p7l582t3217r706b3255],
57	inhibitors	NNS	O	inhibitor	prep_of	54	SENT_187	[p7l721t3217r878b3246],
58	designed	VBN	O	design	conj_but	20	SENT_187	[p7l893t3217r1040b3255],
59	for	IN	O	for	_	0	SENT_187	[p7l1054t3217r1102b3246],
60	each	DT	O	each	det	62	SENT_187	[p7l1115t3217r1190b3246],
61	individual	JJ	O	individual	amod	62	SENT_187	[p7l1204t3217r1370b3246],
62	tumor	NN	O	tumor	prep_for	58	SENT_187	[p7l1384t3221r1488b3246],
63	.	.	O	.	_	0	SENT_187	[p7l1384t3221r1488b3246],

1	Also	RB	O	also	advmod	4	SENT_188	[p7l1505t3217r1591b3252],
2	,	,	O	,	_	0	SENT_188	[p7l1505t3217r1591b3252],
3	there	EX	O	there	expl	4	SENT_188	[p7l1606t3217r1688b3246],
4	is	VBZ	O	be	_	0	SENT_188	[p7l1702t3217r1728b3246],
5	a	DT	O	a	det	8	SENT_188	[p7l1744t3226r1761b3246],
6	strong	JJ	O	strong	amod	8	SENT_188	[p7l1776t3221r1877b3255],
7	DRUG	NN	O	drug	nn	8	SENT_188	[p7l1192t3278r1296b3305],
8	RESISTANCE	NN	O	resistance	nsubj	4	SENT_188	[p7l1306t3278r1528b3305],
9	IN	IN	O	in	_	0	SENT_188	[p7l1538t3279r1577b3305],
10	CANCER	NNP	O	CANCER	prep_in	8	SENT_188	[p7l1587t3278r1738b3305],
11	623	CD	NUMBER	623	num	10	SENT_188	[p7l1826t3275r1886b3305],

1	Annu	NNP	PERSON	Annu	_	0	SENT_189	[p8l270t1578r293b1658],
2	.	.	O	.	_	0	SENT_189	[p8l270t1578r293b1658],

1	Rev.	NNP	O	Rev.	nn	2	SENT_190	[p8l270t1507r293b1567],
2	Med	NNP	O	Med	_	0	SENT_190	[p8l270t1430r293b1497],
3	.	.	O	.	_	0	SENT_190	[p8l270t1430r293b1497],

1	2002.53:6	CD	NUMBER	2002.53:6	_	0	SENT_191	[p8l270t1185r293b1419],
2	l5-627	NN	O	l5-627	dep	1	SENT_191	[p8l270t1185r293b1419],
3	.	.	O	.	_	0	SENT_191	[p8l270t1185r293b1419],

1	Downloaded	VBN	O	download	_	0	SENT_192	[p8l270t1004r293b1174],
2	from	IN	O	from	_	0	SENT_192	[p8l270t931r293b995],
3	www	NN	O	www	prep_from	1	SENT_192	[p8l270t702r293b922],
4	.	.	O	.	_	0	SENT_192	[p8l270t702r293b922],

1	annualrevi	NN	O	annualrevus	nn	2	SENT_193	[p8l270t702r293b922],
2	ews.org	NN	O	ews.org	_	0	SENT_193	[p8l277t577r300b680],
3	by	IN	O	by	_	0	SENT_193	[p8l303t1591r334b1624],
4	University	NNP	ORGANIZATION	University	prep_by	2	SENT_193	[p8l303t1443r334b1582],
5	of	IN	ORGANIZATION	of	_	0	SENT_193	[p8l303t1404r327b1433],
6	Wisconsin	NNP	ORGANIZATION	Wisconsin	prep_of	4	SENT_193	[p8l303t1258r327b1398],
7	-	:	O	-	_	0	SENT_193	[p8l317t1239r320b1248],
8	Madison	NNP	O	Madison	dep	2	SENT_193	[p8l303t1112r327b1229],
9	on	IN	O	on	_	0	SENT_193	[p8l311t1071r327b1103],
10	01/05/14	CD	DATE	01/05/14	prep_on	8	SENT_193	[p8l303t938r327b1061],
11	.	.	O	.	_	0	SENT_193	[p8l303t938r327b1061],

1	For	IN	O	for	_	0	SENT_194	[p8l304t881r327b927],
2	personal	JJ	O	personal	amod	3	SENT_194	[p8l303t760r334b872],
3	use	NN	O	use	pobj	1	SENT_194	[p8l311t707r327b751],
4	only	RB	O	only	advmod	3	SENT_194	[p8l303t612r334b677],
5	.	.	O	.	_	0	SENT_194	[p8l303t612r334b677],

1	ed	VBN	O	ed	_	0	SENT_195	[p8l281t3364r304b3395],
2	from	IN	O	from	prep	1	SENT_195	[p8l281t3291r304b3355],
3	www.annuaJreviews.org	NN	O	www.annuajreviews.org	dep	2	SENT_195	[p8l281t2898r311b3223],
4	/	:	O	/	punct	3	SENT_195	[p8l314t3298r338b3389],
5	O5/l4	NN	O	o5/l4	dep	3	SENT_195	[p8l314t3298r338b3389],
6	.	.	O	.	_	0	SENT_195	[p8l314t3298r338b3389],

1	For	IN	O	for	_	0	SENT_196	[p8l315t3181r338b3228],
2	personal	JJ	O	personal	amod	3	SENT_196	[p8l314t3061r345b3173],
3	use	NN	O	use	pobj	1	SENT_196	[p8l322t3008r338b3052],
4	only	RB	O	only	advmod	3	SENT_196	[p8l314t2933r345b2998],
5	.	.	O	.	_	0	SENT_196	[p8l314t2933r345b2998],

1	need	NN	O	need	_	0	SENT_197	[p8l543t41r621b70],
2	to	TO	O	to	aux	4	SENT_197	[p8l636t46r667b70],
3	be	VB	O	be	cop	4	SENT_197	[p8l683t41r721b70],
4	able	JJ	O	able	dep	1	SENT_197	[p8l739t41r806b70],
5	to	TO	O	to	_	0	SENT_197	[p8l822t45r853b70],
6	“	CD	NUMBER	“	num	9	SENT_197	[p8l870t41r1005b79],
7	image	NN	O	image	nn	9	SENT_197	[p8l870t41r1005b79],
8	”	NN	O	”	nn	9	SENT_197	[p8l870t41r1005b79],
9	activity	NN	O	activity	prep_to	4	SENT_197	[p8l1023t41r1145b79],
10	of	IN	O	of	_	0	SENT_197	[p8l1162t41r1197b70],
11	drug	NN	O	drug	nn	12	SENT_197	[p8l1211t41r1285b79],
12	transporters	NNS	O	transporter	prep_of	9	SENT_197	[p8l1302t45r1496b79],
13	in	FW	O	in	nn	14	SENT_197	[p8l1513t41r1544b70],
14	vivo	FW	O	vivo	advmod	4	SENT_197	[p8l1560t41r1630b70],
15	using	VBG	O	use	xcomp	4	SENT_197	[p8l1647t41r1735b79],
16	imaging	NN	O	imaging	nn	17	SENT_197	[p8l1752t41r1886b79],
17	agents	NNS	O	agent	dobj	15	SENT_197	[p8l544t95r657b128],
18	,	,	O	,	_	0	SENT_197	[p8l544t95r657b128],
19	such	JJ	O	such	_	0	SENT_197	[p8l672t90r746b119],
20	as	IN	O	as	_	0	SENT_197	[p8l758t99r790b119],
21	99mTc	NN	O	99mtc	prep_such_as	17	SENT_197	[p8l803t84r1087b124],
22	—	CD	NUMBER	—	num	23	SENT_197	[p8l803t84r1087b124],
23	sestamibi	NNS	O	sestamibus	tmod	15	SENT_197	[p8l803t84r1087b124],
24	,	,	O	,	_	0	SENT_197	[p8l803t84r1087b124],
25	which	WDT	O	which	nsubj	27	SENT_197	[p8l1100t90r1201b119],
26	are	VBP	O	be	cop	27	SENT_197	[p8l1214t99r1262b119],
27	substrates	NNS	O	substrate	rcmod	23	SENT_197	[p8l1276t90r1436b119],
28	for	IN	O	for	_	0	SENT_197	[p8l1449t90r1497b119],
29	ABC	NNP	ORGANIZATION	ABC	nn	30	SENT_197	[p8l1508t90r1592b119],
30	transporters	NNS	O	transporter	prep_for	27	SENT_197	[p8l1605t95r1799b128],
31	such	JJ	O	such	_	0	SENT_197	[p8l1813t90r1887b119],
32	as	IN	O	as	_	0	SENT_197	[p8l544t148r575b169],
33	P	NN	O	p	nn	35	SENT_197	[p8l588t139r834b177],
34	—	CD	NUMBER	—	num	35	SENT_197	[p8l588t139r834b177],
35	glycoprotein	NN	O	glycoprotein	prep_such_as	30	SENT_197	[p8l588t139r834b177],
36	(	CD	NUMBER	(	num	35	SENT_197	[p8l846t139r921b175],
37	50	CD	NUMBER	50	num	38	SENT_197	[p8l846t139r921b175],
38	)	NN	O	)	dep	23	SENT_197	[p8l846t139r921b175],
39	.	.	O	.	_	0	SENT_197	[p8l846t139r921b175],

1	One	CD	NUMBER	one	num	2	SENT_198	[p8l593t189r661b218],
2	consequence	NN	O	consequence	nsubj	14	SENT_198	[p8l669t198r879b227],
3	of	IN	O	of	_	0	SENT_198	[p8l888t189r924b218],
4	enumerating	VBG	O	enumerate	prepc_of	2	SENT_198	[p8l929t189r1135b227],
5	the	DT	O	the	det	7	SENT_198	[p8l1143t189r1192b218],
6	Various	JJ	O	various	amod	7	SENT_198	[p8l1201t189r1320b218],
7	transporters	NNS	O	transporter	dobj	4	SENT_198	[p8l1328t194r1522b227],
8	that	WDT	O	that	nsubj	9	SENT_198	[p8l1531t189r1593b218],
9	handle	VBP	O	handle	rcmod	7	SENT_198	[p8l1600t189r1709b218],
10	anticancer	JJ	O	anticancer	amod	11	SENT_198	[p8l1718t189r1888b218],
11	drugs	NNS	O	drug	dobj	9	SENT_198	[p8l543t238r633b276],
12	was	VBD	O	be	cop	14	SENT_198	[p8l643t247r705b268],
13	the	DT	O	the	det	14	SENT_198	[p8l714t238r764b268],
14	discovery	NN	O	discovery	_	0	SENT_198	[p8l773t238r931b276],
15	that	IN	O	that	complm	20	SENT_198	[p8l940t238r1002b268],
16	these	DT	O	these	det	17	SENT_198	[p8l1010t238r1094b268],
17	transporters	NNS	O	transporter	nsubjpass	20	SENT_198	[p8l1103t243r1296b276],
18	are	VBP	O	be	auxpass	20	SENT_198	[p8l1307t247r1355b268],
19	also	RB	O	also	advmod	20	SENT_198	[p8l1365t238r1429b268],
20	involved	VBN	O	involve	ccomp	14	SENT_198	[p8l1438t238r1580b268],
21	in	IN	O	in	_	0	SENT_198	[p8l1588t238r1619b267],
22	pharmacokinetics	NNS	O	pharmacokinetic	prep_in	20	SENT_198	[p8l1627t238r1886b276, p8l543t288r587b317],
23	of	IN	O	of	_	0	SENT_198	[p8l598t288r634b317],
24	many	JJ	O	many	amod	26	SENT_198	[p8l640t297r731b326],
25	different	JJ	O	different	amod	26	SENT_198	[p8l741t288r882b317],
26	drugs	NNS	O	drug	prep_of	22	SENT_198	[p8l891t288r981b326],
27	in	IN	O	in	_	0	SENT_198	[p8l992t288r1023b317],
28	common	JJ	O	common	amod	30	SENT_198	[p8l1033t297r1177b317],
29	clinical	JJ	O	clinical	amod	30	SENT_198	[p8l1186t288r1307b317],
30	use	NN	O	use	prep_in	26	SENT_198	[p8l1317t297r1379b317],
31	.	.	O	.	_	0	SENT_198	[p8l1317t297r1379b317],

1	For	IN	O	for	_	0	SENT_199	[p8l1391t289r1448b317],
2	example	NN	O	example	prep_for	9	SENT_199	[p8l1457t288r1604b326],
3	,	,	O	,	_	0	SENT_199	[p8l1457t288r1604b326],
4	P	NN	O	p	nsubjpass	9	SENT_199	[p8l1615t289r1692b326],
5	—	CD	NUMBER	—	num	6	SENT_199	[p8l1615t289r1692b326],
6	gp	NN	O	gp	dep	4	SENT_199	[p8l1615t289r1692b326],
7	is	VBZ	O	be	auxpass	9	SENT_199	[p8l1702t288r1728b317],
8	normally	RB	O	normally	advmod	9	SENT_199	[p8l1738t288r1887b326],
9	expressed	VBN	O	express	conj_and	9	SENT_199	[p8l543t338r705b376],
10	at	IN	O	at	_	0	SENT_199	[p8l717t342r746b367],
11	high	JJ	O	high	amod	12	SENT_199	[p8l756t338r829b376],
12	levels	NNS	O	level	prep_at	9	SENT_199	[p8l841t338r934b367],
13	in	IN	O	in	_	0	SENT_199	[p8l946t338r977b367],
14	the	DT	O	the	det	15	SENT_199	[p8l989t338r1038b367],
15	mucosa	NN	O	mucosa	prep_in	12	SENT_199	[p8l1050t347r1176b367],
16	of	IN	O	of	_	0	SENT_199	[p8l1187t338r1223b367],
17	the	DT	O	the	det	19	SENT_199	[p8l1231t338r1281b367],
18	GI	NN	O	gi	nn	19	SENT_199	[p8l1293t338r1335b367],
19	tract	NN	O	tract	prep_of	15	SENT_199	[p8l1346t342r1428b373],
20	,	,	O	,	_	0	SENT_199	[p8l1346t342r1428b373],
21	in	IN	O	in	_	0	SENT_199	[p8l1441t338r1472b367],
22	biliary	JJ	O	biliary	amod	24	SENT_199	[p8l1483t338r1590b376],
23	epithelial	JJ	O	epithelial	amod	24	SENT_199	[p8l1602t338r1755b376],
24	cells	NNS	O	cell	prep_in	9	SENT_199	[p8l1767t338r1841b367],
25	of	IN	O	of	_	0	SENT_199	[p8l1854t338r1890b367],
26	the	DT	O	the	det	27	SENT_199	[p8l543t387r592b417],
27	liver	NN	O	liver	prep_of	24	SENT_199	[p8l604t387r685b422],
28	,	,	O	,	_	0	SENT_199	[p8l604t387r685b422],
29	in	IN	O	in	_	0	SENT_199	[p8l698t387r729b416],
30	proximal	JJ	O	proximal	amod	32	SENT_199	[p8l741t387r890b425],
31	tubule	JJ	O	tubule	amod	32	SENT_199	[p8l902t387r1003b417],
32	cells	NNS	O	cell	prep_in	9	SENT_199	[p8l1015t387r1089b417],
33	of	IN	O	of	_	0	SENT_199	[p8l1102t387r1138b417],
34	the	DT	O	the	det	35	SENT_199	[p8l1147t387r1196b417],
35	kidney	NN	O	kidney	prep_of	32	SENT_199	[p8l1208t387r1326b425],
36	,	,	O	,	_	0	SENT_199	[p8l1208t387r1326b425],
37	in	IN	O	in	_	0	SENT_199	[p8l1339t387r1370b416],
38	the	DT	O	the	det	40	SENT_199	[p8l1382t387r1431b417],
39	adrenal	JJ	O	adrenal	amod	40	SENT_199	[p8l1444t387r1564b417],
40	cortex	NN	O	cortex	prep_in	9	SENT_199	[p8l1576t392r1687b422],
41	,	,	O	,	_	0	SENT_199	[p8l1576t392r1687b422],
42	in	IN	O	in	_	0	SENT_199	[p8l1700t387r1731b416],
43	capillary	JJ	O	capillary	amod	45	SENT_199	[p8l1743t387r1887b425],
44	endothelial	JJ	O	endothelial	amod	45	SENT_199	[p8l543t437r726b466],
45	cells	NNS	O	cell	prep_in	40	SENT_199	[p8l736t437r810b466],
46	of	IN	O	of	_	0	SENT_199	[p8l821t437r857b466],
47	the	DT	O	the	det	48	SENT_199	[p8l864t437r913b466],
48	brain	NN	O	brain	prep_of	45	SENT_199	[p8l922t437r1016b472],
49	,	,	O	,	_	0	SENT_199	[p8l922t437r1016b472],
50	testes	NNS	O	testis	prep_of	45	SENT_199	[p8l1027t441r1117b466],
51	and	CC	O	and	_	0	SENT_199	[p8l1128t437r1187b466],
52	ovary	NN	O	ovary	prep_of	45	SENT_199	[p8l1196t446r1294b475],
53	,	,	O	,	_	0	SENT_199	[p8l1196t446r1294b475],
54	and	CC	O	and	_	0	SENT_199	[p8l1306t437r1364b466],
55	in	IN	O	in	_	0	SENT_199	[p8l1373t437r1405b466],
56	the	DT	O	the	det	57	SENT_199	[p8l1414t437r1464b466],
57	placenta	NN	O	placenta	prep_in	9	SENT_199	[p8l1473t437r1619b475],
58	.	.	O	.	_	0	SENT_199	[p8l1473t437r1619b475],

1	These	DT	O	these	det	2	SENT_200	[p8l1631t437r1728b466],
2	locations	NNS	O	location	nsubj	3	SENT_200	[p8l1738t437r1886b466],
3	argue	VBP	O	argue	conj_and	3	SENT_200	[p8l544t495r633b524],
4	for	IN	O	for	_	0	SENT_200	[p8l644t486r692b515],
5	a	DT	O	a	det	6	SENT_200	[p8l703t495r720b515],
6	role	NN	O	role	prep_for	3	SENT_200	[p8l730t486r793b515],
7	of	IN	O	of	_	0	SENT_200	[p8l805t486r841b515],
8	P	NN	O	p	nn	10	SENT_200	[p8l848t487r925b524],
9	—	CD	NUMBER	—	num	10	SENT_200	[p8l848t487r925b524],
10	gp	NN	O	gp	prep_of	6	SENT_200	[p8l848t487r925b524],
11	in	IN	O	in	_	0	SENT_200	[p8l937t486r968b515],
12	excretion	NN	O	excretion	prep_in	10	SENT_200	[p8l979t486r1131b515],
13	of	IN	O	of	_	0	SENT_200	[p8l1143t486r1178b515],
14	drugs	NNS	O	drug	prep_of	12	SENT_200	[p8l1187t486r1276b524],
15	from	IN	O	from	_	0	SENT_200	[p8l1288t486r1368b515],
16	intestine	NN	O	intestine	prep_from	3	SENT_200	[p8l1378t486r1527b521],
17	,	,	O	,	_	0	SENT_200	[p8l1378t486r1527b521],
18	liver	NN	O	liver	conj_and	16	SENT_200	[p8l1539t486r1620b521],
19	,	,	O	,	_	0	SENT_200	[p8l1539t486r1620b521],
20	and	CC	O	and	_	0	SENT_200	[p8l1633t486r1691b515],
21	kidney	NN	O	kidney	conj_and	16	SENT_200	[p8l1701t486r1813b524],
22	into	IN	O	into	_	0	SENT_200	[p8l1824t486r1887b515],
23	stool	NN	O	stool	prep_into	16	SENT_200	[p8l544t535r631b570],
24	,	,	O	,	_	0	SENT_200	[p8l544t535r631b570],
25	bile	NN	O	bile	conj_and	23	SENT_200	[p8l646t535r707b565],
26	and	CC	O	and	_	0	SENT_200	[p8l721t535r780b565],
27	urine	NN	O	urine	conj_and	23	SENT_200	[p8l792t535r887b570],
28	;	:	O	;	_	0	SENT_200	[p8l792t535r887b570],
29	in	IN	O	in	_	0	SENT_200	[p8l902t535r933b564],
30	blocking	VBG	O	block	prepc_in	16	SENT_200	[p8l945t535r1090b573],
31	absorption	NN	O	absorption	dobj	30	SENT_200	[p8l1104t535r1278b573],
32	of	IN	O	of	_	0	SENT_200	[p8l1291t535r1327b565],
33	drugs	NNS	O	drug	prep_of	31	SENT_200	[p8l1338t535r1428b573],
34	from	IN	O	from	_	0	SENT_200	[p8l1442t535r1522b565],
35	the	DT	O	the	det	37	SENT_200	[p8l1535t535r1584b565],
36	GI	NN	O	gi	nn	37	SENT_200	[p8l1598t535r1640b565],
37	tract	NN	O	tract	prep_from	30	SENT_200	[p8l1653t540r1736b570],
38	;	:	O	;	_	0	SENT_200	[p8l1653t540r1736b570],
39	and	CC	O	and	_	0	SENT_200	[p8l1752t535r1810b565],
40	as	IN	O	as	_	0	SENT_200	[p8l1824t544r1856b565],
41	a	DT	O	a	det	42	SENT_200	[p8l1870t544r1888b565],
42	barrier	NN	O	barrier	prep_as	3	SENT_200	[p8l542t584r653b613],
43	to	TO	O	to	aux	44	SENT_200	[p8l664t589r695b613],
44	transport	VB	O	transport	infmod	42	SENT_200	[p8l707t589r854b622],
45	into	IN	O	into	_	0	SENT_200	[p8l864t584r928b613],
46	brain	NN	O	brain	prep_into	44	SENT_200	[p8l939t584r1033b619],
47	,	,	O	,	_	0	SENT_200	[p8l939t584r1033b619],
48	testes	NNS	O	testis	prep_into	44	SENT_200	[p8l1046t589r1146b619],
49	,	,	O	,	_	0	SENT_200	[p8l1046t589r1146b619],
50	ovary	NN	O	ovary	prep_into	44	SENT_200	[p8l1159t594r1257b622],
51	,	,	O	,	_	0	SENT_200	[p8l1159t594r1257b622],
52	and	CC	O	and	_	0	SENT_200	[p8l1270t584r1329b613],
53	the	DT	O	the	det	54	SENT_200	[p8l1340t584r1389b613],
54	fetus	NN	O	fetus	conj_and	46	SENT_200	[p8l1401t584r1480b613],
55	(	CD	NUMBER	(	number	56	SENT_200	[p8l1493t585r1568b620],
56	23	CD	NUMBER	23	num	57	SENT_200	[p8l1493t585r1568b620],
57	)	NN	O	)	dep	54	SENT_200	[p8l1493t585r1568b620],
58	.	.	O	.	_	0	SENT_200	[p8l1493t585r1568b620],

1	The	DT	O	the	det	2	SENT_201	[p8l593t634r656b663],
2	generation	NN	O	generation	_	0	SENT_201	[p8l667t634r841b672],
3	of	IN	O	of	_	0	SENT_201	[p8l852t634r888b663],
4	a	DT	O	a	det	5	SENT_201	[p8l897t643r914b663],
5	mouse	NN	O	mouse	prep_of	2	SENT_201	[p8l924t643r1031b663],
6	lacking	VBG	O	lack	partmod	5	SENT_201	[p8l1042t634r1163b672],
7	mdrla	NN	O	mdrlum	dobj	6	SENT_201	[p8l1173t634r1279b663],
8	and	CC	O	and	_	0	SENT_201	[p8l1290t634r1348b663],
9	mdrlb	NN	O	mdrlb	dobj	6	SENT_201	[p8l1359t634r1466b663],
10	by	IN	O	by	_	0	SENT_201	[p8l1476t634r1517b672],
11	insertional	JJ	O	insertional	amod	13	SENT_201	[p8l1528t634r1702b663],
12	mutagene	JJ	O	mutagene	amod	13	SENT_201	[p8l1713t639r1886b672],
13	—	NN	O	—	agent	6	SENT_201	[p8l1713t639r1886b672],

1	sis	NN	O	si	nsubj	2	SENT_202	[p8l544t704r585b734],
2	demonstrated	VBD	O	demonstrate	_	0	SENT_202	[p8l596t705r818b734],
3	that	IN	O	that	complm	11	SENT_202	[p8l828t705r890b734],
4	loss	NN	O	loss	nsubj	11	SENT_202	[p8l899t705r961b734],
5	of	IN	O	of	_	0	SENT_202	[p8l972t704r1008b734],
6	P	NN	O	p	nn	8	SENT_202	[p8l1015t705r1092b742],
7	—	CD	NUMBER	—	num	8	SENT_202	[p8l1015t705r1092b742],
8	gp	NN	O	gp	prep_of	4	SENT_202	[p8l1015t705r1092b742],
9	was	VBD	O	be	cop	11	SENT_202	[p8l1102t714r1164b734],
10	not	RB	O	not	neg	11	SENT_202	[p8l1175t709r1227b734],
11	lethal	JJ	O	lethal	ccomp	2	SENT_202	[p8l1236t704r1327b734],
12	to	TO	O	to	_	0	SENT_202	[p8l1337t709r1368b734],
13	the	DT	O	the	det	14	SENT_202	[p8l1378t705r1427b734],
14	animals	NNS	O	animal	prep_to	11	SENT_202	[p8l1438t704r1574b739],
15	,	,	O	,	_	0	SENT_202	[p8l1438t704r1574b739],
16	but	CC	O	but	_	0	SENT_202	[p8l1585t705r1637b734],
17	they	PRP	O	they	nsubj	20	SENT_202	[p8l1646t704r1716b742],
18	were	VBD	O	be	cop	20	SENT_202	[p8l1726t714r1805b734],
19	Very	RB	O	very	advmod	20	SENT_202	[p8l1815t714r1887b742],
20	susceptible	JJ	O	susceptible	conj_but	2	SENT_202	[p8l544t754r726b792],
21	to	TO	O	to	_	0	SENT_202	[p8l739t759r770b783],
22	toxic	JJ	O	toxic	amod	23	SENT_202	[p8l783t754r864b783],
23	effects	NNS	O	effect	prep_to	20	SENT_202	[p8l878t754r985b783],
24	of	IN	O	of	_	0	SENT_202	[p8l999t754r1035b783],
25	many	JJ	O	many	amod	27	SENT_202	[p8l1045t764r1135b792],
26	different	JJ	O	different	amod	27	SENT_202	[p8l1149t754r1290b783],
27	drugs	NNS	O	drug	prep_of	23	SENT_202	[p8l1302t754r1392b792],
28	because	IN	O	because	_	0	SENT_202	[p8l1405t754r1536b783],
29	of	IN	O	of	_	0	SENT_202	[p8l1549t754r1585b783],
30	increased	VBN	O	increase	amod	31	SENT_202	[p8l1595t754r1751b783],
31	absorption	NN	O	absorption	prep_because_of	20	SENT_202	[p8l1764t754r1886b792, p8l543t804r607b833],
32	and	CC	O	and	_	0	SENT_202	[p8l617t804r675b833],
33	neurotoxicity	NN	O	neurotoxicity	prep_because_of	20	SENT_202	[p8l685t804r905b842],
34	(	CD	NUMBER	(	number	35	SENT_202	[p8l916t804r991b840],
35	51	CD	NUMBER	51	num	36	SENT_202	[p8l916t804r991b840],
36	)	NN	O	)	dep	33	SENT_202	[p8l916t804r991b840],
37	.	.	O	.	_	0	SENT_202	[p8l916t804r991b840],

1	Studies	NNS	O	study	nsubj	12	SENT_203	[p8l1004t804r1123b833],
2	with	IN	O	with	_	0	SENT_203	[p8l1134t804r1206b833],
3	mice	NNS	O	mouse	prep_with	1	SENT_203	[p8l1216t804r1295b833],
4	deﬁcient	JJ	O	deﬁcient	amod	3	SENT_203	[p8l1305t804r1448b833],
5	in	IN	O	in	_	0	SENT_203	[p8l1456t804r1488b833],
6	mdrla/mdrlb	NN	O	mdrla/mdrlb	prep_in	4	SENT_203	[p8l1497t804r1722b833],
7	and	CC	O	and	_	0	SENT_203	[p8l1733t804r1791b833],
8	mrpl	NN	O	mrpl	prep_in	4	SENT_203	[p8l1800t804r1883b842],
9	and	CC	O	and	_	0	SENT_203	[p8l544t854r602b883],
10	cell	NN	O	cell	nn	11	SENT_203	[p8l617t854r675b883],
11	lines	NNS	O	line	prep_in	4	SENT_203	[p8l690t854r767b883],
12	derived	VBN	O	derive	_	0	SENT_203	[p8l783t854r905b883],
13	from	IN	O	from	_	0	SENT_203	[p8l919t854r999b883],
14	these	DT	O	these	det	19	SENT_203	[p8l1013t854r1097b883],
15	triple	JJ	O	triple	amod	19	SENT_203	[p8l1112t854r1199b892],
16	knockout	JJ	O	knockout	amod	19	SENT_203	[p8l1213t854r1367b883],
17	[	NN	O	[	nn	19	SENT_203	[p8l1384t854r1666b890],
18	mdrla/1b	NN	O	mdrla/1b	nn	19	SENT_203	[p8l1384t854r1666b890],
19	(	NN	O	(	prep_from	12	SENT_203	[p8l1384t854r1666b890],
20	.	.	O	.	_	0	SENT_203	[p8l1384t854r1666b890],

1	—	NN	O	—	_	0	SENT_204	[p8l1384t854r1666b890],
2	.	.	O	.	_	0	SENT_204	[p8l1384t854r1666b890],

1	/	:	O	/	_	0	SENT_205	[p8l1384t854r1666b890],
2	.	.	O	.	_	0	SENT_205	[p8l1384t854r1666b890],

1	—	NN	O	—	_	0	SENT_206	[p8l1384t854r1666b890],
2	.	.	O	.	_	0	SENT_206	[p8l1384t854r1666b890],
3	)	SYM	O	)	dep	1	SENT_206	[p8l1384t854r1666b890],

1	,	,	O	,	_	0	SENT_207	[p8l1384t854r1666b890],
2	mrpl	NN	O	mrpl	nn	3	SENT_207	[p8l1683t854r1884b891],
3	(	NN	O	(	_	0	SENT_207	[p8l1683t854r1884b891],
4	.	.	O	.	_	0	SENT_207	[p8l1683t854r1884b891],

1	—	NN	O	—	_	0	SENT_208	[p8l1683t854r1884b891],
2	.	.	O	.	_	0	SENT_208	[p8l1683t854r1884b891],

1	/	:	O	/	_	0	SENT_209	[p8l1683t854r1884b891],
2	.	.	O	.	_	0	SENT_209	[p8l1683t854r1884b891],

1	—	NN	O	—	dep	4	SENT_210	[p8l1683t854r1884b891],
2	.	.	O	.	_	0	SENT_210	[p8l1683t854r1884b891],
3	)	CD	NUMBER	)	dep	4	SENT_210	[p8l1683t854r1884b891],
4	]	CD	NUMBER	]	_	0	SENT_210	[p8l1683t854r1884b891],

1	mice	NNS	O	mouse	nsubj	2	SENT_211	[p8l543t904r622b933],
2	indicate	VBP	O	indicate	_	0	SENT_211	[p8l635t904r765b933],
3	that	IN	O	that	complm	10	SENT_211	[p8l777t904r839b933],
4	P	NN	O	p	nn	6	SENT_211	[p8l850t904r927b941],
5	—	CD	NUMBER	—	num	6	SENT_211	[p8l850t904r927b941],
6	gp	NN	O	gp	nsubj	10	SENT_211	[p8l850t904r927b941],
7	and	CC	O	and	_	0	SENT_211	[p8l940t904r998b933],
8	MRP1	NN	O	mrp1	nn	9	SENT_211	[p8l1010t904r1114b932],
9	transporters	NNS	O	transporter	nsubj	10	SENT_211	[p8l1129t908r1323b941],
10	contribute	VBP	O	contribute	ccomp	2	SENT_211	[p8l1336t904r1502b933],
11	signiﬁcantly	RB	O	signiﬁcantly	advmod	10	SENT_211	[p8l1516t904r1718b941],
12	to	TO	O	to	_	0	SENT_211	[p8l1730t908r1761b933],
13	the	DT	O	the	det	14	SENT_211	[p8l1773t904r1823b933],
14	development	NN	O	development	prep_to	10	SENT_211	[p8l1836t904r1886b933, p8l543t954r717b991],
15	of	IN	O	of	_	0	SENT_211	[p8l730t953r766b983],
16	resistance	NN	O	resistance	prep_of	14	SENT_211	[p8l775t953r938b983],
17	to	TO	O	to	_	0	SENT_211	[p8l951t958r982b983],
18	paclitaxel	NN	O	paclitaxel	nn	21	SENT_211	[p8l994t953r1154b991],
19	(	CD	NUMBER	(	num	21	SENT_211	[p8l1169t954r1286b989],
20	taxol	NN	O	taxol	nn	21	SENT_211	[p8l1169t954r1286b989],
21	)	NN	O	)	prep_to	10	SENT_211	[p8l1169t954r1286b989],
22	,	,	O	,	_	0	SENT_211	[p8l1169t954r1286b989],
23	anthracyclines	NNS	O	anthracycline	appos	21	SENT_211	[p8l1301t953r1547b991],
24	,	,	O	,	_	0	SENT_211	[p8l1301t953r1547b991],
25	and	CC	O	and	_	0	SENT_211	[p8l1562t954r1620b983],
26	Vinca	NNP	PERSON	Vinca	nn	27	SENT_211	[p8l1635t955r1725b983],
27	alkaloids	NNS	O	alkaloid	nsubj	28	SENT_211	[p8l1739t953r1886b983],
28	(	VBP	O	(	conj_and	2	SENT_211	[p8l544t1003r619b1039],
29	52	CD	NUMBER	52	num	30	SENT_211	[p8l544t1003r619b1039],
30	)	CD	NUMBER	)	dobj	28	SENT_211	[p8l544t1003r619b1039],
31	.	.	O	.	_	0	SENT_211	[p8l544t1003r619b1039],

1	In	IN	O	in	_	0	SENT_212	[p8l635t1004r668b1032],
2	addition	NN	O	addition	prep_in	15	SENT_212	[p8l683t1003r826b1037],
3	,	,	O	,	_	0	SENT_212	[p8l683t1003r826b1037],
4	exposure	NN	O	exposure	nsubj	15	SENT_212	[p8l841t1012r989b1041],
5	of	IN	O	of	_	0	SENT_212	[p8l1003t1003r1039b1032],
6	these	DT	O	these	det	9	SENT_212	[p8l1050t1003r1134b1032],
7	triple	JJ	O	triple	amod	9	SENT_212	[p8l1147t1003r1234b1041],
8	knockout	JJ	O	knockout	amod	9	SENT_212	[p8l1247t1003r1401b1032],
9	mice	NNS	O	mouse	prep_of	4	SENT_212	[p8l1414t1003r1493b1032],
10	to	TO	O	to	_	0	SENT_212	[p8l1507t1007r1538b1032],
11	therapeutic	JJ	O	therapeutic	amod	12	SENT_212	[p8l1552t1003r1735b1041],
12	doses	NNS	O	dose	prep_to	9	SENT_212	[p8l1749t1003r1839b1032],
13	of	IN	O	of	_	0	SENT_212	[p8l1854t1003r1890b1032],
14	vincristine	NN	O	vincristine	prep_of	12	SENT_212	[p8l543t1053r717b1082],
15	resulted	VBD	O	result	_	0	SENT_212	[p8l726t1053r857b1082],
16	in	IN	O	in	_	0	SENT_212	[p8l866t1053r897b1082],
17	severe	JJ	O	severe	amod	18	SENT_212	[p8l908t1062r1009b1082],
18	damage	NN	O	damage	prep_in	15	SENT_212	[p8l1019t1053r1147b1091],
19	to	TO	O	to	_	0	SENT_212	[p8l1156t1057r1187b1082],
20	bone	NN	O	bone	nn	21	SENT_212	[p8l1196t1053r1276b1082],
21	marrow	NN	O	marrow	prep_to	15	SENT_212	[p8l1285t1062r1412b1082],
22	and	CC	O	and	_	0	SENT_212	[p8l1422t1053r1481b1082],
23	gastrointestinal	JJ	O	gastrointestinal	amod	24	SENT_212	[p8l1490t1053r1742b1091],
24	mucosa	NN	O	mucosa	conj_and	21	SENT_212	[p8l1751t1062r1886b1087],
25	,	,	O	,	_	0	SENT_212	[p8l1751t1062r1886b1087],
26	indicating	VBG	O	indicate	xcomp	15	SENT_212	[p8l543t1103r708b1141],
27	that	IN	O	that	complm	35	SENT_212	[p8l717t1103r779b1132],
28	both	DT	O	both	det	31	SENT_212	[p8l788t1103r861b1132],
29	P	NN	O	p	nn	31	SENT_212	[p8l870t1103r947b1141],
30	—	CD	NUMBER	—	num	31	SENT_212	[p8l870t1103r947b1141],
31	gp	NN	O	gp	nsubj	35	SENT_212	[p8l870t1103r947b1141],
32	and	CC	O	and	_	0	SENT_212	[p8l958t1103r1016b1132],
33	MRP1	NN	O	mrp1	nsubj	35	SENT_212	[p8l1025t1103r1128b1132],
34	are	VBP	O	be	cop	35	SENT_212	[p8l1143t1112r1191b1132],
35	compensatory	JJ	O	compensatory	ccomp	26	SENT_212	[p8l1201t1107r1432b1141],
36	transporters	NNS	O	transporter	nsubj	43	SENT_212	[p8l1442t1107r1636b1141],
37	for	IN	O	for	_	0	SENT_212	[p8l1646t1103r1694b1132],
38	Vinca	NNP	LOCATION	Vinca	nn	39	SENT_212	[p8l1705t1104r1795b1132],
39	alkaloids	NNS	O	alkaloid	prep_for	36	SENT_212	[p8l1806t1103r1886b1132, p8l543t1153r622b1182],
40	in	IN	O	in	_	0	SENT_212	[p8l632t1153r663b1182],
41	these	DT	O	these	det	42	SENT_212	[p8l672t1153r756b1182],
42	tissues	NNS	O	tissue	prep_in	39	SENT_212	[p8l765t1153r874b1182],
43	(	VBP	O	(	ccomp	35	SENT_212	[p8l885t1153r960b1189],
44	53	CD	NUMBER	53	num	45	SENT_212	[p8l885t1153r960b1189],
45	)	CD	NUMBER	)	dobj	43	SENT_212	[p8l885t1153r960b1189],
46	.	.	O	.	_	0	SENT_212	[p8l885t1153r960b1189],

1	These	DT	O	these	det	2	SENT_213	[p8l971t1153r1069b1182],
2	results	NNS	O	result	nsubj	3	SENT_213	[p8l1078t1153r1185b1182],
3	suggest	VBP	O	suggest	_	0	SENT_213	[p8l1196t1157r1319b1190],
4	that	IN	O	that	complm	12	SENT_213	[p8l1327t1153r1389b1182],
5	P	NN	O	p	nn	7	SENT_213	[p8l1397t1153r1474b1191],
6	—	CD	NUMBER	—	num	7	SENT_213	[p8l1397t1153r1474b1191],
7	gp	NN	O	gp	nsubj	12	SENT_213	[p8l1397t1153r1474b1191],
8	and	CC	O	and	_	0	SENT_213	[p8l1484t1153r1543b1182],
9	MRP1	NN	O	mrp1	nsubj	12	SENT_213	[p8l1551t1153r1655b1182],
10	are	VBP	O	be	cop	12	SENT_213	[p8l1669t1162r1717b1182],
11	important	JJ	O	important	amod	12	SENT_213	[p8l1727t1153r1888b1191],
12	determinants	NNS	O	determinant	ccomp	3	SENT_213	[p8l543t1203r755b1232],
13	of	IN	O	of	_	0	SENT_213	[p8l772t1202r808b1232],
14	the	DT	O	the	det	15	SENT_213	[p8l820t1203r869b1232],
15	pharmacokinetics	NNS	O	pharmacokinetic	prep_of	12	SENT_213	[p8l884t1202r1175b1240],
16	of	IN	O	of	_	0	SENT_213	[p8l1191t1202r1227b1232],
17	many	JJ	O	many	amod	19	SENT_213	[p8l1239t1212r1329b1240],
18	different	JJ	O	different	amod	19	SENT_213	[p8l1345t1202r1486b1232],
19	drugs	NNS	O	drug	prep_of	15	SENT_213	[p8l1501t1203r1600b1240],
20	,	,	O	,	_	0	SENT_213	[p8l1501t1203r1600b1240],
21	and	CC	O	and	cc	12	SENT_213	[p8l1617t1203r1676b1232],
22	further	RB	O	further	advmod	12	SENT_213	[p8l1690t1202r1810b1237],
23	,	,	O	,	_	0	SENT_213	[p8l1690t1202r1810b1237],
24	that	IN	O	that	dep	35	SENT_213	[p8l1826t1203r1888b1232],
25	inhibitors	NNS	O	inhibitor	nsubjpass	35	SENT_213	[p8l543t1253r700b1282],
26	of	IN	O	of	_	0	SENT_213	[p8l710t1253r746b1282],
27	P	NN	O	p	nn	29	SENT_213	[p8l751t1254r828b1291],
28	—	CD	NUMBER	—	num	29	SENT_213	[p8l751t1254r828b1291],
29	gp	NN	O	gp	prep_of	25	SENT_213	[p8l751t1254r828b1291],
30	and	CC	O	and	_	0	SENT_213	[p8l838t1253r896b1282],
31	possibly	RB	O	possibly	advmod	32	SENT_213	[p8l904t1253r1041b1291],
32	MRP1	NN	O	mrp1	prep_of	25	SENT_213	[p8l1050t1253r1154b1282],
33	can	MD	O	can	aux	35	SENT_213	[p8l1166t1262r1222b1282],
34	be	VB	O	be	auxpass	35	SENT_213	[p8l1230t1253r1268b1282],
35	used	VBN	O	use	ccomp	12	SENT_213	[p8l1277t1253r1353b1282],
36	to	TO	O	to	aux	37	SENT_213	[p8l1361t1257r1391b1282],
37	enhance	VB	O	enhance	ccomp	35	SENT_213	[p8l1401t1253r1535b1282],
38	uptake	NN	O	uptake	dobj	37	SENT_213	[p8l1543t1253r1652b1291],
39	of	IN	O	of	_	0	SENT_213	[p8l1662t1253r1697b1282],
40	these	DT	O	these	det	41	SENT_213	[p8l1703t1253r1787b1282],
41	drugs	NNS	O	drug	prep_of	38	SENT_213	[p8l1796t1253r1886b1291],
42	that	WDT	O	that	nsubjpass	44	SENT_213	[p8l543t1303r605b1332],
43	are	VBP	O	be	auxpass	44	SENT_213	[p8l615t1312r663b1332],
44	given	VBN	O	give	rcmod	41	SENT_213	[p8l674t1303r763b1340],
45	orally	RB	O	orally	advmod	44	SENT_213	[p8l773t1303r868b1340],
46	and	CC	O	and	_	0	SENT_213	[p8l879t1303r938b1332],
47	perhaps	RB	O	perhaps	advmod	37	SENT_213	[p8l947t1303r1074b1340],
48	to	TO	O	to	aux	49	SENT_213	[p8l1085t1307r1116b1332],
49	inﬂuence	VB	O	inﬂuence	ccomp	35	SENT_213	[p8l1126t1303r1277b1332],
50	their	PRP$	O	they	poss	51	SENT_213	[p8l1287t1303r1363b1332],
51	penetration	NN	O	penetration	dobj	49	SENT_213	[p8l1371t1303r1558b1340],
52	into	IN	O	into	_	0	SENT_213	[p8l1567t1303r1631b1332],
53	the	DT	O	the	det	56	SENT_213	[p8l1641t1303r1690b1332],
54	central	JJ	O	central	amod	56	SENT_213	[p8l1701t1303r1812b1332],
55	nervous	JJ	O	nervous	amod	56	SENT_213	[p8l1822t1312r1886b1332, p8l543t1361r619b1381],
56	system	NN	O	system	prep_into	49	SENT_213	[p8l629t1357r750b1390],
57	.	.	O	.	_	0	SENT_213	[p8l629t1357r750b1390],

1	Evidence	NN	O	evidence	nsubjpass	30	SENT_214	[p8l761t1352r914b1381],
2	that	WDT	O	that	dobj	6	SENT_214	[p8l923t1352r985b1381],
3	P	NN	O	p	nsubj	6	SENT_214	[p8l992t1353r1070b1390],
4	—	CD	NUMBER	—	num	5	SENT_214	[p8l992t1353r1070b1390],
5	gp	NN	O	gp	dep	3	SENT_214	[p8l992t1353r1070b1390],
6	serves	VBZ	O	serve	rcmod	1	SENT_214	[p8l1080t1361r1180b1381],
7	a	DT	O	a	det	9	SENT_214	[p8l1190t1361r1207b1381],
8	normal	JJ	O	normal	amod	9	SENT_214	[p8l1215t1352r1331b1381],
9	role	NN	O	role	dobj	6	SENT_214	[p8l1339t1352r1403b1381],
10	in	IN	O	in	_	0	SENT_214	[p8l1412t1352r1443b1381],
11	the	DT	O	the	det	13	SENT_214	[p8l1451t1352r1501b1381],
12	physiological	JJ	O	physiological	amod	13	SENT_214	[p8l1509t1352r1732b1390],
13	transport	NN	O	transport	prep_in	6	SENT_214	[p8l1741t1357r1888b1390],
14	of	IN	O	of	_	0	SENT_214	[p8l544t1402r579b1431],
15	opioid	JJ	O	opioid	amod	16	SENT_214	[p8l590t1402r695b1440],
16	compounds	NNS	O	compound	prep_of	13	SENT_214	[p8l707t1402r896b1440],
17	out	IN	O	out	_	0	SENT_214	[p8l911t1406r963b1431],
18	of	IN	O	of	_	0	SENT_214	[p8l975t1402r1011b1431],
19	the	DT	O	the	det	22	SENT_214	[p8l1021t1402r1070b1431],
20	central	JJ	O	central	amod	22	SENT_214	[p8l1084t1402r1195b1431],
21	nervous	JJ	O	nervous	amod	22	SENT_214	[p8l1208t1411r1337b1431],
22	system	NN	O	system	prep_out_of	6	SENT_214	[p8l1352t1407r1465b1440],
23	into	IN	O	into	_	0	SENT_214	[p8l1477t1402r1540b1431],
24	the	DT	O	the	det	25	SENT_214	[p8l1554t1402r1603b1431],
25	bloodstream	NN	O	bloodstream	prep_into	6	SENT_214	[p8l1615t1402r1821b1431],
26	has	VBZ	O	have	aux	30	SENT_214	[p8l1833t1402r1886b1431],
27	also	RB	O	also	advmod	30	SENT_214	[p8l544t1452r608b1481],
28	recently	RB	DATE	recently	advmod	30	SENT_214	[p8l620t1452r753b1489],
29	been	VBN	O	be	auxpass	30	SENT_214	[p8l765t1452r842b1481],
30	reported	VBN	O	report	_	0	SENT_214	[p8l854t1452r992b1489],
31	(	CD	NUMBER	(	number	32	SENT_214	[p8l1004t1452r1079b1488],
32	54	CD	NUMBER	54	num	33	SENT_214	[p8l1004t1452r1079b1488],
33	)	NN	O	)	dobj	30	SENT_214	[p8l1004t1452r1079b1488],
34	.	.	O	.	_	0	SENT_214	[p8l1004t1452r1079b1488],

1	Recent	JJ	O	recent	amod	2	SENT_215	[p8l1093t1452r1208b1481],
2	data	NNS	O	datum	nsubj	4	SENT_215	[p8l1220t1452r1288b1481],
3	also	RB	O	also	advmod	4	SENT_215	[p8l1300t1452r1365b1481],
4	suggest	VBP	O	suggest	_	0	SENT_215	[p8l1378t1456r1501b1489],
5	that	IN	O	that	complm	17	SENT_215	[p8l1512t1452r1574b1481],
6	a	DT	O	a	det	8	SENT_215	[p8l1586t1461r1603b1481],
7	noncoding	JJ	O	noncoding	amod	8	SENT_215	[p8l1614t1452r1788b1489],
8	polymorphism	NN	O	polymorphism	nsubjpass	17	SENT_215	[p8l1800t1452r1886b1489, p8l543t1501r711b1539],
9	in	IN	O	in	_	0	SENT_215	[p8l722t1501r753b1530],
10	the	DT	O	the	det	11	SENT_215	[p8l764t1501r814b1530],
11	P	NN	O	p	prep_in	8	SENT_215	[p8l825t1502r902b1539],
12	—	CD	NUMBER	—	num	14	SENT_215	[p8l825t1502r902b1539],
13	gp	NN	O	gp	nn	14	SENT_215	[p8l825t1502r902b1539],
14	gene	NN	O	gene	dep	11	SENT_215	[p8l914t1510r991b1539],
15	is	VBZ	O	be	auxpass	17	SENT_215	[p8l1002t1501r1028b1530],
16	closely	RB	O	closely	advmod	17	SENT_215	[p8l1040t1501r1156b1539],
17	linked	VBN	O	link	ccomp	4	SENT_215	[p8l1168t1501r1271b1530],
18	to	TO	O	to	_	0	SENT_215	[p8l1282t1506r1312b1530],
19	levels	NNS	O	level	prep_to	17	SENT_215	[p8l1324t1501r1417b1530],
20	of	IN	O	of	_	0	SENT_215	[p8l1430t1501r1466b1530],
21	expression	NN	O	expression	prep_of	19	SENT_215	[p8l1475t1501r1650b1539],
22	of	IN	O	of	_	0	SENT_215	[p8l1662t1501r1698b1530],
23	P	NN	O	p	nn	25	SENT_215	[p8l1706t1502r1783b1539],
24	—	CD	NUMBER	—	num	25	SENT_215	[p8l1706t1502r1783b1539],
25	gp	NN	O	gp	prep_of	21	SENT_215	[p8l1706t1502r1783b1539],
26	in	IN	O	in	_	0	SENT_215	[p8l1795t1501r1826b1530],
27	the	DT	O	the	det	29	SENT_215	[p8l1837t1501r1887b1530],
28	GI	NN	O	gi	nn	29	SENT_215	[p8l544t1551r586b1580],
29	tract	NN	O	tract	prep_in	17	SENT_215	[p8l598t1555r680b1585],
30	,	,	O	,	_	0	SENT_215	[p8l598t1555r680b1585],
31	which	WDT	O	which	nsubj	32	SENT_215	[p8l694t1551r794b1580],
32	results	VBZ	O	result	rcmod	29	SENT_215	[p8l807t1551r913b1580],
33	in	IN	O	in	_	0	SENT_215	[p8l927t1551r958b1580],
34	alterations	NNS	O	alteration	prep_in	32	SENT_215	[p8l971t1551r1142b1580],
35	in	IN	O	in	_	0	SENT_215	[p8l1155t1551r1186b1580],
36	absorption	NN	O	absorption	prep_in	34	SENT_215	[p8l1200t1551r1373b1589],
37	of	IN	O	of	_	0	SENT_215	[p8l1386t1551r1422b1580],
38	commonly	RB	O	commonly	advmod	39	SENT_215	[p8l1432t1551r1608b1589],
39	used	VBN	O	use	amod	40	SENT_215	[p8l1621t1551r1696b1580],
40	drugs	NNS	O	drug	prep_of	36	SENT_215	[p8l1709t1551r1799b1589],
41	such	JJ	O	such	_	0	SENT_215	[p8l1813t1551r1887b1580],
42	as	IN	O	as	_	0	SENT_215	[p8l544t1610r576b1630],
43	digoxin	NN	O	digoxin	prep_such_as	40	SENT_215	[p8l587t1601r712b1638],
44	(	CD	NUMBER	(	num	43	SENT_215	[p8l723t1601r798b1637],
45	55	CD	NUMBER	55	num	46	SENT_215	[p8l723t1601r798b1637],
46	)	NN	O	)	dep	43	SENT_215	[p8l723t1601r798b1637],
47	.	.	O	.	_	0	SENT_215	[p8l723t1601r798b1637],

1	It	PRP	O	it	nsubjpass	3	SENT_216	[p8l810t1601r835b1630],
2	is	VBZ	O	be	auxpass	3	SENT_216	[p8l845t1601r870b1630],
3	assumed	VBN	O	assume	_	0	SENT_216	[p8l882t1601r1023b1630],
4	that	IN	O	that	complm	19	SENT_216	[p8l1033t1601r1095b1630],
5	pharmacogenomic	JJ	O	pharmacogenomic	amod	6	SENT_216	[p8l1103t1601r1409b1638],
6	analysis	NN	O	analysis	nsubj	19	SENT_216	[p8l1420t1601r1551b1638],
7	of	IN	O	of	_	0	SENT_216	[p8l1562t1601r1598b1630],
8	other	JJ	O	other	amod	10	SENT_216	[p8l1606t1601r1690b1630],
9	ABC	NNP	ORGANIZATION	ABC	nn	10	SENT_216	[p8l1699t1601r1783b1630],
10	transporters	NNS	O	transporter	prep_of	6	SENT_216	[p8l1793t1605r1886b1630, p8l542t1655r666b1688],
11	,	,	O	,	_	0	SENT_216	[p8l1793t1605r1886b1630, p8l542t1655r666b1688],
12	such	JJ	O	such	_	0	SENT_216	[p8l680t1651r754b1680],
13	as	IN	O	as	_	0	SENT_216	[p8l766t1660r798b1680],
14	the	DT	O	the	det	16	SENT_216	[p8l810t1651r860b1680],
15	MRP	NN	O	mrp	nn	16	SENT_216	[p8l871t1651r958b1679],
16	family	NN	O	family	prep_such_as	6	SENT_216	[p8l969t1650r1082b1688],
17	,	,	O	,	_	0	SENT_216	[p8l969t1650r1082b1688],
18	will	MD	O	will	aux	19	SENT_216	[p8l1095t1650r1158b1680],
19	reveal	VB	O	reveal	ccomp	3	SENT_216	[p8l1169t1651r1268b1680],
20	similarly	RB	O	similarly	advmod	21	SENT_216	[p8l1281t1650r1426b1688],
21	important	JJ	O	important	amod	22	SENT_216	[p8l1438t1650r1599b1688],
22	roles	NNS	O	role	dobj	19	SENT_216	[p8l1609t1651r1688b1680],
23	in	IN	O	in	_	0	SENT_216	[p8l1700t1650r1732b1679],
24	handling	VBG	O	handle	prepc_in	19	SENT_216	[p8l1743t1650r1887b1688],
25	many	JJ	O	many	amod	27	SENT_216	[p8l543t1709r633b1738],
26	different	JJ	O	different	amod	27	SENT_216	[p8l645t1700r786b1729],
27	drugs	NNS	O	drug	dobj	24	SENT_216	[p8l798t1700r897b1738],
28	.	.	O	.	_	0	SENT_216	[p8l798t1700r897b1738],

1	The	DT	O	the	det	2	SENT_217	[p8l593t1749r656b1778],
2	knowledge	NN	O	knowledge	dep	25	SENT_217	[p8l664t1749r844b1787],
3	that	WDT	O	that	det	4	SENT_217	[p8l852t1749r914b1778],
4	expression	NN	O	expression	dobj	17	SENT_217	[p8l921t1749r1097b1787],
5	of	IN	O	of	_	0	SENT_217	[p8l1105t1749r1141b1778],
6	a	DT	O	a	det	8	SENT_217	[p8l1146t1758r1164b1778],
7	drug	NN	O	drug	nn	8	SENT_217	[p8l1171t1749r1423b1787],
8	—	NN	O	—	prep_of	4	SENT_217	[p8l1171t1749r1423b1787],
9	resistance	NN	O	resistance	nn	10	SENT_217	[p8l1171t1749r1423b1787],
10	gene	NN	O	gene	nsubj	17	SENT_217	[p8l1431t1758r1517b1787],
11	,	,	O	,	_	0	SENT_217	[p8l1431t1758r1517b1787],
12	such	JJ	O	such	_	0	SENT_217	[p8l1528t1749r1601b1778],
13	as	IN	O	as	_	0	SENT_217	[p8l1610t1758r1642b1778],
14	MDRl	NN	O	mdrl	prep_such_as	10	SENT_217	[p8l1649t1749r1768b1783],
15	,	,	O	,	_	0	SENT_217	[p8l1649t1749r1768b1783],
16	can	MD	O	can	aux	17	SENT_217	[p8l1778t1758r1834b1778],
17	result	VB	O	result	rcmod	2	SENT_217	[p8l1841t1758r1886b1778, p8l544t1798r602b1827],
18	in	IN	O	in	_	0	SENT_217	[p8l611t1798r643b1827],
19	clinically	RB	O	clinically	advmod	20	SENT_217	[p8l652t1798r805b1836],
20	signiﬁcant	JJ	O	signiﬁcant	amod	22	SENT_217	[p8l817t1798r988b1836],
21	drug	NN	O	drug	nn	22	SENT_217	[p8l997t1798r1071b1836],
22	resistance	NN	O	resistance	prep_in	17	SENT_217	[p8l1081t1798r1252b1833],
23	,	,	O	,	_	0	SENT_217	[p8l1081t1798r1252b1833],
24	has	VBZ	O	have	aux	25	SENT_217	[p8l1263t1798r1317b1827],
25	led	VBN	O	lead	_	0	SENT_217	[p8l1327t1798r1377b1827],
26	to	TO	O	to	_	0	SENT_217	[p8l1386t1803r1417b1827],
27	the	DT	O	the	det	28	SENT_217	[p8l1427t1798r1477b1827],
28	idea	NN	O	idea	prep_to	25	SENT_217	[p8l1486t1798r1555b1827],
29	that	IN	O	that	complm	36	SENT_217	[p8l1564t1798r1626b1827],
30	drug	NN	O	drug	nn	33	SENT_217	[p8l1635t1798r1887b1836],
31	—	NN	O	—	nn	33	SENT_217	[p8l1635t1798r1887b1836],
32	resistance	NN	O	resistance	nn	33	SENT_217	[p8l1635t1798r1887b1836],
33	genes	NNS	O	gene	nsubjpass	36	SENT_217	[p8l543t1856r636b1885],
34	can	MD	O	can	aux	36	SENT_217	[p8l649t1856r705b1876],
35	be	VB	O	be	auxpass	36	SENT_217	[p8l716t1847r755b1876],
36	used	VBN	O	use	ccomp	25	SENT_217	[p8l766t1847r842b1876],
37	as	IN	O	as	_	0	SENT_217	[p8l854t1856r886b1876],
38	selectable	JJ	O	selectable	amod	39	SENT_217	[p8l900t1847r1061b1876],
39	markers	NNS	O	marker	prep_as	36	SENT_217	[p8l1073t1847r1205b1876],
40	in	IN	O	in	_	0	SENT_217	[p8l1217t1847r1249b1876],
41	gene	NN	O	gene	nn	42	SENT_217	[p8l1261t1856r1337b1885],
42	therapy	NN	O	therapy	prep_in	39	SENT_217	[p8l1350t1847r1472b1885],
43	(	CD	NUMBER	(	num	42	SENT_217	[p8l1486t1847r1561b1883],
44	56	CD	NUMBER	56	num	45	SENT_217	[p8l1486t1847r1561b1883],
45	)	NN	O	)	nsubj	25	SENT_217	[p8l1486t1847r1561b1883],
46	.	.	O	.	_	0	SENT_217	[p8l1486t1847r1561b1883],

1	One	CD	NUMBER	one	nsubj	11	SENT_218	[p8l1575t1847r1642b1876],
2	of	IN	O	of	_	0	SENT_218	[p8l1655t1847r1691b1876],
3	the	DT	O	the	det	4	SENT_218	[p8l1700t1847r1749b1876],
4	barriers	NNS	O	barrier	prep_of	1	SENT_218	[p8l1761t1847r1886b1876],
5	to	TO	O	to	_	0	SENT_218	[p8l543t1901r574b1926],
6	successful	JJ	O	successful	amod	8	SENT_218	[p8l587t1896r755b1926],
7	gene	NN	O	gene	nn	8	SENT_218	[p8l768t1905r844b1934],
8	therapy	NN	O	therapy	prep_to	4	SENT_218	[p8l856t1896r979b1934],
9	is	VBZ	O	be	cop	11	SENT_218	[p8l991t1896r1017b1926],
10	the	DT	O	the	det	11	SENT_218	[p8l1029t1896r1079b1926],
11	inefﬁciency	NN	O	inefﬁciency	_	0	SENT_218	[p8l1091t1896r1284b1934],
12	of	IN	O	of	_	0	SENT_218	[p8l1296t1896r1332b1926],
13	transfer	NN	O	transfer	prep_of	11	SENT_218	[p8l1341t1896r1467b1926],
14	of	IN	O	of	_	0	SENT_218	[p8l1479t1896r1515b1925],
15	therapeutic	JJ	O	therapeutic	amod	16	SENT_218	[p8l1523t1896r1706b1934],
16	genes	NNS	O	gene	prep_of	13	SENT_218	[p8l1719t1905r1811b1934],
17	into	IN	O	into	_	0	SENT_218	[p8l1824t1896r1887b1926],
18	target	NN	O	target	nn	19	SENT_218	[p8l543t1950r636b1984],
19	cells	NNS	O	cell	prep_into	16	SENT_218	[p8l646t1946r729b1975],
20	.	.	O	.	_	0	SENT_218	[p8l646t1946r729b1975],

1	Use	NN	O	use	nsubjpass	25	SENT_219	[p8l742t1947r805b1975],
2	of	IN	O	of	_	0	SENT_219	[p8l816t1946r852b1975],
3	cancer	NN	O	cancer	nn	7	SENT_219	[p8l860t1955r967b1975],
4	drug	NN	O	drug	nn	7	SENT_219	[p8l977t1946r1236b1984],
5	—	NN	O	—	nn	7	SENT_219	[p8l977t1946r1236b1984],
6	resistance	NN	O	resistance	nn	7	SENT_219	[p8l977t1946r1236b1984],
7	genes	NNS	O	gene	prep_of	1	SENT_219	[p8l1247t1955r1339b1984],
8	as	IN	O	as	_	0	SENT_219	[p8l1351t1955r1383b1975],
9	linked	VBN	O	link	amod	10	SENT_219	[p8l1394t1946r1497b1975],
10	markers	NNS	O	marker	prep_as	1	SENT_219	[p8l1507t1946r1638b1975],
11	to	TO	O	to	aux	12	SENT_219	[p8l1649t1950r1680b1975],
12	allow	VB	O	allow	infmod	10	SENT_219	[p8l1692t1946r1780b1975],
13	selection	NN	O	selection	dobj	12	SENT_219	[p8l1793t1946r1886b1975, p8l543t1995r607b2024],
14	of	IN	O	of	_	0	SENT_219	[p8l619t1995r654b2024],
15	cells	NNS	O	cell	prep_of	13	SENT_219	[p8l663t1995r737b2024],
16	to	TO	O	to	_	0	SENT_219	[p8l750t2000r780b2024],
17	which	WDT	O	which	rel	22	SENT_219	[p8l792t1995r893b2024],
18	therapeutic	JJ	O	therapeutic	amod	19	SENT_219	[p8l904t1995r1087b2033],
19	genes	NNS	O	gene	nsubjpass	22	SENT_219	[p8l1099t2004r1191b2033],
20	have	VBP	O	have	aux	22	SENT_219	[p8l1203t1995r1279b2024],
21	been	VBN	O	be	auxpass	22	SENT_219	[p8l1290t1995r1368b2024],
22	transferred	VBN	O	transfer	rcmod	15	SENT_219	[p8l1380t1995r1559b2024],
23	has	VBZ	O	have	aux	25	SENT_219	[p8l1570t1995r1623b2024],
24	been	VBN	O	be	auxpass	25	SENT_219	[p8l1635t1995r1713b2024],
25	suggested	VBN	O	suggest	_	0	SENT_219	[p8l1726t1995r1888b2033],
26	as	IN	O	as	_	0	SENT_219	[p8l544t2053r576b2074],
27	a	DT	O	a	det	28	SENT_219	[p8l593t2053r610b2074],
28	means	NN	O	means	prep_as	25	SENT_219	[p8l625t2053r729b2074],
29	to	TO	O	to	aux	30	SENT_219	[p8l746t2048r777b2074],
30	improve	VB	O	improve	xcomp	25	SENT_219	[p8l793t2044r929b2082],
31	efﬁciency	NN	O	efﬁciency	dobj	30	SENT_219	[p8l945t2044r1105b2082],
32	of	IN	O	of	_	0	SENT_219	[p8l1122t2044r1158b2074],
33	gene	NN	O	gene	nn	34	SENT_219	[p8l1171t2053r1248b2082],
34	therapy	NN	O	therapy	prep_of	31	SENT_219	[p8l1264t2044r1392b2082],
35	.	.	O	.	_	0	SENT_219	[p8l1264t2044r1392b2082],

1	Many	JJ	O	many	amod	3	SENT_220	[p8l1410t2045r1505b2082],
2	different	JJ	O	different	amod	3	SENT_220	[p8l1521t2044r1662b2074],
3	vectors	NNS	O	vector	nsubjpass	6	SENT_220	[p8l1678t2049r1795b2074],
4	have	VBP	O	have	aux	6	SENT_220	[p8l1811t2044r1887b2074],
5	been	VBN	O	be	auxpass	6	SENT_220	[p8l543t2094r620b2123],
6	developed	VBN	O	develop	_	0	SENT_220	[p8l637t2094r805b2132],
7	using	VBG	O	use	xcomp	6	SENT_220	[p8l821t2094r909b2132],
8	MDRl	NN	O	mdrl	dobj	7	SENT_220	[p8l925t2094r1032b2123],
9	and	CC	O	and	_	0	SENT_220	[p8l1053t2094r1111b2123],
10	other	JJ	O	other	amod	14	SENT_220	[p8l1128t2094r1212b2123],
11	drug	NN	O	drug	nn	14	SENT_220	[p8l1228t2094r1480b2132],
12	—	NN	O	—	nn	14	SENT_220	[p8l1228t2094r1480b2132],
13	resistance	NN	O	resistance	nn	14	SENT_220	[p8l1228t2094r1480b2132],
14	genes	NNS	O	gene	dobj	7	SENT_220	[p8l1497t2103r1589b2132],
15	for	IN	O	for	_	0	SENT_220	[p8l1607t2094r1655b2123],
16	gene	NN	O	gene	nn	17	SENT_220	[p8l1671t2103r1747b2132],
17	therapy	NN	O	therapy	prep_for	7	SENT_220	[p8l1764t2094r1886b2132],
18	(	CD	NUMBER	(	number	19	SENT_220	[p8l544t2143r619b2179],
19	57	CD	NUMBER	57	num	20	SENT_220	[p8l544t2143r619b2179],
20	)	NN	O	)	dep	7	SENT_220	[p8l544t2143r619b2179],
21	.	.	O	.	_	0	SENT_220	[p8l544t2143r619b2179],

1	Clinically	RB	O	clinically	advmod	6	SENT_221	[p8l638t2143r807b2181],
2	,	,	O	,	_	0	SENT_221	[p8l638t2143r807b2181],
3	attempts	NNS	O	attempt	nsubjpass	6	SENT_221	[p8l825t2148r963b2181],
4	have	VBP	O	have	aux	6	SENT_221	[p8l980t2143r1056b2172],
5	been	VBN	O	be	auxpass	6	SENT_221	[p8l1072t2143r1150b2172],
6	made	VBN	O	make	_	0	SENT_221	[p8l1166t2143r1255b2172],
7	to	TO	O	to	aux	8	SENT_221	[p8l1271t2148r1302b2172],
8	introduce	VB	O	introduce	xcomp	6	SENT_221	[p8l1319t2143r1474b2172],
9	P	NN	O	p	nn	11	SENT_221	[p8l1490t2144r1567b2181],
10	—	CD	NUMBER	—	num	11	SENT_221	[p8l1490t2144r1567b2181],
11	gp	NN	O	gp	dobj	8	SENT_221	[p8l1490t2144r1567b2181],
12	into	IN	O	into	_	0	SENT_221	[p8l1584t2143r1647b2172],
13	bone	NN	O	bone	nn	15	SENT_221	[p8l1663t2143r1743b2172],
14	marrow	NN	O	marrow	nn	15	SENT_221	[p8l1760t2152r1887b2172],
15	cells	NNS	O	cell	prep_into	8	SENT_221	[p8l543t2192r617b2221],
16	to	TO	O	to	aux	17	SENT_221	[p8l630t2196r661b2221],
17	protect	VB	O	protect	xcomp	8	SENT_221	[p8l673t2196r788b2230],
18	them	PRP	O	they	dobj	17	SENT_221	[p8l799t2192r882b2221],
19	from	IN	O	from	_	0	SENT_221	[p8l893t2192r974b2221],
20	the	DT	O	the	det	22	SENT_221	[p8l985t2192r1034b2221],
21	cytotoxic	JJ	O	cytotoxic	amod	22	SENT_221	[p8l1047t2192r1199b2230],
22	effects	NNS	O	effect	prep_from	17	SENT_221	[p8l1212t2192r1319b2221],
23	of	IN	O	of	_	0	SENT_221	[p8l1333t2192r1368b2221],
24	anticancer	JJ	O	anticancer	amod	25	SENT_221	[p8l1378t2192r1548b2221],
25	drugs	NNS	O	drug	prep_of	22	SENT_221	[p8l1559t2192r1658b2230],
26	.	.	O	.	_	0	SENT_221	[p8l1559t2192r1658b2230],

1	In	IN	O	in	_	0	SENT_222	[p8l1673t2193r1706b2221],
2	the	DT	O	the	det	3	SENT_222	[p8l1718t2192r1767b2221],
3	mouse	NN	O	mouse	pobj	1	SENT_222	[p8l1780t2201r1887b2221],

1	624	CD	NUMBER	624	_	0	SENT_223	[p8l435t2251r496b2281],
2	GOTTESMAN	NNP	O	GOTTESMAN	dep	1	SENT_223	[p8l585t2254r812b2281],

1	this	DT	O	this	nsubj	2	SENT_224	[p8l534t2377r592b2406],
2	works	VBZ	O	work	dep	20	SENT_224	[p8l611t2377r709b2406],
3	reasonably	RB	O	reasonably	advmod	4	SENT_224	[p8l727t2377r906b2415],
4	well	RB	O	well	acomp	2	SENT_224	[p8l924t2377r993b2406],
5	because	IN	O	because	_	0	SENT_224	[p8l1010t2377r1141b2406],
6	efﬁciency	NN	O	efﬁciency	prep_because	4	SENT_224	[p8l1158t2377r1319b2415],
7	of	IN	O	of	_	0	SENT_224	[p8l1337t2377r1372b2406],
8	transfer	NN	O	transfer	prep_of	6	SENT_224	[p8l1387t2377r1513b2406],
9	of	IN	O	of	_	0	SENT_224	[p8l1530t2377r1566b2406],
10	genes	NNS	O	gene	prep_of	8	SENT_224	[p8l1581t2386r1672b2415],
11	into	IN	O	into	_	0	SENT_224	[p8l1690t2377r1753b2406],
12	mouse	NN	O	mouse	nn	16	SENT_224	[p8l1771t2386r1878b2406],
13	bone	NN	O	bone	nn	16	SENT_224	[p8l534t2426r614b2455],
14	marrow	NN	O	marrow	nn	16	SENT_224	[p8l626t2435r753b2455],
15	stem	NN	O	stem	nn	16	SENT_224	[p8l767t2431r843b2455],
16	cells	NNS	O	cell	prep_into	2	SENT_224	[p8l855t2426r929b2455],
17	is	VBZ	O	be	cop	20	SENT_224	[p8l942t2426r968b2455],
18	relatively	RB	O	relatively	advmod	19	SENT_224	[p8l980t2426r1134b2464],
19	high	JJ	O	high	amod	20	SENT_224	[p8l1146t2426r1220b2464],
20	(	NN	O	(	_	0	SENT_224	[p8l1233t2426r1308b2462],
21	58	CD	NUMBER	58	num	22	SENT_224	[p8l1233t2426r1308b2462],
22	)	NN	O	)	nsubj	20	SENT_224	[p8l1233t2426r1308b2462],
23	.	.	O	.	_	0	SENT_224	[p8l1233t2426r1308b2462],

1	In	IN	O	in	_	0	SENT_225	[p8l1322t2427r1356b2455],
2	the	DT	O	the	det	4	SENT_225	[p8l1368t2426r1417b2455],
3	human	JJ	O	human	amod	4	SENT_225	[p8l1429t2426r1542b2455],
4	transfer	NN	O	transfer	prep_in	7	SENT_225	[p8l1554t2426r1680b2455],
5	efﬁciencies	NNS	O	efﬁciencies	nsubj	7	SENT_225	[p8l1692t2426r1878b2455],
6	are	VBP	O	be	cop	7	SENT_225	[p8l535t2485r584b2506],
7	low	JJ	O	low	_	0	SENT_225	[p8l595t2476r661b2506],
8	.	.	O	.	_	0	SENT_225	[p8l595t2476r661b2506],

1	Whereas	IN	O	whereas	mark	8	SENT_226	[p8l674t2476r817b2506],
2	expression	NN	O	expression	nsubj	8	SENT_226	[p8l830t2476r1006b2514],
3	of	IN	O	of	_	0	SENT_226	[p8l1017t2476r1053b2506],
4	P	NN	O	p	nn	6	SENT_226	[p8l1061t2477r1138b2514],
5	—	CD	NUMBER	—	num	6	SENT_226	[p8l1061t2477r1138b2514],
6	gp	NN	O	gp	prep_of	2	SENT_226	[p8l1061t2477r1138b2514],
7	might	MD	O	might	aux	8	SENT_226	[p8l1150t2476r1246b2514],
8	have	VB	O	have	advcl	33	SENT_226	[p8l1256t2476r1332b2506],
9	a	DT	O	a	det	12	SENT_226	[p8l1345t2485r1362b2506],
10	small	JJ	O	small	amod	12	SENT_226	[p8l1374t2476r1461b2506],
11	selective	JJ	O	selective	amod	12	SENT_226	[p8l1474t2476r1615b2506],
12	advantage	NN	O	advantage	dobj	8	SENT_226	[p8l1627t2476r1792b2514],
13	after	IN	O	after	_	0	SENT_226	[p8l1804t2476r1879b2506],
14	taxol	NN	O	taxol	nn	15	SENT_226	[p8l534t2526r616b2555],
15	treatment	NN	O	treatment	prep_after	8	SENT_226	[p8l625t2530r781b2555],
16	of	IN	O	of	_	0	SENT_226	[p8l789t2526r825b2555],
17	patients	NNS	O	patient	prep_of	15	SENT_226	[p8l830t2526r958b2564],
18	undergoing	VBG	O	undergo	xcomp	8	SENT_226	[p8l967t2526r1154b2564],
19	bone	NN	O	bone	nn	21	SENT_226	[p8l1163t2526r1243b2555],
20	marrow	NN	O	marrow	nn	21	SENT_226	[p8l1251t2535r1378b2555],
21	transplants	NNS	O	transplant	dobj	18	SENT_226	[p8l1387t2526r1565b2564],
22	in	IN	O	in	_	0	SENT_226	[p8l1574t2526r1605b2555],
23	association	NN	O	association	prep_in	18	SENT_226	[p8l1615t2526r1797b2555],
24	with	IN	O	with	_	0	SENT_226	[p8l1806t2526r1879b2555],
25	breast	NN	O	breast	nn	27	SENT_226	[p8l534t2576r633b2606],
26	cancer	NN	O	cancer	nn	27	SENT_226	[p8l644t2585r752b2606],
27	treatment	NN	O	treatment	prep_with	23	SENT_226	[p8l762t2581r926b2611],
28	,	,	O	,	_	0	SENT_226	[p8l762t2581r926b2611],
29	the	DT	O	the	det	30	SENT_226	[p8l939t2576r989b2606],
30	effect	NN	O	effect	nsubj	33	SENT_226	[p8l1000t2576r1093b2606],
31	is	VBZ	O	be	cop	33	SENT_226	[p8l1103t2576r1129b2606],
32	not	RB	O	not	neg	33	SENT_226	[p8l1141t2581r1194b2606],
33	dramatic	JJ	O	dramatic	_	0	SENT_226	[p8l1205t2576r1348b2606],
34	or	CC	O	or	_	0	SENT_226	[p8l1360t2585r1394b2606],
35	therapeutic	JJ	O	therapeutic	amod	36	SENT_226	[p8l1404t2576r1587b2614],
36	(	NN	O	(	conj_or	33	SENT_226	[p8l1600t2576r1675b2612],
37	59	CD	NUMBER	59	num	38	SENT_226	[p8l1600t2576r1675b2612],
38	)	NN	O	)	dep	36	SENT_226	[p8l1600t2576r1675b2612],
39	.	.	O	.	_	0	SENT_226	[p8l1600t2576r1675b2612],

1	In	IN	O	in	_	0	SENT_227	[p8l1688t2577r1722b2605],
2	addition	NN	O	addition	prep_in	9	SENT_227	[p8l1734t2576r1877b2611],
3	,	,	O	,	_	0	SENT_227	[p8l1734t2576r1877b2611],
4	some	DT	O	some	det	5	SENT_227	[p8l536t2635r621b2656],
5	studies	NNS	O	study	nsubj	9	SENT_227	[p8l634t2626r746b2656],
6	in	IN	O	in	_	0	SENT_227	[p8l758t2626r790b2655],
7	the	DT	O	the	det	8	SENT_227	[p8l802t2626r851b2656],
8	mouse	NN	O	mouse	prep_in	5	SENT_227	[p8l863t2635r970b2656],
9	suggest	VBP	O	suggest	_	0	SENT_227	[p8l983t2631r1106b2664],
10	that	IN	O	that	complm	22	SENT_227	[p8l1117t2626r1179b2656],
11	high	JJ	O	high	amod	12	SENT_227	[p8l1190t2626r1263b2664],
12	levels	NNS	O	level	nsubjpass	22	SENT_227	[p8l1274t2626r1368b2656],
13	of	IN	O	of	_	0	SENT_227	[p8l1381t2626r1417b2655],
14	P	NN	O	p	nn	16	SENT_227	[p8l1425t2627r1502b2664],
15	—	CD	NUMBER	—	num	16	SENT_227	[p8l1425t2627r1502b2664],
16	gp	NN	O	gp	prep_of	12	SENT_227	[p8l1425t2627r1502b2664],
17	in	IN	O	in	_	0	SENT_227	[p8l1514t2626r1546b2655],
18	hematopoietic	JJ	O	hematopoietic	amod	19	SENT_227	[p8l1557t2626r1791b2664],
19	cells	NNS	O	cell	prep_in	16	SENT_227	[p8l1804t2626r1877b2656],
20	may	MD	O	may	aux	22	SENT_227	[p8l534t2685r604b2714],
21	be	VB	O	be	auxpass	22	SENT_227	[p8l617t2676r655b2705],
22	associated	VBN	O	associate	ccomp	9	SENT_227	[p8l669t2676r838b2705],
23	under	IN	O	under	_	0	SENT_227	[p8l850t2676r944b2705],
24	some	DT	O	some	det	25	SENT_227	[p8l957t2685r1042b2705],
25	circumstances	NNS	O	circumstance	prep_under	22	SENT_227	[p8l1055t2676r1288b2705],
26	with	IN	O	with	_	0	SENT_227	[p8l1301t2676r1374b2705],
27	a	DT	O	a	det	29	SENT_227	[p8l1387t2685r1404b2705],
28	myeloproliferative	JJ	O	myeloproliferative	amod	29	SENT_227	[p8l1416t2676r1722b2714],
29	disorder	NN	O	disorder	prep_with	25	SENT_227	[p8l1735t2676r1877b2711],
30	,	,	O	,	_	0	SENT_227	[p8l1735t2676r1877b2711],
31	and	CC	O	and	_	0	SENT_227	[p8l535t2726r593b2756],
32	more	RBR	O	more	advmod	35	SENT_227	[p8l605t2735r689b2756],
33	data	NNS	O	datum	nsubjpass	35	SENT_227	[p8l701t2726r769b2756],
34	are	VBP	O	be	auxpass	35	SENT_227	[p8l781t2735r829b2756],
35	needed	VBN	O	need	conj_and	9	SENT_227	[p8l841t2726r958b2756],
36	before	IN	O	before	mark	42	SENT_227	[p8l968t2726r1074b2756],
37	additional	JJ	O	additional	amod	39	SENT_227	[p8l1086t2726r1250b2756],
38	clinical	JJ	O	clinical	amod	39	SENT_227	[p8l1262t2726r1383b2756],
39	trials	NNS	O	trial	nsubjpass	42	SENT_227	[p8l1394t2726r1475b2756],
40	can	MD	O	can	aux	42	SENT_227	[p8l1488t2735r1544b2756],
41	be	VB	O	be	auxpass	42	SENT_227	[p8l1555t2726r1594b2756],
42	attempted	VBN	O	attempt	advcl	35	SENT_227	[p8l1606t2726r1768b2764],
43	(	CD	NUMBER	(	number	44	SENT_227	[p8l1781t2726r1856b2762],
44	60	CD	NUMBER	60	num	45	SENT_227	[p8l1781t2726r1856b2762],
45	)	NN	O	)	dobj	42	SENT_227	[p8l1781t2726r1856b2762],
46	.	.	O	.	_	0	SENT_227	[p8l1781t2726r1856b2762],

1	CONCLUSIONS	NNS	O	conclusion	_	0	SENT_228	[p8l436t2839r773b2873],

1	A	DT	O	a	det	3	SENT_229	[p8l534t2943r563b2972],
2	great	JJ	O	great	amod	3	SENT_229	[p8l577t2947r659b2981],
3	deal	NN	O	deal	nsubjpass	6	SENT_229	[p8l671t2943r739b2972],
4	is	VBZ	O	be	auxpass	6	SENT_229	[p8l752t2943r778b2972],
5	now	RB	DATE	now	advmod	6	SENT_229	[p8l791t2952r860b2972],
6	known	VBN	O	know	_	0	SENT_229	[p8l874t2943r985b2972],
7	about	IN	O	about	_	0	SENT_229	[p8l998t2943r1089b2972],
8	mechanisms	NNS	O	mechanism	prep_about	6	SENT_229	[p8l1102t2943r1305b2972],
9	of	IN	O	of	_	0	SENT_229	[p8l1319t2943r1355b2972],
10	drug	NN	O	drug	nn	11	SENT_229	[p8l1366t2943r1440b2981],
11	resistance	NN	O	resistance	prep_of	8	SENT_229	[p8l1453t2943r1615b2972],
12	in	IN	O	in	_	0	SENT_229	[p8l1629t2943r1660b2972],
13	cancer	NN	O	cancer	nn	14	SENT_229	[p8l1673t2952r1781b2972],
14	cells	NNS	O	cell	prep_in	6	SENT_229	[p8l1793t2943r1876b2972],
15	.	.	O	.	_	0	SENT_229	[p8l1793t2943r1876b2972],

1	Despite	IN	O	despite	_	0	SENT_230	[p8l534t2993r660b3030],
2	the	DT	O	the	det	3	SENT_230	[p8l675t2993r724b3022],
3	development	NN	O	development	prep_despite	26	SENT_230	[p8l739t2993r951b3030],
4	of	IN	O	of	_	0	SENT_230	[p8l966t2993r1001b3022],
5	new	JJ	O	new	dep	6	SENT_230	[p8l1013t3002r1080b3022],
6	targeted	VBN	O	target	amod	8	SENT_230	[p8l1094t2993r1227b3030],
7	anticancer	JJ	O	anticancer	amod	8	SENT_230	[p8l1242t2993r1411b3022],
8	therapies	NNS	O	therapy	prep_of	3	SENT_230	[p8l1425t2993r1583b3030],
9	,	,	O	,	_	0	SENT_230	[p8l1425t2993r1583b3030],
10	mechanisms	NNS	O	mechanism	nsubj	26	SENT_230	[p8l1599t2993r1802b3022],
11	that	WDT	O	that	nsubj	13	SENT_230	[p8l1817t2993r1879b3022],
12	have	VBP	O	have	aux	13	SENT_230	[p8l534t3043r610b3072],
13	evolved	VBN	O	evolve	rcmod	10	SENT_230	[p8l628t3043r756b3072],
14	in	IN	O	in	_	0	SENT_230	[p8l772t3043r804b3071],
15	mammals	NNS	O	mammal	prep_in	13	SENT_230	[p8l821t3043r980b3072],
16	to	TO	O	to	aux	17	SENT_230	[p8l998t3047r1029b3072],
17	protect	VB	O	protect	xcomp	13	SENT_230	[p8l1046t3047r1161b3080],
18	cells	NNS	O	cell	dobj	17	SENT_230	[p8l1178t3043r1252b3072],
19	against	IN	O	against	_	0	SENT_230	[p8l1271t3043r1387b3080],
20	cytotoxic	JJ	O	cytotoxic	amod	21	SENT_230	[p8l1404t3043r1555b3080],
21	compounds	NNS	O	compound	prep_against	17	SENT_230	[p8l1574t3043r1763b3080],
22	in	IN	O	in	_	0	SENT_230	[p8l1781t3043r1812b3071],
23	the	DT	O	the	det	24	SENT_230	[p8l1829t3043r1878b3072],
24	environment	NN	O	environment	prep_in	21	SENT_230	[p8l535t3092r742b3122],
25	will	MD	O	will	aux	26	SENT_230	[p8l757t3092r820b3122],
26	continue	VB	O	continue	_	0	SENT_230	[p8l835t3092r976b3122],
27	to	TO	O	to	aux	28	SENT_230	[p8l991t3097r1022b3122],
28	act	VB	O	act	xcomp	26	SENT_230	[p8l1038t3097r1085b3122],
29	as	IN	O	as	_	0	SENT_230	[p8l1100t3102r1132b3122],
30	obstacles	NNS	O	obstacle	prep_as	28	SENT_230	[p8l1148t3092r1298b3122],
31	to	TO	O	to	_	0	SENT_230	[p8l1314t3097r1344b3122],
32	successful	JJ	O	successful	amod	33	SENT_230	[p8l1361t3092r1529b3122],
33	treatment	NN	O	treatment	prep_to	28	SENT_230	[p8l1544t3097r1701b3122],
34	of	IN	O	of	_	0	SENT_230	[p8l1715t3092r1751b3122],
35	cancer	NN	O	cancer	prep_of	33	SENT_230	[p8l1763t3102r1876b3122],
36	.	.	O	.	_	0	SENT_230	[p8l1763t3102r1876b3122],

1	Additional	JJ	O	additional	amod	2	SENT_231	[p8l534t3142r711b3171],
2	knowledge	NN	O	knowledge	nsubj	11	SENT_231	[p8l719t3142r900b3180],
3	about	IN	O	about	_	0	SENT_231	[p8l910t3142r1000b3171],
4	these	DT	O	these	det	5	SENT_231	[p8l1009t3142r1093b3171],
5	mechanisms	NNS	O	mechanism	prep_about	2	SENT_231	[p8l1102t3142r1305b3171],
6	of	IN	O	of	_	0	SENT_231	[p8l1315t3142r1351b3171],
7	cancer	NN	O	cancer	nn	9	SENT_231	[p8l1358t3151r1465b3171],
8	drug	NN	O	drug	nn	9	SENT_231	[p8l1474t3142r1548b3180],
9	resistance	NN	O	resistance	prep_of	5	SENT_231	[p8l1557t3142r1720b3171],
10	may	MD	O	may	aux	11	SENT_231	[p8l1729t3151r1799b3180],
11	help	VB	O	help	_	0	SENT_231	[p8l1808t3142r1878b3180],
12	to	TO	O	to	aux	13	SENT_231	[p8l534t3197r565b3221],
13	design	VB	O	design	xcomp	11	SENT_231	[p8l574t3192r681b3230],
14	strategies	NNS	O	strategy	nsubj	16	SENT_231	[p8l691t3192r844b3230],
15	to	TO	O	to	aux	16	SENT_231	[p8l853t3197r883b3221],
16	circumvent	VB	O	circumvent	xcomp	13	SENT_231	[p8l893t3192r1078b3221],
17	resistance	NN	O	resistance	nn	20	SENT_231	[p8l1085t3192r1248b3221],
18	and	CC	O	and	_	0	SENT_231	[p8l1257t3192r1316b3221],
19	new	JJ	O	new	nn	20	SENT_231	[p8l1324t3201r1390b3221],
20	drugs	NNS	O	drug	dobj	16	SENT_231	[p8l1399t3192r1489b3230],
21	that	WDT	O	that	nsubj	24	SENT_231	[p8l1499t3192r1560b3221],
22	are	VBP	O	be	cop	24	SENT_231	[p8l1569t3201r1617b3221],
23	less	RBR	O	less	advmod	24	SENT_231	[p8l1626t3192r1686b3221],
24	susceptible	JJ	O	susceptible	rcmod	20	SENT_231	[p8l1697t3192r1878b3230],
25	to	TO	O	to	aux	26	SENT_231	[p8l534t3306r565b3330],
26	known	JJ	O	known	xcomp	24	SENT_231	[p8l579t3301r691b3330],
27	resistance	NN	O	resistance	nn	28	SENT_231	[p8l704t3301r867b3330],
28	mechanisms	NNS	O	mechanism	dobj	26	SENT_231	[p8l881t3301r1093b3330],
29	.	.	O	.	_	0	SENT_231	[p8l881t3301r1093b3330],

1	Some	DT	O	some	nsubj	9	SENT_232	[p8l1110t3301r1203b3330],
2	of	IN	O	of	_	0	SENT_232	[p8l1217t3301r1253b3330],
3	the	DT	O	the	det	4	SENT_232	[p8l1264t3301r1313b3330],
4	knowledge	NN	O	knowledge	prep_of	1	SENT_232	[p8l1327t3301r1507b3339],
5	about	IN	O	about	_	0	SENT_232	[p8l1522t3301r1613b3330],
6	drug	NN	O	drug	nn	7	SENT_232	[p8l1627t3301r1701b3339],
7	resistance	NN	O	resistance	prep_about	4	SENT_232	[p8l1715t3301r1878b3330],
8	has	VBZ	O	have	aux	9	SENT_232	[p8l534t3351r588b3380],
9	revealed	VBN	O	reveal	_	0	SENT_232	[p8l601t3351r740b3380],
10	new	JJ	O	new	amod	11	SENT_232	[p8l752t3360r819b3380],
11	mechanisms	NNS	O	mechanism	dobj	9	SENT_232	[p8l832t3351r1035b3380],
12	relevant	JJ	O	relevant	amod	11	SENT_232	[p8l1049t3351r1180b3380],
13	to	TO	O	to	_	0	SENT_232	[p8l1192t3355r1223b3380],
14	normal	JJ	O	normal	amod	15	SENT_232	[p8l1237t3351r1353b3380],
15	handling	NN	O	handling	prep_to	12	SENT_232	[p8l1366t3351r1510b3389],
16	of	IN	O	of	_	0	SENT_232	[p8l1523t3351r1559b3380],
17	drugs	NNS	O	drug	prep_of	15	SENT_232	[p8l1570t3351r1660b3389],
18	by	IN	O	by	_	0	SENT_232	[p8l1673t3351r1713b3389],
19	the	DT	O	the	det	20	SENT_232	[p8l1726t3351r1776b3380],
20	body	NN	O	body	prep_by	9	SENT_232	[p8l1788t3351r1877b3389],
21	,	,	O	,	_	0	SENT_232	[p8l1788t3351r1877b3389],

1	and	CC	O	and	cc	6	SENT_233	[p9l535t50r594b79],
2	this	DT	O	this	det	3	SENT_233	[p9l603t50r661b79],
3	information	NN	O	information	nsubj	6	SENT_233	[p9l672t50r867b79],
4	will	MD	O	will	aux	6	SENT_233	[p9l877t50r940b79],
5	be	VB	O	be	cop	6	SENT_233	[p9l950t50r988b79],
6	important	JJ	O	important	_	0	SENT_233	[p9l999t50r1160b87],
7	in	IN	O	in	_	0	SENT_233	[p9l1169t50r1200b78],
8	improving	VBG	O	improve	prepc_in	6	SENT_233	[p9l1210t50r1381b87],
9	drug	NN	O	drug	nn	10	SENT_233	[p9l1392t50r1466b87],
10	delivery	NN	O	delivery	dobj	8	SENT_233	[p9l1477t50r1610b87],
11	and	CC	O	and	_	0	SENT_233	[p9l1621t50r1679b79],
12	distribution	NN	O	distribution	dobj	8	SENT_233	[p9l1689t50r1879b79],
13	in	IN	O	in	_	0	SENT_233	[p9l534t99r566b128],
14	patients	NNS	O	patient	prep_in	10	SENT_233	[p9l576t99r713b137],
15	.	.	O	.	_	0	SENT_233	[p9l576t99r713b137],

1	ACKNOWLEDGMENTS	NNS	O	acknowledgment	_	0	SENT_234	[p9l434t236r856b265],

1	I	PRP	O	I	nsubj	3	SENT_235	[p9l534t311r547b339],
2	am	VBP	O	be	cop	3	SENT_235	[p9l562t320r611b340],
3	grateful	JJ	O	grateful	_	0	SENT_235	[p9l625t311r753b348],
4	to	TO	O	to	_	0	SENT_235	[p9l767t315r798b340],
5	my	PRP$	O	my	poss	7	SENT_235	[p9l812t320r864b348],
6	many	JJ	O	many	amod	7	SENT_235	[p9l878t320r968b348],
7	coworkers	NNS	O	coworker	prep_to	3	SENT_235	[p9l983t311r1152b340],
8	and	CC	O	and	_	0	SENT_235	[p9l1168t311r1226b340],
9	colleagues	NNS	O	colleague	conj_and	7	SENT_235	[p9l1240t311r1423b348],
10	,	,	O	,	_	0	SENT_235	[p9l1240t311r1423b348],
11	especially	RB	O	especially	advmod	13	SENT_235	[p9l1439t311r1603b348],
12	Ira	NNP	PERSON	Ira	nn	13	SENT_235	[p9l1618t311r1663b340],
13	Pastan	NNP	PERSON	Pastan	advmod	3	SENT_235	[p9l1677t311r1792b345],
14	,	,	O	,	_	0	SENT_235	[p9l1677t311r1792b345],
15	who	WP	O	who	nsubj	17	SENT_235	[p9l1808t311r1878b340],
16	have	VBP	O	have	aux	17	SENT_235	[p9l534t360r610b389],
17	contributed	VBN	O	contribute	rcmod	13	SENT_235	[p9l628t360r815b389],
18	over	IN	O	over	_	0	SENT_235	[p9l832t369r904b389],
19	the	DT	DURATION	the	det	20	SENT_235	[p9l920t360r970b389],
20	years	NNS	DURATION	year	prep_over	17	SENT_235	[p9l987t369r1073b398],
21	to	TO	O	to	_	0	SENT_235	[p9l1091t364r1121b389],
22	the	DT	O	the	det	23	SENT_235	[p9l1139t360r1188b389],
23	ideas	NNS	O	idea	prep_to	17	SENT_235	[p9l1206t360r1289b389],
24	presented	VBN	O	present	partmod	23	SENT_235	[p9l1307t360r1466b398],
25	in	IN	O	in	_	0	SENT_235	[p9l1482t360r1513b389],
26	the	DT	O	the	det	27	SENT_235	[p9l1530t360r1580b389],
27	review	NN	O	review	prep_in	24	SENT_235	[p9l1597t360r1713b394],
28	,	,	O	,	_	0	SENT_235	[p9l1597t360r1713b394],
29	to	TO	O	to	_	0	SENT_235	[p9l1732t364r1763b389],
30	Susan	NNP	PERSON	Susan	nn	31	SENT_235	[p9l1781t360r1878b389],
31	Bates	NNP	PERSON	Bates	prep_to	24	SENT_235	[p9l534t411r625b439],
32	and	CC	O	and	_	0	SENT_235	[p9l643t410r701b439],
33	Suresh	NNP	PERSON	Suresh	nn	35	SENT_235	[p9l718t410r829b439],
34	V.	NNP	PERSON	V.	nn	35	SENT_235	[p9l846t411r878b439],
35	Ambudkar	NNP	PERSON	Ambudkar	prep_to	24	SENT_235	[p9l896t410r1073b439],
36	for	IN	O	for	_	0	SENT_235	[p9l1089t410r1137b439],
37	critical	JJ	O	critical	amod	38	SENT_235	[p9l1153t410r1266b439],
38	reading	NN	O	reading	prep_for	35	SENT_235	[p9l1283t410r1406b448],
39	and	CC	O	and	_	0	SENT_235	[p9l1424t410r1482b439],
40	comments	NNS	O	comment	prep_for	35	SENT_235	[p9l1499t415r1667b439],
41	on	IN	O	on	_	0	SENT_235	[p9l1685t419r1725b439],
42	the	DT	O	the	det	43	SENT_235	[p9l1741t410r1791b439],
43	text	NN	O	text	prep_on	35	SENT_235	[p9l1807t414r1877b444],
44	,	,	O	,	_	0	SENT_235	[p9l1807t414r1877b444],
45	and	CC	O	and	_	0	SENT_235	[p9l535t460r594b489],
46	to	TO	O	to	_	0	SENT_235	[p9l606t464r636b489],
47	Gregar	NNP	PERSON	Gregar	nn	49	SENT_235	[p9l650t460r764b497],
48	D.	NNP	PERSON	D.	nn	49	SENT_235	[p9l775t460r813b489],
49	Odegaarden	NNP	PERSON	Odegaarden	prep_to	24	SENT_235	[p9l828t460r1026b497],
50	and	CC	O	and	_	0	SENT_235	[p9l1039t460r1098b489],
51	Joyce	NNP	PERSON	Joyce	nn	53	SENT_235	[p9l1110t460r1203b497],
52	L.	NNP	PERSON	L.	nn	53	SENT_235	[p9l1215t460r1248b489],
53	Sharrar	NNP	PERSON	Sharrar	prep_to	24	SENT_235	[p9l1264t460r1385b489],
54	for	IN	O	for	_	0	SENT_235	[p9l1396t460r1444b489],
55	help	NN	O	help	prep_for	24	SENT_235	[p9l1456t460r1526b497],
56	in	IN	O	in	_	0	SENT_235	[p9l1539t460r1570b488],
57	preparation	NN	O	preparation	prep_in	13	SENT_235	[p9l1582t460r1771b497],
58	of	IN	O	of	_	0	SENT_235	[p9l1784t460r1819b489],
59	the	DT	O	the	det	60	SENT_235	[p9l1829t460r1879b489],
60	manuscript	NN	O	manuscript	prep_of	57	SENT_235	[p9l534t509r726b547],
61	.	.	O	.	_	0	SENT_235	[p9l534t509r726b547],

1	Annu	NNP	PERSON	Annu	_	0	SENT_236	[p9l281t658r304b731],
2	.	.	O	.	_	0	SENT_236	[p9l300t619r304b623],

1	Rev.	NNP	O	Rev.	nn	2	SENT_237	[p9l281t515r304b575],
2	Med	NNP	O	Med	_	0	SENT_237	[p9l281t438r304b505],
3	.	.	O	.	_	0	SENT_237	[p9l281t438r304b505],

1	2002.53:6	CD	NUMBER	2002.53:6	_	0	SENT_238	[p9l281t193r304b427],
2	l5-627	NN	O	l5-627	dep	1	SENT_238	[p9l281t193r304b427],
3	.	.	O	.	_	0	SENT_238	[p9l281t193r304b427],

1	Download	NN	O	download	_	0	SENT_239	[p9l281t45r304b183],
2	by	IN	O	by	_	0	SENT_239	[p9l314t665r345b697],
3	I	PRP	O	I	dep	4	SENT_239	[p9l315t609r338b623],
4	Iniversity	NN	O	iniversity	prep_by	1	SENT_239	[p9l314t451r345b576],
5	of	IN	O	of	_	0	SENT_239	[p9l314t412r338b441],
6	Wisconsin	NNP	LOCATION	Wisconsin	prep_of	4	SENT_239	[p9l314t266r338b406],
7	-	:	O	-	_	0	SENT_239	[p9l328t247r331b256],
8	Madison	NNP	O	Madison	dep	1	SENT_239	[p9l314t122r338b237],
9	on	IN	O	on	_	0	SENT_239	[p9l322t80r338b112],
10	01	CD	NUMBER	01	prep_on	8	SENT_239	[p9l314t44r338b71],

1	Visit	NN	O	visit	_	0	SENT_240	[p9l614t675r691b703],
2	the	DT	O	the	det	6	SENT_240	[p9l701t676r752b703],
3	Annual	JJ	SET	annual	amod	6	SENT_240	[p9l763t675r887b703],
4	Reviews	NNS	MISC	review	nn	6	SENT_240	[p9l899t675r1034b703],
5	home	NN	O	home	nn	6	SENT_240	[p9l1046t676r1136b703],
6	page	NN	O	page	dep	1	SENT_240	[p9l1148t684r1225b711],
7	at	IN	O	at	_	0	SENT_240	[p9l1237t678r1269b703],
8	www.AnnualReviews.org	NN	O	www.annualreviews.org	nn	9	SENT_240	[p9l1279t675r1699b711],
9	w.annualreviews.org	NN	O	w.annualreviews.org	prep_at	6	SENT_240	[p9l7t2882r81b3563],
10	personal	JJ	O	personal	amod	11	SENT_240	[p9l89t3283r164b3560],
11	use	NN	O	use	npadvmod	12	SENT_240	[p9l107t3153r146b3261],
12	only	RB	O	only	advmod	9	SENT_240	[p9l89t2969r164b3129],
13	.	.	O	.	_	0	SENT_240	[p9l89t2969r164b3129],

1	LITERATURE	NN	O	literature	nsubj	2	SENT_241	[p9l435t799r675b828],
2	CITED	VBD	O	cite	_	0	SENT_241	[p9l686t799r804b828],

1	1	LS	NUMBER	1	_	0	SENT_242	[p9l476t876r497b902],
2	.	.	O	.	_	0	SENT_242	[p9l476t876r497b902],

1	Barinaga	NNP	O	Barinaga	nn	2	SENT_243	[p9l517t876r651b910],
2	M.	NNP	O	M.	_	0	SENT_243	[p9l657t877r697b902],
3	1997	CD	DATE	1997	dep	2	SENT_243	[p9l709t876r787b903],
4	.	.	O	.	_	0	SENT_243	[p9l709t876r787b903],

1	From	IN	O	from	_	0	SENT_244	[p9l795t877r876b902],
2	bench	NN	O	bench	nn	3	SENT_244	[p9l882t876r971b902],
3	top	NN	O	top	pobj	1	SENT_244	[p9l977t880r1024b910],
4	to	TO	O	to	_	0	SENT_244	[p9l1031t880r1059b902],
5	bedside	NN	O	bedside	prep_to	3	SENT_244	[p9l1065t876r1130b902, p9l518t921r583b947],
6	.	.	O	.	_	0	SENT_244	[p9l1065t876r1130b902, p9l518t921r583b947],

1	Science	NNP	O	Science	_	0	SENT_245	[p9l596t921r708b948],
2	278	CD	NUMBER	278	num	1	SENT_245	[p9l719t921r914b948],
3	:	:	O	:	_	0	SENT_245	[p9l719t921r914b948],
4	l036	CD	NUMBER	l036	num	5	SENT_245	[p9l719t921r914b948],
5	—	CD	NUMBER	—	dep	1	SENT_245	[p9l719t921r914b948],
6	39	CD	NUMBER	39	number	7	SENT_245	[p9l719t921r914b948],
7	2	CD	NUMBER	2	dep	5	SENT_245	[p9l473t966r497b992],
8	.	.	O	.	_	0	SENT_245	[p9l473t966r497b992],

1	Nabholtz	NNP	ORGANIZATION	Nabholtz	nn	2	SENT_246	[p9l516t966r652b992],
2	JM	NN	ORGANIZATION	jm	_	0	SENT_246	[p9l659t967r714b997],
3	,	,	O	,	_	0	SENT_246	[p9l659t967r714b997],
4	Slamon	NNP	PERSON	Slamon	nn	5	SENT_246	[p9l729t966r841b992],
5	D.	NNP	O	D.	appos	2	SENT_246	[p9l848t967r881b992],
6	2001	CD	DATE	2001	dep	5	SENT_246	[p9l891t966r971b992],
7	.	.	O	.	_	0	SENT_246	[p9l891t966r971b992],

1	New	NNP	O	New	amod	2	SENT_247	[p9l980t967r1048b992],
2	adjuvant	JJ	O	adjuvant	amod	3	SENT_247	[p9l1056t966r1130b1000, p9l517t1014r580b1036],
3	strategies	NNS	O	strategy	npadvmod	4	SENT_247	[p9l591t1010r729b1044],
4	for	IN	O	for	dep	8	SENT_247	[p9l741t1010r784b1036],
5	breast	NN	O	breast	nn	6	SENT_247	[p9l794t1010r883b1036],
6	cancer	NN	O	cancer	pobj	4	SENT_247	[p9l894t1018r998b1036],
7	:	:	O	:	_	0	SENT_247	[p9l894t1018r998b1036],
8	meeting	VBG	O	meet	_	0	SENT_247	[p9l1012t1010r1131b1044],
9	the	DT	O	the	det	10	SENT_247	[p9l517t1055r561b1081],
10	challenge	NN	O	challenge	dobj	8	SENT_247	[p9l568t1055r710b1089],
11	of	IN	O	of	_	0	SENT_247	[p9l717t1055r750b1081],
12	integrating	VBG	O	integrate	prepc_of	10	SENT_247	[p9l754t1055r914b1089],
13	chemotherapy	NN	O	chemotherapy	dobj	12	SENT_247	[p9l921t1055r1130b1089],
14	and	CC	O	and	_	0	SENT_247	[p9l517t1100r570b1126],
15	trastuzumab	NN	O	trastuzumab	nn	18	SENT_247	[p9l580t1100r761b1126],
16	(	CD	NUMBER	(	num	18	SENT_247	[p9l774t1100r951b1134],
17	Herceptin	NN	O	herceptin	nn	18	SENT_247	[p9l774t1100r951b1134],
18	)	NN	O	)	conj_and	13	SENT_247	[p9l774t1100r951b1134],
19	.	.	O	.	_	0	SENT_247	[p9l774t1100r951b1134],

1	Semin	NNP	PERSON	Semin	_	0	SENT_248	[p9l964t1100r1060b1126],
2	.	.	O	.	_	0	SENT_248	[p9l964t1100r1060b1126],

1	on	IN	O	on	dep	5	SENT_249	[p9l1075t1101r1130b1126],
2	-	:	O	-	_	0	SENT_249	[p9l1075t1101r1130b1126],
3	the	DT	O	the	det	5	SENT_249	[p9l1264t1100r1308b1126],
4	Philadelphia	NNP	LOCATION	Philadelphia	nn	5	SENT_249	[p9l1318t1100r1504b1134],
5	chromosome	NN	O	chromosome	_	0	SENT_249	[p9l1513t1100r1712b1126],
6	.	.	O	.	_	0	SENT_249	[p9l1513t1100r1712b1126],

1	N.	NNP	O	N.	nn	2	SENT_250	[p9l1722t1101r1753b1126],
2	Engl	NNP	O	Engl	_	0	SENT_250	[p9l1765t1100r1841b1133],
3	.	.	O	.	_	0	SENT_250	[p9l1765t1100r1841b1133],

1	J.	NNP	O	J.	nn	2	SENT_251	[p9l1853t1101r1875b1126],
2	col.	NNP	O	col.	_	0	SENT_251	[p9l517t1144r567b1170],
3	28	CD	NUMBER	28	number	4	SENT_251	[p9l581t1144r616b1170],
4	(	CD	NUMBER	(	num	5	SENT_251	[p9l629t1144r726b1178],
5	Suppl	NN	O	suppl	dep	2	SENT_251	[p9l629t1144r726b1178],
6	3	CD	NUMBER	3	num	7	SENT_251	[p9l738t1144r852b1176],
7	)	NN	O	)	dep	2	SENT_251	[p9l738t1144r852b1176],
8	:	:	O	:	_	0	SENT_251	[p9l738t1144r852b1176],
9	l	NN	O	l	dep	2	SENT_251	[p9l738t1144r852b1176],
10	—	CD	NUMBER	—	num	12	SENT_251	[p9l738t1144r852b1176],
11	l2	NN	O	l2	nn	12	SENT_251	[p9l738t1144r852b1176],
12	Med	NNP	O	Med	dep	9	SENT_251	[p9l1262t1144r1335b1170],
13	.	.	O	.	_	0	SENT_251	[p9l1262t1144r1335b1170],

1	344	CD	NUMBER	344	_	0	SENT_252	[p9l1350t1144r1545b1170],
2	:	:	O	:	_	0	SENT_252	[p9l1350t1144r1545b1170],
3	l038	CD	NUMBER	l038	num	4	SENT_252	[p9l1350t1144r1545b1170],
4	—	CD	NUMBER	—	dep	1	SENT_252	[p9l1350t1144r1545b1170],
5	42	CD	NUMBER	42	number	6	SENT_252	[p9l1350t1144r1545b1170],
6	3	CD	NUMBER	3	dep	4	SENT_252	[p9l473t1189r497b1216],
7	.	.	O	.	_	0	SENT_252	[p9l473t1189r497b1216],

1	Pastan	NNP	O	Pastan	nn	2	SENT_253	[p9l517t1190r613b1215],
2	I	NNP	O	I	_	0	SENT_253	[p9l620t1190r639b1220],
3	,	,	O	,	_	0	SENT_253	[p9l620t1190r639b1220],
4	Kreitman	NNP	PERSON	Kreitman	nn	5	SENT_253	[p9l654t1189r794b1215],
5	RJ	NN	O	rj	appos	2	SENT_253	[p9l800t1190r846b1216],
6	.	.	O	.	_	0	SENT_253	[p9l800t1190r846b1216],

1	1998	CD	DATE	1998	_	0	SENT_254	[p9l859t1189r936b1216],
2	.	.	O	.	_	0	SENT_254	[p9l859t1189r936b1216],

1	Imn1unotox	NN	O	imn1unotox	_	0	SENT_255	[p9l945t1190r1130b1215],
2	-	:	O	-	_	0	SENT_255	[p9l945t1190r1130b1215],
3	5	CD	NUMBER	5	dep	1	SENT_255	[p9l1220t1189r1244b1216],
4	.	.	O	.	_	0	SENT_255	[p9l1220t1189r1244b1216],

1	Pluen	NNP	MISC	Pluen	nn	2	SENT_256	[p9l1264t1189r1348b1215],
2	A	NNP	MISC	A	_	0	SENT_256	[p9l1357t1189r1391b1220],
3	,	,	O	,	_	0	SENT_256	[p9l1357t1189r1391b1220],
4	Boucher	NNP	PERSON	Boucher	nn	5	SENT_256	[p9l1409t1189r1536b1215],
5	Y	NN	PERSON	y	appos	2	SENT_256	[p9l1544t1190r1573b1220],
6	,	,	O	,	_	0	SENT_256	[p9l1544t1190r1573b1220],
7	Ramanujan	NNP	PERSON	Ramanujan	nn	8	SENT_256	[p9l1591t1189r1761b1223],
8	S	NNP	O	S	appos	2	SENT_256	[p9l1771t1189r1797b1220],
9	,	,	O	,	_	0	SENT_256	[p9l1771t1189r1797b1220],
10	et	FW	O	et	nn	12	SENT_256	[p9l1808t1193r1834b1215],
11	al.	FW	O	al.	nn	12	SENT_256	[p9l1844t1189r1876b1215],
12	ins	NNS	O	in	appos	2	SENT_256	[p9l517t1234r558b1260],
13	for	IN	O	for	_	0	SENT_256	[p9l568t1234r612b1260],
14	targeted	VBN	O	target	amod	16	SENT_256	[p9l620t1234r739b1268],
15	cancer	NN	O	cancer	nn	16	SENT_256	[p9l748t1242r845b1260],
16	therapy	NN	O	therapy	prep_for	12	SENT_256	[p9l854t1234r969b1268],
17	.	.	O	.	_	0	SENT_256	[p9l854t1234r969b1268],

1	Adv	NNP	O	Adv	_	0	SENT_257	[p9l978t1234r1040b1260],
2	.	.	O	.	_	0	SENT_257	[p9l978t1234r1040b1260],

1	Drug	NN	O	drug	_	0	SENT_258	[p9l1052t1235r1131b1268],
2	2001	CD	DATE	2001	dep	1	SENT_258	[p9l1264t1234r1345b1260],
3	.	.	O	.	_	0	SENT_258	[p9l1264t1234r1345b1260],

1	Role	NN	O	role	_	0	SENT_259	[p9l1361t1234r1430b1260],
2	of	IN	O	of	_	0	SENT_259	[p9l1444t1234r1476b1260],
3	tumor	NN	O	tumor	nn	6	SENT_259	[p9l1487t1234r1650b1260],
4	—	NN	O	—	nn	6	SENT_259	[p9l1487t1234r1650b1260],
5	host	NN	O	host	nn	6	SENT_259	[p9l1487t1234r1650b1260],
6	interactions	NNS	O	interaction	prep_of	1	SENT_259	[p9l1663t1234r1836b1260],
7	in	IN	O	in	_	0	SENT_259	[p9l1850t1234r1878b1260],
8	Deliv	NNP	O	Deliv	prep_in	1	SENT_259	[p9l516t1279r600b1306],
9	.	.	O	.	_	0	SENT_259	[p9l516t1279r600b1306],

1	Rev.	NNP	O	Rev.	_	0	SENT_260	[p9l612t1280r671b1306],
2	31:53	CD	NUMBER	31:53	number	3	SENT_260	[p9l686t1279r824b1306],
3	-88	CD	NUMBER	-88	dep	1	SENT_260	[p9l686t1279r824b1306],
4	interstitial	JJ	O	interstitial	amod	5	SENT_260	[p9l1264t1279r1414b1306],
5	diffusion	NN	O	diffusion	dep	3	SENT_260	[p9l1430t1279r1563b1306],
6	of	IN	O	of	_	0	SENT_260	[p9l1579t1279r1611b1306],
7	macromolecules	NNS	O	macromolecule	prep_of	1	SENT_260	[p9l1624t1279r1876b1306],
8	:	:	O	:	_	0	SENT_260	[p9l1624t1279r1876b1306],

1	DRUG	NN	O	drug	nn	2	SENT_261	[p9l1107t1337r1210b1364],
2	RESISTANCE	NN	O	resistance	_	0	SENT_261	[p9l1221t1337r1442b1364],
3	IN	IN	O	in	_	0	SENT_261	[p9l1453t1338r1491b1364],
4	CANCER	NNP	O	CANCER	prep_in	2	SENT_261	[p9l1502t1337r1652b1364],
5	625	CD	NUMBER	625	num	4	SENT_261	[p9l1741t1334r1801b1364],

1	4	LS	NUMBER	4	_	0	SENT_262	[p9l1219t876r1244b902],
2	.	.	O	.	_	0	SENT_262	[p9l1219t876r1244b902],

1	Druker	NNP	PERSON	Druker	nn	2	SENT_263	[p9l1264t876r1369b902],
2	BJ	NNP	O	BJ	_	0	SENT_263	[p9l1381t877r1428b907],
3	,	,	O	,	_	0	SENT_263	[p9l1381t877r1428b907],
4	Sawyers	NNP	ORGANIZATION	Sawyers	nn	5	SENT_263	[p9l1455t876r1578b910],
5	CL	NN	ORGANIZATION	cl	appos	2	SENT_263	[p9l1592t876r1647b907],
6	,	,	O	,	_	0	SENT_263	[p9l1592t876r1647b907],
7	Kantarjian	JJ	O	kantarjian	amod	8	SENT_263	[p9l1674t876r1830b910],
8	H	NN	O	h	appos	2	SENT_263	[p9l1843t877r1877b907],
9	,	,	O	,	_	0	SENT_263	[p9l1843t877r1877b907],
10	et	FW	O	et	nn	11	SENT_263	[p9l1264t925r1290b947],
11	al.	FW	O	al.	appos	2	SENT_263	[p9l1300t921r1332b947],
12	2001	CD	DATE	2001	dep	11	SENT_263	[p9l1344t921r1424b948],
13	.	.	O	.	_	0	SENT_263	[p9l1344t921r1424b948],

1	Activity	NN	O	activity	_	0	SENT_264	[p9l1435t921r1555b955],
2	of	IN	O	of	_	0	SENT_264	[p9l1565t921r1597b947],
3	a	DT	O	a	det	5	SENT_264	[p9l1604t929r1620b947],
4	speciﬁc	NN	O	speciﬁc	nn	5	SENT_264	[p9l1630t921r1741b955],
5	inhibitor	NN	O	inhibitor	prep_of	1	SENT_264	[p9l1750t921r1879b947],
6	of	IN	O	of	_	0	SENT_264	[p9l1264t966r1296b992],
7	the	DT	O	the	det	10	SENT_264	[p9l1309t966r1354b992],
8	BCR-ABL	NN	MISC	bcr-abl	nn	10	SENT_264	[p9l1369t966r1530b992],
9	tyrosine	NN	O	tyrosine	nn	10	SENT_264	[p9l1545t966r1665b1000],
10	kinase	NN	O	kinase	prep_of	1	SENT_264	[p9l1680t966r1774b992],
11	in	IN	O	in	_	0	SENT_264	[p9l1790t966r1818b992],
12	the	DT	O	the	det	14	SENT_264	[p9l1833t966r1878b992],
13	blast	NN	O	blast	nn	14	SENT_264	[p9l1263t1010r1334b1036],
14	crisis	NN	O	crisis	prep_in	1	SENT_264	[p9l1347t1010r1424b1036],
15	of	IN	O	of	_	0	SENT_264	[p9l1439t1010r1471b1036],
16	chronic	JJ	O	chronic	amod	18	SENT_264	[p9l1483t1010r1593b1036],
17	myeloid	JJ	O	myeloid	amod	18	SENT_264	[p9l1607t1010r1729b1044],
18	leukemia	NN	O	leukemia	prep_of	14	SENT_264	[p9l1743t1010r1879b1036],
19	and	CC	O	and	_	0	SENT_264	[p9l1264t1055r1317b1081],
20	acute	JJ	O	acute	amod	22	SENT_264	[p9l1335t1059r1412b1081],
21	lymphoblastic	JJ	O	lymphoblastic	amod	22	SENT_264	[p9l1431t1055r1641b1089],
22	leukemia	NN	O	leukemia	conj_and	14	SENT_264	[p9l1659t1055r1795b1081],
23	with	IN	O	with	_	0	SENT_264	[p9l1813t1055r1878b1081],
24	cranial	JJ	O	cranial	prep_with	22	SENT_264	[p9l637t1569r883b1633],
25	vs.	CC	O	vs.	prep	24	SENT_264	[p9l933t1589r1031b1633],
26	subcutaneous	JJ	O	subcutaneous	amod	27	SENT_264	[p9l1088t1569r1577b1633],
27	tumors	NNS	O	tumor	dep	25	SENT_264	[p9l1628t1579r1900b1633],
28	.	.	O	.	_	0	SENT_264	[p9l1628t1579r1900b1633],

1	Proc	NNP	O	Proc	_	0	SENT_265	[p9l1953t1571r2141b1633],
2	.	.	O	.	_	0	SENT_265	[p9l1953t1571r2141b1633],

1	Natl.	NNP	O	Natl.	nn	2	SENT_266	[p9l633t1681r806b1745],
2	Acad	NNP	O	Acad	_	0	SENT_266	[p9l835t1681r1042b1745],
3	.	.	O	.	_	0	SENT_266	[p9l835t1681r1042b1745],

1	Sci	NNP	O	Sci	_	0	SENT_267	[p9l1076t1682r1200b1746],
2	.	.	O	.	_	0	SENT_267	[p9l1076t1682r1200b1746],

1	USA	NNP	LOCATION	USA	_	0	SENT_268	[p9l1242t1682r1398b1746],
2	98:4628	CD	NUMBER	98:4628	number	3	SENT_268	[p9l1427t1681r1859b1746],
3	—	CD	NUMBER	—	dep	1	SENT_268	[p9l1427t1681r1859b1746],
4	33	CD	NUMBER	33	dep	3	SENT_268	[p9l1427t1681r1859b1746],

1	6	CD	NUMBER	6	_	0	SENT_269	[p9l528t1791r587b1856],
2	.	.	O	.	_	0	SENT_269	[p9l528t1791r587b1856],

1	Green	NNP	ORGANIZATION	Green	nn	2	SENT_270	[p9l638t1792r858b1856],
2	SK	NNP	ORGANIZATION	SK	_	0	SENT_270	[p9l887t1792r1019b1867],
3	,	,	O	,	_	0	SENT_270	[p9l887t1792r1019b1867],
4	Frankel	NNP	PERSON	Frankel	nn	5	SENT_270	[p9l1072t1791r1350b1855],
5	A	NNP	O	A	appos	2	SENT_270	[p9l1377t1792r1460b1867],
6	,	,	O	,	_	0	SENT_270	[p9l1377t1792r1460b1867],
7	Kerbel	NNP	PERSON	Kerbel	nn	8	SENT_270	[p9l1516t1791r1759b1855],
8	RS	NN	O	r	appos	5	SENT_270	[p9l1786t1792r1914b1856],
9	.	.	O	.	_	0	SENT_270	[p9l1786t1792r1914b1856],

1	1999	CD	DATE	1999	_	0	SENT_271	[p9l1954t1792r2145b1856],
2	.	.	O	.	_	0	SENT_271	[p9l1954t1792r2145b1856],

1	Adhesion-dependent	JJ	O	adhesion-dependent	amod	3	SENT_272	[p9l636t1902r1397b1986],
2	multicellular	JJ	O	multicellular	amod	3	SENT_272	[p9l1455t1902r1925b1967],
3	drug	NN	O	drug	_	0	SENT_272	[p9l1984t1902r2148b1986],
4	resistance	NN	O	resistance	dep	3	SENT_272	[p9l635t2015r1015b2080],
5	.	.	O	.	_	0	SENT_272	[p9l635t2015r1015b2080],

1	Anticancer-Drug	NNP	O	Anticancer-Drug	nn	2	SENT_273	[p9l1045t2016r1675b2098],
2	Designs	NNS	O	design	_	0	SENT_273	[p9l1706t2017r2002b2098],
3	14	CD	NUMBER	14	dep	2	SENT_273	[p9l2043t2015r2143b2080],
4	:	:	O	:	_	0	SENT_273	[p9l2043t2015r2143b2080],
5	15	CD	NUMBER	15	number	6	SENT_273	[p9l645t2126r721b2190],
6	3	CD	NUMBER	3	dep	3	SENT_273	[p9l730t2126r906b2190],
7	—	NN	O	—	dep	6	SENT_273	[p9l730t2126r906b2190],
8	68	CD	NUMBER	68	num	7	SENT_273	[p9l730t2126r906b2190],

1	7	CD	NUMBER	7	_	0	SENT_274	[p9l527t2239r587b2302],
2	.	.	O	.	_	0	SENT_274	[p9l527t2239r587b2302],

1	Longo-Sorbello	NNP	O	Longo-Sorbello	nn	2	SENT_275	[p9l635t2238r1215b2321],
2	GS	NN	O	g	_	0	SENT_275	[p9l1258t2238r1392b2314],
3	,	,	O	,	_	0	SENT_275	[p9l1258t2238r1392b2314],
4	Bertino	NNP	PERSON	Bertino	nn	5	SENT_275	[p9l1473t2237r1745b2302],
5	JR.	NNP	O	JR.	appos	2	SENT_275	[p9l1786t2239r1900b2303],
6	2001	CD	DATE	2001	dep	5	SENT_275	[p9l1946t2238r2145b2303],
7	.	.	O	.	_	0	SENT_275	[p9l1946t2238r2145b2303],

1	Current	JJ	DATE	current	amod	2	SENT_276	[p9l637t2350r916b2415],
2	understanding	NN	O	understanding	_	0	SENT_276	[p9l969t2350r1488b2433],
3	of	IN	O	of	_	0	SENT_276	[p9l1545t2350r1624b2414],
4	methotrexate	NN	O	methotrexate	nn	5	SENT_276	[p9l1673t2350r2149b2414],
5	pharmacology	NN	O	pharmacology	prep_of	2	SENT_276	[p9l635t2461r1159b2545],
6	and	CC	O	and	_	0	SENT_276	[p9l1240t2461r1370b2525],
7	efﬁcacy	NN	O	efﬁcacy	conj_and	5	SENT_276	[p9l1448t2461r1732b2545],
8	in	IN	O	in	_	0	SENT_276	[p9l1810t2461r1880b2524],
9	acute	JJ	O	acute	amod	10	SENT_276	[p9l1960t2471r2149b2525],
10	leukemias	NNS	O	leukemia	prep_in	2	SENT_276	[p9l636t2572r1024b2636],
11	.	.	O	.	_	0	SENT_276	[p9l636t2572r1024b2636],

1	Use	NN	O	use	_	0	SENT_277	[p9l1076t2574r1216b2637],
2	of	IN	O	of	_	0	SENT_277	[p9l1265t2572r1344b2636],
3	newer	JJR	O	newer	amod	4	SENT_277	[p9l1385t2593r1607b2636],
4	antifolates	NNS	O	antifolate	prep_of	1	SENT_277	[p9l1654t2572r2031b2636],
5	in	IN	O	in	_	0	SENT_277	[p9l2080t2572r2150b2636],
6	clinical	JJ	O	clinical	amod	7	SENT_277	[p9l637t2685r904b2749],
7	trials	NNS	O	trial	prep_in	1	SENT_277	[p9l963t2685r1163b2749],
8	.	.	O	.	_	0	SENT_277	[p9l963t2685r1163b2749],

1	Haematologica	NNP	O	Haematologica	_	0	SENT_278	[p9l1225t2685r1791b2766],
2	86:12127	CD	NUMBER	86:12127	dep	1	SENT_278	[p9l1854t2685r2152b2749, p9l637t2795r722b2859],

1	8	CD	NUMBER	8	_	0	SENT_279	[p9l530t2908r587b2972],
2	.	.	O	.	_	0	SENT_279	[p9l530t2908r587b2972],

1	Gottesman	NNP	PERSON	Gottesman	nn	2	SENT_280	[p9l638t2908r1032b2972],
2	MM	NN	O	mm	_	0	SENT_280	[p9l1068t2909r1249b2983],
3	,	,	O	,	_	0	SENT_280	[p9l1068t2909r1249b2983],
4	Ambudkar	NNP	O	Ambudkar	nn	5	SENT_280	[p9l1321t2907r1713b2971],
5	SV	NNP	O	SV	appos	2	SENT_280	[p9l1749t2908r1870b2983],
6	,	,	O	,	_	0	SENT_280	[p9l1749t2908r1870b2983],
7	Ni	NN	MISC	nus	nn	8	SENT_280	[p9l1942t2907r2031b2971],
8	B	NN	O	b	appos	2	SENT_280	[p9l2068t2909r2146b2983],
9	,	,	O	,	_	0	SENT_280	[p9l2068t2909r2146b2983],
10	et	FW	O	et	nn	11	SENT_280	[p9l637t3029r701b3084],
11	al.	FW	O	al.	appos	2	SENT_280	[p9l745t3019r825b3084],
12	1994	CD	DATE	1994	dep	11	SENT_280	[p9l882t3020r1073b3084],
13	.	.	O	.	_	0	SENT_280	[p9l882t3020r1073b3084],

1	Exploiting	VBG	O	exploit	_	0	SENT_281	[p9l1120t3019r1505b3103],
2	multidrug	JJ	O	multidrug	amod	3	SENT_281	[p9l1549t3019r1909b3103],
3	resistance	NN	O	resistance	dobj	1	SENT_281	[p9l1952t3019r2147b3084, p9l636t3142r827b3196],
4	to	TO	O	to	aux	5	SENT_281	[p9l852t3142r919b3196],
5	treat	VB	O	treat	xcomp	1	SENT_281	[p9l944t3142r1107b3196],
6	cancer	NN	O	cancer	dobj	5	SENT_281	[p9l1130t3152r1380b3196],
7	.	.	O	.	_	0	SENT_281	[p9l1130t3152r1380b3196],

1	Cold	NNP	O	Cold	nn	4	SENT_282	[p9l1413t3132r1589b3197],
2	Spring	NNP	DATE	Spring	nn	4	SENT_282	[p9l1609t3133r1851b3214],
3	Harbor	NNP	O	Harbor	nn	4	SENT_282	[p9l1873t3132r2153b3196],
4	Symp	NNP	O	Symp	_	0	SENT_282	[p9l636t3246r847b3327],
5	.	.	O	.	_	0	SENT_282	[p9l636t3246r847b3327],

1	Quant	NN	O	quant	_	0	SENT_283	[p9l885t3246r1123b3325],
2	.	.	O	.	_	0	SENT_283	[p9l885t3246r1123b3325],

1	Biol	NNP	O	Biol	_	0	SENT_284	[p9l1155t3244r1323b3309],
2	.	.	O	.	_	0	SENT_284	[p9l1155t3244r1323b3309],

1	592677-83	CD	NUMBER	592677-83	_	0	SENT_285	[p9l1358t3244r1743b3310],

1	9	CD	NUMBER	9	_	0	SENT_286	[p9l527t3357r587b3422],
2	.	.	O	.	_	0	SENT_286	[p9l527t3357r587b3422],

1	Liu	NNP	PERSON	Liu	nn	2	SENT_287	[p9l635t3357r761b3421],
2	YY	NNP	O	YY	_	0	SENT_287	[p9l801t3359r939b3433],
3	,	,	O	,	_	0	SENT_287	[p9l801t3359r939b3433],
4	Han	NNP	ORGANIZATION	Han	nn	5	SENT_287	[p9l1019t3359r1170b3421],
5	TY	NNP	ORGANIZATION	TY	appos	2	SENT_287	[p9l1209t3359r1337b3433],
6	,	,	O	,	_	0	SENT_287	[p9l1209t3359r1337b3433],
7	Giuliano	NNP	PERSON	Giuliano	nn	8	SENT_287	[p9l1419t3357r1736b3422],
8	AE	NNP	PERSON	AE	appos	2	SENT_287	[p9l1776t3357r1916b3433],
9	,	,	O	,	_	0	SENT_287	[p9l1776t3357r1916b3433],
10	et	FW	O	et	nn	11	SENT_287	[p9l1960t3367r2025b3421],
11	al.	FW	O	al.	appos	2	SENT_287	[p9l2064t3357r2145b3421],
12	2001	CD	DATE	2001	dep	11	SENT_287	[p9l637t3470r836b3534],
13	.	.	O	.	_	0	SENT_287	[p9l637t3470r836b3534],

1	Ceramide	NN	O	ceramide	nn	2	SENT_288	[p9l863t3470r1217b3534],
2	glycosylation	NN	O	glycosylation	nsubj	3	SENT_288	[p9l1240t3470r1732b3553],
3	potentiates	VBZ	O	potentiate	_	0	SENT_288	[p9l1752t3470r2147b3553],

1	Annu	NNP	PERSON	Annu	_	0	SENT_289	[p10l7t1740r64b1937],
2	.	.	O	.	_	0	SENT_289	[p10l7t1740r64b1937],

1	Rev.	NNP	O	Rev.	nn	2	SENT_290	[p10l8t1566r65b1713],
2	Med	NNP	O	Med	_	0	SENT_290	[p10l7t1375r64b1539],
3	.	.	O	.	_	0	SENT_290	[p10l7t1375r64b1539],

1	2002.53	CD	NUMBER	2002.53	num	2	SENT_291	[p10l7t1087r65b1347],
2	:6	CD	NUMBER	:6	_	0	SENT_291	[p10l7t1021r65b1075],
3	1	CD	NUMBER	1	num	4	SENT_291	[p10l7t986r64b1009],
4	5-627	NN	O	5-627	dep	2	SENT_291	[p10l7t771r65b974],
5	.	.	O	.	_	0	SENT_291	[p10l7t771r65b974],

1	Downloaded	VBN	O	download	_	0	SENT_292	[p10l7t325r65b743],
2	from	IN	O	from	_	0	SENT_292	[p10l7t146r64b304],
3	WW	NN	O	ww	prep_from	1	SENT_292	[p10l26t8r65b124],

1	by	IN	O	by	_	0	SENT_293	[p10l89t1773r164b1854],
2	University	NNP	ORGANIZATION	University	pobj	1	SENT_293	[p10l89t1405r164b1750],
3	of	IN	ORGANIZATION	of	_	0	SENT_293	[p10l89t1311r146b1381],
4	Wisconsin	NNP	ORGANIZATION	Wisconsin	nn	6	SENT_293	[p10l89t948r146b1295],
5	—	NNP	O	—	nn	6	SENT_293	[p10l124t904r130b925],
6	Madison	NNP	O	Madison	prep_of	2	SENT_293	[p10l89t592r146b878],
7	on	IN	O	on	_	0	SENT_293	[p10l107t490r146b569],
8	01/05/14	CD	DATE	01/05/14	prep_on	6	SENT_293	[p10l89t162r147b467],
9	.	.	O	.	_	0	SENT_293	[p10l89t162r147b467],

1	For	IN	O	for	_	0	SENT_294	[p10l91t22r146b136],

1	11a	NN	O	11a	_	0	SENT_295	[p10l443t1149r582b1212],
2	.	.	O	.	_	0	SENT_295	[p10l443t1149r582b1212],

1	cellular	JJ	O	cellular	amod	3	SENT_296	[p10l637t24r911b88],
2	multidrug	JJ	O	multidrug	amod	3	SENT_296	[p10l954t24r1314b108],
3	resistance	NN	O	resistance	_	0	SENT_296	[p10l1358t24r1738b88],
4	.	.	O	.	_	0	SENT_296	[p10l1358t24r1738b88],

1	FASEB	NNP	ORGANIZATION	FASEB	nn	2	SENT_297	[p10l1787t25r2045b89],
2	J.	NNP	O	J.	_	0	SENT_297	[p10l2089t26r2141b89],
3	15	CD	NUMBER	15	num	2	SENT_297	[p10l645t136r745b201],
4	:	:	O	:	_	0	SENT_297	[p10l645t136r745b201],
5	719-30	CD	NUMBER	719-30	dep	2	SENT_297	[p10l777t137r1049b202],
6	Lowe	NNP	PERSON	Lowe	nn	7	SENT_297	[p10l635t250r840b313],
7	SW	NNP	O	SW	dep	2	SENT_297	[p10l862t249r1006b325],
8	,	,	O	,	_	0	SENT_297	[p10l862t249r1006b325],
9	Ruley	NNP	PERSON	Ruley	appos	2	SENT_297	[p10l1043t249r1259b332],
10	HE	PRP	O	he	dep	9	SENT_297	[p10l1278t250r1418b325],
11	,	,	O	,	_	0	SENT_297	[p10l1278t250r1418b325],
12	Jacks	NNPS	ORGANIZATION	Jacks	appos	2	SENT_297	[p10l1454t249r1649b313],
13	T	NN	ORGANIZATION	t	dep	12	SENT_297	[p10l1670t250r1737b325],
14	,	,	O	,	_	0	SENT_297	[p10l1670t250r1737b325],
15	et	FW	O	et	nn	16	SENT_297	[p10l1759t259r1823b313],
16	al.	FW	O	al.	appos	2	SENT_297	[p10l1842t249r1923b313],
17	1993	CD	DATE	1993	dep	16	SENT_297	[p10l1954t249r2146b314],
18	.	.	O	.	_	0	SENT_297	[p10l1954t249r2146b314],

1	p53-dependent	JJ	O	p53-dependent	amod	2	SENT_298	[p10l635t361r1182b445],
2	apoptosis	NN	O	apoptosis	nsubj	3	SENT_298	[p10l1229t361r1569b445],
3	modulates	VBZ	O	modulate	_	0	SENT_298	[p10l1618t361r1992b425],
4	the	DT	O	the	det	5	SENT_298	[p10l2039t361r2149b425],
5	cytotoxicity	NN	O	cytotoxicity	dobj	3	SENT_298	[p10l637t473r1071b557],
6	of	IN	O	of	_	0	SENT_298	[p10l1094t473r1174b538],
7	anticancer	JJ	O	anticancer	amod	8	SENT_298	[p10l1191t473r1566b538],
8	agents	NNS	O	agent	prep_of	5	SENT_298	[p10l1587t483r1836b557],
9	.	.	O	.	_	0	SENT_298	[p10l1587t483r1836b557],

1	Cell	NN	O	cell	_	0	SENT_299	[p10l1867t473r2015b539],
2	74	CD	NUMBER	74	num	1	SENT_299	[p10l2035t474r2143b538],
3	:	:	O	:	_	0	SENT_299	[p10l2035t474r2143b538],
4	957-67	CD	NUMBER	957-67	dep	1	SENT_299	[p10l637t586r906b651],
5	Synold	JJ	O	synold	amod	6	SENT_299	[p10l639t698r895b781],
6	TW	NNP	O	TW	dep	1	SENT_299	[p10l936t699r1087b774],
7	,	,	O	,	_	0	SENT_299	[p10l936t699r1087b774],
8	Dussault	NNP	PERSON	Dussault	appos	1	SENT_299	[p10l1170t698r1492b762],
9	I	PRP	O	I	dep	8	SENT_299	[p10l1531t699r1579b774],
10	,	,	O	,	_	0	SENT_299	[p10l1531t699r1579b774],
11	Forman	NNP	PERSON	Forman	nn	12	SENT_299	[p10l1661t699r1945b762],
12	BM	NN	O	bm	appos	1	SENT_299	[p10l1986t699r2145b762],
13	.	.	O	.	_	0	SENT_299	[p10l1986t699r2145b762],

1	2001	CD	DATE	2001	_	0	SENT_300	[p10l637t811r836b875],
2	.	.	O	.	_	0	SENT_300	[p10l637t811r836b875],

1	The	DT	O	the	det	5	SENT_301	[p10l875t810r1015b875],
2	orphan	JJ	O	orphan	amod	5	SENT_301	[p10l1051t810r1303b894],
3	nuclear	JJ	O	nuclear	amod	5	SENT_301	[p10l1337t810r1607b875],
4	receptor	NN	O	receptor	nn	5	SENT_301	[p10l1639t820r1940b894],
5	SXR	NN	O	sxr	nsubj	7	SENT_301	[p10l1975t811r2151b875],
6	coordinately	RB	O	coordinately	advmod	7	SENT_301	[p10l637t923r1093b1006],
7	regulates	VBZ	O	regulate	_	0	SENT_301	[p10l1138t923r1465b1006],
8	drug	NN	O	drug	nn	9	SENT_301	[p10l1512t923r1677b1006],
9	metabolism	NN	O	metabolism	dobj	7	SENT_301	[p10l1723t922r2151b987],
10	and	CC	O	and	_	0	SENT_301	[p10l638t1036r767b1100],
11	efﬂux	NN	O	efﬂux	dobj	7	SENT_301	[p10l793t1036r1020b1100],
12	.	.	O	.	_	0	SENT_301	[p10l793t1036r1020b1100],

1	Nat	NN	PERSON	nat	_	0	SENT_302	[p10l1047t1038r1195b1100],
2	.	.	O	.	_	0	SENT_302	[p10l1047t1038r1195b1100],

1	Med	NNP	O	Med	_	0	SENT_303	[p10l1226t1036r1404b1100],
2	.	.	O	.	_	0	SENT_303	[p10l1226t1036r1404b1100],

1	7	CD	NUMBER	7	_	0	SENT_304	[p10l1440t1037r1502b1100],
2	:	:	O	:	_	0	SENT_304	[p10l1440t1037r1502b1100],
3	584-90	CD	NUMBER	584-90	num	9	SENT_304	[p10l1535t1036r1807b1101],
4	Dalton	NNP	LOCATION	Dalton	nn	9	SENT_304	[p10l636t1148r884b1212],
5	WS	NNP	LOCATION	WS	nn	9	SENT_304	[p10l933t1148r1089b1224],
6	,	,	O	,	_	0	SENT_304	[p10l933t1148r1089b1224],
7	Scheper	NNP	PERSON	Scheper	appos	9	SENT_304	[p10l1193t1148r1487b1231],
8	R	NNP	O	R	nn	9	SENT_304	[p10l1535t1149r1648b1212],
9	]	NN	O	]	dep	1	SENT_304	[p10l1535t1149r1648b1212],
10	.	.	O	.	_	0	SENT_304	[p10l1535t1149r1648b1212],

1	1999	CD	DATE	1999	_	0	SENT_305	[p10l1712t1148r1903b1213],
2	.	.	O	.	_	0	SENT_305	[p10l1712t1148r1903b1213],

1	Lung	NN	O	lung	nn	3	SENT_306	[p10l1957t1150r2148b1231],
2	resistance-related	JJ	O	resistance-related	amod	3	SENT_306	[p10l635t1260r1278b1325],
3	protein	NN	O	protein	_	0	SENT_306	[p10l1297t1260r1575b1344],
4	:	:	O	:	_	0	SENT_306	[p10l1297t1260r1575b1344],
5	determining	VBG	O	determine	dep	3	SENT_306	[p10l1603t1260r2043b1344],
6	its	PRP$	O	its	poss	7	SENT_306	[p10l2065t1260r2147b1324],
7	role	NN	O	role	dobj	5	SENT_306	[p10l635t1373r776b1437],
8	in	IN	O	in	_	0	SENT_306	[p10l800t1373r869b1436],
9	multidrug	JJ	O	multidrug	amod	10	SENT_306	[p10l892t1373r1252b1456],
10	resistance	NN	O	resistance	prep_in	5	SENT_306	[p10l1275t1373r1655b1437],
11	.	.	O	.	_	0	SENT_306	[p10l1275t1373r1655b1437],

1	J.	NNP	O	J.	nn	4	SENT_307	[p10l1681t1376r1733b1438],
2	Natl.	NNP	O	Natl.	nn	4	SENT_307	[p10l1762t1373r1936b1438],
3	Cancer	NNP	O	Cancer	nn	4	SENT_307	[p10l1973t1374r2147b1438, p10l637t1507r755b1549],
4	Inst	NNP	O	Inst	_	0	SENT_307	[p10l774t1487r926b1549],
5	.	.	O	.	_	0	SENT_307	[p10l774t1487r926b1549],

1	9121604-5	CD	NUMBER	9121604-5	num	3	SENT_308	[p10l962t1485r1348b1551],
2	Borst	NNP	ORGANIZATION	Borst	nn	3	SENT_308	[p10l636t1600r834b1662],
3	P	NN	ORGANIZATION	p	_	0	SENT_308	[p10l866t1600r925b1674],
4	,	,	O	,	_	0	SENT_308	[p10l866t1600r925b1674],
5	Evers	NNP	ORGANIZATION	Evers	nn	6	SENT_308	[p10l992t1600r1197b1662],
6	R	NNP	ORGANIZATION	R	appos	3	SENT_308	[p10l1232t1600r1311b1674],
7	,	,	O	,	_	0	SENT_308	[p10l1232t1600r1311b1674],
8	Kool	NNP	ORGANIZATION	Kool	nn	9	SENT_308	[p10l1380t1597r1557b1662],
9	M	NNP	ORGANIZATION	M	appos	3	SENT_308	[p10l1590t1600r1690b1674],
10	,	,	O	,	_	0	SENT_308	[p10l1590t1600r1690b1674],
11	et	FW	O	et	nn	12	SENT_308	[p10l1728t1607r1792b1662],
12	al.	FW	O	al.	appos	3	SENT_308	[p10l1826t1597r1907b1662],
13	2000	CD	DATE	2000	dep	12	SENT_308	[p10l1946t1598r2145b1663],
14	.	.	O	.	_	0	SENT_308	[p10l1946t1598r2145b1663],

1	A	DT	O	a	det	2	SENT_309	[p10l636t1711r700b1774],
2	family	NN	O	family	_	0	SENT_309	[p10l731t1710r967b1794],
3	of	IN	O	of	_	0	SENT_309	[p10l999t1710r1078b1775],
4	drug	NN	O	drug	nn	5	SENT_309	[p10l1103t1711r1267b1794],
5	transporters	NNS	O	transporter	prep_of	2	SENT_309	[p10l1299t1720r1750b1794],
6	:	:	O	:	_	0	SENT_309	[p10l1299t1720r1750b1794],
7	the	DT	O	the	det	10	SENT_309	[p10l1787t1711r1897b1775],
8	multidrug	JJ	O	multidrug	amod	10	SENT_309	[p10l1927t1710r2147b1775, p10l637t1823r801b1906],
9	resistance-associated	JJ	O	resistance-associated	amod	10	SENT_309	[p10l868t1823r1640b1887],
10	proteins	NNS	O	protein	dep	2	SENT_309	[p10l1705t1823r2019b1906],
11	.	.	O	.	_	0	SENT_309	[p10l1705t1823r2019b1906],

1	J.	NNP	O	J.	nn	4	SENT_310	[p10l2089t1825r2141b1888],
2	Natl.	NNP	O	Natl.	nn	4	SENT_310	[p10l633t1935r806b2001],
3	Cancer	NNP	O	Cancer	nn	4	SENT_310	[p10l845t1937r1113b2001],
4	Inst	NNP	O	Inst	_	0	SENT_310	[p10l1132t1938r1285b2001],
5	.	.	O	.	_	0	SENT_310	[p10l1132t1938r1285b2001],

1	9221295-301	CD	NUMBER	9221295-301	num	3	SENT_311	[p10l1320t1935r1794b2001],
2	Ambudkar	NNP	O	Ambudkar	nn	3	SENT_311	[p10l636t2047r1027b2112],
3	SV	NNP	O	SV	_	0	SENT_311	[p10l1047t2048r1167b2124],
4	,	,	O	,	_	0	SENT_311	[p10l1047t2048r1167b2124],
5	Dey	NNP	PERSON	Dey	nn	6	SENT_311	[p10l1206t2049r1355b2131],
6	S	NNP	O	S	appos	3	SENT_311	[p10l1377t2048r1442b2124],
7	,	,	O	,	_	0	SENT_311	[p10l1377t2048r1442b2124],
8	Hrycyna	NNP	LOCATION	Hrycyna	nn	9	SENT_311	[p10l1481t2049r1796b2131],
9	CA	NNP	LOCATION	CA	appos	3	SENT_311	[p10l1814t2048r1958b2124],
10	,	,	O	,	_	0	SENT_311	[p10l1814t2048r1958b2124],
11	et	FW	O	et	nn	12	SENT_311	[p10l1981t2058r2046b2112],
12	al.	FW	O	al.	appos	3	SENT_311	[p10l2065t2048r2145b2112],
13	1999	CD	DATE	1999	dep	12	SENT_311	[p10l645t2160r836b2226],
14	.	.	O	.	_	0	SENT_311	[p10l645t2160r836b2226],

1	Biochemical	JJ	MISC	biochemical	_	0	SENT_312	[p10l869t2160r1352b2236],
2	,	,	O	,	_	0	SENT_312	[p10l869t2160r1352b2236],
3	cellular	JJ	O	cellular	amod	6	SENT_312	[p10l1385t2160r1659b2225],
4	and	CC	O	and	_	0	SENT_312	[p10l1688t2160r1818b2225],
5	pharmacological	JJ	O	pharmacological	amod	6	SENT_312	[p10l1844t2160r2147b2243, p10l637t2271r971b2355],
6	aspects	NNS	O	aspect	appos	1	SENT_312	[p10l1006t2281r1265b2355],
7	of	IN	O	of	_	0	SENT_312	[p10l1300t2271r1380b2335],
8	the	DT	O	the	det	10	SENT_312	[p10l1406t2271r1516b2335],
9	multidrug	JJ	O	multidrug	amod	10	SENT_312	[p10l1549t2271r1909b2355],
10	transporter	NN	O	transporter	prep_of	6	SENT_312	[p10l1942t2281r2147b2335, p10l635t2393r867b2467],
11	.	.	O	.	_	0	SENT_312	[p10l1942t2281r2147b2335, p10l635t2393r867b2467],

1	Anna	NNP	PERSON	Anna	_	0	SENT_313	[p10l914t2385r1126b2448],
2	.	.	O	.	_	0	SENT_313	[p10l914t2385r1126b2448],

1	Rev.	NNP	O	Rev.	nn	2	SENT_314	[p10l1181t2386r1325b2449],
2	Pharmacol	NNP	PERSON	Pharmacol	_	0	SENT_314	[p10l1382t2383r1804b2448],
3	.	.	O	.	_	0	SENT_314	[p10l1382t2383r1804b2448],

1	Toxicol	NNP	O	Toxicol	_	0	SENT_315	[p10l1866t2383r2141b2448],
2	.	.	O	.	_	0	SENT_315	[p10l1866t2383r2141b2448],

1	39:361	CD	NUMBER	39:361	num	4	SENT_316	[p10l639t2496r1024b2561],
2	-98	CD	NUMBER	-98	num	4	SENT_316	[p10l639t2496r1024b2561],
3	Juliano	NNP	O	Juliano	nn	4	SENT_316	[p10l635t2606r898b2671],
4	RL	NNP	O	RL	_	0	SENT_316	[p10l923t2608r1058b2683],
5	,	,	O	,	_	0	SENT_316	[p10l923t2608r1058b2683],
6	Ling	NNP	O	Ling	nn	7	SENT_316	[p10l1106t2606r1277b2690],
7	V.	NNP	O	V.	appos	4	SENT_316	[p10l1302t2608r1372b2671],
8	1976	CD	DATE	1976	dep	7	SENT_316	[p10l1410t2606r1601b2672],
9	.	.	O	.	_	0	SENT_316	[p10l1410t2606r1601b2672],

1	A	DT	O	a	det	3	SENT_317	[p10l1629t2607r1694b2669],
2	surface	NN	O	surface	nn	3	SENT_317	[p10l1721t2606r1980b2670],
3	glycoprotein	NN	O	glycoprotein	_	0	SENT_317	[p10l2005t2606r2147b2690, p10l637t2718r981b2802],
4	modulating	VBG	O	modulate	partmod	3	SENT_317	[p10l1022t2718r1438b2802],
5	drug	NN	O	drug	nn	6	SENT_317	[p10l1480t2718r1645b2802],
6	permeability	NN	O	permeability	dobj	4	SENT_317	[p10l1686t2718r2149b2802],
7	in	IN	O	in	_	0	SENT_317	[p10l636t2831r706b2894],
8	Chinese	JJ	MISC	chinese	amod	12	SENT_317	[p10l749t2831r1042b2896],
9	hamster	NN	O	hamster	nn	12	SENT_317	[p10l1085t2831r1376b2895],
10	ovary	NN	O	ovary	nn	12	SENT_317	[p10l1419t2851r1621b2914],
11	cell	NN	O	cell	nn	12	SENT_317	[p10l1665t2831r1795b2895],
12	mutants	NNS	O	mutant	prep_in	6	SENT_317	[p10l1838t2840r2145b2895],
13	.	.	O	.	_	0	SENT_317	[p10l1838t2840r2145b2895],

1	Biochim	NNP	O	Biochim	_	0	SENT_318	[p10l634t2943r953b3008],
2	.	.	O	.	_	0	SENT_318	[p10l634t2943r953b3008],

1	Biophys	NNS	O	biophy	_	0	SENT_319	[p10l985t2943r1296b3026],
2	.	.	O	.	_	0	SENT_319	[p10l985t2943r1296b3026],

1	Acta	NN	PERSON	acta	_	0	SENT_320	[p10l1324t2944r1495b3008],
2	455	CD	NUMBER	455	num	1	SENT_320	[p10l1521t2943r1676b3008],
3	:	:	O	:	_	0	SENT_320	[p10l1521t2943r1676b3008],
4	152-62	CD	NUMBER	152-62	dep	1	SENT_320	[p10l1694t2943r1958b3008],
5	Ueda	NNP	O	Ueda	nn	6	SENT_320	[p10l636t3054r829b3119],
6	K	NNP	O	K	dep	1	SENT_320	[p10l859t3056r941b3130],
7	,	,	O	,	_	0	SENT_320	[p10l859t3056r941b3130],
8	Cardarelli	NNP	PERSON	Cardarelli	nn	9	SENT_320	[p10l1004t3054r1368b3119],
9	C	NNP	O	C	appos	1	SENT_320	[p10l1400t3055r1477b3130],
10	,	,	O	,	_	0	SENT_320	[p10l1400t3055r1477b3130],
11	Gottesman	NNP	PERSON	Gottesman	nn	12	SENT_320	[p10l1541t3055r1935b3119],
12	MM	NN	O	mm	appos	1	SENT_320	[p10l1965t3056r2146b3130],
13	,	,	O	,	_	0	SENT_320	[p10l1965t3056r2146b3130],
14	et	FW	O	et	nn	15	SENT_320	[p10l637t3177r701b3231],
15	al.	FW	O	al.	appos	1	SENT_320	[p10l744t3167r824b3231],
16	1987	CD	DATE	1987	dep	15	SENT_320	[p10l880t3167r1071b3232],
17	.	.	O	.	_	0	SENT_320	[p10l880t3167r1071b3232],

1	Expression	NN	O	expression	nsubj	13	SENT_321	[p10l1117t3167r1525b3250],
2	of	IN	O	of	_	0	SENT_321	[p10l1568t3167r1647b3231],
3	a	DT	O	a	det	7	SENT_321	[p10l1685t3187r1723b3231],
4	full	JJ	O	full	amod	7	SENT_321	[p10l1764t3167r2150b3250],
5	—	NN	O	—	nn	7	SENT_321	[p10l1764t3167r2150b3250],
6	length	NN	O	length	nn	7	SENT_321	[p10l1764t3167r2150b3250],
7	CDNA	NN	ORGANIZATION	cdna	prep_of	1	SENT_321	[p10l637t3278r871b3342],
8	for	IN	O	for	_	0	SENT_321	[p10l891t3278r998b3342],
9	the	DT	O	the	det	12	SENT_321	[p10l1016t3278r1126b3342],
10	human	JJ	O	human	amod	12	SENT_321	[p10l1146t3278r1396b3342],
11	MDRl	NN	O	mdrl	nn	12	SENT_321	[p10l1415t3278r1661b3341],
12	gene	NN	O	gene	prep_for	7	SENT_321	[p10l1691t3298r1860b3361],
13	confers	VBZ	O	confer	_	0	SENT_321	[p10l1882t3278r2147b3342],
14	resistance	NN	O	resistance	dobj	13	SENT_321	[p10l204t3599r668b3681],
15	to	TO	O	to	_	0	SENT_321	[p10l698t3611r785b3681],
16	colchicine	NN	O	colchicine	prep_to	13	SENT_321	[p10l815t3599r1323b3697],
17	,	,	O	,	_	0	SENT_321	[p10l815t3599r1323b3697],
18	doxorubicin	NN	O	doxorubicin	appos	16	SENT_321	[p10l1358t3599r1950b3696],
19	,	,	O	,	_	0	SENT_321	[p10l1358t3599r1950b3696],
20	and	CC	O	and	advmod	16	SENT_321	[p10l1985t3599r2152b3681],

1	Vinblastine	NNP	O	Vinblastine	_	0	SENT_322	[p11l205t29r744b112],
2	.	.	O	.	_	0	SENT_322	[p11l205t29r744b112],

1	Proc	NNP	O	Proc	_	0	SENT_323	[p11l802t32r1043b112],
2	.	.	O	.	_	0	SENT_323	[p11l802t32r1043b112],

1	Natl.	NNP	O	Natl.	nn	2	SENT_324	[p11l1103t29r1327b113],
2	Acad	NNP	O	Acad	_	0	SENT_324	[p11l1383t29r1649b113],
3	.	.	O	.	_	0	SENT_324	[p11l1383t29r1649b113],

1	Sci	NNP	O	Sci	_	0	SENT_325	[p11l1713t31r1873b113],
2	.	.	O	.	_	0	SENT_325	[p11l1713t31r1873b113],

1	USA	NNP	LOCATION	USA	_	0	SENT_326	[p11l1947t31r2147b113],
2	84:3004	CD	NUMBER	84:3004	num	1	SENT_326	[p11l210t175r704b257],
3	—	CD	NUMBER	—	number	4	SENT_326	[p11l210t175r704b257],
4	8	CD	NUMBER	8	dep	1	SENT_326	[p11l210t175r704b257],
5	Chen	NNP	O	Chen	dep	4	SENT_326	[p11l207t319r452b401],
6	C-J	NN	O	c-j	dep	1	SENT_326	[p11l486t319r671b417],
7	,	,	O	,	_	0	SENT_326	[p11l486t319r671b417],
8	Chin	NNP	ORGANIZATION	Chin	nn	9	SENT_326	[p11l739t319r964b401],
9	JE	NNP	ORGANIZATION	JE	appos	6	SENT_326	[p11l997t321r1138b417],
10	,	,	O	,	_	0	SENT_326	[p11l997t321r1138b417],
11	Ueda	NNP	PERSON	Ueda	nn	12	SENT_326	[p11l1204t319r1453b401],
12	K	NNP	PERSON	K	appos	1	SENT_326	[p11l1485t321r1591b417],
13	,	,	O	,	_	0	SENT_326	[p11l1485t321r1591b417],
14	et	FW	O	et	nn	15	SENT_326	[p11l1629t331r1712b401],
15	al.	FW	O	al.	appos	1	SENT_326	[p11l1746t319r1849b401],
16	1986	CD	DATE	1986	dep	15	SENT_326	[p11l1899t319r2144b403],
17	.	.	O	.	_	0	SENT_326	[p11l1899t319r2144b403],

1	Internal	JJ	O	internal	amod	2	SENT_327	[p11l205t464r570b547],
2	duplication	NN	O	duplication	_	0	SENT_327	[p11l622t464r1149b572],
3	and	CC	O	and	_	0	SENT_327	[p11l1201t464r1368b547],
4	homology	NN	O	homology	conj_and	2	SENT_327	[p11l1416t464r1892b572],
5	with	IN	O	with	_	0	SENT_327	[p11l1944t464r2152b547],
6	bacterial	JJ	O	bacterial	amod	8	SENT_327	[p11l204t607r609b691],
7	transport	NN	O	transport	nn	8	SENT_327	[p11l663t620r1083b715],
8	proteins	NNS	O	protein	prep_with	2	SENT_327	[p11l1133t607r1510b715],
9	in	IN	O	in	_	0	SENT_327	[p11l1567t607r1655b690],
10	the	DT	O	the	det	17	SENT_327	[p11l1709t607r1849b691],
11	mdrl	NN	O	mdrl	nn	17	SENT_327	[p11l1904t607r2140b691],
12	(	NN	O	(	nn	17	SENT_327	[p11l209t753r980b859],
13	P	NN	O	p	nn	17	SENT_327	[p11l209t753r980b859],
14	—	CD	NUMBER	—	num	17	SENT_327	[p11l209t753r980b859],
15	glycoprotein	NN	O	glycoprotein	nn	17	SENT_327	[p11l209t753r980b859],
16	)	NN	O	)	nn	17	SENT_327	[p11l209t753r980b859],
17	gene	NN	O	gene	prep_in	2	SENT_327	[p11l1057t778r1276b859],
18	from	IN	O	from	_	0	SENT_327	[p11l1349t753r1577b835],
19	multidrugresistant	JJ	O	multidrugresistant	amod	21	SENT_327	[p11l1648t753r2147b859, p11l204t897r598b980],
20	human	JJ	O	human	amod	21	SENT_327	[p11l628t897r948b980],
21	cells	NNS	O	cell	prep_from	17	SENT_327	[p11l981t897r1217b980],
22	.	.	O	.	_	0	SENT_327	[p11l981t897r1217b980],

1	Cell	NN	O	cell	_	0	SENT_328	[p11l1263t897r1453b981],
2	472381-89	CD	NUMBER	472381-89	num	4	SENT_328	[p11l1483t897r1984b981],
3	Croop	NNP	O	Croop	nn	4	SENT_328	[p11l207t1041r497b1148],
4	JM	NN	O	jm	dep	1	SENT_328	[p11l530t1043r704b1139],
5	,	,	O	,	_	0	SENT_328	[p11l530t1043r704b1139],
6	Raymond	NNP	PERSON	Raymond	nn	7	SENT_328	[p11l772t1040r1230b1148],
7	M	NNP	PERSON	M	appos	4	SENT_328	[p11l1263t1043r1390b1139],
8	,	,	O	,	_	0	SENT_328	[p11l1263t1043r1390b1139],
9	Haber	NNP	O	Haber	nn	10	SENT_328	[p11l1459t1040r1746b1123],
10	D	NNP	O	D	appos	4	SENT_328	[p11l1778t1043r1885b1139],
11	,	,	O	,	_	0	SENT_328	[p11l1778t1043r1885b1139],
12	et	FW	O	et	nn	13	SENT_328	[p11l1925t1053r2007b1123],
13	al.	FW	O	al.	appos	4	SENT_328	[p11l2041t1040r2144b1123],
14	1989	CD	DATE	1989	dep	13	SENT_328	[p11l216t1186r462b1270],
15	.	.	O	.	_	0	SENT_328	[p11l216t1186r462b1270],

1	The	DT	O	the	det	8	SENT_329	[p11l517t1186r698b1268],
2	three	CD	NUMBER	three	num	3	SENT_329	[p11l747t1186r980b1268],
3	mouse	NN	O	mouse	npadvmod	4	SENT_329	[p11l1030t1211r1335b1268],
4	multidrug	JJ	O	multidrug	amod	8	SENT_329	[p11l1385t1186r1847b1292],
5	resistance	NN	O	resistance	nn	8	SENT_329	[p11l1896t1186r2147b1268, p11l205t1343r451b1414],
6	(	CD	NUMBER	(	num	8	SENT_329	[p11l527t1331r785b1433],
7	mdr	NN	O	mdr	nn	8	SENT_329	[p11l527t1331r785b1433],
8	)	NN	O	)	nn	9	SENT_329	[p11l527t1331r785b1433],
9	genes	NNS	O	gene	nsubjpass	11	SENT_329	[p11l861t1357r1124b1438],
10	are	VBP	O	be	auxpass	11	SENT_329	[p11l1200t1357r1338b1414],
11	expressed	VBN	O	express	_	0	SENT_329	[p11l1410t1331r1871b1438],
12	in	IN	O	in	_	0	SENT_329	[p11l1942t1331r2031b1412],
13	a	DT	O	a	det	17	SENT_329	[p11l2104t1357r2153b1414],
14	tissue	NN	O	tissue	nn	17	SENT_329	[p11l205t1474r871b1582],
15	—	NN	O	—	nn	17	SENT_329	[p11l205t1474r871b1582],
16	speciﬁc	NN	O	speciﬁc	nn	17	SENT_329	[p11l205t1474r871b1582],
17	manner	NN	O	manner	prep_in	11	SENT_329	[p11l923t1501r1276b1557],
18	in	IN	O	in	_	0	SENT_329	[p11l1323t1474r1413b1557],
19	normal	JJ	O	normal	amod	21	SENT_329	[p11l1463t1474r1794b1557],
20	mouse	NN	O	mouse	nn	21	SENT_329	[p11l1844t1501r2150b1557],
21	tissues	NNS	O	tissue	prep_in	17	SENT_329	[p11l205t1618r541b1702],
22	.	.	O	.	_	0	SENT_329	[p11l205t1618r541b1702],

1	Mol	NNP	O	Mol	_	0	SENT_330	[p11l576t1618r785b1702],
2	.	.	O	.	_	0	SENT_330	[p11l576t1618r785b1702],

1	Cell	NN	O	cell	_	0	SENT_331	[p11l835t1618r1042b1702],
2	.	.	O	.	_	0	SENT_331	[p11l835t1618r1042b1702],

1	Biol	NNP	O	Biol	_	0	SENT_332	[p11l1084t1618r1298b1702],
2	.	.	O	.	_	0	SENT_332	[p11l1084t1618r1298b1702],

1	9:1346	CD	NUMBER	9:1346	number	2	SENT_333	[p11l1344t1618r1844b1702],
2	—	CD	NUMBER	—	num	3	SENT_333	[p11l1344t1618r1844b1702],
3	5O	NN	O	5o	_	0	SENT_333	[p11l1344t1618r1844b1702],
4	Lothstein	NN	PERSON	lothstein	nn	5	SENT_333	[p11l204t1764r649b1847],
5	L	NN	PERSON	l	dep	3	SENT_333	[p11l686t1766r781b1861],
6	,	,	O	,	_	0	SENT_333	[p11l686t1766r781b1861],
7	Hsu	NNP	PERSON	Hsu	nn	8	SENT_333	[p11l858t1766r1045b1847],
8	SI	NNP	O	SI	appos	5	SENT_333	[p11l1086t1764r1211b1861],
9	,	,	O	,	_	0	SENT_333	[p11l1086t1764r1211b1861],
10	Horwitz	NNP	ORGANIZATION	Horwitz	nn	11	SENT_333	[p11l1287t1764r1670b1847],
11	SB	NN	ORGANIZATION	sb	appos	5	SENT_333	[p11l1713t1764r1876b1861],
12	,	,	O	,	_	0	SENT_333	[p11l1713t1764r1876b1861],
13	et	FW	O	et	nn	14	SENT_333	[p11l1920t1776r2003b1847],
14	al.	FW	O	al.	appos	5	SENT_333	[p11l2041t1764r2144b1847],
15	1989	CD	DATE	1989	dep	14	SENT_333	[p11l216t1910r462b1994],
16	.	.	O	.	_	0	SENT_333	[p11l216t1910r462b1994],

1	Alternate	JJ	O	alternate	amod	2	SENT_334	[p11l535t1910r972b1993],
2	overexpression	NN	O	overexpression	nsubjpass	10	SENT_334	[p11l1041t1910r1748b2018],
3	of	IN	O	of	_	0	SENT_334	[p11l1817t1910r1919b1993],
4	two	CD	NUMBER	two	num	5	SENT_334	[p11l1977t1923r2150b1993],
5	P	NN	O	p	prep_of	2	SENT_334	[p11l205t2053r905b2161],
6	—	CD	NUMBER	—	num	8	SENT_334	[p11l205t2053r905b2161],
7	glycoprotein	NN	O	glycoprotein	nn	8	SENT_334	[p11l205t2053r905b2161],
8	genes	NNS	O	gene	dep	5	SENT_334	[p11l960t2080r1222b2161],
9	is	VBZ	O	be	auxpass	10	SENT_334	[p11l1279t2053r1351b2137],
10	associated	VBN	O	associate	_	0	SENT_334	[p11l1410t2053r1892b2137],
11	with	IN	O	with	_	0	SENT_334	[p11l1944t2053r2151b2137],
12	changes	NNS	O	change	prep_with	10	SENT_334	[p11l207t2199r580b2305],
13	in	IN	O	in	_	0	SENT_334	[p11l666t2199r755b2280],
14	multidrug	JJ	O	multidrug	amod	15	SENT_334	[p11l837t2199r1300b2305],
15	resistance	NN	O	resistance	prep_in	12	SENT_334	[p11l1382t2199r1847b2281],
16	in	IN	O	in	_	0	SENT_334	[p11l1930t2199r2019b2280],
17	a	DT	O	a	det	21	SENT_334	[p11l2104t2224r2153b2281],
18	J774	NN	O	j774	nn	21	SENT_334	[p11l204t2343r513b2426],
19	.2	NN	NUMBER	.2	nn	21	SENT_334	[p11l204t2343r513b2426],
20	cell	NN	O	cell	nn	21	SENT_334	[p11l592t2343r758b2426],
21	line	NN	O	line	prep_in	15	SENT_334	[p11l834t2343r1032b2426],
22	.	.	O	.	_	0	SENT_334	[p11l834t2343r1032b2426],

1	J.	NNP	O	J.	nn	2	SENT_335	[p11l1111t2346r1178b2427],
2	Biol	NNP	O	Biol	_	0	SENT_335	[p11l1263t2343r1478b2426],
3	.	.	O	.	_	0	SENT_335	[p11l1263t2343r1478b2426],

1	Chem	NNP	O	Chem	_	0	SENT_336	[p11l1572t2343r1857b2427],
2	.	.	O	.	_	0	SENT_336	[p11l1572t2343r1857b2427],

1	264	CD	NUMBER	264	_	0	SENT_337	[p11l1945t2343r2142b2426],
2	:	:	O	:	_	0	SENT_337	[p11l1945t2343r2142b2426],
3	16054-58	CD	NUMBER	16054-58	num	5	SENT_337	[p11l217t2485r671b2569],
4	Higgins	NNP	PERSON	Higgins	nn	5	SENT_337	[p11l205t2631r574b2737],
5	CF.	NNP	O	CF.	dep	1	SENT_337	[p11l658t2631r812b2713],
6	1992	CD	DATE	1992	num	5	SENT_337	[p11l910t2631r1156b2715],
7	.	.	O	.	_	0	SENT_337	[p11l910t2631r1156b2715],

1	ABC	NNP	ORGANIZATION	ABC	nn	2	SENT_338	[p11l1242t2631r1480b2713],
2	transporters	NNS	O	transporter	_	0	SENT_338	[p11l1562t2643r2142b2737],
3	:	:	O	:	_	0	SENT_338	[p11l1562t2643r2142b2737],
4	from	IN	O	from	_	0	SENT_338	[p11l205t2776r434b2859],
5	microorganisms	NNS	O	microorganism	prep_from	2	SENT_338	[p11l467t2776r1221b2883],
6	to	TO	O	to	_	0	SENT_338	[p11l1258t2789r1346b2859],
7	man	NN	O	man	prep_to	5	SENT_338	[p11l1382t2802r1607b2859],
8	.	.	O	.	_	0	SENT_338	[p11l1382t2802r1607b2859],

1	Annu	NNP	PERSON	Annu	_	0	SENT_339	[p11l1638t2777r1911b2859],
2	.	.	O	.	_	0	SENT_339	[p11l1638t2777r1911b2859],

1	Rev.	NNP	O	Rev.	nn	3	SENT_340	[p11l1953t2779r2139b2859],
2	Cell	NNP	PERSON	Cell	nn	3	SENT_340	[p11l211t2918r401b3002],
3	Biol	NNP	PERSON	Biol	_	0	SENT_340	[p11l429t2918r644b3001],
4	.	.	O	.	_	0	SENT_340	[p11l429t2918r644b3001],

1	8:67	CD	NUMBER	8:67	num	4	SENT_341	[p11l693t2918r1067b3002],
2	-13	CD	NUMBER	-13	num	4	SENT_341	[p11l693t2918r1067b3002],
3	Goldstein	NNP	PERSON	Goldstein	nn	4	SENT_341	[p11l207t3063r662b3147],
4	LJ	NNP	PERSON	LJ	_	0	SENT_341	[p11l707t3066r848b3162],
5	,	,	O	,	_	0	SENT_341	[p11l707t3066r848b3162],
6	Galski	NNP	PERSON	Galski	nn	7	SENT_341	[p11l943t3063r1247b3147],
7	H	NNP	PERSON	H	appos	4	SENT_341	[p11l1294t3066r1401b3162],
8	,	,	O	,	_	0	SENT_341	[p11l1294t3066r1401b3162],
9	Fojo	NNP	O	Fojo	nn	10	SENT_341	[p11l1494t3063r1705b3171],
10	A	NNP	O	A	appos	4	SENT_341	[p11l1752t3064r1860b3162],
11	,	,	O	,	_	0	SENT_341	[p11l1752t3064r1860b3162],
12	et	FW	O	et	nn	13	SENT_341	[p11l1912t3076r1995b3147],
13	al.	FW	O	al.	appos	4	SENT_341	[p11l2042t3063r2145b3147],
14	1989	CD	DATE	1989	dep	13	SENT_341	[p11l216t3210r462b3294],
15	.	.	O	.	_	0	SENT_341	[p11l216t3210r462b3294],

1	Expression	NN	O	expression	_	0	SENT_342	[p11l527t3210r1051b3317],
2	of	IN	O	of	_	0	SENT_342	[p11l1111t3210r1214b3293],
3	a	DT	O	a	det	6	SENT_342	[p11l1268t3237r1317b3293],
4	multidrug	JJ	O	multidrug	amod	6	SENT_342	[p11l1374t3210r1836b3317],
5	resistance	NN	O	resistance	nn	6	SENT_342	[p11l1896t3210r2147b3293, p11l205t3368r451b3438],
6	gene	NN	O	gene	prep_of	1	SENT_342	[p11l475t3382r693b3463],
7	in	IN	O	in	_	0	SENT_342	[p11l715t3355r804b3436],
8	human	JJ	O	human	amod	9	SENT_342	[p11l824t3355r1145b3438],
9	cancers	NNS	O	cancer	prep_in	1	SENT_342	[p11l1166t3382r1540b3438],
10	.	.	O	.	_	0	SENT_342	[p11l1166t3382r1540b3438],

1	J.	NNP	MISC	J.	nn	4	SENT_343	[p11l1565t3358r1632b3439],
2	Natl.	NNP	MISC	Natl.	nn	4	SENT_343	[p11l1661t3355r1884b3439],
3	Cancer	NNP	MISC	Cancer	nn	4	SENT_343	[p11l1923t3357r2147b3439, p11l207t3526r358b3581],
4	Insz	NNP	MISC	Insz	_	0	SENT_343	[p11l383t3501r578b3581],
5	‘	NN	O	‘	dep	4	SENT_343	[p11l383t3501r578b3581],
6	.	.	O	.	_	0	SENT_343	[p11l383t3501r578b3581],

1	81:1	CD	NUMBER	81:1	num	5	SENT_344	[p11l627t3498r818b3581],
2	16-24	CD	NUMBER	16-24	num	5	SENT_344	[p11l844t3497r1124b3581],
3	De	NNP	O	De	nn	5	SENT_344	[p11l205t3644r340b3725],
4	Vree	NNP	O	Vree	nn	5	SENT_344	[p11l384t3644r611b3725],
5	JML	NNP	O	JML	_	0	SENT_344	[p11l655t3644r901b3740],
6	,	,	O	,	_	0	SENT_344	[p11l655t3644r901b3740],
7	J	NNP	O	J	nn	9	SENT_344	[p11l989t3644r1033b3725],
8	acquemin	NN	O	acquemin	nn	9	SENT_344	[p11l1040t3643r1493b3749],
9	E	NN	O	e	dep	5	SENT_344	[p11l1537t3644r1632b3740],
10	,	,	O	,	_	0	SENT_344	[p11l1537t3644r1632b3740],
11	Sturm	NNP	O	Sturm	nn	12	SENT_344	[p11l1725t3643r2009b3725],
12	E	NNP	O	E	appos	9	SENT_344	[p11l2052t3644r2147b3740],
13	,	,	O	,	_	0	SENT_344	[p11l2052t3644r2147b3740],

1	et	FW	O	et	nn	2	SENT_345	[p12l207t39r290b109],
2	al.	FW	O	al.	_	0	SENT_345	[p12l326t26r429b109],
3	1998	CD	DATE	1998	dep	2	SENT_345	[p12l482t26r727b110],
4	.	.	O	.	_	0	SENT_345	[p12l482t26r727b110],

1	Mutations	NNS	O	mutation	_	0	SENT_346	[p12l769t26r1243b109],
2	in	IN	O	in	_	0	SENT_346	[p12l1281t26r1371b107],
3	the	DT	O	the	det	6	SENT_346	[p12l1405t26r1547b109],
4	MDR3	NN	O	mdr3	nn	6	SENT_346	[p12l1578t26r1889b109],
5	gene	NN	O	gene	nn	6	SENT_346	[p12l1933t53r2150b134],
6	cause	NN	O	cause	prep_in	1	SENT_346	[p12l207t196r464b253],
7	progressive	JJ	O	progressive	amod	10	SENT_346	[p12l540t169r1078b277],
8	familial	JJ	O	familial	amod	10	SENT_346	[p12l1155t169r1518b253],
9	intrahepatic	JJ	O	intrahepatic	amod	10	SENT_346	[p12l1596t169r2150b277],
10	cholestasis	NN	O	cholestasis	dep	6	SENT_346	[p12l207t315r738b398],
11	.	.	O	.	_	0	SENT_346	[p12l207t315r738b398],

1	Proc	NNP	O	Proc	_	0	SENT_347	[p12l763t319r1005b398],
2	.	.	O	.	_	0	SENT_347	[p12l763t319r1005b398],

1	Natl.	NNP	O	Natl.	nn	2	SENT_348	[p12l1032t315r1255b399],
2	Acad	NNP	O	Acad	_	0	SENT_348	[p12l1279t315r1545b399],
3	.	.	O	.	_	0	SENT_348	[p12l1279t315r1545b399],

1	Sci	NNP	O	Sci	_	0	SENT_349	[p12l1578t317r1737b399],
2	.	.	O	.	_	0	SENT_349	[p12l1578t317r1737b399],

1	USA	NNP	LOCATION	USA	_	0	SENT_350	[p12l1779t317r1979b399],
2	95	CD	NUMBER	95	num	1	SENT_350	[p12l2004t314r2142b400],
3	:	:	O	:	_	0	SENT_350	[p12l2004t314r2142b400],
4	282	CD	NUMBER	282	number	5	SENT_350	[p12l207t460r554b542],
5	—	CD	NUMBER	—	dep	1	SENT_350	[p12l207t460r554b542],
6	87	CD	NUMBER	87	num	8	SENT_350	[p12l207t460r554b542],
7	Bogman	NN	ORGANIZATION	bogman	nn	8	SENT_350	[p12l205t606r603b711],
8	K	NN	ORGANIZATION	k	dep	5	SENT_350	[p12l647t606r752b701],
9	,	,	O	,	_	0	SENT_350	[p12l647t606r752b701],
10	Peyer	NNP	ORGANIZATION	Peyer	nn	11	SENT_350	[p12l837t606r1105b711],
11	AK	NNP	ORGANIZATION	AK	appos	1	SENT_350	[p12l1144t604r1338b702],
12	,	,	O	,	_	0	SENT_350	[p12l1144t604r1338b702],
13	Torok	NNP	PERSON	Torok	nn	14	SENT_350	[p12l1423t603r1702b686],
14	M	NNP	O	M	appos	1	SENT_350	[p12l1741t606r1868b702],
15	,	,	O	,	_	0	SENT_350	[p12l1741t606r1868b702],
16	et	FW	O	et	nn	17	SENT_350	[p12l1916t616r2000b686],
17	al.	FW	O	al.	appos	1	SENT_350	[p12l2042t603r2145b686],
18	2001	CD	DATE	2001	dep	17	SENT_350	[p12l207t749r429b831],
19	.	.	O	.	_	0	SENT_350	[p12l448t817r462b831],

1	HMG	NN	O	hmg	_	0	SENT_351	[p12l490t749r1026b831],
2	.	.	O	.	_	0	SENT_351	[p12l490t749r1026b831],

1	—	NN	O	—	_	0	SENT_352	[p12l490t749r1026b831],
2	.	.	O	.	_	0	SENT_352	[p12l490t749r1026b831],

1	CoA	NN	O	coa	_	0	SENT_353	[p12l490t749r1026b831],
2	reductase	NN	O	reductase	nn	3	SENT_353	[p12l1045t749r1490b831],
3	inhibitors	NNS	O	inhibitor	dep	1	SENT_353	[p12l1512t749r1959b831],
4	and	CC	O	and	_	0	SENT_353	[p12l1985t749r2152b831],
5	P-glycoprotein	NN	O	p-glycoprotein	nn	6	SENT_353	[p12l205t894r906b1001],
6	modulation	NN	O	modulation	dep	1	SENT_353	[p12l956t894r1515b977],
7	.	.	O	.	_	0	SENT_353	[p12l956t894r1515b977],

1	Br	NN	O	br	_	0	SENT_354	[p12l1569t897r1692b977],
2	.	.	O	.	_	0	SENT_354	[p12l1569t897r1692b977],

1	J.	NNP	PERSON	J.	nn	2	SENT_355	[p12l1751t897r1819b978],
2	Pharmacal	NNP	PERSON	Pharmacal	_	0	SENT_355	[p12l1879t894r2147b977, p12l205t1036r510b1119],
3	.	.	O	.	_	0	SENT_355	[p12l1879t894r2147b977, p12l205t1036r510b1119],

1	l32	NN	O	l32	_	0	SENT_356	[p12l565t1037r1174b1120],
2	:	:	O	:	_	0	SENT_356	[p12l565t1037r1174b1120],
3	l183	NN	O	l183	nn	7	SENT_356	[p12l565t1037r1174b1120],
4	—	CD	NUMBER	—	num	7	SENT_356	[p12l565t1037r1174b1120],
5	92	CD	NUMBER	92	num	7	SENT_356	[p12l565t1037r1174b1120],
6	Lee	NNP	O	Lee	nn	7	SENT_356	[p12l205t1183r378b1264],
7	CGL	NNP	O	CGL	dep	1	SENT_356	[p12l416t1182r673b1279],
8	,	,	O	,	_	0	SENT_356	[p12l416t1182r673b1279],
9	Gottesman	NNP	PERSON	Gottesman	nn	10	SENT_356	[p12l745t1182r1253b1265],
10	MM	NN	O	mm	appos	7	SENT_356	[p12l1287t1183r1518b1265],
11	.	.	O	.	_	0	SENT_356	[p12l1287t1183r1518b1265],

1	1998	CD	DATE	1998	_	0	SENT_357	[p12l1570t1182r1816b1265],
2	.	.	O	.	_	0	SENT_357	[p12l1570t1182r1816b1265],

1	HIV-1	NN	MISC	hiv-1	_	0	SENT_358	[p12l1857t1182r2140b1264],
2	protease	NN	O	protease	nn	3	SENT_358	[p12l204t1339r595b1433],
3	inhibitors	NNS	O	inhibitor	dep	1	SENT_358	[p12l636t1327r1083b1409],
4	and	CC	O	and	_	0	SENT_358	[p12l1128t1327r1294b1409],
5	the	DT	O	the	det	8	SENT_358	[p12l1333t1327r1474b1409],
6	MDR1	NN	O	mdr1	nn	8	SENT_358	[p12l1509t1327r1815b1408],
7	multidrug	JJ	O	multidrug	amod	8	SENT_358	[p12l1865t1327r2147b1409, p12l207t1472r418b1580],
8	transporter	NN	O	transporter	conj_and	3	SENT_358	[p12l448t1485r974b1580],
9	.	.	O	.	_	0	SENT_358	[p12l448t1485r974b1580],

1	J.	NNP	PERSON	J.	nn	2	SENT_359	[p12l1007t1475r1075b1556],
2	Clin	NNP	PERSON	Clin	_	0	SENT_359	[p12l1120t1472r1333b1556],
3	.	.	O	.	_	0	SENT_359	[p12l1120t1472r1333b1556],

1	Invest	VB	O	invest	_	0	SENT_360	[p12l1371t1475r1667b1556],
2	.	.	O	.	_	0	SENT_360	[p12l1371t1475r1667b1556],

1	101:287	CD	NUMBER	101:287	num	2	SENT_361	[p12l1719t1472r2153b1555],
2	—	CD	NUMBER	—	_	0	SENT_361	[p12l1719t1472r2153b1555],
3	88	CD	NUMBER	88	num	5	SENT_361	[p12l210t1616r316b1698],
4	Ramachandra	NN	PERSON	ramachandra	nn	5	SENT_361	[p12l205t1760r855b1843],
5	M	NN	PERSON	m	dep	2	SENT_361	[p12l896t1761r1024b1857],
6	,	,	O	,	_	0	SENT_361	[p12l896t1761r1024b1857],
7	Ambudkar	NNP	O	Ambudkar	nn	8	SENT_361	[p12l1113t1760r1616b1843],
8	SV	NNP	O	SV	appos	5	SENT_361	[p12l1660t1760r1816b1857],
9	,	,	O	,	_	0	SENT_361	[p12l1660t1760r1816b1857],
10	Chen	NNP	PERSON	Chen	nn	11	SENT_361	[p12l1906t1760r2152b1843],
11	D	NNP	PERSON	D	appos	5	SENT_361	[p12l205t1909r313b2005],
12	,	,	O	,	_	0	SENT_361	[p12l205t1909r313b2005],
13	et	FW	O	et	nn	14	SENT_361	[p12l349t1919r432b1989],
14	al.	FW	O	al.	appos	5	SENT_361	[p12l464t1906r567b1989],
15	1998	CD	DATE	1998	dep	14	SENT_361	[p12l615t1906r861b1990],
16	.	.	O	.	_	0	SENT_361	[p12l615t1906r861b1990],

1	Human	JJ	O	human	amod	4	SENT_362	[p12l897t1909r1243b1989],
2	P	NN	O	p	nn	4	SENT_362	[p12l1274t1906r1974b2014],
3	—	CD	NUMBER	—	num	4	SENT_362	[p12l1274t1906r1974b2014],
4	glycoprotein	NN	O	glycoprotein	nsubj	5	SENT_362	[p12l1274t1906r1974b2014],
5	exhibits	VBZ	O	exhibit	_	0	SENT_362	[p12l2006t1933r2147b1989, p12l204t2049r462b2132],
6	reduced	VBN	O	reduce	amod	7	SENT_362	[p12l502t2049r875b2132],
7	afﬁnity	NN	O	afﬁnity	dobj	5	SENT_362	[p12l915t2049r1247b2157],
8	for	IN	O	for	_	0	SENT_362	[p12l1287t2049r1423b2132],
9	substrates	NNS	O	substrate	prep_for	7	SENT_362	[p12l1463t2049r1919b2132],
10	during	IN	O	during	_	0	SENT_362	[p12l1961t2049r2148b2132, p12l205t2195r353b2301],
11	a	DT	O	a	det	14	SENT_362	[p12l399t2220r448b2277],
12	catalytic	JJ	O	catalytic	amod	14	SENT_362	[p12l490t2195r885b2301],
13	transition	NN	O	transition	nn	14	SENT_362	[p12l929t2195r1374b2277],
14	state	NN	O	state	prep_during	9	SENT_362	[p12l1420t2207r1653b2277],
15	.	.	O	.	_	0	SENT_362	[p12l1420t2207r1653b2277],

1	Biochemistry	NNP	O	Biochemistry	nn	6	SENT_363	[p12l1700t2195r2147b2277, p12l209t2342r413b2445],
2	37:5010	CD	NUMBER	37:5010	num	6	SENT_363	[p12l449t2339r1005b2423],
3	—	CD	NUMBER	—	num	6	SENT_363	[p12l449t2339r1005b2423],
4	19	CD	NUMBER	19	num	6	SENT_363	[p12l449t2339r1005b2423],
5	Sauna	NNP	ORGANIZATION	Sauna	nn	6	SENT_363	[p12l209t2482r494b2565],
6	ZE	NNP	ORGANIZATION	ZE	_	0	SENT_363	[p12l551t2484r719b2579],
7	,	,	O	,	_	0	SENT_363	[p12l551t2484r719b2579],
8	Ambudkar	NNP	O	Ambudkar	nn	9	SENT_363	[p12l842t2481r1344b2563],
9	SV	NNP	O	SV	appos	6	SENT_363	[p12l1407t2482r1559b2565],
10	.	.	O	.	_	0	SENT_363	[p12l1407t2482r1559b2565],

1	2000	CD	DATE	2000	_	0	SENT_364	[p12l1629t2482r1884b2565],
2	.	.	O	.	_	0	SENT_364	[p12l1629t2482r1884b2565],

1	Evidence	NN	O	evidence	_	0	SENT_365	[p12l1950t2481r2148b2564, p12l207t2626r478b2710],
2	for	IN	O	for	_	0	SENT_365	[p12l517t2626r654b2710],
3	a	DT	O	a	det	4	SENT_365	[p12l693t2653r742b2710],
4	requirement	NN	O	requirement	prep_for	1	SENT_365	[p12l778t2626r1350b2734],
5	for	IN	O	for	_	0	SENT_365	[p12l1387t2626r1524b2710],
6	ATP	NN	ORGANIZATION	atp	nn	7	SENT_365	[p12l1561t2627r1768b2709],
7	hydrolysis	NN	O	hydrolysis	prep_for	4	SENT_365	[p12l1806t2626r2148b2734, p12l205t2773r383b2880],
8	at	IN	O	at	dep	1	SENT_365	[p12l432t2785r513b2856],
9	two	CD	NUMBER	two	num	11	SENT_365	[p12l553t2785r725b2856],
10	distinct	JJ	O	distinct	amod	11	SENT_365	[p12l770t2773r1116b2856],
11	steps	NNS	O	step	pobj	8	SENT_365	[p12l1160t2785r1387b2880],
12	during	IN	O	during	dep	1	SENT_365	[p12l1434t2773r1737b2880],
13	a	DT	O	a	det	15	SENT_365	[p12l1782t2799r1832b2856],
14	single	JJ	O	single	amod	15	SENT_365	[p12l1876t2773r2151b2881],
15	turnover	NN	O	turnover	pobj	12	SENT_365	[p12l205t2931r602b3001],
16	of	IN	O	of	_	0	SENT_365	[p12l644t2918r746b3001],
17	the	DT	O	the	det	19	SENT_365	[p12l781t2918r922b3001],
18	catalytic	JJ	O	catalytic	amod	19	SENT_365	[p12l967t2918r1362b3026],
19	cycle	NN	O	cycle	prep_of	15	SENT_365	[p12l1407t2918r1651b3026],
20	of	IN	O	of	_	0	SENT_365	[p12l1695t2918r1797b3001],
21	human	JJ	O	human	prep_of	19	SENT_365	[p12l1831t2918r2152b3001],

1	626	CD	NUMBER	626	_	0	SENT_366	[p12l358t3101r419b3131],
2	GOTTESMAN	NNP	O	GOTTESMAN	dep	1	SENT_366	[p12l508t3104r735b3131],

1	P-glycoprotein	NN	O	p-glycoprotein	_	0	SENT_367	[p12l600t3340r1177b3425],
2	.	.	O	.	_	0	SENT_367	[p12l600t3340r1177b3425],

1	Proc	NNP	O	Proc	_	0	SENT_368	[p12l1239t3342r1432b3406],
2	.	.	O	.	_	0	SENT_368	[p12l1239t3342r1432b3406],

1	Natl.	NNP	O	Natl.	nn	2	SENT_369	[p12l1496t3340r1674b3406],
2	Acad	NNP	O	Acad	_	0	SENT_369	[p12l1735t3340r1947b3406],
3	.	.	O	.	_	0	SENT_369	[p12l1735t3340r1947b3406],

1	Sci	NNP	O	Sci	_	0	SENT_370	[p12l2014t3341r2142b3406],
2	.	.	O	.	_	0	SENT_370	[p12l2014t3341r2142b3406],

1	USA	NNP	LOCATION	USA	_	0	SENT_371	[p12l609t3455r768b3521],
2	97:2515	CD	NUMBER	97:2515	number	3	SENT_371	[p12l798t3454r1244b3521],
3	—	CD	NUMBER	—	dep	1	SENT_371	[p12l798t3454r1244b3521],
4	20	CD	NUMBER	20	dep	3	SENT_371	[p12l798t3454r1244b3521],

1	26	CD	NUMBER	26	_	0	SENT_372	[p12l442t3568r551b3635],
2	.	.	O	.	_	0	SENT_372	[p12l442t3568r551b3635],

1	Sauna	NNP	O	Sauna	nn	2	SENT_373	[p12l603t3569r830b3634],
2	ZE	NNP	O	ZE	_	0	SENT_373	[p12l854t3570r987b3646],
3	,	,	O	,	_	0	SENT_373	[p12l854t3570r987b3646],
4	Ambudkar	NNP	O	Ambudkar	nn	5	SENT_373	[p12l1039t3568r1440b3634],
5	SV	NNP	O	SV	appos	2	SENT_373	[p12l1467t3569r1589b3634],
6	.	.	O	.	_	0	SENT_373	[p12l1467t3569r1589b3634],

1	2001	CD	DATE	2001	_	0	SENT_374	[p12l1621t3569r1824b3635],
2	.	.	O	.	_	0	SENT_374	[p12l1621t3569r1824b3635],

1	Characterization	NN	O	characterization	_	0	SENT_375	[p12l1856t3568r2148b3635, p12l600t3681r954b3748],
2	of	IN	O	of	_	0	SENT_375	[p12l974t3681r1056b3748],
3	the	DT	O	the	det	5	SENT_375	[p12l1068t3681r1180b3748],
4	catalytic	JJ	O	catalytic	amod	5	SENT_375	[p12l1200t3681r1515b3767],
5	cycle	NN	O	cycle	prep_of	1	SENT_375	[p12l1536t3682r1729b3767],
6	of	IN	O	of	_	0	SENT_375	[p12l1750t3681r1831b3748],
7	ATP	NN	O	atp	nn	8	SENT_375	[p12l1844t3682r2009b3747],
8	hyAnnu	NN	O	hyannu	prep_of	1	SENT_375	[p12l2027t3681r2148b3767, p13l6t3388r64b3588],
9	.	.	O	.	_	0	SENT_375	[p12l2027t3681r2148b3767, p13l6t3388r64b3588],

1	Rev.	NNP	O	Rev.	nn	2	SENT_376	[p13l7t3210r64b3360],
2	Med	NNP	O	Med	_	0	SENT_376	[p13l6t3012r64b3182],
3	.	.	O	.	_	0	SENT_376	[p13l6t3012r64b3182],

1	2002.53:615	CD	NUMBER	2002.53:615	num	2	SENT_377	[p13l6t2394r65b2984],
2	-627	CD	NUMBER	-627	_	0	SENT_377	[p13l6t2394r65b2984],
3	.	.	O	.	_	0	SENT_377	[p13l6t2394r65b2984],

1	Downloaded	VBN	O	download	_	0	SENT_378	[p13l6t1937r65b2366],
2	from	IN	O	from	_	0	SENT_378	[p13l6t1753r64b1914],
3	www.annualreviews.org	NN	O	www.annualreviews.org	prep_from	1	SENT_378	[p13l6t912r82b1730],
4	by	IN	O	by	_	0	SENT_378	[p13l90t3422r166b3504],
5	University	NNP	ORGANIZATION	University	prep_by	1	SENT_378	[p13l90t3044r166b3398],
6	of	IN	ORGANIZATION	of	_	0	SENT_378	[p13l90t2947r149b3019],
7	Wisconsin	NNP	ORGANIZATION	Wisconsin	nn	9	SENT_378	[p13l90t2576r149b2930],
8	—	NNP	O	—	nn	9	SENT_378	[p13l126t2530r131b2552],
9	Madison	NNP	O	Madison	prep_of	5	SENT_378	[p13l90t2212r149b2504],
10	on	IN	O	on	_	0	SENT_378	[p13l108t2106r149b2187],
11	01/05	CD	NUMBER	01/05	prep_on	9	SENT_378	[p13l89t1869r149b2082],
12	/	:	O	/	punct	13	SENT_378	[p13l89t1869r149b2082],
13	14	CD	NUMBER	14	dep	11	SENT_378	[p13l90t1770r149b1860],
14	.	.	O	.	_	0	SENT_378	[p13l90t1770r149b1860],

1	For	IN	O	for	_	0	SENT_379	[p13l92t1626r149b1743],
2	personal	JJ	O	personal	amod	3	SENT_379	[p13l90t1322r166b1605],
3	use	NN	O	use	pobj	1	SENT_379	[p13l108t1189r149b1299],
4	only	RB	O	only	advmod	3	SENT_379	[p13l90t1001r166b1164],
5	.	.	O	.	_	0	SENT_379	[p13l90t1001r166b1164],

1	drolysis	NN	O	drolysis	_	0	SENT_380	[p13l601t22r894b107],
2	by	IN	O	by	_	0	SENT_380	[p13l913t22r1005b107],
3	human	JJ	O	human	amod	4	SENT_380	[p13l1023t22r1278b88],
4	P-glycoprotein	NN	O	p-glycoprotein	prep_by	1	SENT_380	[p13l1295t22r1872b107],
5	.	.	O	.	_	0	SENT_380	[p13l1295t22r1872b107],

1	J.	NNP	O	J.	nn	2	SENT_381	[p13l1892t24r1946b89],
2	Biol	NNP	O	Biol	_	0	SENT_381	[p13l1970t22r2142b88],
3	.	.	O	.	_	0	SENT_381	[p13l1970t22r2142b88],

1	Chem	NNP	O	Chem	_	0	SENT_382	[p13l605t136r832b203],
2	.	.	O	.	_	0	SENT_382	[p13l605t136r832b203],

1	276	CD	NUMBER	276	_	0	SENT_383	[p13l869t136r1026b202],
2	:	:	O	:	_	0	SENT_383	[p13l869t136r1026b202],
3	1	CD	NUMBER	1	num	4	SENT_383	[p13l1044t137r1071b201],
4	1653-61	CD	NUMBER	1653-61	dep	1	SENT_383	[p13l1091t136r1401b202],
5	Cole	NNP	O	Cole	nn	6	SENT_383	[p13l601t249r776b316],
6	SP	NN	O	sp	dep	4	SENT_383	[p13l804t250r914b328],
7	,	,	O	,	_	0	SENT_383	[p13l804t250r914b328],
8	Bhardwaj	NNP	PERSON	Bhardwaj	nn	9	SENT_383	[p13l968t249r1324b335],
9	G	NNP	O	G	appos	6	SENT_383	[p13l1358t250r1443b328],
10	,	,	O	,	_	0	SENT_383	[p13l1358t250r1443b328],
11	Gerlach	NNP	PERSON	Gerlach	nn	13	SENT_383	[p13l1497t250r1792b316],
12	J	NNP	PERSON	J	nn	13	SENT_383	[p13l1817t251r1852b316],
13	H	NNP	PERSON	H	appos	6	SENT_383	[p13l1855t251r1940b328],
14	,	,	O	,	_	0	SENT_383	[p13l1855t251r1940b328],
15	et	FW	O	et	nn	16	SENT_383	[p13l1970t260r2037b316],
16	al.	FW	O	al.	appos	6	SENT_383	[p13l2063t250r2146b316],
17	1992	CD	DATE	1992	dep	16	SENT_383	[p13l609t365r805b432],
18	.	.	O	.	_	0	SENT_383	[p13l609t365r805b432],

1	Overexpression	NN	O	overexpression	_	0	SENT_384	[p13l870t365r1455b450],
2	of	IN	O	of	_	0	SENT_384	[p13l1514t365r1596b431],
3	a	DT	O	a	det	5	SENT_384	[p13l1649t385r1688b431],
4	transporter	NN	O	transporter	nn	5	SENT_384	[p13l1745t374r2153b450],
5	gene	NN	O	gene	prep_of	1	SENT_384	[p13l601t500r775b565],
6	in	IN	O	in	_	0	SENT_384	[p13l802t479r873b544],
7	a	DT	O	a	det	13	SENT_384	[p13l901t500r940b545],
8	multidrug-resistant	JJ	O	multidrug-resistant	amod	13	SENT_384	[p13l965t479r1680b565],
9	human	JJ	O	human	amod	13	SENT_384	[p13l1705t479r1960b545],
10	lung	NN	O	lung	nn	13	SENT_384	[p13l1986t479r2149b565],
11	cancer	NN	O	cancer	nn	13	SENT_384	[p13l601t614r846b659],
12	cell	NN	O	cell	nn	13	SENT_384	[p13l871t593r1003b659],
13	line	NN	O	line	prep_in	1	SENT_384	[p13l1030t593r1187b659],
14	.	.	O	.	_	0	SENT_384	[p13l1030t593r1187b659],

1	Science	NNP	O	Science	_	0	SENT_385	[p13l1218t594r1502b660],
2	258	CD	NUMBER	258	num	1	SENT_385	[p13l1531t593r1688b660],
3	:	:	O	:	_	0	SENT_385	[p13l1531t593r1688b660],
4	1650-54	CD	NUMBER	1650-54	num	6	SENT_385	[p13l1706t593r2023b660],
5	Belinsky	NNP	ORGANIZATION	Belinsky	nn	6	SENT_385	[p13l601t708r931b793],
6	MG	NN	ORGANIZATION	mg	dep	1	SENT_385	[p13l952t708r1121b786],
7	,	,	O	,	_	0	SENT_385	[p13l952t708r1121b786],
8	Bain	NNP	ORGANIZATION	Bain	nn	9	SENT_385	[p13l1162t708r1337b774],
9	LJ	NNP	ORGANIZATION	LJ	appos	6	SENT_385	[p13l1357t709r1469b786],
10	,	,	O	,	_	0	SENT_385	[p13l1357t709r1469b786],
11	Balsara	NNP	LOCATION	Balsara	nn	12	SENT_385	[p13l1510t708r1791b774],
12	BB	NNP	LOCATION	BB	appos	6	SENT_385	[p13l1810t709r1953b786],
13	,	,	O	,	_	0	SENT_385	[p13l1810t709r1953b786],
14	et	FW	O	et	nn	15	SENT_385	[p13l1977t718r2043b774],
15	al.	FW	O	al.	appos	6	SENT_385	[p13l2063t708r2146b774],
16	1998	CD	DATE	1998	dep	15	SENT_385	[p13l609t822r805b889],
17	.	.	O	.	_	0	SENT_385	[p13l609t822r805b889],

1	Characterization	NN	O	characterization	_	0	SENT_386	[p13l852t822r1472b888],
2	of	IN	O	of	_	0	SENT_386	[p13l1513t822r1595b888],
3	MOAT-C	NN	O	moat-c	prep_of	1	SENT_386	[p13l1629t822r1974b888],
4	and	CC	O	and	_	0	SENT_386	[p13l2019t822r2152b888],
5	MOAT-D	NN	O	moat-d	nn	7	SENT_386	[p13l600t938r951b1004],
6	new	JJ	O	new	amod	7	SENT_386	[p13l1011t958r1163b1003],
7	members	NNS	O	member	conj_and	1	SENT_386	[p13l1222t937r1563b1003],
8	of	IN	O	of	_	0	SENT_386	[p13l1624t937r1705b1003],
9	the	DT	O	the	det	10	SENT_386	[p13l1757t937r1869b1003],
10	MRP	NN	O	mrp	prep_of	7	SENT_386	[p13l1928t938r2153b1004],
11	/	:	O	/	punct	1	SENT_386	[p13l1928t938r2153b1004],
12	CMOAT	NN	O	cmoat	nn	13	SENT_386	[p13l601t1053r903b1118],
13	subfamily	NN	O	subfamily	dep	1	SENT_386	[p13l924t1052r1293b1138],
14	of	IN	O	of	_	0	SENT_386	[p13l1313t1052r1393b1118],
15	transporter	NN	O	transporter	nn	16	SENT_386	[p13l1404t1062r1811b1138],
16	proteins	NNS	O	protein	prep_of	13	SENT_386	[p13l1825t1052r2146b1138],
17	.	.	O	.	_	0	SENT_386	[p13l1825t1052r2146b1138],

1	J.	NNP	O	J.	nn	4	SENT_387	[p13l599t1170r652b1234],
2	Natl.	NNP	O	Natl.	nn	4	SENT_387	[p13l684t1167r862b1234],
3	Cancer	NNP	O	Cancer	nn	4	SENT_387	[p13l901t1169r1176b1234],
4	Inst	NNP	O	Inst	_	0	SENT_387	[p13l1195t1170r1351b1233],
5	.	.	O	.	_	0	SENT_387	[p13l1195t1170r1351b1233],

1	90:1735	CD	NUMBER	90:1735	num	2	SENT_388	[p13l1387t1167r1826b1235],
2	—	CD	NUMBER	—	_	0	SENT_388	[p13l1387t1167r1826b1235],
3	41	CD	NUMBER	41	num	5	SENT_388	[p13l1387t1167r1826b1235],
4	Loe	NN	O	loe	nn	5	SENT_388	[p13l600t1285r744b1348],
5	DW	NN	O	dw	dep	2	SENT_388	[p13l776t1285r940b1361],
6	,	,	O	,	_	0	SENT_388	[p13l776t1285r940b1361],
7	Deeley	NNP	PERSON	Deeley	nn	11	SENT_388	[p13l1005t1283r1267b1368],
8	RG	NNP	O	RG	nn	11	SENT_388	[p13l1300t1283r1448b1361],
9	,	,	O	,	_	0	SENT_388	[p13l1300t1283r1448b1361],
10	Cole	NNP	O	Cole	appos	11	SENT_388	[p13l1514t1283r1688b1349],
11	SPC.	NNP	O	SPC.	appos	5	SENT_388	[p13l1723t1283r1905b1349],
12	1998	CD	DATE	1998	num	11	SENT_388	[p13l1950t1283r2146b1350],
13	.	.	O	.	_	0	SENT_388	[p13l1950t1283r2146b1350],

1	Characterization	NN	O	characterization	dep	13	SENT_389	[p13l601t1397r1221b1464],
2	of	IN	O	of	_	0	SENT_389	[p13l1264t1398r1345b1464],
3	Vincristine	NNP	O	Vincristine	nn	4	SENT_389	[p13l1381t1397r1776b1464],
4	transport	NN	O	transport	prep_of	1	SENT_389	[p13l1818t1407r2152b1483],
5	by	IN	O	by	_	0	SENT_389	[p13l599t1513r691b1598],
6	the	DT	O	the	det	10	SENT_389	[p13l732t1513r845b1579],
7	Mr	NNP	O	Mr	nn	10	SENT_389	[p13l885t1515r989b1593],
8	190,000	CD	NUMBER	190,000	num	10	SENT_389	[p13l1037t1514r1331b1591],
9	multidrug	JJ	O	multidrug	amod	10	SENT_389	[p13l1372t1513r1740b1599],
10	resistance	NN	O	resistance	prep_by	4	SENT_389	[p13l1780t1513r2150b1579],
11	protein	NN	O	protein	dep	13	SENT_389	[p13l600t1628r865b1714],
12	(	CD	NUMBER	(	num	11	SENT_389	[p13l903t1629r1179b1710],
13	MRP	NN	O	mrp	dep	16	SENT_389	[p13l903t1629r1179b1710],
14	)	CD	NUMBER	)	dep	13	SENT_389	[p13l903t1629r1179b1710],
15	:	:	O	:	_	0	SENT_389	[p13l903t1629r1179b1710],
16	evidence	NN	O	evidence	_	0	SENT_389	[p13l1222t1628r1550b1695],
17	for	IN	O	for	_	0	SENT_389	[p13l1587t1628r1695b1695],
18	cotransport	NN	O	cotransport	prep_for	16	SENT_389	[p13l1730t1638r2152b1714],
19	with	IN	O	with	_	0	SENT_389	[p13l601t1744r766b1810],
20	reduced	VBN	O	reduce	amod	21	SENT_389	[p13l783t1744r1081b1810],
21	glutathione	NN	O	glutathione	prep_with	18	SENT_389	[p13l1101t1744r1539b1829],
22	.	.	O	.	_	0	SENT_389	[p13l1101t1744r1539b1829],

1	Cancer	NN	O	cancer	_	0	SENT_390	[p13l1568t1745r1842b1810],
2	Res	NNP	O	Res	dep	1	SENT_390	[p13l1854t1747r2005b1810],
3	.	.	O	.	_	0	SENT_390	[p13l1854t1747r2005b1810],

1	58	CD	NUMBER	58	_	0	SENT_391	[p13l2034t1743r2144b1810],
2	:	:	O	:	_	0	SENT_391	[p13l2034t1743r2144b1810],
3	5130-36	CD	NUMBER	5130-36	num	5	SENT_391	[p13l602t1859r927b1925],
4	Borst	NNP	ORGANIZATION	Borst	nn	5	SENT_391	[p13l600t1976r804b2040],
5	P	NN	ORGANIZATION	p	dep	1	SENT_391	[p13l837t1976r896b2052],
6	,	,	O	,	_	0	SENT_391	[p13l837t1976r896b2052],
7	Evers	NNP	ORGANIZATION	Evers	nn	8	SENT_391	[p13l966t1976r1174b2040],
8	R	NNP	ORGANIZATION	R	appos	5	SENT_391	[p13l1211t1976r1292b2052],
9	,	,	O	,	_	0	SENT_391	[p13l1211t1976r1292b2052],
10	Kool	NNP	O	Kool	nn	11	SENT_391	[p13l1363t1974r1544b2040],
11	M	NNP	O	M	appos	5	SENT_391	[p13l1578t1976r1680b2052],
12	,	,	O	,	_	0	SENT_391	[p13l1578t1976r1680b2052],
13	et	FW	O	et	nn	14	SENT_391	[p13l1719t1984r1785b2039],
14	al.	FW	O	al.	appos	5	SENT_391	[p13l1820t1974r1902b2040],
15	1999	CD	DATE	1999	dep	14	SENT_391	[p13l1950t1975r2146b2041],
16	.	.	O	.	_	0	SENT_391	[p13l1950t1975r2146b2041],

1	The	DT	O	the	det	5	SENT_392	[p13l600t2089r744b2155],
2	multidrug	JJ	O	multidrug	amod	5	SENT_392	[p13l780t2089r1149b2174],
3	resistance	NN	O	resistance	nn	5	SENT_392	[p13l1184t2089r1554b2155],
4	protein	NN	O	protein	nn	5	SENT_392	[p13l1589t2089r1855b2174],
5	family	NN	O	family	_	0	SENT_392	[p13l1891t2089r2146b2174],
6	.	.	O	.	_	0	SENT_392	[p13l1891t2089r2146b2174],

1	Biochim	NNP	O	Biochim	_	0	SENT_393	[p13l598t2205r926b2271],
2	.	.	O	.	_	0	SENT_393	[p13l598t2205r926b2271],

1	Biophys	NNS	O	biophy	_	0	SENT_394	[p13l958t2205r1276b2289],
2	.	.	O	.	_	0	SENT_394	[p13l958t2205r1276b2289],

1	Acta	NNP	PERSON	Acta	_	0	SENT_395	[p13l1305t2206r1481b2271],
2	146l	CD	NUMBER	146l	num	1	SENT_395	[p13l1516t2205r1999b2271],
3	:347	CD	NUMBER	:347	num	4	SENT_395	[p13l1516t2205r1999b2271],
4	—	NN	O	—	dep	1	SENT_395	[p13l1516t2205r1999b2271],
5	57	CD	NUMBER	57	num	7	SENT_395	[p13l1516t2205r1999b2271],
6	Kool	NNP	O	Kool	nn	7	SENT_395	[p13l602t2320r783b2386],
7	M	NN	O	m	dep	4	SENT_395	[p13l807t2322r908b2398],
8	,	,	O	,	_	0	SENT_395	[p13l807t2322r908b2398],
9	Van	NNP	PERSON	Van	nn	12	SENT_395	[p13l957t2322r1101b2386],
10	Der	NNP	PERSON	Der	nn	12	SENT_395	[p13l1125t2322r1265b2386],
11	Linden	NNP	PERSON	Linden	nn	12	SENT_395	[p13l1287t2320r1553b2386],
12	M	NN	O	m	appos	7	SENT_395	[p13l1575t2322r1677b2398],
13	,	,	O	,	_	0	SENT_395	[p13l1575t2322r1677b2398],
14	de	FW	O	de	dep	7	SENT_395	[p13l1727t2320r1812b2386],
15	Haas	NNP	O	Haas	nn	16	SENT_395	[p13l1836t2322r2020b2386],
16	M	NN	O	m	dep	1	SENT_395	[p13l2046t2322r2147b2398],
17	,	,	O	,	_	0	SENT_395	[p13l2046t2322r2147b2398],
18	et	FW	O	et	nn	19	SENT_395	[p13l601t2445r667b2501],
19	al.	FW	O	al.	appos	16	SENT_395	[p13l693t2435r776b2501],
20	.	.	O	.	_	0	SENT_395	[p13l693t2435r776b2501],

1	MRP3	NN	O	mrp3	_	0	SENT_396	[p13l805t2436r1069b2513],
2	,	,	O	,	_	0	SENT_396	[p13l805t2436r1069b2513],
3	an	DT	O	a	det	6	SENT_396	[p13l1100t2456r1184b2501],
4	organic	JJ	O	organic	amod	6	SENT_396	[p13l1211t2435r1486b2520],
5	anion	NN	O	anion	nn	6	SENT_396	[p13l1515t2435r1720b2501],
6	transporter	NN	O	transporter	appos	1	SENT_396	[p13l1745t2445r2153b2520],
7	able	JJ	O	able	amod	6	SENT_396	[p13l603t2550r754b2616],
8	to	TO	O	to	aux	9	SENT_396	[p13l784t2560r854b2616],
9	transport	VB	O	transport	xcomp	7	SENT_396	[p13l884t2560r1218b2635],
10	anti-cancer	JJ	O	anti-cancer	amod	11	SENT_396	[p13l1247t2550r1664b2616],
11	drugs	NNS	O	drug	dobj	9	SENT_396	[p13l1692t2550r1916b2635],
12	.	.	O	.	_	0	SENT_396	[p13l1692t2550r1916b2635],

1	Proc	NNP	O	Proc	_	0	SENT_397	[p13l1949t2553r2142b2616],
2	.	.	O	.	_	0	SENT_397	[p13l1949t2553r2142b2616],

1	Natl.	NNP	O	Natl.	nn	2	SENT_398	[p13l597t2665r775b2732],
2	Acad	NNP	O	Acad	_	0	SENT_398	[p13l803t2665r1016b2731],
3	.	.	O	.	_	0	SENT_398	[p13l803t2665r1016b2731],

1	Sci	NNP	O	Sci	_	0	SENT_399	[p13l1051t2667r1178b2732],
2	.	.	O	.	_	0	SENT_399	[p13l1051t2667r1178b2732],

1	USA	NNP	LOCATION	USA	_	0	SENT_400	[p13l1221t2667r1381b2732],
2	96:6914	CD	NUMBER	96:6914	number	3	SENT_400	[p13l1411t2665r1855b2732],
3	—	CD	NUMBER	—	dep	1	SENT_400	[p13l1411t2665r1855b2732],
4	19	CD	NUMBER	19	num	5	SENT_400	[p13l1411t2665r1855b2732],
5	Wijnholds	NNS	O	wijnhold	dep	3	SENT_400	[p13l600t2780r985b2866],
6	J	NN	O	j	nn	12	SENT_400	[p13l1015t2783r1049b2847],
7	,	,	O	,	_	0	SENT_400	[p13l1056t2835r1070b2859],
8	Mo1CAAM	NN	O	mo1caam	dep	12	SENT_400	[p13l1127t2781r1611b2859],
9	,	,	O	,	_	0	SENT_400	[p13l1127t2781r1611b2859],
10	van	NN	O	van	dep	12	SENT_400	[p13l1669t2802r1800b2847],
11	Deemter	NN	O	deemter	nn	12	SENT_400	[p13l1829t2783r2153b2847],
12	L	NN	O	l	dep	1	SENT_400	[p13l600t2898r676b2974],
13	,	,	O	,	_	0	SENT_400	[p13l600t2898r676b2974],
14	et	FW	O	et	nn	15	SENT_400	[p13l707t2906r773b2962],
15	al.	FW	O	al.	appos	12	SENT_400	[p13l802t2896r884b2962],
16	.	.	O	.	_	0	SENT_400	[p13l802t2896r884b2962],

1	Multidrug-resistance	JJ	O	multidrug-resistance	amod	2	SENT_401	[p13l915t2896r1698b2981],
2	protein	NN	O	protein	nsubj	9	SENT_401	[p13l1725t2896r1991b2981],
3	5	CD	NUMBER	5	dep	2	SENT_401	[p13l2019t2896r2058b2962],
4	is	VBZ	O	be	cop	9	SENT_401	[p13l2090t2896r2148b2962],
5	a	DT	O	a	det	9	SENT_401	[p13l603t3032r642b3077],
6	multispeciﬁc	JJ	O	multispeciﬁc	amod	9	SENT_401	[p13l673t3011r1157b3097],
7	organic	JJ	O	organic	amod	9	SENT_401	[p13l1193t3011r1469b3097],
8	anion	NN	O	anion	nn	9	SENT_401	[p13l1507t3011r1712b3077],
9	transporter	NN	O	transporter	_	0	SENT_401	[p13l1745t3021r2153b3097],
10	able	JJ	O	able	amod	9	SENT_401	[p13l603t3127r754b3193],
11	to	TO	O	to	aux	12	SENT_401	[p13l774t3137r844b3193],
12	transport	VB	O	transport	xcomp	10	SENT_401	[p13l863t3137r1197b3213],
13	nucleotide	NN	O	nucleotide	nn	14	SENT_401	[p13l1214t3127r1604b3193],
14	analogs	NNS	O	analog	dobj	12	SENT_401	[p13l1625t3127r1927b3213],
15	.	.	O	.	_	0	SENT_401	[p13l1625t3127r1927b3213],

1	Proc	NNP	O	Proc	_	0	SENT_402	[p13l1949t3130r2142b3193],
2	.	.	O	.	_	0	SENT_402	[p13l1949t3130r2142b3193],

1	Natl.	NNP	O	Natl.	nn	2	SENT_403	[p13l597t3243r775b3309],
2	Acad	NNP	O	Acad	_	0	SENT_403	[p13l803t3243r1016b3309],
3	.	.	O	.	_	0	SENT_403	[p13l803t3243r1016b3309],

1	Sci	NNP	O	Sci	_	0	SENT_404	[p13l1051t3244r1178b3309],
2	.	.	O	.	_	0	SENT_404	[p13l1051t3244r1178b3309],

1	USA	NNP	LOCATION	USA	nn	6	SENT_405	[p13l1221t3244r1381b3309],
2	97:7476	CD	NUMBER	97:7476	num	6	SENT_405	[p13l1411t3243r1849b3310],
3	—	CD	NUMBER	—	num	6	SENT_405	[p13l1411t3243r1849b3310],
4	81	CD	NUMBER	81	num	6	SENT_405	[p13l1411t3243r1849b3310],
5	Doyle	NNP	ORGANIZATION	Doyle	nn	6	SENT_405	[p13l600t3357r827b3443],
6	LA	NNP	ORGANIZATION	LA	_	0	SENT_405	[p13l859t3359r1003b3436],
7	,	,	O	,	_	0	SENT_405	[p13l859t3359r1003b3436],
8	Yang	NNP	PERSON	Yang	nn	9	SENT_405	[p13l1068t3360r1258b3443],
9	W	NNP	PERSON	W	appos	6	SENT_405	[p13l1290t3360r1389b3435],
10	,	,	O	,	_	0	SENT_405	[p13l1290t3360r1389b3435],
11	Abruzzo	NNP	ORGANIZATION	Abruzzo	nn	12	SENT_405	[p13l1454t3357r1775b3423],
12	LV	NNP	ORGANIZATION	LV	appos	6	SENT_405	[p13l1807t3360r1929b3435],
13	,	,	O	,	_	0	SENT_405	[p13l1807t3360r1929b3435],
14	et	FW	O	et	nn	15	SENT_405	[p13l1965t3368r2032b3423],
15	a1	FW	O	a1	appos	6	SENT_405	[p13l2064t3358r2146b3423],
16	.	.	O	.	_	0	SENT_405	[p13l2064t3358r2146b3423],

1	1998	CD	DATE	1998	_	0	SENT_406	[p13l610t3473r805b3539],
2	.	.	O	.	_	0	SENT_406	[p13l610t3473r805b3539],

1	A	DT	O	a	det	4	SENT_407	[p13l842t3473r908b3538],
2	multidrug	JJ	O	multidrug	amod	4	SENT_407	[p13l941t3472r1309b3558],
3	resistance	NN	O	resistance	nn	4	SENT_407	[p13l1342t3472r1712b3538],
4	transporter	NN	O	transporter	_	0	SENT_407	[p13l1744t3482r2152b3558],
5	from	IN	O	from	_	0	SENT_407	[p13l601t3588r782b3654],
6	human	JJ	O	human	amod	10	SENT_407	[p13l817t3588r1072b3654],
7	MCF-7	NN	MISC	mcf-7	nn	10	SENT_407	[p13l1107t3588r1379b3654],
8	breast	NN	O	breast	nn	10	SENT_407	[p13l1417t3588r1642b3654],
9	cancer	NN	O	cancer	nn	10	SENT_407	[p13l1678t3608r1922b3654],
10	cells	NNS	O	cell	prep_from	4	SENT_407	[p13l1957t3588r2146b3654],
11	.	.	O	.	_	0	SENT_407	[p13l1957t3588r2146b3654],

1	Proc	NNP	O	Proc	_	0	SENT_408	[p13l599t3704r792b3768],
2	.	.	O	.	_	0	SENT_408	[p13l599t3704r792b3768],

1	Natl.	NNP	O	Natl.	nn	2	SENT_409	[p13l846t3702r1024b3768],
2	Acad	NNP	O	Acad	_	0	SENT_409	[p13l1076t3702r1288b3768],
3	.	.	O	.	_	0	SENT_409	[p13l1076t3702r1288b3768],

1	Sci	NNP	O	Sci	_	0	SENT_410	[p13l1346t3703r1473b3769],
2	.	.	O	.	_	0	SENT_410	[p13l1346t3703r1473b3769],

1	USA	NNP	LOCATION	USA	_	0	SENT_411	[p13l1539t3703r1699b3769],
2	95:15665	CD	NUMBER	95:15665	num	3	SENT_411	[p13l1751t3702r2152b3769],
3	—	CD	NUMBER	—	dep	1	SENT_411	[p13l1751t3702r2152b3769],

1	70	CD	NUMBER	70	num	2	SENT_412	[p14l601t31r692b97],
2	Allikmets	NNS	O	allikmet	_	0	SENT_412	[p14l600t144r967b210],
3	R	NN	O	r	dep	2	SENT_412	[p14l1005t146r1085b222],
4	,	,	O	,	_	0	SENT_412	[p14l1005t146r1085b222],
5	Schriml	NNP	ORGANIZATION	Schriml	nn	6	SENT_412	[p14l1159t144r1452b211],
6	LM	NNP	ORGANIZATION	LM	appos	3	SENT_412	[p14l1488t146r1647b222],
7	,	,	O	,	_	0	SENT_412	[p14l1488t146r1647b222],
8	Hutchinson	NNP	PERSON	Hutchinson	nn	9	SENT_412	[p14l1719t144r2151b210],
9	A	NNP	O	A	appos	3	SENT_412	[p14l600t259r686b337],
10	,	,	O	,	_	0	SENT_412	[p14l600t259r686b337],
11	et	FW	O	et	nn	12	SENT_412	[p14l715t269r781b325],
12	al.	FW	O	al.	appos	3	SENT_412	[p14l806t259r888b325],
13	1998	CD	DATE	1998	dep	12	SENT_412	[p14l927t259r1122b326],
14	.	.	O	.	_	0	SENT_412	[p14l927t259r1122b326],

1	A	DT	O	a	det	11	SENT_413	[p14l1151t259r1217b324],
2	human	JJ	O	human	amod	11	SENT_413	[p14l1241t259r1496b325],
3	placenta-speciﬁc	JJ	O	placenta-speciﬁc	amod	11	SENT_413	[p14l1518t259r2149b344],
4	ATP	NN	O	atp	nn	11	SENT_413	[p14l600t373r1084b459],
5	—	NN	O	—	nn	11	SENT_413	[p14l600t373r1084b459],
6	binding	NN	O	binding	nn	11	SENT_413	[p14l600t373r1084b459],
7	cassette	NN	O	cassette	nn	11	SENT_413	[p14l1136t383r1425b439],
8	gene	NN	O	gene	nn	11	SENT_413	[p14l1478t394r1651b459],
9	(	CD	NUMBER	(	num	11	SENT_413	[p14l1705t373r2006b454],
10	ABCP	NN	ORGANIZATION	abcp	nn	11	SENT_413	[p14l1705t373r2006b454],
11	)	NN	O	)	_	0	SENT_413	[p14l1705t373r2006b454],
12	on	IN	O	on	_	0	SENT_413	[p14l2060t394r2151b439],
13	chromosome	NN	O	chromosome	nn	14	SENT_413	[p14l601t487r1085b553],
14	4q22	NN	O	4q22	prep_on	11	SENT_413	[p14l1103t487r1289b572],
15	that	WDT	O	that	nsubjpass	17	SENT_413	[p14l1309t487r1449b553],
16	is	VBZ	O	be	auxpass	17	SENT_413	[p14l1467t486r1525b553],
17	involved	VBN	O	involve	rcmod	14	SENT_413	[p14l1546t486r1868b553],
18	in	IN	O	in	_	0	SENT_413	[p14l1886t486r1956b552],
19	multidrug	JJ	O	multidrug	amod	20	SENT_413	[p14l1976t487r2148b553, p14l600t601r822b686],
20	resistance	NN	O	resistance	prep_in	17	SENT_413	[p14l860t601r1248b667],
21	.	.	O	.	_	0	SENT_413	[p14l860t601r1248b667],

1	Cancer	NN	O	cancer	_	0	SENT_414	[p14l1295t602r1569b667],
2	Res	NNP	O	Res	dep	1	SENT_414	[p14l1600t604r1751b667],
3	.	.	O	.	_	0	SENT_414	[p14l1600t604r1751b667],

1	58:5337	CD	NUMBER	58:5337	num	5	SENT_415	[p14l1798t600r2152b667],
2	—	CD	NUMBER	—	num	5	SENT_415	[p14l1798t600r2152b667],
3	39	CD	NUMBER	39	num	5	SENT_415	[p14l603t717r690b783],
4	Miyake	NNP	ORGANIZATION	Miyake	nn	5	SENT_415	[p14l600t829r884b915],
5	K	NNP	ORGANIZATION	K	_	0	SENT_415	[p14l919t831r1004b907],
6	,	,	O	,	_	0	SENT_415	[p14l919t831r1004b907],
7	Mickley	NNP	ORGANIZATION	Mickley	nn	8	SENT_415	[p14l1070t829r1380b915],
8	L	NNP	ORGANIZATION	L	appos	5	SENT_415	[p14l1413t831r1489b908],
9	,	,	O	,	_	0	SENT_415	[p14l1413t831r1489b908],
10	Litman	NNP	PERSON	Litman	nn	11	SENT_415	[p14l1555t829r1826b895],
11	T	NN	O	t	appos	5	SENT_415	[p14l1859t831r1927b908],
12	,	,	O	,	_	0	SENT_415	[p14l1859t831r1927b908],
13	et	FW	O	et	nn	14	SENT_415	[p14l1964t839r2031b895],
14	al.	FW	O	al.	appos	5	SENT_415	[p14l2064t829r2146b895],
15	1999	CD	DATE	1999	dep	14	SENT_415	[p14l609t945r805b1012],
16	.	.	O	.	_	0	SENT_415	[p14l609t945r805b1012],

1	Molecular	JJ	O	molecular	amod	2	SENT_416	[p14l828t945r1216b1011],
2	cloning	NN	O	cloning	_	0	SENT_416	[p14l1233t945r1512b1030],
3	of	IN	O	of	_	0	SENT_416	[p14l1533t945r1614b1011],
4	cDNAs	NNS	O	cdna	prep_of	2	SENT_416	[p14l1628t945r1902b1011],
5	which	WDT	O	which	nsubjpass	8	SENT_416	[p14l1923t945r2151b1011],
6	is	VBZ	O	be	auxpass	8	SENT_416	[p14l600t1059r658b1125],
7	highly	RB	O	highly	advmod	8	SENT_416	[p14l690t1059r928b1144],
8	overexpressed	VBN	O	overexpress	rcmod	4	SENT_416	[p14l959t1059r1491b1144],
9	in	IN	O	in	_	0	SENT_416	[p14l1520t1059r1591b1124],
10	mitoXantroneresistant	JJ	O	mitoxantroneresistant	amod	11	SENT_416	[p14l1619t1059r2148b1125, p14l600t1173r913b1239],
11	cells	NNS	O	cell	prep_in	8	SENT_416	[p14l953t1173r1142b1239],
12	:	:	O	:	_	0	SENT_416	[p14l953t1173r1142b1239],
13	demonstration	NN	O	demonstration	dep	2	SENT_416	[p14l1189t1173r1725b1239],
14	of	IN	O	of	_	0	SENT_416	[p14l1766t1173r1847b1239],
15	homol34	NN	O	homol34	prep_of	13	SENT_416	[p14l1880t1173r2148b1239, p14l444t145r551b211],
16	.	.	O	.	_	0	SENT_416	[p14l1880t1173r2148b1239, p14l444t145r551b211],

1	ogy	NN	O	ogy	_	0	SENT_417	[p14l209t1500r379b1581],
2	to	TO	O	to	_	0	SENT_417	[p14l411t1486r498b1556],
3	ABC	NNP	ORGANIZATION	ABC	nn	5	SENT_417	[p14l530t1475r767b1557],
4	transport	NN	O	transport	nn	5	SENT_417	[p14l800t1486r1218b1581],
5	genes	NNS	O	gene	prep_to	1	SENT_417	[p14l1249t1500r1535b1581],
6	.	.	O	.	_	0	SENT_417	[p14l1249t1500r1535b1581],

1	Cancer	NN	O	cancer	_	0	SENT_418	[p14l1579t1475r1921b1557],
2	Res	NNP	O	Res	dep	1	SENT_418	[p14l1945t1477r2133b1557],
3	.	.	O	.	_	0	SENT_418	[p14l1945t1477r2133b1557],

1	5928-13	CD	NUMBER	5928-13	_	0	SENT_419	[p14l209t1617r584b1701],

1	Komatani	JJ	PERSON	komatani	amod	2	SENT_420	[p14l209t1763r663b1845],
2	H	NN	PERSON	h	_	0	SENT_420	[p14l713t1765r819b1861],
3	,	,	O	,	_	0	SENT_420	[p14l713t1765r819b1861],
4	Kotani	NNP	PERSON	Kotani	nn	5	SENT_420	[p14l920t1763r1231b1845],
5	H	NNP	O	H	appos	2	SENT_420	[p14l1279t1765r1387b1861],
6	,	,	O	,	_	0	SENT_420	[p14l1279t1765r1387b1861],
7	Hara	NNP	O	Hara	nn	8	SENT_420	[p14l1484t1765r1712b1845],
8	Y	NN	O	y	appos	2	SENT_420	[p14l1759t1765r1850b1861],
9	,	,	O	,	_	0	SENT_420	[p14l1759t1765r1850b1861],
10	et	FW	O	et	nn	11	SENT_420	[p14l1904t1775r1987b1845],
11	al.	FW	O	al.	appos	2	SENT_420	[p14l2036t1763r2139b1845],
12	2001	CD	DATE	2001	dep	11	SENT_420	[p14l209t1907r463b1989],
13	.	.	O	.	_	0	SENT_420	[p14l209t1907r463b1989],

1	Identiﬁcation	NN	O	identiﬁcation	nsubj	8	SENT_421	[p14l518t1907r1143b1989],
2	of	IN	O	of	_	0	SENT_421	[p14l1194t1907r1295b1989],
3	breast	NN	O	breast	nn	4	SENT_421	[p14l1335t1907r1616b1989],
4	cancer	NN	O	cancer	prep_of	1	SENT_421	[p14l1664t1933r1970b1989],
5	resistant	JJ	O	resistant	amod	8	SENT_421	[p14l2016t1934r2141b1989, p14l211t2049r507b2132],
6	protein/mitoxantrone	NN	O	protein/mitoxantrone	nn	8	SENT_421	[p14l597t2049r1589b2156],
7	resistance	NN	O	resistance	nn	8	SENT_421	[p14l1682t2049r2144b2132],
8	protein/placenta	NN	O	protein/placenta	_	0	SENT_421	[p14l205t2194r1387b2300],
9	—	CD	NUMBER	—	num	10	SENT_421	[p14l205t2194r1387b2300],
10	speciﬁc	NN	O	speciﬁc	dobj	8	SENT_421	[p14l205t2194r1387b2300],
11	,	,	O	,	_	0	SENT_421	[p14l205t2194r1387b2300],
12	AT	IN	O	at	dep	23	SENT_421	[p14l1538t2194r1680b2275],
13	P	NN	O	p	nn	17	SENT_421	[p14l1683t2194r2143b2300],
14	—	NN	O	—	nn	17	SENT_421	[p14l1683t2194r2143b2300],
15	binding	NN	O	binding	nn	17	SENT_421	[p14l1683t2194r2143b2300],
16	cassette	NN	O	cassette	nn	17	SENT_421	[p14l207t2349r569b2419],
17	transporter	NN	O	transporter	pobj	12	SENT_421	[p14l634t2349r1144b2444],
18	as	IN	O	as	_	0	SENT_421	[p14l1208t2363r1298b2419],
19	a	DT	O	a	det	20	SENT_421	[p14l1367t2363r1415b2419],
20	transporter	NN	O	transporter	prep_as	17	SENT_421	[p14l1478t2349r1988b2444],
21	of	IN	O	of	_	0	SENT_421	[p14l2051t2337r2153b2419],
22	NB	NN	O	nb	prep_of	20	SENT_421	[p14l206t2479r581b2562],
23	—	NN	O	—	rcmod	10	SENT_421	[p14l206t2479r581b2562],
24	506	CD	NUMBER	506	num	23	SENT_421	[p14l206t2479r581b2562],
25	and	CC	O	and	_	0	SENT_421	[p14l669t2479r835b2561],
26	J-107088	NN	O	j-107088	dobj	8	SENT_421	[p14l917t2480r1379b2577],
27	,	,	O	,	_	0	SENT_421	[p14l917t2480r1379b2577],
28	topoisomerase	NN	O	topoisomerase	nn	30	SENT_421	[p14l1467t2479r2144b2586],
29	I	NN	O	i	nn	30	SENT_421	[p14l207t2625r242b2705],
30	inhibitors	NNS	O	inhibitor	appos	26	SENT_421	[p14l340t2624r786b2706],
31	with	IN	O	with	_	0	SENT_421	[p14l887t2624r1093b2706],
32	an	DT	O	a	det	34	SENT_421	[p14l1192t2649r1298b2706],
33	indolocarbazole	JJ	O	indolocarbazole	amod	34	SENT_421	[p14l1395t2624r2144b2706],
34	structure	NN	O	structure	prep_with	8	SENT_421	[p14l211t2780r639b2851],
35	.	.	O	.	_	0	SENT_421	[p14l211t2780r639b2851],

1	Cancer	NN	O	cancer	_	0	SENT_422	[p14l683t2769r1026b2852],
2	Res	NNP	O	Res	dep	1	SENT_422	[p14l1051t2771r1239b2851],
3	.	.	O	.	_	0	SENT_422	[p14l1051t2771r1239b2851],

1	61:2827	CD	NUMBER	61:2827	number	2	SENT_423	[p14l1286t2768r1841b2851],
2	—	CD	NUMBER	—	_	0	SENT_423	[p14l1286t2768r1841b2851],
3	32	CD	NUMBER	32	num	5	SENT_423	[p14l1286t2768r1841b2851],
4	Borst	NNP	ORGANIZATION	Borst	nn	5	SENT_423	[p14l207t2913r461b2992],
5	P	NN	ORGANIZATION	p	dep	2	SENT_423	[p14l523t2913r598b3008],
6	,	,	O	,	_	0	SENT_423	[p14l523t2913r598b3008],
7	Zelcer	NNP	PERSON	Zelcer	nn	8	SENT_423	[p14l727t2910r1027b2992],
8	N	NNP	O	N	appos	2	SENT_423	[p14l1089t2913r1197b3008],
9	,	,	O	,	_	0	SENT_423	[p14l1089t2913r1197b3008],
10	Van	NNP	PERSON	Van	nn	12	SENT_423	[p14l1327t2937r1491b2993],
11	Helvoort	NNP	PERSON	Helvoort	nn	12	SENT_423	[p14l1555t2910r1971b2993],
12	A.	NNP	O	A.	appos	8	SENT_423	[p14l2033t2911r2139b2993],
13	2000	CD	DATE	2000	num	12	SENT_423	[p14l209t3055r463b3137],
14	.	.	O	.	_	0	SENT_423	[p14l209t3055r463b3137],

1	ABC	NNP	ORGANIZATION	ABC	nn	2	SENT_424	[p14l496t3055r733b3137],
2	transporters	NNS	O	transporter	_	0	SENT_424	[p14l762t3067r1313b3161],
3	in	IN	O	in	_	0	SENT_424	[p14l1344t3054r1431b3136],
4	lipid	NN	O	lipid	nn	5	SENT_424	[p14l1459t3054r1672b3161],
5	transport	NN	O	transport	prep_in	2	SENT_424	[p14l1699t3067r2139b3161],
6	.	.	O	.	_	0	SENT_424	[p14l1699t3067r2139b3161],

1	Biochim	NNP	O	Biochim	_	0	SENT_425	[p14l204t3199r613b3281],
2	.	.	O	.	_	0	SENT_425	[p14l204t3199r613b3281],

1	Biophys	NNS	O	biophy	_	0	SENT_426	[p14l653t3199r1051b3305],
2	.	.	O	.	_	0	SENT_426	[p14l653t3199r1051b3305],

1	Acta	NNP	PERSON	Acta	_	0	SENT_427	[p14l1087t3200r1307b3281],
2	1486:128	CD	NUMBER	1486:128	num	1	SENT_427	[p14l1352t3199r1958b3281],
3	—	CD	NUMBER	—	number	4	SENT_427	[p14l1352t3199r1958b3281],
4	44	CD	NUMBER	44	dep	1	SENT_427	[p14l1352t3199r1958b3281],
5	Childs	NNP	O	Childs	dep	4	SENT_427	[p14l209t3343r509b3426],
6	S	NN	O	s	dep	1	SENT_427	[p14l559t3343r644b3441],
7	,	,	O	,	_	0	SENT_427	[p14l559t3343r644b3441],
8	Yeh	NNP	O	Yeh	nn	9	SENT_427	[p14l735t3343r917b3425],
9	RL	NNP	O	RL	appos	6	SENT_427	[p14l961t3346r1133b3441],
10	,	,	O	,	_	0	SENT_427	[p14l961t3346r1133b3441],
11	Hui	NNP	PERSON	Hui	nn	12	SENT_427	[p14l1224t3343r1398b3425],
12	D	NNP	PERSON	D	appos	1	SENT_427	[p14l1443t3346r1549b3441],
13	,	,	O	,	_	0	SENT_427	[p14l1443t3346r1549b3441],
14	et	FW	O	et	nn	15	SENT_427	[p14l1601t3356r1683b3425],
15	al.	FW	O	al.	appos	1	SENT_427	[p14l1729t3343r1831b3425],
16	1998	CD	DATE	1998	dep	15	SENT_427	[p14l1893t3343r2137b3427],
17	.	.	O	.	_	0	SENT_427	[p14l1893t3343r2137b3427],

1	Taxol	NN	O	taxol	nn	2	SENT_428	[p14l207t3485r469b3568],
2	resistance	NN	O	resistance	nsubj	3	SENT_428	[p14l533t3485r996b3568],
3	mediated	VBN	O	mediate	_	0	SENT_428	[p14l1062t3485r1491b3568],
4	by	IN	O	by	_	0	SENT_428	[p14l1554t3485r1669b3592],
5	transfec	NN	O	transfec	nn	7	SENT_428	[p14l1735t3485r2141b3568],
6	—	CD	NUMBER	—	num	7	SENT_428	[p14l1735t3485r2141b3568],
7	tion	NN	O	tion	prep_by	3	SENT_428	[p14l207t3629r387b3711],
8	of	IN	O	of	_	0	SENT_428	[p14l425t3629r526b3711],
9	the	DT	O	the	det	14	SENT_428	[p14l554t3629r695b3711],
10	liVer	NN	O	liver	nn	14	SENT_428	[p14l732t3629r1335b3735],
11	—	NN	O	—	nn	14	SENT_428	[p14l732t3629r1335b3735],
12	speciﬁc	NN	O	speciﬁc	nn	14	SENT_428	[p14l732t3629r1335b3735],
13	sister	NN	O	sister	nn	14	SENT_428	[p14l1378t3629r1622b3711],
14	gene	NN	O	gene	prep_of	7	SENT_428	[p14l1658t3654r1874b3735],
15	of	IN	O	of	_	0	SENT_428	[p14l1913t3629r2014b3711],
16	Pglycoprotein	NN	LOCATION	pglycoprotein	prep_of	14	SENT_428	[p14l2043t3631r2142b3709, p15l209t25r822b132],
17	.	.	O	.	_	0	SENT_428	[p14l2043t3631r2142b3709, p15l209t25r822b132],

1	Cancer	NN	O	cancer	_	0	SENT_429	[p15l868t27r1210b108],
2	Res	NNP	O	Res	dep	1	SENT_429	[p15l1234t28r1423b107],
3	.	.	O	.	_	0	SENT_429	[p15l1234t28r1423b107],

1	58:4160	CD	NUMBER	58:4160	num	5	SENT_430	[p15l1468t25r2022b107],
2	—	CD	NUMBER	—	num	5	SENT_430	[p15l1468t25r2022b107],
3	67	CD	NUMBER	67	num	5	SENT_430	[p15l1468t25r2022b107],
4	Laing	NNP	ORGANIZATION	Laing	nn	5	SENT_430	[p15l206t167r477b274],
5	NM	NNP	ORGANIZATION	NM	_	0	SENT_430	[p15l499t170r712b265],
6	,	,	O	,	_	0	SENT_430	[p15l499t170r712b265],
7	Belinsky	NNP	PERSON	Belinsky	nn	8	SENT_430	[p15l757t167r1171b274],
8	MG	NN	O	mg	appos	5	SENT_430	[p15l1193t168r1404b265],
9	,	,	O	,	_	0	SENT_430	[p15l1193t168r1404b265],
10	Kruh	NNP	PERSON	Kruh	nn	11	SENT_430	[p15l1452t167r1689b250],
11	GD	NN	O	gd	appos	5	SENT_430	[p15l1713t168r1903b265],
12	,	,	O	,	_	0	SENT_430	[p15l1713t168r1903b265],
13	et	FW	O	et	nn	14	SENT_430	[p15l1930t180r2013b249],
14	al.	FW	O	al.	appos	5	SENT_430	[p15l2035t168r2138b250],
15	1998	CD	DATE	1998	dep	14	SENT_430	[p15l218t312r463b396],
16	.	.	O	.	_	0	SENT_430	[p15l218t312r463b396],

1	Ampliﬁcation	NN	O	ampliﬁcation	nsubjpass	14	SENT_431	[p15l515t312r1166b418],
2	of	IN	O	of	_	0	SENT_431	[p15l1213t312r1314b394],
3	the	DT	O	the	det	6	SENT_431	[p15l1352t312r1492b394],
4	AT	NNP	O	AT	nn	6	SENT_431	[p15l1538t312r1680b393],
5	P	NN	O	p	nn	6	SENT_431	[p15l1683t312r2143b418],
6	—	NN	O	—	prep_of	1	SENT_431	[p15l1683t312r2143b418],
7	binding	NN	O	binding	prep	6	SENT_431	[p15l1683t312r2143b418],
8	cassette	NN	O	cassette	nn	11	SENT_431	[p15l207t467r569b537],
9	2	CD	NUMBER	2	num	11	SENT_431	[p15l601t455r655b536],
10	transporter	NN	O	transporter	nn	11	SENT_431	[p15l685t467r1195b562],
11	gene	NN	O	gene	dep	7	SENT_431	[p15l1224t481r1442b562],
12	is	VBZ	O	be	auxpass	14	SENT_431	[p15l1472t455r1545b537],
13	functionally	RB	O	functionally	advmod	14	SENT_431	[p15l1578t455r2143b562],
14	linked	VBN	O	link	_	0	SENT_431	[p15l207t598r498b680],
15	with	IN	O	with	_	0	SENT_431	[p15l534t598r740b680],
16	enhanced	VBN	O	enhance	amod	17	SENT_431	[p15l776t598r1218b680],
17	efﬂux	NN	O	efﬂux	prep_with	14	SENT_431	[p15l1254t598r1522b680],
18	of	IN	O	of	_	0	SENT_431	[p15l1560t598r1661b680],
19	estramustine	NN	O	estramustine	prep_of	17	SENT_431	[p15l1691t610r2141b680, p15l207t743r379b825],
20	in	IN	O	in	_	0	SENT_431	[p15l431t743r521b824],
21	ovarian	JJ	O	ovarian	amod	23	SENT_431	[p15l573t743r917b825],
22	carcinoma	NN	O	carcinoma	nn	23	SENT_431	[p15l969t743r1458b825],
23	cells	NNS	O	cell	prep_in	19	SENT_431	[p15l1508t743r1743b825],
24	.	.	O	.	_	0	SENT_431	[p15l1508t743r1743b825],

1	Cancer	NN	O	cancer	_	0	SENT_432	[p15l1806t744r2149b825],
2	Res	NNP	O	Res	dep	1	SENT_432	[p15l204t890r392b969],
3	.	.	O	.	_	0	SENT_432	[p15l204t890r392b969],

1	58	CD	NUMBER	58	_	0	SENT_433	[p15l437t887r991b969],
2	:	:	O	:	_	0	SENT_433	[p15l437t887r991b969],
3	l332	CD	NUMBER	l332	num	4	SENT_433	[p15l437t887r991b969],
4	—	CD	NUMBER	—	dep	1	SENT_433	[p15l437t887r991b969],
5	37	CD	NUMBER	37	num	7	SENT_433	[p15l437t887r991b969],
6	Lyall	NNP	ORGANIZATION	Lyall	nn	7	SENT_433	[p15l206t1029r446b1136],
7	RM	NN	ORGANIZATION	rm	dep	4	SENT_433	[p15l481t1032r687b1127],
8	,	,	O	,	_	0	SENT_433	[p15l481t1032r687b1127],
9	Hwang	NNP	PERSON	Hwang	nn	10	SENT_433	[p15l759t1032r1094b1136],
10	J	NNP	PERSON	J	appos	7	SENT_433	[p15l1131t1032r1199b1127],
11	,	,	O	,	_	0	SENT_433	[p15l1131t1032r1199b1127],
12	Cardarelli	NNP	PERSON	Cardarelli	nn	13	SENT_433	[p15l1273t1029r1738b1112],
13	C	NNP	O	C	appos	7	SENT_433	[p15l1776t1030r1876b1127],
14	,	,	O	,	_	0	SENT_433	[p15l1776t1030r1876b1127],
15	et	FW	O	et	nn	16	SENT_433	[p15l1916t1041r1999b1111],
16	al.	FW	O	al.	appos	7	SENT_433	[p15l2036t1029r2139b1111],
17	1987	CD	DATE	1987	dep	16	SENT_433	[p15l218t1173r463b1256],
18	.	.	O	.	_	0	SENT_433	[p15l218t1173r463b1256],

1	Cancer	NN	O	cancer	_	0	SENT_434	[p15l507t1175r849b1256],
2	Res	NNP	O	Res	dep	1	SENT_434	[p15l874t1176r1062b1256],
3	.	.	O	.	_	0	SENT_434	[p15l874t1176r1062b1256],

1	47:296	CD	NUMBER	47:296	num	2	SENT_435	[p15l1106t1172r1664b1256],
2	l	NN	O	l	_	0	SENT_435	[p15l1106t1172r1664b1256],
3	—	CD	NUMBER	—	number	4	SENT_435	[p15l1106t1172r1664b1256],
4	66	CD	NUMBER	66	dep	2	SENT_435	[p15l1106t1172r1664b1256],
5	Gately	NNP	O	Gately	dep	4	SENT_435	[p15l209t1318r516b1424],
6	DP	NN	O	dp	dep	2	SENT_435	[p15l570t1320r729b1415],
7	,	,	O	,	_	0	SENT_435	[p15l570t1320r729b1415],
8	Howell	NNP	PERSON	Howell	nn	9	SENT_435	[p15l836t1318r1177b1400],
9	SB	NN	O	sb	appos	6	SENT_435	[p15l1234t1318r1395b1401],
10	.	.	O	.	_	0	SENT_435	[p15l1234t1318r1395b1401],

1	1993	CD	DATE	1993	_	0	SENT_436	[p15l1464t1318r1709b1402],
2	.	.	O	.	_	0	SENT_436	[p15l1464t1318r1709b1402],

1	Cellular	JJ	O	cellular	amod	2	SENT_437	[p15l1770t1318r2147b1400],
2	accumulation	NN	O	accumulation	_	0	SENT_437	[p15l209t1461r838b1543],
3	of	IN	O	of	_	0	SENT_437	[p15l874t1461r975b1543],
4	the	DT	O	the	det	7	SENT_437	[p15l1001t1461r1141b1543],
5	anticancer	JJ	O	anticancer	amod	7	SENT_437	[p15l1178t1461r1660b1543],
6	agent	NN	O	agent	nn	7	SENT_437	[p15l1694t1473r1945b1568],
7	cisplatin	NN	O	cisplatin	prep_of	2	SENT_437	[p15l1978t1461r2141b1543, p15l206t1603r496b1710],
8	:	:	O	:	_	0	SENT_437	[p15l1978t1461r2141b1543, p15l206t1603r496b1710],
9	a	DT	O	a	det	10	SENT_437	[p15l532t1630r580b1685],
10	review	NN	O	review	dep	2	SENT_437	[p15l601t1603r931b1686],
11	.	.	O	.	_	0	SENT_437	[p15l601t1603r931b1686],

1	Br	NNP	O	Br	_	0	SENT_438	[p15l958t1607r1081b1686],
2	:	:	O	:	_	0	SENT_438	[p15l958t1607r1081b1686],
3	J.	NNP	O	J.	nn	4	SENT_438	[p15l1114t1607r1180b1687],
4	Cancer	NNP	O	Cancer	dep	1	SENT_438	[p15l1222t1606r1565b1687],
5	67	CD	NUMBER	67	dep	4	SENT_438	[p15l1587t1603r1724b1686],
6	:	:	O	:	_	0	SENT_438	[p15l1587t1603r1724b1686],
7	1	CD	NUMBER	1	number	8	SENT_438	[p15l1746t1604r1780b1685],
8	171-76	CD	NUMBER	171-76	dep	1	SENT_438	[p15l1805t1603r2142b1686],
9	Shen	NN	O	shen	nn	10	SENT_438	[p15l210t1747r439b1829],
10	D	NN	O	d	dep	8	SENT_438	[p15l489t1748r736b1843],
11	.	.	O	.	_	0	SENT_438	[p15l489t1748r736b1843],

1	—	NN	O	—	_	0	SENT_439	[p15l489t1748r736b1843],
2	.	.	O	.	_	0	SENT_439	[p15l489t1748r736b1843],

1	W	NNP	O	W	nn	3	SENT_440	[p15l489t1748r736b1843],
2	,	,	O	,	_	0	SENT_440	[p15l489t1748r736b1843],
3	Pastan	NNP	PERSON	Pastan	_	0	SENT_440	[p15l836t1748r1139b1829],
4	I	PRP	O	I	dep	3	SENT_440	[p15l1189t1748r1250b1843],
5	,	,	O	,	_	0	SENT_440	[p15l1189t1748r1250b1843],
6	Gottesman	NNP	PERSON	Gottesman	nn	7	SENT_440	[p15l1353t1747r1859b1829],
7	MM	NN	O	mm	appos	4	SENT_440	[p15l1908t1748r2138b1829],
8	.	.	O	.	_	0	SENT_440	[p15l1908t1748r2138b1829],

1	1998	CD	DATE	1998	_	0	SENT_441	[p15l218t1891r463b1975],
2	.	.	O	.	_	0	SENT_441	[p15l218t1891r463b1975],

1	Cross-resistance	NN	O	cross-resistance	nsubj	13	SENT_442	[p15l539t1891r1306b1974],
2	to	TO	O	to	_	0	SENT_442	[p15l1376t1904r1463b1974],
3	methotrexate	NN	O	methotrexate	prep_to	1	SENT_442	[p15l1533t1891r2144b1974],
4	and	CC	O	and	_	0	SENT_442	[p15l209t2033r375b2115],
5	metals	NNS	O	metal	conj_and	3	SENT_442	[p15l431t2033r734b2115],
6	in	IN	O	in	_	0	SENT_442	[p15l794t2033r882b2115],
7	human	JJ	O	human	amod	9	SENT_442	[p15l940t2033r1259b2115],
8	cisplatin	NN	O	cisplatin	nn	9	SENT_442	[p15l1317t2033r2147b2140],
9	—	NN	O	—	prep_in	13	SENT_442	[p15l1317t2033r2147b2140],
10	resistant	JJ	O	resistant	amod	12	SENT_442	[p15l1317t2033r2147b2140],
11	cell	NN	O	cell	nn	12	SENT_442	[p15l207t2178r373b2260],
12	lines	NNS	O	line	nsubj	13	SENT_442	[p15l404t2178r620b2260],
13	results	VBZ	O	result	_	0	SENT_442	[p15l652t2178r955b2260],
14	from	IN	O	from	_	0	SENT_442	[p15l988t2178r1215b2260],
15	a	DT	O	a	det	17	SENT_442	[p15l1245t2203r1294b2260],
16	pleiotropic	JJ	O	pleiotropic	amod	17	SENT_442	[p15l1320t2178r1827b2284],
17	defect	NN	O	defect	prep_from	13	SENT_442	[p15l1860t2178r2145b2260],
18	in	IN	O	in	_	0	SENT_442	[p15l207t2322r296b2403],
19	accumulation	NN	O	accumulation	prep_in	17	SENT_442	[p15l339t2322r969b2404],
20	of	IN	O	of	_	0	SENT_442	[p15l1011t2322r1114b2404],
21	these	DT	O	these	det	22	SENT_442	[p15l1147t2322r1385b2404],
22	compounds	NNS	O	compound	prep_of	19	SENT_442	[p15l1429t2322r1965b2428],
23	associated	VBN	O	associate	partmod	22	SENT_442	[p15l2012t2348r2141b2404, p15l210t2464r591b2546],
24	With	IN	O	with	_	0	SENT_442	[p15l628t2464r835b2546],
25	reduced	VBN	O	reduce	amod	29	SENT_442	[p15l871t2464r1243b2546],
26	plasma	NN	O	plasma	nn	29	SENT_442	[p15l1279t2464r1614b2571],
27	membrane	NN	O	membrane	nn	29	SENT_442	[p15l1650t2464r2144b2546],
28	binding	NN	O	binding	nn	29	SENT_442	[p15l205t2607r562b2714],
29	proteins	NNS	O	protein	prep_with	23	SENT_442	[p15l590t2607r991b2714],
30	.	.	O	.	_	0	SENT_442	[p15l590t2607r991b2714],

1	Cancer	NN	O	cancer	_	0	SENT_443	[p15l1030t2610r1373b2691],
2	Res	NNP	O	Res	dep	1	SENT_443	[p15l1391t2611r1581b2690],
3	.	.	O	.	_	0	SENT_443	[p15l1391t2611r1581b2690],

1	58	CD	NUMBER	58	_	0	SENT_444	[p15l1621t2607r1759b2690],
2	:	:	O	:	_	0	SENT_444	[p15l1621t2607r1759b2690],
3	268-75	CD	NUMBER	268-75	num	5	SENT_444	[p15l1795t2607r2139b2690],
4	Shen	NN	O	shen	nn	5	SENT_444	[p15l210t2751r439b2833],
5	D	NN	O	d	dep	1	SENT_444	[p15l467t2753r714b2847],
6	.	.	O	.	_	0	SENT_444	[p15l467t2753r714b2847],

1	—	NN	O	—	_	0	SENT_445	[p15l467t2753r714b2847],
2	.	.	O	.	_	0	SENT_445	[p15l467t2753r714b2847],

1	W	NNP	O	W	_	0	SENT_446	[p15l467t2753r714b2847],
2	,	,	O	,	_	0	SENT_446	[p15l467t2753r714b2847],
3	Goldenberg	NNP	PERSON	Goldenberg	nn	4	SENT_446	[p15l775t2751r1322b2857],
4	S	NNP	O	S	appos	1	SENT_446	[p15l1355t2751r1439b2847],
5	,	,	O	,	_	0	SENT_446	[p15l1355t2751r1439b2847],
6	Pastan	NNP	PERSON	Pastan	appos	1	SENT_446	[p15l1497t2753r1800b2833],
7	I	PRP	O	I	dep	6	SENT_446	[p15l1828t2753r1890b2848],
8	,	,	O	,	_	0	SENT_446	[p15l1828t2753r1890b2848],
9	et	FW	O	et	nn	10	SENT_446	[p15l1924t2763r2007b2833],
10	al.	FW	O	al.	appos	1	SENT_446	[p15l2036t2751r2139b2833],
11	2000	CD	DATE	2000	dep	10	SENT_446	[p15l208t2894r463b2976],
12	.	.	O	.	_	0	SENT_446	[p15l208t2894r463b2976],

1	Decreased	VBN	O	decrease	dep	14	SENT_447	[p15l506t2894r994b2976],
2	accumulation	NN	O	accumulation	dobj	1	SENT_447	[p15l1033t2894r1663b2976],
3	of	IN	O	of	_	0	SENT_447	[p15l1702t2894r1803b2976],
4	[	CD	NUMBER	[	num	5	SENT_447	[p15l1842t2894r2140b2993],
5	l4C	NN	O	l4c	prep_of	2	SENT_447	[p15l1842t2894r2140b2993],
6	]	CD	NUMBER	]	num	7	SENT_447	[p15l1842t2894r2140b2993],
7	carboplatin	NN	O	carboplatin	nsubj	14	SENT_447	[p15l207t3036r734b3143],
8	in	IN	O	in	_	0	SENT_447	[p15l792t3036r881b3118],
9	human	JJ	O	human	amod	13	SENT_447	[p15l939t3036r1257b3118],
10	cisplatin	NN	O	cisplatin	nn	13	SENT_447	[p15l1317t3036r2145b3143],
11	—	NN	O	—	nn	13	SENT_447	[p15l1317t3036r2145b3143],
12	resistant	JJ	O	resistant	amod	13	SENT_447	[p15l1317t3036r2145b3143],
13	cells	NNS	O	cell	prep_in	14	SENT_447	[p15l207t3181r417b3263],
14	results	VBZ	O	result	_	0	SENT_447	[p15l455t3181r758b3263],
15	from	IN	O	from	_	0	SENT_447	[p15l799t3181r1026b3263],
16	reduced	VBN	O	reduce	amod	22	SENT_447	[p15l1060t3181r1433b3263],
17	energy	NN	O	energy	nn	22	SENT_447	[p15l1470t3181r2141b3287],
18	—	NN	O	—	nn	22	SENT_447	[p15l1470t3181r2141b3287],
19	depen	NN	O	depen	nn	22	SENT_447	[p15l1470t3181r2141b3287],
20	—	NN	O	—	nn	22	SENT_447	[p15l1470t3181r2141b3287],
21	dent	NN	O	dent	nn	22	SENT_447	[p15l207t3324r408b3406],
22	uptake	NN	O	uptake	prep_from	14	SENT_447	[p15l437t3324r772b3431],
23	.	.	O	.	_	0	SENT_447	[p15l437t3324r772b3431],

1	J.	NNP	O	J.	nn	2	SENT_448	[p15l808t3327r874b3407],
2	Cell	NNP	O	Cell	_	0	SENT_448	[p15l923t3324r1128b3407],
3	.	.	O	.	_	0	SENT_448	[p15l923t3324r1128b3407],

1	Physiol	NNP	O	Physiol	_	0	SENT_449	[p15l1170t3324r1541b3429],
2	.	.	O	.	_	0	SENT_449	[p15l1170t3324r1541b3429],

1	183	CD	NUMBER	183	_	0	SENT_450	[p15l1595t3324r2142b3406],
2	:	:	O	:	_	0	SENT_450	[p15l1595t3324r2142b3406],
3	l08	CD	NUMBER	l08	num	4	SENT_450	[p15l1595t3324r2142b3406],
4	—	CD	NUMBER	—	dep	1	SENT_450	[p15l1595t3324r2142b3406],
5	l6	NN	O	l6	nn	7	SENT_450	[p15l1595t3324r2142b3406],
6	Mickley	NNP	LOCATION	Mickley	nn	7	SENT_450	[p15l206t3466r594b3573],
7	LA	NNP	LOCATION	LA	dep	4	SENT_450	[p15l624t3467r803b3564],
8	,	,	O	,	_	0	SENT_450	[p15l624t3467r803b3564],
9	Lee	NNP	PERSON	Lee	nn	10	SENT_450	[p15l865t3469r1038b3548],
10	J	NNP	PERSON	J	appos	7	SENT_450	[p15l1069t3469r1138b3564],
11	,	,	O	,	_	0	SENT_450	[p15l1069t3469r1138b3564],
12	Weng	NNP	O	Weng	nn	13	SENT_450	[p15l1199t3469r1467b3573],
13	Z	NNP	O	Z	appos	7	SENT_450	[p15l1498t3469r1593b3564],
14	,	,	O	,	_	0	SENT_450	[p15l1498t3469r1593b3564],
15	et	FW	O	et	nn	16	SENT_450	[p15l1629t3479r1712b3548],
16	al.	FW	O	al.	appos	7	SENT_450	[p15l1743t3466r1846b3548],
17	1998	CD	DATE	1998	dep	16	SENT_450	[p15l1893t3467r2137b3550],
18	.	.	O	.	_	0	SENT_450	[p15l1893t3467r2137b3550],

1	Genetic	JJ	O	genetic	amod	2	SENT_451	[p15l208t3611r567b3693],
2	polymorphism	NN	O	polymorphism	_	0	SENT_451	[p15l614t3611r1301b3717],
3	in	IN	O	in	_	0	SENT_451	[p15l1345t3611r1434b3692],
4	MDR	NN	ORGANIZATION	mdr	prep_in	2	SENT_451	[p15l1475t3614r1731b3692],
5	1	CD	NUMBER	1	num	4	SENT_451	[p15l1746t3611r1814b3693],
6	:	:	O	:	_	0	SENT_451	[p15l1746t3611r1814b3693],
7	a	DT	O	a	det	8	SENT_451	[p15l1871t3636r1920b3693],
8	tool	NN	O	tool	dep	2	SENT_451	[p15l1964t3611r2144b3693],
9	for	IN	O	for	_	0	SENT_451	[p16l207t25r343b107],
10	examining	VBG	O	examine	prepc_for	8	SENT_451	[p16l363t25r854b132],
11	allelic	JJ	O	allelic	amod	12	SENT_451	[p16l879t25r1160b107],
12	expression	NN	O	expression	dobj	10	SENT_451	[p16l1183t25r1682b132],
13	in	IN	O	in	_	0	SENT_451	[p16l1703t25r1792b106],
14	normal	JJ	O	normal	amod	15	SENT_451	[p16l1814t25r2144b107],
15	cells	NNS	O	cell	prep_in	10	SENT_451	[p16l207t167r444b265],
16	,	,	O	,	_	0	SENT_451	[p16l207t167r444b265],
17	unselected	JJ	O	unselected	amod	20	SENT_451	[p16l507t167r1002b249],
18	and	CC	O	and	_	0	SENT_451	[p16l1063t167r1229b249],
19	drug	NN	O	drug	conj_and	17	SENT_451	[p16l1287t167r1919b274],
20	—	NN	O	—	conj_and	8	SENT_451	[p16l1287t167r1919b274],
21	selected	VBN	O	select	partmod	20	SENT_451	[p16l1287t167r1919b274],
22	cell	NN	O	cell	nn	23	SENT_451	[p16l1978t167r2144b249],
23	lines	NNS	O	line	dobj	21	SENT_451	[p16l207t311r450b407],
24	,	,	O	,	_	0	SENT_451	[p16l207t311r450b407],
25	and	CC	O	and	_	0	SENT_451	[p16l483t311r649b393],
26	human	JJ	O	human	amod	27	SENT_451	[p16l674t311r992b393],
27	tumors	NNS	O	tumor	conj_and	8	SENT_451	[p16l1018t323r1365b393],
28	.	.	O	.	_	0	SENT_451	[p16l1018t323r1365b393],

1	Blood	NN	O	blood	_	0	SENT_452	[p16l1395t311r1681b393],
2	91	CD	NUMBER	91	num	1	SENT_452	[p16l1703t311r1841b393],
3	:	:	O	:	_	0	SENT_452	[p16l1703t311r1841b393],
4	174956	CD	NUMBER	174956	dep	1	SENT_452	[p16l1863t311r2145b394, p16l208t455r319b537],

1	45	CD	NUMBER	45	_	0	SENT_453	[p16l7t597r144b681],
2	.	.	O	.	_	0	SENT_453	[p16l7t597r144b681],

1	Abolhoda	NNP	MISC	Abolhoda	nn	2	SENT_454	[p16l206t597r669b679],
2	A	NNP	MISC	A	_	0	SENT_454	[p16l704t598r811b695],
3	,	,	O	,	_	0	SENT_454	[p16l704t598r811b695],
4	Wilson	NNP	PERSON	Wilson	nn	5	SENT_454	[p16l883t597r1217b680],
5	AE	NNP	O	AE	appos	2	SENT_454	[p16l1253t598r1432b695],
6	,	,	O	,	_	0	SENT_454	[p16l1253t598r1432b695],
7	Ross	NNP	PERSON	Ross	nn	8	SENT_454	[p16l1505t600r1729b679],
8	H	NNP	O	H	appos	2	SENT_454	[p16l1768t600r1874b695],
9	,	,	O	,	_	0	SENT_454	[p16l1768t600r1874b695],
10	et	FW	O	et	nn	11	SENT_454	[p16l1915t610r1999b679],
11	al.	FW	O	al.	appos	2	SENT_454	[p16l2035t597r2137b679],
12	1999	CD	DATE	1999	dep	11	SENT_454	[p16l217t742r463b825],
13	.	.	O	.	_	0	SENT_454	[p16l217t742r463b825],

1	Rapid	JJ	O	rapid	amod	2	SENT_455	[p16l532t741r811b848],
2	activation	NN	O	activation	nsubj	6	SENT_455	[p16l876t741r1329b824],
3	of	IN	O	of	_	0	SENT_455	[p16l1394t741r1495b823],
4	MDR1	NN	O	mdr1	nn	5	SENT_455	[p16l1546t742r1850b823],
5	gene	NN	O	gene	prep_of	2	SENT_455	[p16l1926t768r2144b848],
6	nloaded	VBD	O	nload	_	0	SENT_455	[p16l7t3476r64b3735],
7	from	IN	O	from	_	0	SENT_455	[p16l7t3296r64b3454],
8	wwW.annualrevieWs.org	NN	O	www.annualreviews.org	prep_from	6	SENT_455	[p16l7t2473r81b3274],
9	on	IN	O	on	_	0	SENT_455	[p16l107t3641r147b3720],
10	01/05/14	CD	DATE	01/05/14	prep_on	6	SENT_455	[p16l88t3312r147b3618],
11	.	.	O	.	_	0	SENT_455	[p16l88t3312r147b3618],

1	For	IN	O	for	_	0	SENT_456	[p16l91t3172r147b3286],
2	personal	JJ	O	personal	amod	3	SENT_456	[p16l89t2874r164b3152],
3	use	NN	O	use	pobj	1	SENT_456	[p16l107t2744r147b2852],
4	only	RB	O	only	advmod	3	SENT_456	[p16l89t2561r164b2720],
5	.	.	O	.	_	0	SENT_456	[p16l89t2561r164b2720],

1	49a	NN	O	49a	_	0	SENT_457	[p16l434t3287r583b3352],
2	.	.	O	.	_	0	SENT_457	[p16l434t3287r583b3352],

1	DRUG	NN	O	drug	nn	2	SENT_458	[p16l1107t926r1210b953],
2	RESISTANCE	NN	O	resistance	_	0	SENT_458	[p16l1220t926r1442b953],
3	IN	IN	O	in	_	0	SENT_458	[p16l1453t927r1491b953],
4	CANCER	NNP	O	CANCER	prep_in	2	SENT_458	[p16l1502t926r1652b953],
5	627	CD	NUMBER	627	num	4	SENT_458	[p16l1741t923r1801b953],

1	expression	NN	O	expression	_	0	SENT_459	[p16l637t1158r1027b1241],
2	in	IN	O	in	_	0	SENT_459	[p16l1060t1158r1130b1221],
3	human	JJ	O	human	amod	5	SENT_459	[p16l1161t1158r1411b1222],
4	metastatic	JJ	O	metastatic	amod	5	SENT_459	[p16l1444t1158r1813b1222],
5	sarcoma	NN	O	sarcoma	prep_in	1	SENT_459	[p16l1851t1178r2153b1222],
6	after	IN	O	after	prep	1	SENT_459	[p16l638t1270r805b1335],
7	in	FW	O	in	nn	8	SENT_459	[p16l859t1272r924b1335],
8	vivo	FW	O	vivo	dep	9	SENT_459	[p16l979t1272r1128b1335],
9	exposure	NN	O	exposure	dep	6	SENT_459	[p16l1183t1290r1511b1353],
10	to	TO	O	to	_	0	SENT_459	[p16l1564t1280r1632b1335],
11	doxorubicin	NN	O	doxorubicin	prep_to	6	SENT_459	[p16l1687t1270r2147b1335],
12	.	.	O	.	_	0	SENT_459	[p16l1687t1270r2147b1335],

1	Clin	NNP	O	Clin	_	0	SENT_460	[p16l641t1381r807b1446],
2	.	.	O	.	_	0	SENT_460	[p16l641t1381r807b1446],

1	Cancer	NN	O	cancer	_	0	SENT_461	[p16l846t1383r1114b1446],
2	Res	NNP	O	Res	dep	1	SENT_461	[p16l1133t1384r1281b1446],
3	.	.	O	.	_	0	SENT_461	[p16l1133t1384r1281b1446],

1	523352-56	CD	NUMBER	523352-56	num	3	SENT_462	[p16l1317t1381r1705b1446],
2	List	NN	O	list	nn	3	SENT_462	[p16l636t1492r779b1557],
3	AF	NN	O	af	_	0	SENT_462	[p16l813t1493r941b1569],
4	,	,	O	,	_	0	SENT_462	[p16l813t1493r941b1569],
5	Spier	NN	PERSON	spier	nn	6	SENT_462	[p16l1015t1492r1206b1576],
6	C	NN	O	c	appos	3	SENT_462	[p16l1241t1493r1318b1569],
7	,	,	O	,	_	0	SENT_462	[p16l1241t1493r1318b1569],
8	Greer	NNP	PERSON	Greer	nn	9	SENT_462	[p16l1392t1493r1599b1558],
9	J	NNP	PERSON	J	appos	3	SENT_462	[p16l1632t1494r1686b1569],
10	,	,	O	,	_	0	SENT_462	[p16l1632t1494r1686b1569],
11	et	FW	O	et	nn	12	SENT_462	[p16l1726t1502r1791b1557],
12	al.	FW	O	al.	appos	3	SENT_462	[p16l1826t1493r1907b1557],
13	1993	CD	DATE	1993	dep	12	SENT_462	[p16l1956t1493r2147b1558],
14	.	.	O	.	_	0	SENT_462	[p16l1956t1493r2147b1558],

1	Phase	NN	O	phase	nn	3	SENT_463	[p16l637t1605r848b1670],
2	UII	NN	O	uius	nn	3	SENT_463	[p16l865t1605r980b1670],
3	trial	NN	O	trial	_	0	SENT_463	[p16l997t1605r1143b1670],
4	of	IN	O	of	_	0	SENT_463	[p16l1160t1605r1239b1670],
5	cyclosporine	NN	O	cyclosporine	prep_of	3	SENT_463	[p16l1250t1605r1716b1688],
6	as	IN	O	as	_	0	SENT_463	[p16l1735t1625r1805b1670],
7	a	DT	O	a	det	9	SENT_463	[p16l1826t1625r1864b1670],
8	chemotherapy-resistance	JJ	O	chemotherapy-resistance	amod	9	SENT_463	[p16l1879t1605r2149b1670, p16l637t1716r1303b1800],
9	modiﬁer	NN	O	modiﬁer	prep_as	3	SENT_463	[p16l1338t1716r1650b1780],
10	in	IN	O	in	_	0	SENT_463	[p16l1682t1716r1751b1779],
11	acute	JJ	O	acute	amod	12	SENT_463	[p16l1787t1726r1977b1780],
12	leukemia	NN	O	leukemia	prep_in	9	SENT_463	[p16l2011t1716r2150b1780, p16l636t1827r877b1892],
13	.	.	O	.	_	0	SENT_463	[p16l2011t1716r2150b1780, p16l636t1827r877b1892],

1	J.	NNP	PERSON	J.	nn	2	SENT_464	[p16l905t1830r958b1892],
2	Clin	NNP	PERSON	Clin	_	0	SENT_464	[p16l996t1827r1163b1892],
3	.	.	O	.	_	0	SENT_464	[p16l996t1827r1163b1892],

1	Oncol	NN	O	oncol	_	0	SENT_465	[p16l1201t1827r1434b1892],
2	.	.	O	.	_	0	SENT_465	[p16l1201t1827r1434b1892],

1	11:1652	CD	NUMBER	11:1652	num	5	SENT_466	[p16l1476t1827r1905b1892],
2	—	CD	NUMBER	—	num	5	SENT_466	[p16l1476t1827r1905b1892],
3	6O	NNP	O	6O	nn	5	SENT_466	[p16l1476t1827r1905b1892],
4	Marie	NNP	PERSON	Marie	nn	5	SENT_466	[p16l636t1940r854b2004],
5	J-P	NNP	O	J-P	_	0	SENT_466	[p16l886t1941r1011b2015],
6	,	,	O	,	_	0	SENT_466	[p16l886t1941r1011b2015],
7	Bastie	NNP	PERSON	Bastie	nn	8	SENT_466	[p16l1076t1940r1303b2004],
8	J	NNP	O	J	appos	5	SENT_466	[p16l1335t1941r1369b2004],
9	-	:	O	-	_	0	SENT_466	[p16l1374t1941r1486b2015],
10	N	NN	O	n	dep	5	SENT_466	[p16l1374t1941r1486b2015],
11	,	,	O	,	_	0	SENT_466	[p16l1374t1941r1486b2015],
12	Coloma	NNP	O	Coloma	nn	13	SENT_466	[p16l1552t1940r1842b2004],
13	F	NN	O	f	appos	10	SENT_466	[p16l1872t1941r1934b2015],
14	,	,	O	,	_	0	SENT_466	[p16l1872t1941r1934b2015],
15	et	FW	O	et	nn	16	SENT_466	[p16l1970t1950r2035b2004],
16	al.	FW	O	al.	appos	5	SENT_466	[p16l2067t1940r2147b2004],
17	1993	CD	DATE	1993	dep	16	SENT_466	[p16l646t2050r837b2116],
18	.	.	O	.	_	0	SENT_466	[p16l646t2050r837b2116],

1	Cyclosporine	NN	O	cyclosporine	nn	2	SENT_467	[p16l865t2050r1353b2134],
2	A	NN	O	a	_	0	SENT_467	[p16l1376t2051r1440b2113],
3	as	IN	O	as	_	0	SENT_467	[p16l1466t2071r1535b2114],
4	a	DT	O	a	det	6	SENT_467	[p16l1562t2071r1601b2114],
5	modiﬁer	NN	O	modiﬁer	nn	6	SENT_467	[p16l1622t2050r1934b2114],
6	agent	NN	O	agent	prep_as	2	SENT_467	[p16l1957t2060r2153b2134],
7	in	IN	O	in	_	0	SENT_467	[p16l637t2162r706b2226],
8	the	DT	O	the	det	10	SENT_467	[p16l726t2162r835b2227],
9	salvage	NN	O	salvage	nn	10	SENT_467	[p16l859t2162r1126b2246],
10	treatment	NN	O	treatment	prep_in	2	SENT_467	[p16l1147t2172r1494b2227],
11	of	IN	O	of	_	0	SENT_467	[p16l1513t2162r1593b2227],
12	acute	JJ	O	acute	amod	16	SENT_467	[p16l1608t2172r1797b2227],
13	leukemia	NN	O	leukemia	dep	12	SENT_467	[p16l1818t2162r2153b2227],
14	(	CD	NUMBER	(	num	13	SENT_467	[p16l640t2274r836b2353],
15	AL	NNP	O	AL	nn	16	SENT_467	[p16l640t2274r836b2353],
16	)	NNP	O	)	prep_of	2	SENT_467	[p16l640t2274r836b2353],
17	.	.	O	.	_	0	SENT_467	[p16l640t2274r836b2353],

1	Leukemia	NN	O	leukemia	_	0	SENT_468	[p16l864t2274r1221b2338],
2	72821-24	CD	NUMBER	72821-24	num	4	SENT_468	[p16l1248t2274r1592b2338],
3	Chan	NNP	O	Chan	nn	4	SENT_468	[p16l638t2386r829b2450],
4	HS	NN	O	h	dep	1	SENT_468	[p16l857t2386r991b2462],
5	,	,	O	,	_	0	SENT_468	[p16l857t2386r991b2462],
6	Haddad	NNP	PERSON	Haddad	nn	7	SENT_468	[p16l1048t2386r1333b2450],
7	G	NNP	PERSON	G	appos	4	SENT_468	[p16l1361t2386r1444b2462],
8	,	,	O	,	_	0	SENT_468	[p16l1361t2386r1444b2462],
9	Thorner	NNP	PERSON	Thorner	nn	10	SENT_468	[p16l1500t2386r1796b2450],
10	PS	NNP	O	PS	appos	4	SENT_468	[p16l1822t2386r1942b2462],
11	,	,	O	,	_	0	SENT_468	[p16l1822t2386r1942b2462],
12	et	FW	O	et	nn	13	SENT_468	[p16l1974t2395r2038b2450],
13	al.	FW	O	al.	appos	4	SENT_468	[p16l2067t2386r2147b2450],
14	1991	CD	DATE	1991	dep	13	SENT_468	[p16l646t2499r837b2563],
15	.	.	O	.	_	0	SENT_468	[p16l646t2499r837b2563],

1	P-glycoprotein	NN	O	p-glycoprotein	nn	2	SENT_469	[p16l865t2498r1410b2582],
2	expression	NN	O	expression	_	0	SENT_469	[p16l1434t2498r1824b2582],
3	as	IN	O	as	_	0	SENT_469	[p16l1849t2518r1919b2562],
4	a	DT	O	a	det	5	SENT_469	[p16l1947t2518r1984b2562],
5	predictor	NN	O	predictor	prep_as	2	SENT_469	[p16l2005t2518r2149b2582, p16l637t2610r851b2675],
6	of	IN	O	of	_	0	SENT_469	[p16l878t2610r957b2675],
7	the	DT	O	the	det	8	SENT_469	[p16l978t2610r1087b2675],
8	outcome	NN	O	outcome	prep_of	5	SENT_469	[p16l1116t2621r1429b2675],
9	of	IN	O	of	_	0	SENT_469	[p16l1458t2610r1538b2675],
10	therapy	NN	O	therapy	prep_of	8	SENT_469	[p16l1558t2611r1831b2694],
11	for	IN	O	for	_	0	SENT_469	[p16l1859t2610r1966b2675],
12	neuroblastoma	NN	O	neuroblastoma	prep_for	2	SENT_469	[p16l1991t2631r2150b2675, p16l636t2723r1062b2788],
13	.	.	O	.	_	0	SENT_469	[p16l1991t2631r2150b2675, p16l636t2723r1062b2788],

1	N.	NNP	O	N.	nn	2	SENT_470	[p16l1080t2726r1156b2788],
2	Engl	NNP	O	Engl	_	0	SENT_470	[p16l1180t2723r1367b2806],
3	.	.	O	.	_	0	SENT_470	[p16l1180t2723r1367b2806],

1	J.	NNP	O	J.	nn	2	SENT_471	[p16l1390t2726r1443b2789],
2	Med	NNP	O	Med	_	0	SENT_471	[p16l1465t2723r1644b2788],
3	.	.	O	.	_	0	SENT_471	[p16l1465t2723r1644b2788],

1	325	CD	NUMBER	325	_	0	SENT_472	[p16l1671t2723r1823b2788],
2	:	:	O	:	_	0	SENT_472	[p16l1671t2723r1823b2788],
3	1608-14	CD	NUMBER	1608-14	num	5	SENT_472	[p16l1841t2723r2151b2788],
4	Bradshaw	NNP	ORGANIZATION	Bradshaw	nn	5	SENT_472	[p16l637t2836r1000b2900],
5	DM	NN	ORGANIZATION	dm	dep	1	SENT_472	[p16l1029t2838r1194b2912],
6	,	,	O	,	_	0	SENT_472	[p16l1029t2838r1194b2912],
7	Arceci	NNP	PERSON	Arceci	nn	8	SENT_472	[p16l1250t2836r1492b2900],
8	R.	NNP	O	R.	appos	5	SENT_472	[p16l1521t2838r1598b2900],
9	1998	CD	DATE	1998	num	8	SENT_472	[p16l1639t2837r1830b2901],
10	.	.	O	.	_	0	SENT_472	[p16l1639t2837r1830b2901],

1	Clinical	JJ	O	clinical	amod	2	SENT_473	[p16l1864t2836r2152b2901],
2	relevance	NN	O	relevance	_	0	SENT_473	[p16l636t2949r982b3013],
3	of	IN	O	of	_	0	SENT_473	[p16l1022t2948r1101b3013],
4	transmembrane	JJ	O	transmembrane	amod	6	SENT_473	[p16l1133t2949r1698b3013],
5	drug	NN	O	drug	nn	6	SENT_473	[p16l1738t2949r1903b3032],
6	efﬂux	NN	O	efﬂux	prep_of	2	SENT_473	[p16l1943t2948r2152b3013],
7	as	IN	O	as	_	0	SENT_473	[p16l638t3082r709b3126],
8	a	DT	O	a	det	9	SENT_473	[p16l746t3082r784b3126],
9	mechanism	NN	O	mechanism	prep_as	2	SENT_473	[p16l816t3061r1234b3126],
10	of	IN	O	of	_	0	SENT_473	[p16l1267t3061r1347b3126],
11	multidrug	JJ	O	multidrug	amod	12	SENT_473	[p16l1374t3061r1734b3145],
12	resistance	NN	O	resistance	prep_of	9	SENT_473	[p16l1767t3061r2147b3126],
13	.	.	O	.	_	0	SENT_473	[p16l1767t3061r2147b3126],

1	J.	NNP	PERSON	J.	nn	2	SENT_474	[p16l635t3176r687b3239],
2	Clin	NNP	PERSON	Clin	_	0	SENT_474	[p16l726t3174r892b3239],
3	.	.	O	.	_	0	SENT_474	[p16l726t3174r892b3239],

1	Oncol	NN	O	oncol	_	0	SENT_475	[p16l930t3174r1163b3239],
2	.	.	O	.	_	0	SENT_475	[p16l930t3174r1163b3239],

1	16:3674	CD	NUMBER	16:3674	num	2	SENT_476	[p16l1206t3174r1635b3240],
2	—	CD	NUMBER	—	_	0	SENT_476	[p16l1206t3174r1635b3240],
3	90	CD	NUMBER	90	num	5	SENT_476	[p16l1206t3174r1635b3240],
4	Advani	NNP	ORGANIZATION	Advani	nn	5	SENT_476	[p16l637t3286r902b3351],
5	R	NN	ORGANIZATION	r	dep	2	SENT_476	[p16l933t3289r1012b3363],
6	,	,	O	,	_	0	SENT_476	[p16l933t3289r1012b3363],
7	Saba	NNP	LOCATION	Saba	nn	8	SENT_476	[p16l1077t3287r1253b3352],
8	HI	NNP	LOCATION	HI	appos	5	SENT_476	[p16l1282t3288r1396b3363],
9	,	,	O	,	_	0	SENT_476	[p16l1282t3288r1396b3363],
10	Tallman	NNP	PERSON	Tallman	nn	11	SENT_476	[p16l1458t3287r1756b3351],
11	MS	NN	O	m	appos	5	SENT_476	[p16l1785t3287r1936b3363],
12	,	,	O	,	_	0	SENT_476	[p16l1785t3287r1936b3363],
13	et	FW	O	et	nn	14	SENT_476	[p16l1971t3296r2036b3351],
14	al.	FW	O	al.	appos	5	SENT_476	[p16l2067t3287r2147b3351],
15	1999	CD	DATE	1999	dep	14	SENT_476	[p16l646t3400r837b3465],
16	.	.	O	.	_	0	SENT_476	[p16l646t3400r837b3465],

1	Treatment	NN	O	treatment	_	0	SENT_477	[p16l896t3401r1270b3464],
2	of	IN	O	of	_	0	SENT_477	[p16l1324t3399r1404b3464],
3	refractory	JJ	O	refractory	prep_of	1	SENT_477	[p16l1451t3399r1812b3483],
4	and	CC	O	and	_	0	SENT_477	[p16l1869t3399r1999b3464],
5	relapsed	VBD	O	relapse	conj_and	1	SENT_477	[p16l2052t3419r2150b3464, p16l637t3512r871b3596],
6	acute	JJ	O	acute	amod	7	SENT_477	[p16l898t3522r1088b3576],
7	myelogenous	JJ	O	myelogenous	amod	8	SENT_477	[p16l1114t3512r1601b3596],
8	leukemia	NN	O	leukemia	dobj	5	SENT_477	[p16l1630t3512r1966b3576],
9	with	IN	O	with	_	0	SENT_477	[p16l1991t3512r2153b3576],
10	combination	NN	O	combination	nn	11	SENT_477	[p16l637t3624r1095b3688],
11	chemotherapy	NN	O	chemotherapy	prep_with	5	SENT_477	[p16l1122t3624r1639b3708],
12	plus	CC	O	plus	prep	11	SENT_477	[p16l1666t3624r1815b3708],
13	the	DT	O	the	det	14	SENT_477	[p16l1844t3624r1953b3688],
14	mulAnnu	NNP	O	mulAnnu	dep	12	SENT_477	[p16l1980t3624r2149b3688, p17l7t1164r64b1361],
15	.	.	O	.	_	0	SENT_477	[p16l1980t3624r2149b3688, p17l7t1164r64b1361],

1	Rev.	NNP	O	Rev.	nn	2	SENT_478	[p17l8t990r65b1137],
2	Med	NNP	O	Med	_	0	SENT_478	[p17l7t799r64b963],
3	.	.	O	.	_	0	SENT_478	[p17l7t799r64b963],

1	2002.53:6	CD	NUMBER	2002.53:6	_	0	SENT_479	[p17l7t193r65b771],
2	l5-627	NN	O	l5-627	dep	1	SENT_479	[p17l7t193r65b771],
3	.	.	O	.	_	0	SENT_479	[p17l7t193r65b771],

1	Dow	NNP	MISC	Dow	_	0	SENT_480	[p17l8t9r65b166],
2	by	IN	O	by	_	0	SENT_480	[p17l89t1197r164b1278],
3	University	NNP	ORGANIZATION	University	prep_by	1	SENT_480	[p17l89t829r164b1174],
4	of	IN	ORGANIZATION	of	_	0	SENT_480	[p17l89t735r147b805],
5	Wisconsin	NNP	ORGANIZATION	Wisconsin	nn	7	SENT_480	[p17l89t371r147b719],
6	—	NNP	O	—	nn	7	SENT_480	[p17l124t326r130b347],
7	Madison	NNP	O	Madison	prep_of	1	SENT_480	[p17l89t14r147b301],
8	tidrug	NN	O	tidrug	nn	14	SENT_480	[p17l637t8r853b91],
9	resistance	NN	O	resistance	nn	14	SENT_480	[p17l873t8r1234b72],
10	modulator	NN	O	modulator	nn	14	SENT_480	[p17l1255t8r1633b72],
11	PSC833	NN	O	psc833	nn	14	SENT_480	[p17l1651t8r1946b72],
12	(	CD	NUMBER	(	num	14	SENT_480	[p17l1973t8r2149b87, p17l640t120r929b204],
13	Valspodar	NNP	O	Valspodar	nn	14	SENT_480	[p17l1973t8r2149b87, p17l640t120r929b204],
14	)	NN	O	)	dep	7	SENT_480	[p17l1973t8r2149b87, p17l640t120r929b204],
15	.	.	O	.	_	0	SENT_480	[p17l1973t8r2149b87, p17l640t120r929b204],

1	Blood	NN	O	blood	_	0	SENT_481	[p17l957t120r1181b185],
2	932787-95	CD	NUMBER	932787-95	num	4	SENT_481	[p17l1203t120r1590b186],
3	Crankshaw	NNP	ORGANIZATION	Crankshaw	nn	4	SENT_481	[p17l638t233r1047b298],
4	CL	NN	ORGANIZATION	cl	dep	1	SENT_481	[p17l1071t234r1205b309],
5	,	,	O	,	_	0	SENT_481	[p17l1071t234r1205b309],
6	Marmion	NNP	PERSON	Marmion	nn	7	SENT_481	[p17l1250t233r1592b297],
7	M	NNP	O	M	appos	4	SENT_481	[p17l1614t235r1713b309],
8	,	,	O	,	_	0	SENT_481	[p17l1614t235r1713b309],
9	Luker	NNP	PERSON	Luker	nn	10	SENT_481	[p17l1759t233r1978b297],
10	GD	NN	O	gd	appos	4	SENT_481	[p17l2000t234r2148b309],
11	,	,	O	,	_	0	SENT_481	[p17l2000t234r2148b309],
12	et	FW	O	et	nn	13	SENT_481	[p17l637t355r702b410],
13	al.	FW	O	al.	appos	4	SENT_481	[p17l719t346r799b410],
14	1998	CD	DATE	1998	dep	13	SENT_481	[p17l829t346r1020b411],
15	.	.	O	.	_	0	SENT_481	[p17l829t346r1020b411],

1	Novel	JJ	O	novel	amod	3	SENT_482	[p17l1041t345r1261b411],
2	technetium	NN	O	technetium	nn	3	SENT_482	[p17l1277t345r1686b410],
3	(	NN	O	(	_	0	SENT_482	[p17l1704t346r1949b426],
4	III	CD	NUMBER	iii	num	5	SENT_482	[p17l1704t346r1949b426],
5	)	NN	O	)	dep	3	SENT_482	[p17l1704t346r1949b426],
6	.	.	O	.	_	0	SENT_482	[p17l1704t346r1949b426],

1	—	NN	O	—	_	0	SENT_483	[p17l1704t346r1949b426],
2	.	.	O	.	_	0	SENT_483	[p17l1704t346r1949b426],

1	Q	NNP	O	Q	nn	2	SENT_484	[p17l1704t346r1949b426],
2	complexes	NNS	O	complex	_	0	SENT_484	[p17l1966t366r2149b410, p17l636t459r864b542],
3	for	IN	O	for	_	0	SENT_484	[p17l910t459r1016b524],
4	functional	JJ	O	functional	amod	5	SENT_484	[p17l1057t459r1428b524],
5	imaging	NN	O	imaging	prep_for	2	SENT_484	[p17l1471t459r1769b542],
6	of	IN	O	of	_	0	SENT_484	[p17l1814t459r1893b524],
7	multidrug	JJ	O	multidrug	amod	10	SENT_484	[p17l1929t459r2150b524, p17l637t572r802b655],
8	resistance	NN	O	resistance	nn	10	SENT_484	[p17l837t572r1198b636],
9	(	NN	O	(	nn	10	SENT_484	[p17l1237t573r1546b651],
10	MDR1	NN	O	mdr1	prep_of	5	SENT_484	[p17l1237t573r1546b651],
11	)	CD	NUMBER	)	num	12	SENT_484	[p17l1237t573r1546b651],
12	P	NN	O	p	dep	2	SENT_484	[p17l1584t572r2147b655],
13	—	CD	NUMBER	—	num	14	SENT_484	[p17l1584t572r2147b655],
14	glycoprotein	NN	O	glycoprotein	dep	12	SENT_484	[p17l1584t572r2147b655],
15	.	.	O	.	_	0	SENT_484	[p17l1584t572r2147b655],

1	J.	NNP	O	J.	nn	2	SENT_485	[p17l635t687r687b749],
2	Nucl	NNP	O	Nucl	_	0	SENT_485	[p17l718t684r907b749],
3	.	.	O	.	_	0	SENT_485	[p17l718t684r907b749],

1	Med	NNP	O	Med	_	0	SENT_486	[p17l938t684r1117b749],
2	.	.	O	.	_	0	SENT_486	[p17l938t684r1117b749],

1	39:77	CD	NUMBER	39:77	num	4	SENT_487	[p17l1154t684r1496b750],
2	-86	CD	NUMBER	-86	num	4	SENT_487	[p17l1154t684r1496b750],
3	Schinkel	NNP	PERSON	Schinkel	nn	4	SENT_487	[p17l639t797r956b862],
4	AH	NNP	O	AH	_	0	SENT_487	[p17l996t797r1146b873],
5	,	,	O	,	_	0	SENT_487	[p17l996t797r1146b873],
6	Mayer	NNP	PERSON	Mayer	nn	7	SENT_487	[p17l1228t798r1467b880],
7	U	NNP	PERSON	U	appos	4	SENT_487	[p17l1506t798r1590b873],
8	,	,	O	,	_	0	SENT_487	[p17l1506t798r1590b873],
9	Wagenaar	NNP	PERSON	Wagenaar	nn	10	SENT_487	[p17l1671t798r2037b880],
10	E	NNP	O	E	appos	4	SENT_487	[p17l2075t798r2149b873],
11	,	,	O	,	_	0	SENT_487	[p17l2075t798r2149b873],
12	et	FW	O	et	nn	13	SENT_487	[p17l637t919r703b973],
13	al.	FW	O	al.	appos	4	SENT_487	[p17l736t909r816b973],
14	1997	CD	DATE	1997	dep	13	SENT_487	[p17l862t910r1053b975],
15	.	.	O	.	_	0	SENT_487	[p17l862t910r1053b975],

1	Normal	JJ	O	normal	amod	2	SENT_488	[p17l1091t909r1370b973],
2	Viability	NN	O	viability	_	0	SENT_488	[p17l1403t909r1707b993],
3	and	CC	O	and	_	0	SENT_488	[p17l1742t909r1872b973],
4	altered	JJ	O	altered	amod	5	SENT_488	[p17l1906t909r2153b973],
5	pharmacokinetics	NNS	O	pharmacokinetic	conj_and	2	SENT_488	[p17l636t1021r1282b1105],
6	in	IN	O	in	_	0	SENT_488	[p17l1317t1021r1386b1085],
7	mice	NNS	O	mouse	prep_in	2	SENT_488	[p17l1419t1021r1594b1086],
8	lacking	VBG	O	lack	partmod	2	SENT_488	[p17l1628t1021r1895b1105],
9	mdrl	NN	O	mdrl	nn	15	SENT_488	[p17l1929t1021r2149b1086],
10	—	NN	O	—	nn	15	SENT_488	[p17l1929t1021r2149b1086],
11	type	NN	O	type	nn	15	SENT_488	[p17l637t1144r793b1218],
12	(	CD	NUMBER	(	num	15	SENT_488	[p17l821t1134r1519b1218],
13	drug-transporting	JJ	O	drug-transporting	amod	15	SENT_488	[p17l821t1134r1519b1218],
14	)	NN	O	)	nn	15	SENT_488	[p17l821t1134r1519b1218],
15	P	NN	O	p	dobj	8	SENT_488	[p17l1548t1135r2147b1218],
16	—	CD	NUMBER	—	num	17	SENT_488	[p17l1548t1135r2147b1218],
17	g1ycoproteins	NNS	O	g1ycoprotein	dep	15	SENT_488	[p17l1548t1135r2147b1218],
18	.	.	O	.	_	0	SENT_488	[p17l1548t1135r2147b1218],

1	Proc	NNP	O	Proc	_	0	SENT_489	[p17l635t1249r824b1311],
2	.	.	O	.	_	0	SENT_489	[p17l635t1249r824b1311],

1	Natl.	NNP	O	Natl.	nn	2	SENT_490	[p17l854t1247r1028b1311],
2	Acad	NNP	O	Acad	_	0	SENT_490	[p17l1056t1247r1264b1311],
3	.	.	O	.	_	0	SENT_490	[p17l1056t1247r1264b1311],

1	Sci	NNP	O	Sci	_	0	SENT_491	[p17l1298t1248r1423b1312],
2	.	.	O	.	_	0	SENT_491	[p17l1298t1248r1423b1312],

1	USA	NNP	LOCATION	USA	nn	6	SENT_492	[p17l1465t1248r1620b1312],
2	94:4028	CD	NUMBER	94:4028	num	6	SENT_492	[p17l1650t1247r2082b1312],
3	—	CD	NUMBER	—	num	6	SENT_492	[p17l1650t1247r2082b1312],
4	33	CD	NUMBER	33	num	6	SENT_492	[p17l1650t1247r2082b1312],
5	Allen	NNP	PERSON	Allen	nn	6	SENT_492	[p17l636t1359r839b1424],
6	JD	NNP	O	JD	_	0	SENT_492	[p17l862t1361r982b1436],
7	,	,	O	,	_	0	SENT_492	[p17l862t1361r982b1436],
8	Brinkhuis	NNP	PERSON	Brinkhuis	nn	9	SENT_492	[p17l1030t1359r1389b1424],
9	RF	NNP	O	RF	appos	6	SENT_492	[p17l1414t1361r1537b1436],
10	,	,	O	,	_	0	SENT_492	[p17l1414t1361r1537b1436],
11	Van	NNP	PERSON	Van	nn	13	SENT_492	[p17l1585t1380r1714b1424],
12	Deemter	NNP	PERSON	Deemter	nn	13	SENT_492	[p17l1737t1361r2053b1424],
13	L	NNP	PERSON	L	appos	6	SENT_492	[p17l2075t1361r2149b1436],
14	,	,	O	,	_	0	SENT_492	[p17l2075t1361r2149b1436],
15	et	FW	O	et	nn	16	SENT_492	[p17l637t1480r702b1535],
16	al.	FW	O	al.	appos	6	SENT_492	[p17l731t1471r811b1535],
17	2000	CD	DATE	2000	dep	16	SENT_492	[p17l847t1471r1045b1535],
18	.	.	O	.	_	0	SENT_492	[p17l847t1471r1045b1535],

1	Extensive	JJ	O	extensive	amod	2	SENT_493	[p17l1078t1470r1435b1535],
2	contribution	NN	O	contribution	_	0	SENT_493	[p17l1465t1470r1910b1535],
3	of	IN	O	of	_	0	SENT_493	[p17l1941t1470r2020b1535],
4	the	DT	O	the	det	7	SENT_493	[p17l2042t1471r2152b1535],
5	multidrug	JJ	O	multidrug	amod	7	SENT_493	[p17l637t1582r996b1665],
6	transporter	NN	O	transporter	nn	7	SENT_493	[p17l1025t1592r1423b1665],
7	P-glycoprotein	NN	O	p-glycoprotein	prep_of	2	SENT_493	[p17l1449t1582r1995b1665],
8	and	CC	O	and	_	0	SENT_493	[p17l2023t1582r2153b1646],
9	mrpl	NN	O	mrpl	prep_of	2	SENT_493	[p17l637t1694r821b1777],
10	to	TO	O	to	_	0	SENT_493	[p17l844t1703r912b1757],
11	basal	JJ	O	basal	amod	13	SENT_493	[p17l928t1693r1116b1757],
12	drug	NN	O	drug	nn	13	SENT_493	[p17l1133t1693r1297b1777],
13	resistance	NN	O	resistance	prep_to	2	SENT_493	[p17l1313t1693r1693b1757],
14	.	.	O	.	_	0	SENT_493	[p17l1313t1693r1693b1757],

1	CcmcerRes	NNS	O	ccmcerre	_	0	SENT_494	[p17l1719t1694r2143b1758],
2	.	.	O	.	_	0	SENT_494	[p17l1719t1694r2143b1758],

1	60:576	CD	NUMBER	60:576	num	2	SENT_495	[p17l638t1804r1073b1869],
2	l	NN	O	l	_	0	SENT_495	[p17l638t1804r1073b1869],
3	—	CD	NUMBER	—	number	4	SENT_495	[p17l638t1804r1073b1869],
4	66	CD	NUMBER	66	dep	2	SENT_495	[p17l638t1804r1073b1869],
5	Johnson	NNP	PERSON	Johnson	dep	4	SENT_495	[p17l636t1916r936b1980],
6	DR	NN	O	dr	dep	2	SENT_495	[p17l960t1917r1105b1991],
7	,	,	O	,	_	0	SENT_495	[p17l960t1917r1105b1991],
8	Finch	NNP	PERSON	Finch	nn	9	SENT_495	[p17l1154t1916r1362b1980],
9	R	NNP	PERSON	R	appos	6	SENT_495	[p17l1386t1917r1464b1991],
10	,	,	O	,	_	0	SENT_495	[p17l1386t1917r1464b1991],
11	Lin	NNP	PERSON	Lin	nn	12	SENT_495	[p17l1513t1916r1639b1979],
12	P	NN	PERSON	p	appos	2	SENT_495	[p17l1662t1917r1720b1991],
13	,	,	O	,	_	0	SENT_495	[p17l1662t1917r1720b1991],
14	et	FW	O	et	nn	15	SENT_495	[p17l1749t1926r1813b1980],
15	al.	FW	O	al.	appos	2	SENT_495	[p17l1838t1916r1919b1980],
16	2001	CD	DATE	2001	dep	15	SENT_495	[p17l1948t1916r2147b1980],
17	.	.	O	.	_	0	SENT_495	[p17l1948t1916r2147b1980],

1	The	DT	O	the	det	3	SENT_496	[p17l637t2028r777b2092],
2	pharmacological	JJ	O	pharmacological	amod	3	SENT_496	[p17l806t2028r1419b2112],
3	phenotype	NN	O	phenotype	_	0	SENT_496	[p17l1449t2028r1830b2112],
4	of	IN	O	of	_	0	SENT_496	[p17l1862t2028r1941b2092],
5	combined	VBN	O	combine	prep_of	3	SENT_496	[p17l1966t2049r2150b2092, p17l203t2349r466b2432],

1	multidrug-resistance	JJ	O	multidrug-resistance	amod	2	SENT_497	[p17l484t2349r1452b2456],
2	mdr1a/1b	NN	O	mdr1a/1b	_	0	SENT_497	[p17l1472t2349r1958b2432],
3	-	:	O	-	_	0	SENT_497	[p17l1472t2349r1958b2432],
4	and	CC	O	and	_	0	SENT_497	[p17l1983t2349r2150b2432],
5	mrp	NN	O	mrp	nn	6	SENT_497	[p17l205t2519r391b2600],
6	l	NN	O	l	conj_and	2	SENT_497	[p17l406t2493r441b2575],
7	—	CD	NUMBER	—	num	9	SENT_497	[p17l457t2492r900b2575],
8	deﬁcient	JJ	O	deﬁcient	amod	9	SENT_497	[p17l457t2492r900b2575],
9	mice	NNS	O	mouse	dep	6	SENT_497	[p17l974t2492r1224b2575],
10	.	.	O	.	_	0	SENT_497	[p17l974t2492r1224b2575],

1	Cancer	NN	O	cancer	_	0	SENT_498	[p17l1312t2494r1656b2576],
2	Res	NNP	O	Res	dep	1	SENT_498	[p17l1724t2495r1913b2576],
3	.	.	O	.	_	0	SENT_498	[p17l1724t2495r1913b2576],

1	61	CD	NUMBER	61	_	0	SENT_499	[p17l2003t2492r2105b2576],
2	:	:	O	:	_	0	SENT_499	[p17l2127t2519r2140b2575],
3	1469-76	CD	NUMBER	1469-76	dep	1	SENT_499	[p17l216t2636r614b2720],

1	King	NNP	O	King	nn	2	SENT_500	[p17l207t2782r437b2888],
2	M	NNP	O	M	_	0	SENT_500	[p17l484t2784r612b2880],
3	,	,	O	,	_	0	SENT_500	[p17l484t2784r612b2880],
4	Su	NNP	O	Su	nn	5	SENT_500	[p17l708t2782r827b2865],
5	W	NNP	O	W	appos	2	SENT_500	[p17l872t2784r996b2880],
6	,	,	O	,	_	0	SENT_500	[p17l872t2784r996b2880],
7	Chang	NNP	PERSON	Chang	nn	8	SENT_500	[p17l1091t2782r1393b2888],
8	A	NNP	O	A	appos	2	SENT_500	[p17l1442t2782r1548b2879],
9	,	,	O	,	_	0	SENT_500	[p17l1442t2782r1548b2879],
10	et	FW	O	et	nn	11	SENT_500	[p17l1600t2794r1684b2864],
11	al.	FW	O	al.	appos	2	SENT_500	[p17l1730t2782r1833b2864],
12	2001	CD	DATE	2001	dep	11	SENT_500	[p17l1888t2782r2143b2864],
13	.	.	O	.	_	0	SENT_500	[p17l1888t2782r2143b2864],

1	Transport	NN	O	transport	_	0	SENT_501	[p17l205t2930r659b3035],
2	of	IN	O	of	_	0	SENT_501	[p17l689t2927r791b3010],
3	opioids	NNS	O	opioid	prep_of	1	SENT_501	[p17l815t2927r1156b3035],
4	from	IN	O	from	_	0	SENT_501	[p17l1189t2927r1417b3010],
5	the	DT	O	the	det	6	SENT_501	[p17l1445t2927r1586b3010],
6	brain	NN	O	brain	prep_from	3	SENT_501	[p17l1616t2927r1858b3010],
7	to	TO	O	to	_	0	SENT_501	[p17l1888t2940r1975b3010],
8	the	DT	O	the	det	9	SENT_501	[p17l2007t2927r2148b3010],
9	periphery	NN	O	periphery	prep_to	6	SENT_501	[p17l204t3070r654b3178],
10	by	IN	O	by	_	0	SENT_501	[p17l710t3071r826b3178],
11	P	NN	O	p	nn	13	SENT_501	[p17l884t3070r1608b3178],
12	—	CD	NUMBER	—	num	13	SENT_501	[p17l884t3070r1608b3178],
13	glycoprotein	NN	O	glycoprotein	prep_by	9	SENT_501	[p17l884t3070r1608b3178],
14	:	:	O	:	_	0	SENT_501	[p17l884t3070r1608b3178],
15	peripheral	JJ	O	peripheral	amod	16	SENT_501	[p17l1671t3070r2148b3178],
16	actions	NNS	O	action	dep	1	SENT_501	[p17l207t3216r534b3298],
17	of	IN	O	of	_	0	SENT_501	[p17l591t3216r693b3298],
18	central	JJ	O	central	amod	19	SENT_501	[p17l738t3216r1055b3298],
19	drugs	NNS	O	drug	prep_of	16	SENT_501	[p17l1110t3216r1392b3322],
20	.	.	O	.	_	0	SENT_501	[p17l1110t3216r1392b3322],

1	Nat	NN	PERSON	nat	_	0	SENT_502	[p17l1447t3219r1637b3298],
2	.	.	O	.	_	0	SENT_502	[p17l1447t3219r1637b3298],

1	Neurosci	NNP	PERSON	Neurosci	_	0	SENT_503	[p17l1697t3219r2137b3298],
2	.	.	O	.	_	0	SENT_503	[p17l1697t3219r2137b3298],

1	4:221	CD	NUMBER	4:221	_	0	SENT_504	[p17l204t3360r647b3442],
2	—	CD	NUMBER	—	num	3	SENT_504	[p17l204t3360r647b3442],
3	22	CD	NUMBER	22	dep	1	SENT_504	[p17l204t3360r647b3442],

1	Hoffmeyer	NNP	PERSON	Hoffmeyer	nn	2	SENT_505	[p17l205t3503r718b3611],
2	S	NNP	O	S	_	0	SENT_505	[p17l765t3504r851b3602],
3	,	,	O	,	_	0	SENT_505	[p17l765t3504r851b3602],
4	Burk	NNP	PERSON	Burk	nn	5	SENT_505	[p17l945t3503r1181b3587],
5	o	NN	O	o	appos	2	SENT_505	[p17l1227t3504r1332b3602],
6	,	,	O	,	_	0	SENT_505	[p17l1227t3504r1332b3602],
7	Von	NNP	PERSON	Von	nn	9	SENT_505	[p17l1428t3530r1599b3587],
8	Richter	NNP	PERSON	Richter	nn	9	SENT_505	[p17l1646t3503r1993b3587],
9	O	NNP	PERSON	O	appos	2	SENT_505	[p17l2040t3504r2145b3602],
10	,	,	O	,	_	0	SENT_505	[p17l2040t3504r2145b3602],
11	et	FW	O	et	nn	12	SENT_505	[p17l206t3661r289b3731],
12	al.	FW	O	al.	appos	2	SENT_505	[p17l352t3649r455b3731],
13	2000	CD	DATE	2000	dep	12	SENT_505	[p17l526t3649r781b3731],
14	.	.	O	.	_	0	SENT_505	[p17l526t3649r781b3731],

1	Functional	JJ	O	functional	amod	2	SENT_506	[p17l851t3649r1352b3731],
2	polymorphisms	NNS	O	polymorphism	_	0	SENT_506	[p17l1415t3649r2146b3755],
3	of	IN	O	of	_	0	SENT_506	[p18l207t26r308b109],
4	the	DT	O	the	det	9	SENT_506	[p18l342t26r482b109],
5	human	JJ	O	human	amod	9	SENT_506	[p18l524t26r844b109],
6	multidrug	JJ	O	multidrug	amod	9	SENT_506	[p18l885t26r1854b134],
7	—	NN	O	—	nn	9	SENT_506	[p18l885t26r1854b134],
8	resistance	NN	O	resistance	nn	9	SENT_506	[p18l885t26r1854b134],
9	gene	NN	O	gene	prep_of	2	SENT_506	[p18l1898t53r2140b134],
10	:	:	O	:	_	0	SENT_506	[p18l1898t53r2140b134],
11	multiple	JJ	O	multiple	amod	13	SENT_506	[p18l205t169r595b277],
12	sequence	NN	O	sequence	nn	13	SENT_506	[p18l632t196r1058b277],
13	Variations	NNS	O	variation	dep	2	SENT_506	[p18l1091t169r1548b253],
14	and	CC	O	and	_	0	SENT_506	[p18l1586t169r1752b252],
15	correlation	NN	O	correlation	dep	2	SENT_506	[p18l1785t169r2145b252, p18l205t315r386b397],
16	of	IN	O	of	_	0	SENT_506	[p18l420t315r522b397],
17	one	CD	NUMBER	one	num	18	SENT_506	[p18l547t340r713b397],
18	allele	NN	O	allele	prep_of	15	SENT_506	[p18l748t315r998b397],
19	with	IN	O	with	_	0	SENT_506	[p18l1031t315r1238b397],
20	P	NN	O	p	nn	23	SENT_506	[p18l1271t315r1971b421],
21	—	CD	NUMBER	—	num	23	SENT_506	[p18l1271t315r1971b421],
22	glycoprotein	NN	O	glycoprotein	nn	23	SENT_506	[p18l1271t315r1971b421],
23	expression	NN	O	expression	prep_with	18	SENT_506	[p18l2004t340r2145b397, p18l203t459r596b565],
24	and	CC	O	and	_	0	SENT_506	[p18l639t459r805b541],
25	activity	NN	O	activity	conj_and	18	SENT_506	[p18l847t459r1192b565],
26	in	FW	O	in	prep	25	SENT_506	[p18l1238t462r1321b541],
27	vivo	FW	O	vivo	pobj	26	SENT_506	[p18l1363t462r1580b542],
28	.	.	O	.	_	0	SENT_506	[p18l1363t462r1580b542],

1	Proc	NNP	O	Proc	_	0	SENT_507	[p18l1625t462r1866b541],
2	.	.	O	.	_	0	SENT_507	[p18l1625t462r1866b541],

1	Natl.	NNP	O	Natl.	nn	2	SENT_508	[p18l1914t459r2137b542],
2	Acad	NNP	O	Acad	_	0	SENT_508	[p18l197t601r463b685],
3	.	.	O	.	_	0	SENT_508	[p18l197t601r463b685],

1	Sci	NNP	O	Sci	_	0	SENT_509	[p18l507t603r666b685],
2	.	.	O	.	_	0	SENT_509	[p18l507t603r666b685],

1	USA	NNP	LOCATION	USA	nn	3	SENT_510	[p18l721t603r920b685],
2	97:3473	CD	NUMBER	97:3473	num	3	SENT_510	[p18l958t602r1514b685],
3	—	NN	O	—	_	0	SENT_510	[p18l958t602r1514b685],
4	78	CD	NUMBER	78	num	6	SENT_510	[p18l958t602r1514b685],
5	Gottesman	NNP	ORGANIZATION	Gottesman	nn	6	SENT_510	[p18l207t747r713b830],
6	MM	NN	ORGANIZATION	mm	dep	3	SENT_510	[p18l751t749r984b845],
7	,	,	O	,	_	0	SENT_510	[p18l751t749r984b845],
8	Hrycyna	NNP	PERSON	Hrycyna	nn	9	SENT_510	[p18l1061t749r1465b854],
9	CA	NNP	O	CA	appos	6	SENT_510	[p18l1502t747r1688b845],
10	,	,	O	,	_	0	SENT_510	[p18l1502t747r1688b845],
11	Schoenlein	NNP	ORGANIZATION	Schoenlein	nn	12	SENT_510	[p18l1768t746r2145b830, p18l205t892r379b974],
12	PV	NNP	ORGANIZATION	PV	appos	6	SENT_510	[p18l439t894r598b989],
13	,	,	O	,	_	0	SENT_510	[p18l439t894r598b989],
14	1995	CD	DATE	1995	appos	6	SENT_510	[p18l675t892r920b976],
15	.	.	O	.	_	0	SENT_510	[p18l675t892r920b976],

1	Genetic	JJ	O	genetic	amod	2	SENT_511	[p18l988t892r1349b974],
2	analysis	NN	O	analysis	_	0	SENT_511	[p18l1415t892r1787b998],
3	of	IN	O	of	_	0	SENT_511	[p18l1852t892r1955b974],
4	the	DT	O	the	det	6	SENT_511	[p18l2007t892r2148b974],
5	multidrug	JJ	O	multidrug	amod	6	SENT_511	[p18l205t1037r667b1145],
6	transporter	NN	O	transporter	prep_of	2	SENT_511	[p18l710t1049r1237b1145],
7	.	.	O	.	_	0	SENT_511	[p18l710t1049r1237b1145],

1	Anna	NNP	PERSON	Anna	_	0	SENT_512	[p18l1278t1038r1550b1120],
2	.	.	O	.	_	0	SENT_512	[p18l1278t1038r1550b1120],

1	Rev.	NNP	O	Rev.	nn	2	SENT_513	[p18l1600t1040r1786b1121],
2	Genet	NNP	PERSON	Genet	_	0	SENT_513	[p18l1844t1039r2137b1121],
3	.	.	O	.	_	0	SENT_513	[p18l1844t1039r2137b1121],

1	29:607	CD	NUMBER	29:607	num	2	SENT_514	[p18l207t1179r704b1263],
2	—	CD	NUMBER	—	_	0	SENT_514	[p18l207t1179r704b1263],
3	49	CD	NUMBER	49	num	5	SENT_514	[p18l207t1179r704b1263],
4	Gottesman	NNP	ORGANIZATION	Gottesman	nn	5	SENT_514	[p18l207t1324r715b1407],
5	MM	NN	ORGANIZATION	mm	dep	2	SENT_514	[p18l751t1326r982b1421],
6	,	,	O	,	_	0	SENT_514	[p18l751t1326r982b1421],
7	Licht	NN	ORGANIZATION	licht	nn	8	SENT_514	[p18l1058t1324r1306b1407],
8	T	NN	ORGANIZATION	t	appos	5	SENT_514	[p18l1341t1326r1427b1421],
9	,	,	O	,	_	0	SENT_514	[p18l1341t1326r1427b1421],
10	Zhou	NNP	PERSON	Zhou	nn	11	SENT_514	[p18l1501t1324r1748b1407],
11	Y	NN	PERSON	y	appos	5	SENT_514	[p18l1785t1326r1877b1421],
12	,	,	O	,	_	0	SENT_514	[p18l1785t1326r1877b1421],
13	et	FW	O	et	nn	14	SENT_514	[p18l1919t1337r2002b1407],
14	al.	FW	O	al.	appos	5	SENT_514	[p18l2040t1324r2143b1407],
15	2000	CD	DATE	2000	dep	14	SENT_514	[p18l207t1470r462b1553],
16	.	.	O	.	_	0	SENT_514	[p18l207t1470r462b1553],

1	Selectable	JJ	O	selectable	amod	2	SENT_515	[p18l520t1470r1000b1553],
2	markers	NNS	O	marker	_	0	SENT_515	[p18l1050t1470r1423b1553],
3	for	IN	O	for	_	0	SENT_515	[p18l1477t1470r1613b1553],
4	gene	NN	O	gene	nn	5	SENT_515	[p18l1662t1497r1881b1578],
5	therapy	NN	O	therapy	prep_for	2	SENT_515	[p18l1931t1470r2145b1553, p18l207t1640r387b1721],
6	.	.	O	.	_	0	SENT_515	[p18l1931t1470r2145b1553, p18l207t1640r387b1721],

1	In	IN	O	in	dep	6	SENT_516	[p18l418t1616r514b1696],
2	Gene	NNP	O	Gene	nn	3	SENT_516	[p18l542t1615r781b1697],
3	Therapy	NN	O	therapy	pobj	1	SENT_516	[p18l813t1613r1230b1720],
4	:	:	O	:	_	0	SENT_516	[p18l813t1613r1230b1720],
5	Therapeutic	JJ	O	therapeutic	amod	6	SENT_516	[p18l1266t1613r1827b1720],
6	Mechanisms	NNS	O	mechanism	_	0	SENT_516	[p18l1847t1613r2145b1696, p18l205t1761r530b1840],
7	and	CC	O	and	_	0	SENT_516	[p18l591t1758r770b1840],
8	Strategies	NNS	O	strategy	conj_and	6	SENT_516	[p18l827t1759r1314b1862],
9	,	,	O	,	_	0	SENT_516	[p18l827t1759r1314b1862],
10	ed	VBN	O	ed	partmod	6	SENT_516	[p18l1382t1758r1512b1840],
11	.	.	O	.	_	0	SENT_516	[p18l1382t1758r1512b1840],

1	D	NN	O	d	nn	2	SENT_517	[p18l1580t1759r1659b1839],
2	Lasic	NNP	PERSON	Lasic	_	0	SENT_517	[p18l1722t1758r2001b1854],
3	,	,	O	,	_	0	SENT_517	[p18l1722t1758r2001b1854],
4	N	NNP	O	N	nn	5	SENT_517	[p18l2065t1759r2149b1840],
5	Templeton	NNP	PERSON	Templeton	appos	2	SENT_517	[p18l205t1902r731b2008],
6	,	,	O	,	_	0	SENT_517	[p18l205t1902r731b2008],
7	16:333	CD	NUMBER	16:333	number	8	SENT_517	[p18l790t1902r1305b1985],
8	—	CD	NUMBER	—	appos	2	SENT_517	[p18l790t1902r1305b1985],
9	52	CD	NUMBER	52	dep	8	SENT_517	[p18l790t1902r1305b1985],
10	.	.	O	.	_	0	SENT_517	[p18l790t1902r1305b1985],

1	New	NNP	LOCATION	New	nn	2	SENT_518	[p18l1354t1904r1570b1984],
2	York	NNP	LOCATION	York	_	0	SENT_518	[p18l1616t1902r1866b1984],
3	:	:	O	:	_	0	SENT_518	[p18l1616t1902r1866b1984],
4	Marcel	NNP	PERSON	Marcel	nn	7	SENT_518	[p18l1918t1904r2146b1984, p18l206t2045r340b2127],
5	Dekker	NNP	PERSON	Dekker	nn	7	SENT_518	[p18l373t2045r718b2127],
6	Sorrentino	NNP	PERSON	Sorrentino	nn	7	SENT_518	[p18l208t2188r699b2272],
7	BP	NNP	O	BP	dep	2	SENT_518	[p18l756t2191r909b2286],
8	,	,	O	,	_	0	SENT_518	[p18l756t2191r909b2286],
9	Brandt	NNP	PERSON	Brandt	nn	10	SENT_518	[p18l1023t2188r1343b2271],
10	SJ	NNP	O	SJ	appos	7	SENT_518	[p18l1399t2189r1531b2286],
11	,	,	O	,	_	0	SENT_518	[p18l1399t2189r1531b2286],
12	Bodine	NNP	PERSON	Bodine	nn	13	SENT_518	[p18l1643t2188r1980b2271],
13	D	NNP	O	D	appos	7	SENT_518	[p18l2037t2191r2145b2286],
14	,	,	O	,	_	0	SENT_518	[p18l2037t2191r2145b2286],
15	et	FW	O	et	nn	16	SENT_518	[p18l206t2347r289b2417],
16	al.	FW	O	al.	appos	7	SENT_518	[p18l327t2334r430b2417],
17	1992	CD	DATE	1992	dep	16	SENT_518	[p18l485t2334r731b2418],
18	.	.	O	.	_	0	SENT_518	[p18l485t2334r731b2418],

1	Retroviral	JJ	MISC	retroviral	amod	2	SENT_519	[p18l775t2334r1248b2417],
2	transfer	NN	O	transfer	nsubj	8	SENT_519	[p18l1287t2334r1646b2417],
3	of	IN	O	of	_	0	SENT_519	[p18l1684t2334r1785b2417],
4	the	DT	O	the	det	7	SENT_519	[p18l1815t2334r1956b2417],
5	human	JJ	O	human	amod	7	SENT_519	[p18l1993t2334r2145b2417, p18l205t2506r405b2562],
6	MDR1	NN	O	mdr1	nn	7	SENT_519	[p18l423t2480r729b2560],
7	gene	NN	O	gene	prep_of	2	SENT_519	[p18l763t2506r982b2587],
8	permits	VBZ	O	permit	_	0	SENT_519	[p18l1003t2479r1352b2587],
9	selection	NN	O	selection	nsubj	12	SENT_519	[p18l1382t2479r1795b2562],
10	of	IN	O	of	_	0	SENT_519	[p18l1819t2479r1920b2562],
11	drug	NN	O	drug	prep_of	9	SENT_519	[p18l1937t2479r2148b2587],
12	resistant	JJ	O	resistant	xcomp	8	SENT_519	[p18l204t2621r598b2705],
13	bone	NN	O	bone	nn	15	SENT_519	[p18l637t2621r865b2705],
14	marrow	NN	O	marrow	nn	15	SENT_519	[p18l909t2648r1268b2705],
15	cells	NNS	O	cell	dep	12	SENT_519	[p18l1314t2621r1524b2705],
16	in	IN	O	in	dep	12	SENT_519	[p18l1573t2625r1657b2705],
17	viva	FW	O	viva	pobj	16	SENT_519	[p18l1703t2625r1918b2705],
18	.	.	O	.	_	0	SENT_519	[p18l1703t2625r1918b2705],

1	Science	NNP	O	Science	nn	4	SENT_520	[p18l1969t2624r2144b2705, p18l207t2795r416b2849],
2	257199-103	CD	NUMBER	257199-103	num	4	SENT_520	[p18l452t2767r1006b2851],
3	Moscow	NNP	LOCATION	Moscow	nn	4	SENT_520	[p18l204t2915r604b2995],
4	JA	NNP	O	JA	_	0	SENT_520	[p18l648t2913r795b3010],
5	,	,	O	,	_	0	SENT_520	[p18l648t2913r795b3010],
6	Huang	NNP	PERSON	Huang	nn	7	SENT_520	[p18l882t2915r1192b3020],
7	H	NNP	PERSON	H	appos	4	SENT_520	[p18l1236t2915r1343b3010],
8	,	,	O	,	_	0	SENT_520	[p18l1236t2915r1343b3010],
9	Carter	NNP	PERSON	Carter	nn	10	SENT_520	[p18l1431t2912r1724b2995],
10	C	NNP	O	C	appos	4	SENT_520	[p18l1766t2912r1865b3010],
11	,	,	O	,	_	0	SENT_520	[p18l1766t2912r1865b3010],
12	et	FW	O	et	nn	13	SENT_520	[p18l1913t2925r1996b2995],
13	al.	FW	O	al.	appos	4	SENT_520	[p18l2040t2912r2143b2995],
14	1999	CD	DATE	1999	dep	13	SENT_520	[p18l216t3056r462b3139],
15	.	.	O	.	_	0	SENT_520	[p18l216t3056r462b3139],

1	Engraftment	NNP	O	Engraftment	nsubj	8	SENT_521	[p18l517t3055r1107b3163],
2	of	IN	O	of	_	0	SENT_521	[p18l1156t3055r1257b3138],
3	MDRI	NNP	O	MDRI	prep_of	1	SENT_521	[p18l1294t3056r1602b3138],
4	and	CC	O	and	_	0	SENT_521	[p18l1662t3055r1828b3138],
5	NeoR	NN	O	neor	nn	7	SENT_521	[p18l1875t3058r2149b3138],
6	gene	NN	O	gene	nn	7	SENT_521	[p18l207t3201r977b3307],
7	—	NN	O	—	prep_of	1	SENT_521	[p18l207t3201r977b3307],
8	transduced	VBN	O	transduce	_	0	SENT_521	[p18l207t3201r977b3307],
9	hematopoietic	JJ	O	hematopoietic	amod	10	SENT_521	[p18l1031t3201r1695b3307],
10	cells	NNS	O	cell	dobj	8	SENT_521	[p18l1754t3201r1963b3283],
11	after	IN	O	after	_	0	SENT_521	[p18l2023t3201r2145b3283, p18l205t3357r329b3427],
12	breast	NN	O	breast	nn	14	SENT_521	[p18l392t3345r675b3427],
13	cancer	NN	O	cancer	nn	14	SENT_521	[p18l743t3371r1049b3427],
14	chemotherapy	NN	O	chemotherapy	prep_after	8	SENT_521	[p18l1115t3345r1795b3451],
15	.	.	O	.	_	0	SENT_521	[p18l1115t3345r1795b3451],

1	Blood	NN	O	blood	_	0	SENT_522	[p18l1866t3345r2154b3427],
2	94:52	CD	NUMBER	94:52	num	1	SENT_522	[p18l207t3487r637b3571],
3	-61	CD	NUMBER	-61	num	5	SENT_522	[p18l207t3487r637b3571],
4	Bunting	NNP	O	Bunting	nn	5	SENT_522	[p18l205t3633r581b3739],
5	KD	NN	O	kd	dep	1	SENT_522	[p18l606t3634r797b3730],
6	,	,	O	,	_	0	SENT_522	[p18l606t3634r797b3730],
7	Galipeau	NNP	PERSON	Galipeau	nn	8	SENT_522	[p18l843t3633r1264b3739],
8	J	NNP	PERSON	J	appos	5	SENT_522	[p18l1284t3634r1354b3730],
9	,	,	O	,	_	0	SENT_522	[p18l1284t3634r1354b3730],
10	Topham	NNP	PERSON	Topham	nn	11	SENT_522	[p18l1398t3633r1781b3739],
11	D	NNP	O	D	appos	5	SENT_522	[p18l1800t3634r1907b3730],
12	,	,	O	,	_	0	SENT_522	[p18l1800t3634r1907b3730],
13	et	FW	O	et	nn	14	SENT_522	[p18l1934t3644r2017b3715],
14	al.	FW	O	al.	appos	5	SENT_522	[p18l2039t3633r2142b3715],
15	.	.	O	.	_	0	SENT_522	[p18l2039t3633r2142b3715],

1	1998	CD	DATE	1998	_	0	SENT_523	[p19l216t26r462b110],
2	.	.	O	.	_	0	SENT_523	[p19l216t26r462b110],

1	Transduction	NN	O	transduction	_	0	SENT_524	[p19l506t26r1123b109],
2	of	IN	O	of	_	0	SENT_524	[p19l1162t26r1265b109],
3	murine	JJ	O	murine	amod	5	SENT_524	[p19l1295t26r1626b109],
4	bone	NN	O	bone	nn	5	SENT_524	[p19l1664t26r1892b109],
5	marrow	NN	O	marrow	prep_of	1	SENT_524	[p19l1931t52r2145b109, p19l204t195r381b252],

1	cells	NNS	O	cell	nsubj	6	SENT_525	[p19l428t168r639b251],
2	with	IN	O	with	_	0	SENT_525	[p19l686t168r893b252],
3	an	DT	O	a	det	5	SENT_525	[p19l941t195r1047b251],
4	MDR1	NN	O	mdr1	nn	5	SENT_525	[p19l1091t169r1406b250],
5	Vector	NNP	O	Vector	prep_with	1	SENT_525	[p19l1461t181r1754b252],
6	enables	VBZ	O	enable	_	0	SENT_525	[p19l1798t168r2146b251],
7	ex	FW	O	ex	nn	9	SENT_525	[p19l206t340r311b397],
8	Vivo	FW	O	vivo	nn	9	SENT_525	[p19l371t313r571b397],
9	stem	NN	O	stem	nsubj	11	SENT_525	[p19l637t326r854b397],
10	cell	NN	O	cell	nn	11	SENT_525	[p19l914t313r1080b397],
11	expansion	NN	O	expansion	xcomp	6	SENT_525	[p19l1141t313r1640b421],
12	,	,	O	,	_	0	SENT_525	[p19l1141t313r1640b421],
13	but	CC	O	but	_	0	SENT_525	[p19l1702t313r1852b397],
14	these	DT	O	these	det	16	SENT_525	[p19l1909t313r2148b397],
15	expanded	VBN	O	expand	amod	16	SENT_525	[p19l206t460r653b567],
16	grafts	NNS	O	graft	nsubj	17	SENT_525	[p19l700t460r962b567],
17	cause	VBP	O	cause	conj_but	6	SENT_525	[p19l1011t486r1269b543],
18	a	DT	O	a	det	20	SENT_525	[p19l1317t487r1366b543],
19	myeloproliferative	JJ	O	myeloproliferative	amod	20	SENT_525	[p19l1409t460r2145b567, p19l205t605r373b688],
20	syndrome	NN	O	syndrome	dobj	17	SENT_525	[p19l401t605r860b713],
21	in	IN	O	in	_	0	SENT_525	[p19l882t605r971b686],
22	transplanted	VBN	O	transplant	amod	23	SENT_525	[p19l993t605r1569b713],
23	mice	NNS	O	mouse	prep_in	20	SENT_525	[p19l1591t605r1841b688],
24	.	.	O	.	_	0	SENT_525	[p19l1591t605r1841b688],

1	Blood	NN	O	blood	_	0	SENT_526	[p19l1866t605r2154b688],
2	92:2269	CD	NUMBER	92:2269	number	3	SENT_526	[p19l207t747r764b831],
3	—	CD	NUMBER	—	dep	1	SENT_526	[p19l207t747r764b831],
4	79	CD	NUMBER	79	dep	3	SENT_526	[p19l207t747r764b831],

1	I	PRP	O	I	_	0	SENT_527	[p19l430t906r486b932],
2	'	''	O	'	_	0	SENT_527	[p19l430t906r486b932],
3	=	JJ	O	=	prep	1	SENT_527	[p19l430t906r486b932],
4	I	CD	NUMBER	i	dep	3	SENT_527	[p19l430t906r486b932],
5	I	PRP	O	I	dep	1	SENT_527	[p19l430t933r432b948],
6	I	PRP	O	I	dep	5	SENT_527	[p19l483t934r485b950],
7	Q	NNP	O	Q	nn	9	SENT_527	[p19l430t915r485b984],
8	Annual	JJ	SET	annual	amod	9	SENT_527	[p19l494t957r604b984],
9	Review	NN	O	review	dep	5	SENT_527	[p19l611t958r719b984],
10	of	IN	O	of	_	0	SENT_527	[p19l730t957r763b991],
11	Medicine	NNP	O	Medicine	nn	12	SENT_527	[p19l766t957r905b984],
12	Volume	NN	O	volume	prep_of	9	SENT_527	[p19l426t1003r534b1030],
13	53	CD	NUMBER	53	num	12	SENT_527	[p19l544t1003r589b1034],
14	,	,	O	,	_	0	SENT_527	[p19l544t1003r589b1034],
15	2002	CD	DATE	2002	appos	12	SENT_527	[p19l600t1003r673b1030],

1	CONTENTS	NNS	O	contents	_	0	SENT_528	[p19l431t1109r740b1166],

1	FRONTISPIECE	NN	LOCATION	frontispiece	dep	130	SENT_529	[p19l428t1271r696b1308],
2	,	,	O	,	_	0	SENT_529	[p19l428t1271r696b1308],
3	Peter	NNP	PERSON	Peter	dep	130	SENT_529	[p19l708t1274r796b1302],
4	C.	NNP	PERSON	C.	dep	130	SENT_529	[p19l807t1273r841b1303],
5	Nowell	NNP	PERSON	Nowell	dep	130	SENT_529	[p19l853t1273r972b1302],
6	xvi	NN	O	xvi	dep	130	SENT_529	[p19l1820t1273r1871b1302],
7	PROGRESS	NN	O	progress	dep	130	SENT_529	[p19l428t1333r615b1365],
8	WITH	IN	O	with	dep	130	SENT_529	[p19l629t1339r723b1365],
9	CHRONIC	JJ	O	chronic	dep	130	SENT_529	[p19l737t1333r905b1365],
10	MYELOGENOUS	JJ	O	myelogenous	dep	130	SENT_529	[p19l918t1333r1201b1365],
11	LEUKEMIA	NN	O	leukemia	dep	130	SENT_529	[p19l1215t1333r1420b1365],
12	:	:	O	:	_	0	SENT_529	[p19l1215t1333r1420b1365],
13	A	DT	O	a	dep	130	SENT_529	[p19l1440t1333r1472b1365],
14	PERSONAL	JJ	O	personal	dep	130	SENT_529	[p19l1485t1333r1678b1365],
15	PERSPECTIVE	NN	O	perspective	dep	130	SENT_529	[p19l473t1383r713b1414],
16	OVER	IN	O	over	dep	130	SENT_529	[p19l726t1389r823b1414],
17	FOUR	CD	DURATION	four	dep	130	SENT_529	[p19l835t1383r936b1414],
18	DECADES	NNS	DURATION	decade	dep	130	SENT_529	[p19l949t1383r1132b1420],
19	,	,	O	,	_	0	SENT_529	[p19l949t1383r1132b1420],
20	Peter	NNP	PERSON	Peter	dep	130	SENT_529	[p19l1145t1386r1233b1414],
21	C.	NNP	PERSON	C.	dep	130	SENT_529	[p19l1244t1386r1278b1415],
22	Nowell	NNP	PERSON	Nowell	dep	130	SENT_529	[p19l1290t1385r1409b1414],
23	1	CD	NUMBER	1	dep	130	SENT_529	[p19l1856t1386r1868b1414],
24	DIAGNOSIS	NN	O	diagnosis	dep	130	SENT_529	[p19l428t1445r629b1477],
25	AND	CC	O	and	dep	130	SENT_529	[p19l643t1451r720b1477],
26	TREATMENT	NN	O	treatment	dep	130	SENT_529	[p19l733t1445r958b1477],
27	OF	IN	O	of	dep	130	SENT_529	[p19l970t1451r1016b1477],
28	VENOUS	JJ	O	venous	dep	130	SENT_529	[p19l1028t1445r1175b1477],
29	THROMBOEMBOLISM	NN	O	thromboembolism	dep	130	SENT_529	[p19l1189t1445r1579b1482],
30	,	,	O	,	_	0	SENT_529	[p19l1189t1445r1579b1482],
31	Agnes	NNP	PERSON	Agnes	dep	130	SENT_529	[p19l471t1497r574b1534],
32	Y.	NNP	PERSON	Y.	dep	130	SENT_529	[p19l587t1498r612b1526],
33	Y.	NNP	PERSON	Y.	dep	130	SENT_529	[p19l627t1498r652b1526],
34	Lee	NNP	PERSON	Lee	dep	130	SENT_529	[p19l664t1498r724b1526],
35	and	CC	O	and	dep	130	SENT_529	[p19l736t1497r799b1526],
36	Jack	NNP	PERSON	Jack	dep	130	SENT_529	[p19l806t1497r883b1526],
37	Hirsh	NNP	PERSON	Hirsh	dep	130	SENT_529	[p19l891t1497r985b1526],
38	15	CD	NUMBER	15	dep	130	SENT_529	[p19l1835t1497r1869b1526],
39	CYCLOOXYGENASE-2	NN	O	cyclooxygenase-2	dep	130	SENT_529	[p19l429t1556r828b1588],
40	:	:	O	:	_	0	SENT_529	[p19l429t1556r828b1588],
41	A	DT	O	a	dep	130	SENT_529	[p19l848t1556r880b1587],
42	THERAPEUTIC	JJ	O	therapeutic	dep	130	SENT_529	[p19l893t1557r1146b1588],
43	TARGET	NN	O	target	dep	130	SENT_529	[p19l1159t1557r1313b1594],
44	,	,	O	,	_	0	SENT_529	[p19l1159t1557r1313b1594],
45	Marco	NNP	PERSON	Marco	dep	130	SENT_529	[p19l1325t1559r1435b1588],
46	E.	NNP	PERSON	E.	dep	130	SENT_529	[p19l1445t1559r1479b1588],
47	Turini	NNP	PERSON	Turini	dep	130	SENT_529	[p19l1494t1559r1593b1588],
48	and	CC	O	and	dep	130	SENT_529	[p19l1605t1559r1668b1588],
49	Raymond	NNP	PERSON	Raymond	dep	130	SENT_529	[p19l471t1608r631b1646],
50	N.	NNP	PERSON	N.	dep	130	SENT_529	[p19l639t1609r675b1637],
51	DuBois	NNP	PERSON	DuBois	dep	130	SENT_529	[p19l687t1609r812b1638],
52	35	CD	NUMBER	35	dep	130	SENT_529	[p19l1832t1608r1870b1638],
53	NEW	JJ	O	new	dep	130	SENT_529	[p19l428t1682r516b1714],
54	THERAPEUTICS	NNS	O	therapeutics	dep	130	SENT_529	[p19l528t1682r801b1714],
55	FOR	IN	O	for	dep	130	SENT_529	[p19l815t1688r885b1714],
56	CHRONIC	JJ	O	chronic	dep	130	SENT_529	[p19l898t1681r1066b1714],
57	HEART	NN	O	heart	dep	130	SENT_529	[p19l1079t1682r1207b1713],
58	FAILURE	NN	O	failure	dep	130	SENT_529	[p19l1219t1682r1386b1720],
59	,	,	O	,	_	0	SENT_529	[p19l1219t1682r1386b1720],
60	Douglas	NNP	PERSON	Douglas	dep	130	SENT_529	[p19l1399t1684r1540b1722],
61	L.	NNP	PERSON	L.	dep	130	SENT_529	[p19l1549t1685r1582b1713],
62	Mann	NNP	PERSON	Mann	dep	130	SENT_529	[p19l1594t1685r1700b1718],
63	,	,	O	,	_	0	SENT_529	[p19l1594t1685r1700b1718],
64	Anita	NNP	PERSON	Anita	dep	130	SENT_529	[p19l471t1735r562b1764],
65	Deswal	NNP	PERSON	Deswal	dep	130	SENT_529	[p19l572t1734r706b1769],
66	,	,	O	,	_	0	SENT_529	[p19l572t1734r706b1769],
67	Biykem	NNP	PERSON	Biykem	dep	130	SENT_529	[p19l717t1734r839b1772],
68	Bozkurt	NNP	PERSON	Bozkurt	dep	130	SENT_529	[p19l850t1734r988b1769],
69	,	,	O	,	_	0	SENT_529	[p19l850t1734r988b1769],
70	and	CC	O	and	dep	130	SENT_529	[p19l1001t1734r1064b1764],
71	Guillermo	NNP	PERSON	Guillermo	dep	130	SENT_529	[p19l1075t1734r1243b1764],
72	Torre-Amione	NNP	O	Torre-Amione	dep	130	SENT_529	[p19l1256t1735r1483b1764],
73	59	CD	NUMBER	59	dep	130	SENT_529	[p19l1832t1734r1871b1764],
74	THROMBOTIC	NN	O	thrombotic	dep	130	SENT_529	[p19l428t1795r674b1826],
75	THROMBOCYTOPENIC	NN	O	thrombocytopenic	dep	130	SENT_529	[p19l686t1795r1077b1826],
76	PURPURAZ	NN	O	purpuraz	dep	130	SENT_529	[p19l1090t1795r1273b1826],
77	THE	DT	O	the	dep	130	SENT_529	[p19l1293t1795r1369b1826],
78	SYSTEMIC	JJ	O	systemic	dep	130	SENT_529	[p19l1382t1794r1565b1827],
79	CLUMPING	NN	O	clumping	dep	130	SENT_529	[p19l474t1844r670b1876],
80	“	CD	NUMBER	“	dep	130	SENT_529	[p19l682t1844r878b1882],
81	PLAGUE	NN	O	plague	dep	130	SENT_529	[p19l682t1844r878b1882],
82	,	,	O	,	_	0	SENT_529	[p19l682t1844r878b1882],
83	”	CD	NUMBER	”	dep	130	SENT_529	[p19l682t1844r878b1882],
84	Joel	NNP	PERSON	Joel	dep	130	SENT_529	[p19l889t1847r959b1877],
85	L.	NNP	PERSON	L.	dep	130	SENT_529	[p19l968t1848r1000b1876],
86	Moake	NNP	PERSON	Moake	dep	130	SENT_529	[p19l1012t1847r1124b1876],
87	75	CD	NUMBER	75	dep	130	SENT_529	[p19l1831t1847r1870b1876],
88	POSITRON	NNP	O	POSITRON	dep	130	SENT_529	[p19l428t1907r611b1938],
89	EMISSION	NNP	O	EMISSION	dep	130	SENT_529	[p19l623t1907r800b1938],
90	TOMOGRAPHY	NNP	O	TOMOGRAPHY	dep	130	SENT_529	[p19l813t1907r1071b1938],
91	SCANNING	NNP	O	SCANNING	dep	130	SENT_529	[p19l1085t1907r1286b1939],
92	:	:	O	:	_	0	SENT_529	[p19l1085t1907r1286b1939],
93	CURRENT	JJ	DATE	current	dep	130	SENT_529	[p19l1307t1907r1482b1939],
94	AND	CC	O	and	dep	130	SENT_529	[p19l1494t1913r1572b1938],
95	FUTURE	JJ	DATE	future	dep	130	SENT_529	[p19l473t1957r620b1988],
96	APPLICATIONS	NNS	O	application	dep	130	SENT_529	[p19l632t1957r907b1994],
97	,	,	O	,	_	0	SENT_529	[p19l632t1957r907b1994],
98	Johannes	NNP	PERSON	Johannes	dep	130	SENT_529	[p19l919t1959r1076b1989],
99	Czernin	NNP	PERSON	Czernin	dep	130	SENT_529	[p19l1088t1959r1217b1989],
100	and	CC	O	and	dep	130	SENT_529	[p19l1229t1959r1292b1988],
101	Michael	NNP	PERSON	Michael	dep	130	SENT_529	[p19l1300t1959r1437b1988],
102	E.	NNP	PERSON	E.	dep	130	SENT_529	[p19l1446t1960r1480b1988],
103	Phelps	NNP	PERSON	Phelps	dep	130	SENT_529	[p19l1493t1959r1606b1996],
104	89	CD	NUMBER	89	dep	130	SENT_529	[p19l1833t1959r1871b1989],
105	ATTENTION	NN	O	attention	dep	130	SENT_529	[p19l428t2019r640b2051],
106	DEFICIT/HYPERACTIVITY	NN	O	deficit/hyperactivity	dep	130	SENT_529	[p19l653t2018r1109b2055],
107	DISORDER	NN	O	disorder	dep	130	SENT_529	[p19l1122t2019r1311b2051],
108	ACROSS	IN	O	across	dep	130	SENT_529	[p19l1323t2019r1469b2051],
109	THE	DT	O	the	dep	130	SENT_529	[p19l1483t2025r1553b2050],
110	LIFESPAN	NN	O	lifespan	dep	130	SENT_529	[p19l473t2069r659b2106],
111	,	,	O	,	_	0	SENT_529	[p19l473t2069r659b2106],
112	Timothy	NNP	PERSON	Timothy	dep	130	SENT_529	[p19l673t2071r805b2108],
113	E.	NNP	PERSON	E.	dep	130	SENT_529	[p19l815t2072r849b2100],
114	Wilens	NNP	PERSON	Wilens	dep	130	SENT_529	[p19l863t2071r981b2105],
115	,	,	O	,	_	0	SENT_529	[p19l863t2071r981b2105],
116	Joseph	NNP	PERSON	Joseph	dep	130	SENT_529	[p19l992t2071r1107b2108],
117	Biederman	NNP	PERSON	Biederman	dep	130	SENT_529	[p19l1117t2071r1309b2105],
118	,	,	O	,	_	0	SENT_529	[p19l1117t2071r1309b2105],
119	and	CC	O	and	dep	130	SENT_529	[p19l1322t2071r1385b2100],
120	Thomas	NNP	PERSON	Thomas	dep	130	SENT_529	[p19l1395t2071r1525b2100],
121	J.	NNP	PERSON	J.	dep	130	SENT_529	[p19l1534t2072r1561b2101],
122	Spencer	NNP	PERSON	Spencer	dep	130	SENT_529	[p19l1574t2071r1708b2108],
123	113	CD	NUMBER	113	dep	130	SENT_529	[p19l1814t2071r1869b2100],
124	WILL	MD	O	will	dep	130	SENT_529	[p19l428t2131r525b2163],
125	THE	DT	O	the	dep	130	SENT_529	[p19l537t2137r607b2162],
126	PIG	NN	O	pig	dep	130	SENT_529	[p19l620t2131r683b2163],
127	SOLVE	VB	O	solve	dep	130	SENT_529	[p19l696t2131r816b2163],
128	THE	DT	O	the	dep	130	SENT_529	[p19l829t2137r899b2162],
129	TRANSPLANTATION	NN	O	transplantation	dep	130	SENT_529	[p19l911t2131r1265b2163],
130	BACKLOG	NN	O	backlog	_	0	SENT_529	[p19l1278t2131r1489b2168],
131	?	.	O	?	_	0	SENT_529	[p19l1278t2131r1489b2168],

1	,	,	O	,	_	0	SENT_530	[p19l1278t2131r1489b2168],
2	David	NNP	PERSON	David	nn	4	SENT_530	[p19l1501t2133r1605b2163],
3	K.C.	NNP	PERSON	K.C.	nn	4	SENT_530	[p19l1614t2134r1688b2163],
4	Cooper	NNP	PERSON	Cooper	nsubj	28	SENT_530	[p19l474t2184r601b2220],
5	,	,	O	,	_	0	SENT_530	[p19l474t2184r601b2220],
6	Bernd	NNP	PERSON	Bernd	nn	7	SENT_530	[p19l612t2183r716b2212],
7	Gollackner	NNP	PERSON	Gollackner	nsubj	28	SENT_530	[p19l727t2183r915b2217],
8	,	,	O	,	_	0	SENT_530	[p19l727t2183r915b2217],
9	and	CC	O	and	_	0	SENT_530	[p19l928t2183r991b2212],
10	David	NNP	PERSON	David	nn	12	SENT_530	[p19l999t2183r1103b2212],
11	H.	NNP	PERSON	H.	nn	12	SENT_530	[p19l1111t2184r1150b2212],
12	Sachs	NNP	PERSON	Sachs	conj_and	4	SENT_530	[p19l1163t2183r1258b2213],
13	133	CD	NUMBER	133	num	15	SENT_530	[p19l1814t2183r1869b2212],
14	IMMUNOLOGIC	NNP	MISC	IMMUNOLOGIC	nn	15	SENT_530	[p19l428t2243r697b2274],
15	CONTROL	NNP	MISC	CONTROL	dep	12	SENT_530	[p19l711t2242r888b2275],
16	OF	IN	MISC	of	_	0	SENT_530	[p19l901t2249r946b2274],
17	HIV-I	NN	MISC	hiv-i	prep_of	15	SENT_530	[p19l958t2243r1082b2280],
18	,	,	O	,	_	0	SENT_530	[p19l958t2243r1082b2280],
19	Rajesh	NNP	PERSON	Rajesh	nn	21	SENT_530	[p19l1094t2245r1207b2283],
20	T.	NNP	PERSON	T.	nn	21	SENT_530	[p19l1216t2246r1243b2274],
21	Gandhi	NNP	PERSON	Gandhi	conj_and	17	SENT_530	[p19l1254t2245r1377b2275],
22	and	CC	O	and	_	0	SENT_530	[p19l1384t2245r1447b2274],
23	Bruce	NNP	PERSON	Bruce	nn	25	SENT_530	[p19l1452t2246r1551b2274],
24	D.	NNP	PERSON	D.	nn	25	SENT_530	[p19l1558t2246r1597b2274],
25	Walker	NNP	PERSON	Walker	conj_and	17	SENT_530	[p19l1608t2245r1722b2275],
26	149	CD	NUMBER	149	num	27	SENT_530	[p19l1814t2245r1871b2275],
27	THE	DT	O	the	dep	25	SENT_530	[p19l428t2306r504b2336],
28	EXPANDING	VBG	O	expand	_	0	SENT_530	[p19l516t2306r734b2337],
29	PHARMACOPOEIA	NN	O	pharmacopoeia	dobj	28	SENT_530	[p19l746t2306r1065b2337],
30	FOR	IN	O	for	_	0	SENT_530	[p19l1077t2311r1147b2337],
31	BIPOLAR	NN	MISC	bipolar	nn	32	SENT_530	[p19l1160t2306r1321b2337],
32	DISORDER	NN	O	disorder	prep_for	29	SENT_530	[p19l1333t2306r1531b2343],
33	,	,	O	,	_	0	SENT_530	[p19l1333t2306r1531b2343],
34	Philip	NNP	PERSON	Philip	nn	35	SENT_530	[p19l1544t2308r1645b2345],
35	B.	NNP	PERSON	B.	appos	32	SENT_530	[p19l1655t2309r1690b2337],

1	Annu	NNP	PERSON	Annu	_	0	SENT_531	[p19l288t2379r311b2459],
2	.	.	O	.	_	0	SENT_531	[p19l288t2379r311b2459],

1	Rev.	NNP	O	Rev.	nn	2	SENT_532	[p19l288t2309r311b2368],
2	Med	NNP	O	Med	_	0	SENT_532	[p19l288t2231r311b2298],
3	.	.	O	.	_	0	SENT_532	[p19l288t2231r311b2298],

1	2002532615-627	CD	NUMBER	2002532615-627	_	0	SENT_533	[p19l288t1986r311b2220],
2	.	.	O	.	_	0	SENT_533	[p19l288t1986r311b2220],

1	Downloaded	VBN	O	download	_	0	SENT_534	[p19l288t1805r311b1975],
2	from	IN	O	from	_	0	SENT_534	[p19l288t1731r311b1796],
3	ww	NN	O	ww	nn	4	SENT_534	[p19l296t1675r311b1722],
4	w.a.nnua]reviews.org	NN	O	w.a.nnua]reviews.org	prep_from	1	SENT_534	[p19l288t1385r318b1660],
5	by	IN	O	by	_	0	SENT_534	[p19l321t2393r352b2425],
6	University	NNP	ORGANIZATION	University	dep	10	SENT_534	[p19l321t2243r352b2383],
7	of	IN	ORGANIZATION	of	_	0	SENT_534	[p19l321t2205r345b2234],
8	Wisconsin	NNP	ORGANIZATION	Wisconsin	prep_of	6	SENT_534	[p19l321t2058r345b2198],
9	-	:	O	-	_	0	SENT_534	[p19l335t2040r338b2048],
10	Madison	NNP	O	Madison	prep_by	1	SENT_534	[p19l321t1914r345b2030],
11	on	IN	O	on	_	0	SENT_534	[p19l329t1872r345b1904],
12	01/05/14	CD	DATE	01/05/14	prep_on	1	SENT_534	[p19l321t1738r345b1863],
13	.	.	O	.	_	0	SENT_534	[p19l321t1738r345b1863],

1	For	IN	O	for	_	0	SENT_535	[p19l322t1680r345b1727],
2	personal	JJ	O	personal	amod	3	SENT_535	[p19l321t1547r352b1659],
3	use	NN	O	use	pobj	1	SENT_535	[p19l329t1494r345b1538],
4	only	RB	O	only	advmod	3	SENT_535	[p19l321t1420r352b1485],
5	.	.	O	.	_	0	SENT_535	[p19l321t1420r352b1485],

1	Mitchell	NNP	PERSON	Mitchell	nn	8	SENT_536	[p19l472t2357r611b2387],
2	and	CC	O	and	_	0	SENT_536	[p19l622t2357r685b2387],
3	Gin	NNP	PERSON	Gin	conj_and	1	SENT_536	[p19l695t2358r755b2387],
4	S.	NNP	PERSON	S.	nn	8	SENT_536	[p19l767t2358r795b2387],
5	Malhi	NNP	PERSON	Malhi	nn	8	SENT_536	[p19l807t2357r907b2387],
6	173	CD	NUMBER	173	num	8	SENT_536	[p19l1814t2358r1869b2387],
7	HEART	NN	O	heart	nn	8	SENT_536	[p19l428t2418r555b2449],
8	TRANSPLANTATION	NN	O	transplantation	_	0	SENT_536	[p19l568t2418r931b2449],
9	:	:	O	:	_	0	SENT_536	[p19l568t2418r931b2449],
10	A	DT	O	a	det	12	SENT_536	[p19l952t2417r984b2449],
11	THIRTY-YEAR	NN	DURATION	thirty-year	nn	12	SENT_536	[p19l996t2418r1252b2449],
12	PERSPECTIVE	NN	O	perspective	dep	8	SENT_536	[p19l1264t2418r1513b2455],
13	,	,	O	,	_	0	SENT_536	[p19l1264t2418r1513b2455],
14	Douglas	NNP	PERSON	Douglas	nn	16	SENT_536	[p19l1526t2420r1667b2457],
15	N.	NNP	PERSON	N.	nn	16	SENT_536	[p19l1676t2421r1713b2449],
16	Miniati	NNP	PERSON	Miniati	conj_and	12	SENT_536	[p19l472t2470r595b2499],
17	and	CC	O	and	_	0	SENT_536	[p19l606t2469r669b2499],
18	Robert	NNP	PERSON	Robert	nn	20	SENT_536	[p19l677t2469r792b2499],
19	C.	NNP	PERSON	C.	nn	20	SENT_536	[p19l803t2470r837b2499],
20	Robbins	NNP	PERSON	Robbins	conj_and	12	SENT_536	[p19l849t2469r985b2499],
21	189	CD	NUMBER	189	num	23	SENT_536	[p19l1814t2469r1871b2499],
22	CLINICAL	NNP	O	CLINICAL	nn	23	SENT_536	[p19l429t2529r604b2561],
23	TRIALS	NNPS	O	TRIALS	dep	65	SENT_536	[p19l616t2529r745b2561],
24	OF	IN	O	of	_	0	SENT_536	[p19l760t2535r805b2561],
25	HIV	NN	O	hiv	nn	26	SENT_536	[p19l818t2529r897b2561],
26	VACCINES	NNS	O	vaccine	prep_of	23	SENT_536	[p19l910t2529r1103b2567],
27	,	,	O	,	_	0	SENT_536	[p19l910t2529r1103b2567],
28	Barney	NNP	PERSON	Barney	nn	32	SENT_536	[p19l1115t2532r1234b2569],
29	S.	NNP	PERSON	S.	nn	32	SENT_536	[p19l1245t2532r1274b2561],
30	Graham	NNP	PERSON	Graham	nn	32	SENT_536	[p19l1288t2531r1424b2561],
31	207	CD	NUMBER	207	num	32	SENT_536	[p19l1811t2532r1870b2561],
32	CHEMOPREVENTION	NNP	O	CHEMOPREVENTION	prep_of	23	SENT_536	[p19l429t2591r793b2623],
33	OF	IN	O	of	_	0	SENT_536	[p19l805t2597r851b2623],
34	AERODIGESTIVE	NNP	O	AERODIGESTIVE	nn	36	SENT_536	[p19l863t2591r1157b2623],
35	TRACT	NN	O	tract	nn	36	SENT_536	[p19l1169t2592r1292b2623],
36	CANCERS	NNS	O	cancer	prep_of	32	SENT_536	[p19l1305t2591r1488b2629],
37	,	,	O	,	_	0	SENT_536	[p19l1305t2591r1488b2629],
38	Edward	NNP	PERSON	Edward	nn	40	SENT_536	[p19l1500t2594r1632b2623],
39	S.	NNP	PERSON	S.	nn	40	SENT_536	[p19l1642t2594r1670b2624],
40	Kim	NNP	PERSON	Kim	prep_of	23	SENT_536	[p19l472t2644r551b2677],
41	,	,	O	,	_	0	SENT_536	[p19l472t2644r551b2677],
42	Waun	NNP	PERSON	Waun	nn	44	SENT_536	[p19l564t2644r655b2672],
43	Ki	NN	PERSON	kus	nn	44	SENT_536	[p19l666t2644r705b2672],
44	Hong	NNP	PERSON	Hong	prep_of	23	SENT_536	[p19l715t2644r816b2680],
45	,	,	O	,	_	0	SENT_536	[p19l715t2644r816b2680],
46	and	CC	O	and	_	0	SENT_536	[p19l829t2643r892b2672],
47	Fadlo	NNP	PERSON	Fadlo	nn	49	SENT_536	[p19l901t2643r996b2672],
48	Raja	NNP	PERSON	Raja	nn	49	SENT_536	[p19l1006t2644r1085b2680],
49	Khuri	NNP	PERSON	Khuri	prep_of	23	SENT_536	[p19l1096t2643r1193b2672],
50	223	CD	NUMBER	223	num	51	SENT_536	[p19l1811t2643r1869b2672],
51	DIABETES	NNPS	MISC	DIABETES	dep	49	SENT_536	[p19l428t2703r608b2734],
52	AND	CC	O	and	_	0	SENT_536	[p19l622t2709r700b2734],
53	CARDIOVASCULAR	NN	O	cardiovascular	nn	54	SENT_536	[p19l714t2702r1053b2734],
54	DISEASE	NN	O	disease	conj_and	26	SENT_536	[p19l1066t2703r1231b2740],
55	,	,	O	,	_	0	SENT_536	[p19l1066t2703r1231b2740],
56	Helaine	NNP	PERSON	Helaine	nn	58	SENT_536	[p19l1243t2705r1375b2734],
57	E.	NNP	PERSON	E.	nn	58	SENT_536	[p19l1386t2706r1419b2734],
58	Resnick	NNP	PERSON	Resnick	conj_and	49	SENT_536	[p19l1431t2705r1562b2734],
59	and	CC	O	and	_	0	SENT_536	[p19l1572t2705r1635b2734],
60	Barbara	NNP	PERSON	Barbara	nn	62	SENT_536	[p19l472t2755r612b2785],
61	V.	NNP	PERSON	V.	nn	62	SENT_536	[p19l625t2756r651b2785],
62	Howard	NNP	PERSON	Howard	conj_and	54	SENT_536	[p19l663t2755r800b2785],
63	245	CD	NUMBER	245	dep	65	SENT_536	[p19l1811t2755r1870b2785],
64	IMMUNE	JJ	O	immune	amod	65	SENT_536	[p19l428t2815r582b2846],
65	RECONSTITUTION	NN	O	reconstitution	dep	68	SENT_536	[p19l594t2815r914b2846],
66	IN	IN	O	in	_	0	SENT_536	[p19l926t2821r964b2846],
67	PATIENTS	NNS	O	patient	prep_in	65	SENT_536	[p19l976t2815r1151b2846],
68	WITH	IN	O	with	dep	91	SENT_536	[p19l1164t2821r1259b2846],
69	HIV	NN	O	hiv	nn	70	SENT_536	[p19l1272t2815r1352b2846],
70	INFECTION	NN	O	infection	pobj	68	SENT_536	[p19l1364t2815r1569b2852],
71	,	,	O	,	_	0	SENT_536	[p19l1364t2815r1569b2852],
72	Gregory	NNP	PERSON	Gregory	nn	75	SENT_536	[p19l1583t2817r1719b2854],
73	D.	NNP	PERSON	D.	nn	75	SENT_536	[p19l472t2857r511b2886],
74	S	NNP	PERSON	S	nn	75	SENT_536	[p19l524t2856r544b2886],
75	empowski	NN	PERSON	empowskus	pobj	68	SENT_536	[p19l546t2856r708b2894],
76	and	CC	O	and	_	0	SENT_536	[p19l719t2856r782b2886],
77	Barton	NNP	PERSON	Barton	nn	82	SENT_536	[p19l790t2857r906b2886],
78	F.	NNP	PERSON	F.	nn	82	SENT_536	[p19l916t2857r944b2886],
79	Haynes	NNP	PERSON	Haynes	nn	82	SENT_536	[p19l956t2857r1081b2894],
80	269	CD	NUMBER	269	num	82	SENT_536	[p19l1811t2856r1871b2886],
81	MULTIPLE	NNP	O	MULTIPLE	nn	82	SENT_536	[p19l428t2916r616b2948],
82	SCLEROSIS	NNS	O	sclerosis	pobj	68	SENT_536	[p19l629t2916r835b2954],
83	,	,	O	,	_	0	SENT_536	[p19l629t2916r835b2954],
84	B.	NNP	PERSON	B.	nn	86	SENT_536	[p19l847t2919r881b2948],
85	Mark	NNP	PERSON	Mark	nn	86	SENT_536	[p19l893t2918r985b2948],
86	Keegan	NNP	PERSON	Keegan	conj_and	82	SENT_536	[p19l994t2919r1117b2956],
87	and	CC	O	and	_	0	SENT_536	[p19l1129t2918r1192b2948],
88	John	NNP	PERSON	John	nn	90	SENT_536	[p19l1200t2918r1280b2948],
89	H.	NNP	PERSON	H.	nn	90	SENT_536	[p19l1290t2919r1329b2948],
90	Noseworthy	NNP	PERSON	Noseworthy	conj_and	82	SENT_536	[p19l1341t2918r1539b2956],
91	285	CD	NUMBER	285	dep	8	SENT_536	[p19l1811t2918r1870b2948],

1	v	LS	O	v	_	0	SENT_537	[p19l1852t3031r1871b3051],

1	Vi	NNP	PERSON	Vi	nn	2	SENT_538	[p19l418t3126r448b3156],
2	CONTENTS	NNP	O	CONTENTS	_	0	SENT_538	[p19l569t3129r760b3156],

1	GENE	NN	O	gene	nn	2	SENT_539	[p19l418t3251r520b3283],
2	EXPRESSION	NN	O	expression	nsubj	3	SENT_539	[p19l533t3252r759b3283],
3	PROFILING	VBG	O	profile	_	0	SENT_539	[p19l771t3252r967b3283],
4	OF	IN	O	of	_	0	SENT_539	[p19l980t3257r1025b3283],
5	LYMPHOID	JJ	O	lymphoid	amod	6	SENT_539	[p19l1037t3252r1232b3283],
6	MALIGNANCIES	NNS	O	malignancy	prep_of	3	SENT_539	[p19l1245t3252r1540b3289],
7	,	,	O	,	_	0	SENT_539	[p19l1245t3252r1540b3289],
8	Louis	NNP	PERSON	Louis	nn	10	SENT_539	[p19l461t3296r554b3325],
9	M.	NNP	PERSON	M.	nn	10	SENT_539	[p19l564t3296r607b3324],
10	Staudt	NNP	PERSON	Staudt	dep	13	SENT_539	[p19l621t3295r727b3325],
11	303	CD	NUMBER	303	num	13	SENT_539	[p19l1801t3295r1859b3325],
12	LIPOTOXIC	NNP	O	LIPOTOXIC	nn	13	SENT_539	[p19l417t3355r614b3387],
13	DISEASES	NNS	O	disease	ccomp	3	SENT_539	[p19l627t3355r813b3393],
14	,	,	O	,	_	0	SENT_539	[p19l627t3355r813b3393],
15	Roger	NNP	PERSON	Roger	nn	17	SENT_539	[p19l825t3358r928b3395],
16	H.	NNP	PERSON	H.	nn	17	SENT_539	[p19l936t3358r975b3387],
17	Unger	NNP	PERSON	Unger	dep	19	SENT_539	[p19l992t3358r1095b3395],
18	319	CD	NUMBER	319	num	19	SENT_539	[p19l1801t3357r1860b3387],
19	DIRECTIONS	NNPS	O	DIRECTIONS	ccomp	3	SENT_539	[p19l418t3417r639b3449],
20	OF	IN	O	of	_	0	SENT_539	[p19l653t3423r698b3449],
21	DRUG	NN	O	drug	nn	22	SENT_539	[p19l710t3417r819b3449],
22	DISCOVERY	NN	O	discovery	prep_of	19	SENT_539	[p19l832t3417r1045b3449],
23	IN	IN	O	in	_	0	SENT_539	[p19l1057t3423r1095b3449],
24	OSTEOPOROSIS	NNP	O	OSTEOPOROSIS	nn	27	SENT_539	[p19l1108t3417r1390b3455],
25	,	,	O	,	_	0	SENT_539	[p19l1108t3417r1390b3455],
26	Gregory	NNP	PERSON	Gregory	appos	27	SENT_539	[p19l1405t3420r1540b3457],
27	R	NNP	PERSON	R	prep_in	22	SENT_539	[p19l1550t3420r1575b3448],
28	.	.	O	.	_	0	SENT_539	[p19l1580t3444r1584b3449],

1	M	NN	O	m	dep	5	SENT_540	[p19l1596t3420r1633b3449],
2	undy	NN	O	undy	dep	1	SENT_540	[p19l1633t3419r1712b3457],
3	337	CD	NUMBER	337	dep	5	SENT_540	[p19l1801t3420r1860b3449],
4	EARLY	NNP	O	EARLY	nn	5	SENT_540	[p19l417t3480r544b3510],
5	MANAGEMENT	NNP	O	MANAGEMENT	dep	10	SENT_540	[p19l556t3480r827b3511],
6	OF	IN	O	of	_	0	SENT_540	[p19l840t3485r886b3511],
7	PROSTATE	NN	O	prostate	nn	8	SENT_540	[p19l897t3480r1087b3511],
8	CANCER	NNP	O	CANCER	prep_of	5	SENT_540	[p19l1100t3479r1262b3511],
9	:	:	O	:	_	0	SENT_540	[p19l1100t3479r1262b3511],
10	HOW	NNP	O	HOW	_	0	SENT_540	[p19l1283t3480r1375b3511],
11	To	TO	O	to	aux	12	SENT_540	[p19l1386t3485r1434b3511],
12	RESPOND	VB	O	respond	infmod	10	SENT_540	[p19l1447t3480r1618b3511],
13	TO	TO	O	to	xcomp	12	SENT_540	[p19l1631t3485r1678b3511],
14	AN	DT	O	a	det	16	SENT_540	[p19l463t3534r515b3560],
15	ELEVATED	JJ	O	elevated	amod	16	SENT_540	[p19l527t3528r720b3560],
16	PSA	NN	O	psa	dobj	13	SENT_540	[p19l733t3528r846b3566],
17	?	.	O	?	_	0	SENT_540	[p19l733t3528r846b3566],

1	,	,	O	,	_	0	SENT_541	[p19l733t3528r846b3566],
2	Eduardo	NNP	PERSON	Eduardo	nn	4	SENT_541	[p19l858t3530r1002b3560],
3	I.	NNP	PERSON	I.	nn	4	SENT_541	[p19l1012t3531r1035b3560],
4	Canto	NNP	PERSON	Canto	nn	11	SENT_541	[p19l1049t3531r1148b3560],
5	and	CC	O	and	_	0	SENT_541	[p19l1160t3530r1223b3560],
6	Kevin	NNP	PERSON	Kevin	nn	8	SENT_541	[p19l1232t3531r1326b3560],
7	M.	NNP	PERSON	M.	nn	8	SENT_541	[p19l1337t3531r1380b3560],
8	Slawin	NNP	PERSON	Slawin	conj_and	4	SENT_541	[p19l1393t3530r1505b3560],
9	355	CD	NUMBER	355	num	8	SENT_541	[p19l1801t3530r1859b3560],
10	RECENT	JJ	O	recent	amod	11	SENT_541	[p19l417t3591r565b3622],
11	ADVANCEMENTS	NNS	O	advancement	_	0	SENT_541	[p19l577t3590r882b3622],
12	IN	IN	O	in	_	0	SENT_541	[p19l896t3597r934b3622],
13	THE	DT	O	the	det	14	SENT_541	[p19l946t3597r1017b3621],
14	TREATMENT	NN	O	treatment	prep_in	11	SENT_541	[p19l1029t3591r1253b3622],
15	OF	IN	O	of	_	0	SENT_541	[p19l1266t3596r1312b3622],
16	CHRONIC	JJ	O	chronic	amod	18	SENT_541	[p19l1324t3590r1492b3622],
17	MYELOGENOUS	JJ	O	myelogenous	amod	18	SENT_541	[p19l463t3640r747b3672],
18	LEUKEMIA	NN	O	leukemia	prep_of	14	SENT_541	[p19l760t3640r966b3678],
19	,	,	O	,	_	0	SENT_541	[p19l760t3640r966b3678],
20	Michael	NNP	PERSON	Michael	nn	22	SENT_541	[p19l978t3642r1114b3672],
21	E.	NNP	PERSON	E.	nn	22	SENT_541	[p19l1124t3643r1158b3672],
22	o’Dwyer	NNP	PERSON	o’Dwyer	conj_and	18	SENT_541	[p19l1172t3642r1329b3680],
23	,	,	O	,	_	0	SENT_541	[p19l1172t3642r1329b3680],
24	Michael	NNP	PERSON	Michael	nn	26	SENT_541	[p19l1340t3642r1477b3672],
25	J.	NNP	PERSON	J.	nn	26	SENT_541	[p19l1486t3643r1512b3672],
26	Mauro	NNP	PERSON	Mauro	conj_and	18	SENT_541	[p19l1524t3643r1645b3676],
27	,	,	O	,	_	0	SENT_541	[p19l1524t3643r1645b3676],
28	and	CC	O	and	_	0	SENT_541	[p19l463t3683r526b3712],
29	Brian	NNP	PERSON	Brian	nn	31	SENT_541	[p19l534t3684r629b3712],
30	J.	NNP	PERSON	J.	nn	31	SENT_541	[p19l639t3684r665b3713],
31	Druker	NNP	PERSON	Druker	conj_and	18	SENT_541	[p19l677t3683r798b3713],
32	369	CD	NUMBER	369	dep	11	SENT_541	[p19l1801t3683r1860b3713],

1	Annu	NNP	PERSON	Annu	_	0	SENT_542	[p20l297t1087r320b1166],
2	.	.	O	.	_	0	SENT_542	[p20l297t1087r320b1166],

1	Rev.	NNP	O	Rev.	nn	2	SENT_543	[p20l297t1016r320b1076],
2	Med	NNP	O	Med	_	0	SENT_543	[p20l297t938r320b1006],
3	.	.	O	.	_	0	SENT_543	[p20l297t938r320b1006],

1	2	CD	NUMBER	2	_	0	SENT_544	[p20l297t912r320b927],
2	002.53:615	CD	NUMBER	002.53:615	number	3	SENT_544	[p20l297t667r320b885],
3	-627	CD	NUMBER	-627	num	1	SENT_544	[p20l297t667r320b885],
4	.	.	O	.	_	0	SENT_544	[p20l297t667r320b885],

1	Downloaded	VBN	O	download	_	0	SENT_545	[p20l297t486r320b656],
2	fror	NN	O	fror	nn	3	SENT_545	[p20l297t430r320b477],
3	n	NN	O	n	dobj	1	SENT_545	[p20l304t384r320b401],
4	www.annualreviews.org	VBG	O	www.annualreviews.org	partmod	3	SENT_545	[p20l297t51r327b374],
5	by	IN	O	by	_	0	SENT_545	[p20l330t1101r361b1133],
6	University	NNP	ORGANIZATION	University	agent	4	SENT_545	[p20l330t951r361b1091],
7	of	IN	ORGANIZATION	of	_	0	SENT_545	[p20l330t912r354b941],
8	Wisconsin	NNP	ORGANIZATION	Wisconsin	prep_of	6	SENT_545	[p20l330t740r354b880],
9	-	:	O	-	_	0	SENT_545	[p20l344t721r347b730],
10	Madison	NNP	O	Madison	dep	3	SENT_545	[p20l330t595r354b711],
11	on	IN	O	on	_	0	SENT_545	[p20l338t553r354b586],
12	01/05/14	CD	DATE	01/05/14	prep_on	10	SENT_545	[p20l330t430r354b544],
13	-	:	O	-	_	0	SENT_545	[p20l345t390r354b401],
14	.	.	O	.	_	0	SENT_545	[p20l345t390r354b401],

1	For	IN	O	for	_	0	SENT_546	[p20l331t333r354b380],
2	personal	JJ	O	personal	amod	3	SENT_546	[p20l330t213r361b325],
3	use	NN	O	use	pobj	1	SENT_546	[p20l338t160r354b204],
4	only	RB	O	only	advmod	3	SENT_546	[p20l330t86r361b151],
5	.	.	O	.	_	0	SENT_546	[p20l330t86r361b151],

1	SURGICAL	JJ	O	surgical	dep	249	SENT_547	[p20l419t21r603b53],
2	MANAGEMENT	NN	O	management	dep	249	SENT_547	[p20l616t22r887b53],
3	OF	IN	O	of	dep	249	SENT_547	[p20l900t27r945b53],
4	HEART	NN	O	heart	dep	249	SENT_547	[p20l957t22r1085b52],
5	FAILURE	NN	O	failure	dep	249	SENT_547	[p20l1097t22r1264b53],
6	:	:	O	:	_	0	SENT_547	[p20l1097t22r1264b53],
7	AN	DT	O	a	dep	249	SENT_547	[p20l1285t21r1344b53],
8	OVERVIEW	NN	O	overview	dep	249	SENT_547	[p20l1357t21r1564b59],
9	,	,	O	,	_	0	SENT_547	[p20l1357t21r1564b59],
10	David	NNP	PERSON	David	dep	249	SENT_547	[p20l461t73r565b102],
11	Zeltsman	NNP	PERSON	Zeltsman	dep	249	SENT_547	[p20l574t73r726b102],
12	and	CC	O	and	dep	249	SENT_547	[p20l738t73r801b102],
13	Michael	NNP	PERSON	Michael	dep	249	SENT_547	[p20l809t73r945b102],
14	A.	NNP	PERSON	A.	dep	249	SENT_547	[p20l954t73r988b102],
15	Acker	NNP	PERSON	Acker	dep	249	SENT_547	[p20l1000t73r1098b102],
16	NEPHRON-SPARING	NNP	O	NEPHRON-SPARING	dep	249	SENT_547	[p20l417t133r772b164],
17	SURGERY	NNP	O	SURGERY	dep	249	SENT_547	[p20l786t133r958b164],
18	FOR	IN	O	for	dep	249	SENT_547	[p20l971t139r1041b164],
19	RENAL	JJ	O	renal	dep	249	SENT_547	[p20l1053t133r1180b164],
20	CELL	NN	O	cell	dep	249	SENT_547	[p20l1193t133r1289b164],
21	CARCINOMA	NN	O	carcinoma	dep	249	SENT_547	[p20l1302t133r1540b170],
22	,	,	O	,	_	0	SENT_547	[p20l1302t133r1540b170],
23	Andrew	NNP	PERSON	Andrew	dep	249	SENT_547	[p20l461t185r589b214],
24	C.	NNP	PERSON	C.	dep	249	SENT_547	[p20l601t185r635b215],
25	Novick	NNP	PERSON	Novick	dep	249	SENT_547	[p20l647t185r763b214],
26	THE	DT	O	the	dep	249	SENT_547	[p20l417t245r493b276],
27	MECHANISMS	NNS	O	mechanism	dep	249	SENT_547	[p20l504t245r753b276],
28	OF	IN	O	of	dep	249	SENT_547	[p20l766t251r811b276],
29	ACTION	NNP	O	ACTION	dep	249	SENT_547	[p20l822t245r965b276],
30	OF	IN	O	of	dep	249	SENT_547	[p20l977t251r1022b276],
31	PPARS	NNP	LOCATION	PPARS	dep	249	SENT_547	[p20l1032t245r1172b282],
32	,	,	O	,	_	0	SENT_547	[p20l1032t245r1172b282],
33	Joel	NNP	PERSON	Joel	dep	249	SENT_547	[p20l1182t247r1252b277],
34	Berger	NNP	PERSON	Berger	dep	249	SENT_547	[p20l1258t248r1373b285],
35	and	CC	O	and	dep	249	SENT_547	[p20l1380t247r1442b276],
36	David	NNP	PERSON	David	dep	249	SENT_547	[p20l1447t247r1551b276],
37	E.	NNP	PERSON	E.	dep	249	SENT_547	[p20l1556t248r1590b276],
38	Moller	NNP	PERSON	Moller	dep	249	SENT_547	[p20l1598t247r1713b276],
39	CANCER	NNP	O	CANCER	dep	249	SENT_547	[p20l418t306r571b339],
40	GENE	NNP	O	GENE	dep	249	SENT_547	[p20l584t306r686b339],
41	THERAPY	NNP	O	THERAPY	dep	249	SENT_547	[p20l698t307r881b338],
42	:	:	O	:	_	0	SENT_547	[p20l698t307r881b338],
43	SCIENTIFIC	NNP	O	SCIENTIFIC	dep	249	SENT_547	[p20l903t306r1103b339],
44	BASIS	NNP	O	BASIS	dep	249	SENT_547	[p20l1116t307r1234b344],
45	,	,	O	,	_	0	SENT_547	[p20l1116t307r1234b344],
46	Pnnit	NNP	PERSON	Pnnit	dep	249	SENT_547	[p20l1247t310r1338b338],
47	D.	NNP	PERSON	D.	dep	249	SENT_547	[p20l1347t310r1385b338],
48	Wadhwa	NNP	PERSON	Wadhwa	dep	249	SENT_547	[p20l1400t309r1548b343],
49	,	,	O	,	_	0	SENT_547	[p20l1400t309r1548b343],
50	Steven	NNP	PERSON	Steven	dep	249	SENT_547	[p20l463t359r569b389],
51	P.	NNP	PERSON	P.	dep	249	SENT_547	[p20l579t360r607b388],
52	Zielske	NNP	PERSON	Zielske	dep	249	SENT_547	[p20l619t359r745b393],
53	,	,	O	,	_	0	SENT_547	[p20l619t359r745b393],
54	Justin	NNP	PERSON	Justin	dep	249	SENT_547	[p20l756t360r854b389],
55	C.	NNP	PERSON	C.	dep	249	SENT_547	[p20l866t360r900b389],
56	Roth	NNP	PERSON	Roth	dep	249	SENT_547	[p20l911t359r1000b393],
57	,	,	O	,	_	0	SENT_547	[p20l911t359r1000b393],
58	Christopher	NNP	PERSON	Christopher	dep	249	SENT_547	[p20l1013t359r1213b397],
59	B.	NNP	PERSON	B.	dep	249	SENT_547	[p20l1221t360r1255b388],
60	Ballas	NNP	PERSON	Ballas	dep	249	SENT_547	[p20l1267t359r1382b393],
61	,	,	O	,	_	0	SENT_547	[p20l1267t359r1382b393],
62	Janice	NNP	PERSON	Janice	dep	249	SENT_547	[p20l1393t360r1500b389],
63	E.	NNP	PERSON	E.	dep	249	SENT_547	[p20l1510t360r1544b388],
64	Bowman	NNP	PERSON	Bowman	dep	249	SENT_547	[p20l1555t360r1710b393],
65	,	,	O	,	_	0	SENT_547	[p20l1555t360r1710b393],
66	and	CC	O	and	dep	249	SENT_547	[p20l463t438r526b467],
67	Stanton	NNP	PERSON	Stanton	dep	249	SENT_547	[p20l536t438r661b468],
68	L.	NNP	PERSON	L.	dep	249	SENT_547	[p20l671t439r703b467],
69	Gerson	NNP	PERSON	Gerson	dep	249	SENT_547	[p20l717t439r837b468],
70	ISCHEMIC	NNP	O	ISCHEMIC	dep	249	SENT_547	[p20l418t499r593b530],
71	STROKE	NNP	O	STROKE	dep	249	SENT_547	[p20l608t498r752b530],
72	THERAPY	NNP	O	THERAPY	dep	249	SENT_547	[p20l765t499r947b536],
73	,	,	O	,	_	0	SENT_547	[p20l765t499r947b536],
74	C.	NNP	PERSON	C.	dep	249	SENT_547	[p20l962t501r996b530],
75	Stapfand	NNP	PERSON	Stapfand	dep	249	SENT_547	[p20l1009t501r1168b538],
76	J.	NNP	PERSON	J.	dep	249	SENT_547	[p20l1176t502r1202b530],
77	P.	NNP	PERSON	P.	dep	249	SENT_547	[p20l1215t502r1243b530],
78	Mohr	NNP	PERSON	Mohr	dep	249	SENT_547	[p20l1255t501r1349b530],
79	THE	DT	O	the	dep	249	SENT_547	[p20l417t561r493b592],
80	PATHOPHYSIOLOGY	NN	O	pathophysiology	dep	249	SENT_547	[p20l505t561r863b592],
81	OF	IN	O	of	dep	249	SENT_547	[p20l876t567r921b592],
82	ASTHMA	NNP	O	ASTHMA	dep	249	SENT_547	[p20l933t561r1103b598],
83	,	,	O	,	_	0	SENT_547	[p20l933t561r1103b598],
84	Lee	NNP	PERSON	Lee	dep	249	SENT_547	[p20l1114t564r1174b592],
85	Maddox	NNP	PERSON	Maddox	dep	249	SENT_547	[p20l1184t563r1322b592],
86	and	CC	O	and	dep	249	SENT_547	[p20l1332t563r1395b592],
87	David	NNP	PERSON	David	dep	249	SENT_547	[p20l1402t563r1506b592],
88	A.	NNP	PERSON	A.	dep	249	SENT_547	[p20l1513t564r1548b592],
89	Schwartz	NNP	PERSON	Schwartz	dep	249	SENT_547	[p20l1561t563r1712b593],
90	VIRAL	NN	O	viral	dep	249	SENT_547	[p20l418t623r532b655],
91	PERSISTENCE2	NN	O	persistence2	dep	249	SENT_547	[p20l544t623r796b655],
92	I	PRP	O	I	dep	249	SENT_547	[p20l816t623r928b655],
93	'	''	O	'	_	0	SENT_547	[p20l816t623r928b655],
94	IIV	NN	O	iiv	dep	249	SENT_547	[p20l816t623r928b655],
95	’S	NN	O	’s	dep	249	SENT_547	[p20l816t623r928b655],
96	STRATEGIES	NNS	O	strategy	dep	249	SENT_547	[p20l943t623r1163b655],
97	OF	IN	O	of	dep	249	SENT_547	[p20l1177t629r1223b655],
98	IMMUNE	NNP	O	IMMUNE	dep	249	SENT_547	[p20l1235t623r1389b655],
99	SYSTEM	NNP	O	SYSTEM	dep	249	SENT_547	[p20l1403t623r1550b655],
100	EVASION	NNP	O	EVASION	dep	249	SENT_547	[p20l463t673r637b710],
101	,	,	O	,	_	0	SENT_547	[p20l463t673r637b710],
102	Welkin	NNP	PERSON	Welkin	dep	249	SENT_547	[p20l651t675r761b705],
103	E.	NNP	PERSON	E.	dep	249	SENT_547	[p20l771t676r805b704],
104	Johnson	NNP	PERSON	Johnson	dep	249	SENT_547	[p20l816t675r955b705],
105	and	CC	O	and	dep	249	SENT_547	[p20l966t675r1029b704],
106	Ronald	NNP	PERSON	Ronald	dep	249	SENT_547	[p20l1037t675r1160b704],
107	C.	NNP	PERSON	C.	dep	249	SENT_547	[p20l1170t676r1204b705],
108	Desrosiers	NNP	PERSON	Desrosiers	dep	249	SENT_547	[p20l1216t676r1394b704],
109	BREAST	NNP	O	BREAST	dep	249	SENT_547	[p20l418t736r563b767],
110	CANCER	NNP	O	CANCER	dep	249	SENT_547	[p20l576t735r728b767],
111	RISK	NN	O	risk	dep	249	SENT_547	[p20l741t736r829b767],
112	REDUCTIONZ	NN	O	reductionz	dep	249	SENT_547	[p20l841t736r1067b767],
113	STRATEGIES	NNS	O	strategy	dep	249	SENT_547	[p20l1089t735r1309b767],
114	FOR	IN	O	for	dep	249	SENT_547	[p20l1323t741r1393b767],
115	WOMEN	NNP	O	WOMEN	dep	249	SENT_547	[p20l1405t736r1552b767],
116	AT	IN	O	at	dep	249	SENT_547	[p20l1564t741r1612b767],
117	INCREASED	NNP	O	INCREASED	dep	249	SENT_547	[p20l463t786r670b817],
118	RISK	NN	O	risk	dep	249	SENT_547	[p20l682t786r781b823],
119	,	,	O	,	_	0	SENT_547	[p20l682t786r781b823],
120	Rowan	NNP	PERSON	Rowan	dep	249	SENT_547	[p20l793t789r909b818],
121	T.	NNP	PERSON	T.	dep	249	SENT_547	[p20l921t789r947b817],
122	Chlebowski	NNP	PERSON	Chlebowski	dep	249	SENT_547	[p20l962t788r1154b818],
123	POTENTIAL	NNP	O	POTENTIAL	dep	249	SENT_547	[p20l417t848r623b879],
124	NEW	NNP	O	NEW	dep	249	SENT_547	[p20l631t848r719b879],
125	THERAPIES	NNP	O	THERAPIES	dep	249	SENT_547	[p20l727t848r927b879],
126	FOR	IN	O	for	dep	249	SENT_547	[p20l937t854r1008b879],
127	THE	DT	O	the	dep	249	SENT_547	[p20l1016t854r1086b879],
128	TREATMENT	NN	O	treatment	dep	249	SENT_547	[p20l1095t848r1319b879],
129	OF	IN	O	of	dep	249	SENT_547	[p20l1328t854r1374b879],
130	HIV-1	NN	O	hiv-1	dep	249	SENT_547	[p20l1382t848r1491b879],
131	INFECTION	NN	O	infection	dep	249	SENT_547	[p20l1504t848r1709b885],
132	,	,	O	,	_	0	SENT_547	[p20l1504t848r1709b885],
133	Jon	NNP	PERSON	Jon	dep	249	SENT_547	[p20l461t926r520b955],
134	H.	NNP	PERSON	H.	dep	249	SENT_547	[p20l530t926r569b954],
135	Condra	NNP	PERSON	Condra	dep	249	SENT_547	[p20l584t925r717b959],
136	,	,	O	,	_	0	SENT_547	[p20l584t925r717b959],
137	Michael	NNP	PERSON	Michael	dep	249	SENT_547	[p20l728t925r865b955],
138	D.	NNP	PERSON	D.	dep	249	SENT_547	[p20l874t926r913b954],
139	Miller	NNP	PERSON	Miller	dep	249	SENT_547	[p20l925t925r1034b959],
140	,	,	O	,	_	0	SENT_547	[p20l925t925r1034b959],
141	Daria	NNP	PERSON	Daria	dep	249	SENT_547	[p20l1045t926r1144b955],
142	J.	NNP	PERSON	J.	dep	249	SENT_547	[p20l1154t926r1181b955],
143	Hazuda	NNP	PERSON	Hazuda	dep	249	SENT_547	[p20l1193t925r1331b959],
144	,	,	O	,	_	0	SENT_547	[p20l1193t925r1331b959],
145	and	CC	O	and	dep	249	SENT_547	[p20l1344t925r1407b955],
146	Emilio	NNP	PERSON	Emilio	dep	249	SENT_547	[p20l1416t925r1526b955],
147	A.	NNP	PERSON	A.	dep	249	SENT_547	[p20l1536t926r1570b954],
148	Emini	NNP	PERSON	Emini	dep	249	SENT_547	[p20l1583t926r1683b955],
149	THE	DT	O	the	dep	249	SENT_547	[p20l417t986r493b1016],
150	CHALLENGE	NN	O	challenge	dep	249	SENT_547	[p20l506t985r730b1017],
151	OF	IN	O	of	dep	249	SENT_547	[p20l743t991r788b1017],
152	VIRAL	JJ	O	viral	dep	249	SENT_547	[p20l800t986r915b1017],
153	RESERVOIRS	NNS	O	reservoir	dep	249	SENT_547	[p20l927t986r1153b1017],
154	IN	IN	O	in	dep	249	SENT_547	[p20l1167t992r1205b1017],
155	HIV-1	NN	O	hiv-1	dep	249	SENT_547	[p20l1217t985r1327b1017],
156	INFECTION	NN	O	infection	dep	249	SENT_547	[p20l1343t986r1548b1023],
157	,	,	O	,	_	0	SENT_547	[p20l1343t986r1548b1023],
158	Joel	NNP	PERSON	Joel	dep	249	SENT_547	[p20l461t1038r531b1067],
159	N.	NNP	PERSON	N.	dep	249	SENT_547	[p20l539t1038r576b1067],
160	Blankson	NNP	PERSON	Blankson	dep	249	SENT_547	[p20l588t1037r752b1071],
161	,	,	O	,	_	0	SENT_547	[p20l588t1037r752b1071],
162	Deborah	NNP	PERSON	Deborah	dep	249	SENT_547	[p20l763t1038r911b1067],
163	Persaud	NNP	PERSON	Persaud	dep	249	SENT_547	[p20l921t1037r1065b1071],
164	,	,	O	,	_	0	SENT_547	[p20l921t1037r1065b1071],
165	and	CC	O	and	dep	249	SENT_547	[p20l1078t1037r1141b1067],
166	Robert	NNP	PERSON	Robert	dep	249	SENT_547	[p20l1149t1038r1264b1067],
167	F.	NNP	PERSON	F.	dep	249	SENT_547	[p20l1273t1038r1301b1067],
168	Siliciano	NNP	PERSON	Siliciano	dep	249	SENT_547	[p20l1315t1037r1461b1067],
169	RATIONAL	NNP	O	RATIONAL	dep	249	SENT_547	[p20l417t1098r609b1129],
170	APPROACH	NNP	O	APPROACH	dep	249	SENT_547	[p20l622t1098r822b1129],
171	TO	TO	O	to	dep	249	SENT_547	[p20l834t1104r882b1129],
172	AIDS	NNP	MISC	AIDS	dep	249	SENT_547	[p20l895t1098r998b1130],
173	DRUG	NN	O	drug	dep	249	SENT_547	[p20l1013t1098r1122b1129],
174	DESIGN	NN	O	design	dep	249	SENT_547	[p20l1134t1098r1274b1129],
175	THROUGH	IN	O	through	dep	249	SENT_547	[p20l1286t1098r1469b1129],
176	STRUCTURAL	JJ	O	structural	dep	249	SENT_547	[p20l464t1146r707b1178],
177	BIOLOGY	NN	O	biology	dep	249	SENT_547	[p20l719t1147r899b1184],
178	,	,	O	,	_	0	SENT_547	[p20l719t1147r899b1184],
179	Alexander	NNP	PERSON	Alexander	dep	249	SENT_547	[p20l910t1149r1082b1178],
180	Wlodawer	NNP	PERSON	Wlodawer	dep	249	SENT_547	[p20l1093t1149r1263b1179],
181	MECHANISMS	NNPS	O	MECHANISMS	dep	249	SENT_547	[p20l418t1209r666b1241],
182	OF	IN	O	of	dep	249	SENT_547	[p20l681t1215r727b1241],
183	CANCER	NNP	O	CANCER	dep	249	SENT_547	[p20l739t1209r892b1241],
184	DRUG	NN	O	drug	dep	249	SENT_547	[p20l905t1209r1014b1241],
185	RESISTANCE	NN	O	resistance	dep	249	SENT_547	[p20l1026t1209r1262b1247],
186	,	,	O	,	_	0	SENT_547	[p20l1026t1209r1262b1247],
187	Michael	NNP	PERSON	Michael	dep	249	SENT_547	[p20l1275t1211r1411b1241],
188	M.	NNP	PERSON	M.	dep	249	SENT_547	[p20l1420t1212r1464b1241],
189	Gottesman	NNP	PERSON	Gottesman	dep	249	SENT_547	[p20l1478t1212r1656b1241],
190	THALIDOMIDE	NNP	O	THALIDOMIDE	dep	249	SENT_547	[p20l417t1272r687b1303],
191	:	:	O	:	_	0	SENT_547	[p20l417t1272r687b1303],
192	EMERGING	NNP	O	EMERGING	dep	249	SENT_547	[p20l708t1272r904b1303],
193	ROLE	NNP	O	ROLE	dep	249	SENT_547	[p20l917t1272r1017b1303],
194	IN	IN	O	in	dep	249	SENT_547	[p20l1030t1278r1068b1303],
195	CANCER	NNP	O	CANCER	dep	249	SENT_547	[p20l1081t1271r1233b1303],
196	MEDICINE	NNP	O	MEDICINE	dep	249	SENT_547	[p20l1246t1272r1441b1309],
197	,	,	O	,	_	0	SENT_547	[p20l1246t1272r1441b1309],
198	Paul	NNP	PERSON	Paul	dep	249	SENT_547	[p20l462t1315r538b1345],
199	Richardson	NNP	PERSON	Richardson	dep	249	SENT_547	[p20l546t1315r746b1349],
200	,	,	O	,	_	0	SENT_547	[p20l546t1315r746b1349],
201	Tern	NNP	O	Tern	dep	249	SENT_547	[p20l759t1316r832b1345],
202	H	NNP	O	H	dep	249	SENT_547	[p20l842t1316r874b1344],
203	ideshima	NN	O	ideshima	dep	249	SENT_547	[p20l875t1315r1031b1349],
204	,	,	O	,	_	0	SENT_547	[p20l875t1315r1031b1349],
205	and	CC	O	and	dep	249	SENT_547	[p20l1044t1315r1107b1345],
206	Kenneth	NNP	PERSON	Kenneth	dep	249	SENT_547	[p20l1116t1315r1252b1345],
207	Anderson	NNP	PERSON	Anderson	dep	249	SENT_547	[p20l1262t1315r1422b1345],
208	INDE	NNP	O	INDE	dep	249	SENT_547	[p20l417t1394r572b1425],
209	}	VBD	O	}	dep	249	SENT_547	[p20l417t1394r572b1425],
210	G3S	CD	NUMBER	g3s	dep	249	SENT_547	[p20l417t1394r572b1425],
211	Subject	NNP	MISC	Subject	dep	249	SENT_547	[p20l460t1445r583b1483],
212	Index	NNP	MISC	Index	dep	249	SENT_547	[p20l594t1445r687b1474],
213	Cumulative	NNP	MISC	Cumulative	dep	249	SENT_547	[p20l460t1495r650b1525],
214	Index	NNP	MISC	Index	dep	249	SENT_547	[p20l661t1495r754b1525],
215	of	IN	MISC	of	dep	249	SENT_547	[p20l766t1495r802b1525],
216	Contributing	VBG	MISC	contribute	dep	249	SENT_547	[p20l811t1495r1021b1533],
217	Authors	NNS	MISC	author	dep	249	SENT_547	[p20l1032t1495r1174b1530],
218	,	,	MISC	,	_	0	SENT_547	[p20l1032t1495r1174b1530],
219	Volumes	NNS	MISC	volume	dep	249	SENT_547	[p20l1187t1495r1330b1525],
220	49-53	CD	NUMBER	49-53	dep	249	SENT_547	[p20l1342t1495r1443b1525],
221	Cumulative	NNP	MISC	Cumulative	dep	249	SENT_547	[p20l460t1544r650b1574],
222	Index	NNP	MISC	Index	dep	249	SENT_547	[p20l661t1544r754b1573],
223	of	IN	MISC	of	dep	249	SENT_547	[p20l766t1544r802b1573],
224	Chapter	NNP	MISC	Chapter	dep	249	SENT_547	[p20l811t1545r942b1582],
225	Titles	NNP	MISC	Titles	dep	249	SENT_547	[p20l953t1544r1054b1579],
226	,	,	O	,	_	0	SENT_547	[p20l953t1544r1054b1579],
227	Volumes	NNP	O	Volumes	dep	249	SENT_547	[p20l1067t1544r1209b1573],
228	49-5	CD	NUMBER	49-5	dep	249	SENT_547	[p20l1221t1544r1302b1574],
229	3	CD	NUMBER	3	dep	249	SENT_547	[p20l1306t1545r1322b1574],
230	ERRATA	NNP	O	ERRATA	dep	249	SENT_547	[p20l417t1605r568b1636],
231	An	DT	O	a	dep	249	SENT_547	[p20l459t1657r509b1686],
232	online	NN	O	online	dep	249	SENT_547	[p20l521t1657r622b1687],
233	log	NN	O	log	dep	249	SENT_547	[p20l634t1657r686b1695],
234	of	IN	O	of	dep	249	SENT_547	[p20l698t1657r734b1687],
235	corrections	NNS	O	correction	dep	249	SENT_547	[p20l743t1657r925b1687],
236	to	TO	O	to	dep	249	SENT_547	[p20l938t1662r968b1687],
237	Annual	JJ	SET	annual	dep	249	SENT_547	[p20l978t1657r1100b1687],
238	Review	NN	O	review	dep	249	SENT_547	[p20l1109t1658r1228b1687],
239	of	IN	O	of	dep	249	SENT_547	[p20l1240t1657r1277b1695],
240	Medicine	NNP	O	Medicine	dep	249	SENT_547	[p20l1281t1657r1435b1687],
241	chapters	NNS	O	chapter	dep	249	SENT_547	[p20l459t1707r595b1745],
242	may	MD	O	may	dep	249	SENT_547	[p20l608t1716r678b1745],
243	be	VB	O	be	dep	249	SENT_547	[p20l689t1707r727b1736],
244	found	VBN	O	find	dep	249	SENT_547	[p20l739t1707r835b1736],
245	at	IN	O	at	dep	249	SENT_547	[p20l847t1712r876b1736],
246	http2	NN	O	http2	dep	249	SENT_547	[p20l886t1707r1578b1745],
247	/	:	O	/	dep	249	SENT_547	[p20l886t1707r1578b1745],
248	/	:	O	/	dep	249	SENT_547	[p20l886t1707r1578b1745],
249	med.annualreviews.org/errata.shtm1	NN	O	med.annualreviews.org/errata.shtm1	_	0	SENT_547	[p20l886t1707r1578b1745],

